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SUMMARY 
Background: 
Blinding diseases like retinitis pigmentosa (RP) or age-related macular 
degeneration (AMD) share a common feature – the loss of vision due to photoreceptor 
cell death. To mimic the pathogenesis of retinal degeneration, we employ a model of 
light-induced retinal degeneration, where photoreceptors undergo apoptosis after 
extensive exposure to white fluorescent light. 
Among several neuroprotective strategies to inhibit or delay neuronal 
degeneration, hypoxic preconditioning has been shown to successfully prevent 
photoreceptor cell death. The molecular mechanisms, which are required for retinal cell 
survival, are largely unknown. However, hypoxia activates various transcription factors, 
which differentially regulate the expression level of potential neuroprotective genes. 
Among those transcription factors, hypoxia-inducible factor 1 (HIF-1) responds very 
specifically to low oxygen levels and alters the gene expression pattern during hypoxia. 
HIF-1 is a heterodimeric transcription factor, consisting of the constitutively expressed 
subunit HIF-1β and the oxygen dependent regulated subunit HIF-1α. Upon oxygen 
deprivation HIF-1α is stabilized, dimerizes with HIF-1β and regulates the expression of 
genes involved in different pathways like metabolism, angiogenesis or cell survival. 
Although studies show a correlation of HIF-1α induction and neuroprotection, the role 
of HIF-1α in retinal neuroprotection after hypoxic preconditioning remains unknown. 
Here, we analyzed the function of retinal HIF-1α stabilization during hypoxic 
preconditioning and its impact on neuroprotection in a model of light induced retinal 
degeneration. Additionally, we investigated the change of retinal gene expression 
pattern due to hypoxic preconditioning to identify possible neuroprotective target 
genes. 
Results: 
To analyze differential gene expression after hypoxic exposure, we isolated 
retinas of mice immediately, 2 hours, 4 hours and 16 hours after hypoxia and 
compared their retinal transcriptome to their corresponding normoxic controls by using 
micro-arrays. Upon hypoxia, we observed a rapid alteration in the retinal transcriptome, 
which was restored within 16 hours of reoxygenation. A strong induction of cyclin-
dependent kinase inhibitor 1a, with a potential role in cell survival, was observed. We 
challenged hypoxic preconditioned p21 knock out mice with toxic levels of white light 
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and showed that p21 expression is not essential to protect the retina against light-
induced retinal degeneration. Selective clustering of differentially regulated genes 
suggested additional potential neuroprotective candidate genes like metallothionein1/2, 
Cebpd or adrenomedullin. 
Further, we used conditional HIF-1α knock out mice to elucidate the role of this 
transcription factor in retinal neuroprotection after hypoxia. The specific deletion of HIF-
1α in photoreceptor cells led to a significant reduction of HIF-1α mRNA and protein 
levels. Accordingly, HIF-1 target gene expression after hypoxia was significantly 
diminished. Surprisingly, the strong neuroprotective effect of hypoxic preconditioning 
persisted in conditional knock out mice showing that HIF-1α is not required to protect 
photoreceptor cells in an autocrine fashion. Additionally, HIF-1α was not required to 
endure hypoxic preconditioning per se. Induction of HIF-2α and pSTAT3 in wild type 
and in knock out mice suggests that these factors might compensate for the lack of 
HIF-1α and confer photoreceptor resistance to light damage after hypoxic 
preconditioning. Furthermore, several potentially neuroprotective genes, detected 
during micro-array analyses of the hypoxic retinal transcriptome, were similarly induced 
in knock out and control mice after hypoxia. 
Conclusion:  
The mechanisms of retinal neuroprotection due to hypoxic preconditioning are largely 
unknown. The discovery of pathways, transcription factors or specific genes which are 
required to facilitate retinal neuroprotection should help to understand molecular 
changes in retinal pathology. Controlling the expression of identified neuroprotective 
genes or upstream transcription factors, which govern death or survival pathways, 
provides a possibility to precisely design prospective therapeutic approaches. This 
study presents an overview of genes, which are differentially regulated in the retina 
after hypoxia and suggests potential target genes for further investigation. Additionally, 
we analyzed the role of HIF-1α and it’s involvement in retinal neuroprotection by 
hypoxic preconditioning. We showed that the photoreceptor cell-specific stabilization of 
HIF-1α during hypoxic preconditioning is not required to protect these cells against 
toxic light exposure. Therefore, we discuss the potential role of further transcription 
factors like HIF-2α and STAT3. 
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ZUSAMMENFASSUNG 
Hintergrund: 
Alters-abhängige Makula Degeneration (AMD) und Retinitis Pigmentosa (RP) 
sind Netzhauterkrankungen, die durch den Verlust von Photorezeptorzellen zu einer 
Beeinträchtigung des Sehvermögens bzw. zur vollständigen Blindheit führen. Um die 
pathologischen Veränderungen in der erkrankten Netzhaut zu simulieren, verwenden 
wir ein etabliertes Maus-Modell in dem der Zelltod von Photorezeptoren durch Licht 
induziert wird. 
Neuroprotektion ist eine Strategie, um die Degeneration von Neuronen zu 
verzögern oder vollständig zu inhibieren. Dabei hat sich gezeigt, dass hypoxisches 
Präkonditionieren – also eine zeitlich begrenzte artifizielle Reduktion der Sauerstoff-
verfügbarkeit – besonders erfolgreich ist. Die Mechanismen, die zu einer 
Schutzreaktion in der Netzhaut führen, sind jedoch weitgehend unbekannt. Allerdings 
weiss man, dass während der Hypoxie eine Reihe von Transkriptionsfaktoren aktiviert 
wird die potentielle neuroprotektive Gene differentiell regulieren. Ein solcher 
Transkriptionsfaktor ist hypoxic-inducible factor 1 (HIF-1), der sehr spezifisch durch 
einen geringen Sauerstoffgehalt aktiviert wird und die Expression mehrer Gene 
reguliert. HIF-1 ist ein Heterodimer, dass aus einer kontinuierlich exprimierten HIF-1β 
Untereinheit und einer Sauerstoff-abhängig regulierten HIF-1α Untereinheit besteht. 
Bei geringen Sauerstoffkonzentrationen wird die HIF-1α Untereinheit stabilisiert, 
dimerisiert mit HIF-1β und reguliert die Expression von Genen mit unterschiedlichen 
zell-biologischen Funktionen, wie z.B. Energiemetabolismus, Entwicklung von 
Blutgefässen oder die Induktion von Zellprotektion. Einige Studien haben Hinweise 
geliefert, dass HIF-1α die treibende Kraft der Netzhautprotektion nach hypoxischen 
Präkonditionieren sein könnte. Jedoch ist ein HIF-1α abhängiger Schutzmechanismus 
in der Netzhaut noch nicht vollständig bewiesen worden. Daher haben wir untersucht, 
ob eine Photorezeptor-spezifische Stabiliserung von HIF-1α während der Hypoxie 
benötigt wird, um die Netzhaut vor einer Licht-induzierten Degeneration zu schützen. 
Ausserdem, haben wir mit Hilfe von Micro-arrays die globale Genexpression in der 
Netzhaut nach hypoxischen Präkonditionieren untersucht, um mögliche 
neuroprotektive Kandidatengene zu indentifizieren. 
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Ergebnisse: 
Um die globale Genexpression in der Netzhaut nach hypoxischen 
Präkonditionieren zu analysieren, haben wir Mäuse einer reduzierten 
Sauerstoffkonzentration ausgesetzt. Anschliessend haben wir Netzhäute direkt oder 2 
Stunden, 4 Stunden und 16 Stunden nach Hypoxie isoliert und die Genexpression mit 
unbehandelten Kontrolltieren verglichen. Dabei haben wir festgestellt, dass es während 
der Hypoxie zu einer starken Veränderung der Genexpression in der Netzhaut kommt, 
die sich jedoch innerhalb von 16 Stunden wieder normalisiert. Die Genexpression von 
Cyclin-dependent kinase inhibitor 1a (p21), welcher möglicherweise protektive 
Eigenschaften besitzt, war direkt nach der Hypoxie stark induziert. Um zu überprüfen 
ob p21 tatsächlich eine Rolle bei der Netzhautprotektion spielen könnte, haben wir 
hypoxisch präkonditionierte p21 “knock out” Mäuse gegen Licht exponiert. Dabei 
haben wir festgestellt, dass der Hypoxie-induzierte Schutz der Netzhaut unabhängig 
von einer p21 Expression funktionieren kann. Durch die funktionelle Gruppierung von 
differentiell regulierten Genen konnten wir weitere mögliche Kandidaten wie 
Metallothionein 1/2, Cebpd oder Adrenomedullin identifizieren. 
Um festzustellen, ob HIF-1α tatsächlich essentiell für die Protektion der Netzhaut 
ist, haben wir Mäuse mit einem Photorezeptor-spezifischen HIF-1α knock out 
analysiert. Funktionell führte das sowohl zu einer reduzierten HIF-1α Genexpression in 
der Retina als auch zu einer reduzierten Proteinakkumulation der HIF-1α Untereinheit 
unter hypoxischen Bedingungen. Dementsprechend waren nach der Hypoxie auch 
Gene, die durch HIF-1 reguliert werden, weniger stark induziert. Nachdem wir 
hypoxisch präkonditionierte HIF-1α knock out Mäuse mit hohen Lichtintensitäten 
gestresst haben, zeigte sich, dass eine HIF-1α Stabilisierung in Photorezeptoren nicht 
zwingend notwendig ist, um eine Neuroprotektion zu gewährleisten. Ausserdem war 
eine Photorezeptor-spezifische HIF-1α Expression nicht erforderlich, um die Netzhaut 
vor transienter Hypoxie per se zu schützen. Die Induktion von HIF-2α und pSTAT3 in 
knock out und Kontrollmäusen könnte ein Hinweis darauf sein, dass diese Faktoren 
den Verlust von HIF-1α kompensieren können und somit die Netzhaut weiterhin gegen 
Lichtschaden schützen. Zusätzlich haben wir beobachtet, dass potentiell 
neuroprotektive Gene in HIF-1α knock out Mäusen und in Kontrollmäusen vergleichbar 
exprimiert wurden. 
Signifikanz: 
Die grundlegeneden Mechanismen, welche die Netzhaut durch hypoxisches 
Präkonditionieren schützen, sind nicht komplett aufgeklärt. Die Identifizerung von 
Signalwegen, von Transkriptionsfaktoren oder von spezifischen Genen, die für einen 
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Schutz der Netzhaut essentiell sind, könnte ebenfalls Aufschluss über grundlegende 
pathologische Veränderungen in Modellen für Netzhauterkrankungen geben. Die 
Kontrolle der Expression von identifizierten Genen bzw. die Kontrolle von 
Transkriptionsfaktoren mit nachgewiesenen Schutzeigenschaften bietet die Möglichkeit 
einer therapeutischen Strategie, um Netzhauterkrankung einzuschränken oder zu 
verhindern. In unserer Studie geben wir einerseits einen generellen Überblick über 
Gene die durch hypoxisches Präkonditionieren differentiell reguliert werden und haben 
andererseits spezifische Kandidaten-Gene mit potentiell neuroprotektiven 
Eigenschaften identifiziert. Nachdem wir mit p21 bereits einen ersten Kandidaten 
selbst analysiert haben, stellt diese Studie weitere Proteine oder Gene zur detaillierten 
Analyse zur Verfügung. Weiterhin haben wir gezeigt, dass eine Photorezeptor-
spezifische Expression von HIF-1α nicht zwingend notwendig ist, um Photorezeptoren 
gegen toxische Lichtintensitäten zuschützen. In diesem Zusammenhang diskutieren 
wir die mögliche Beteiligung von anderen Transkriptionsfaktoren wie HIF-2α und 
pSTAT3. 
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1 INTRODUCTION 
 
1.1 The Retina 
1.1.1 Architecture of the Retina 
The retina is a heterogeneous neuronal tissue, which lines the inside of the 
eyeball (Fig.1.A) and consists of the outer nuclear layer (ONL), the inner nuclear layer 
(INL) and the ganglion cell layer (GCL). The outer and the inner plexiform layers (OPL 
and IPL), where neurons form synaptic connections, separate the three nuclear layers. 
Together with the retinal pigment epithelium (PE), which is a non-neuronal single cell 
layer covering the top of the photoreceptor cells, the retina forms a morphological and 
functional unit to absorb light and to transform it into an electrical signal [1, 2]. To 
receive, process and transmit the light-mediated stimulus, different types of cells 
populate the typical mammalian retina and work closely together (Fig.1B left panel). 
Photon absorbing photoreceptor cells are located in the ONL – opposite to the retinal 
surface where the light invades. That means that the light has to penetrate the whole 
retina to stimulate phototransduction. Photoreceptors connect to bipolar cells, which 
are located in the INL and transmit the signal vertically to ganglion cells. In addition, 
horizontal cells and amacrine cells in the INL interact morphologically and functionally 
with this network to fine-tune the ganglion cell signal [1, 2]. Müller glia cells span the 
retina radially from the inner limiting membrane close to the GCL to the outer limiting 
membrane near the ONL. They are essential for the maintenance of the retinal 
structure and the removal glutamate [3-5] – a neurotransmitter, which causes neuro-
toxicity at high concentrations [6-8]. Ganglion cell axons bundle to form the optic nerve, 
which exits at the centre of the retina to transmit the electro-chemical information to the 
brain. Because this area is free of photoreceptor cells, it is named “blind spot”. Nutrition 
and oxygen are provided via two circulatory blood systems. The inner retina is supplied 
via the central retinal artery, which invades the retina via the blind spot. The retinal 
blood vessel system consists of three layers – the primary (superficial) vessel plexus at 
the inner retinal surface, which is connected to two parallel secondary capillary 
networks: the inner deeper plexus in the IPL and the outer deeper plexus in the OPL 
(Fig.1.B right panel). Photoreceptor cells are supplied by the choroidal blood system, 
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which arises from the long and short posterior arteries and lies between retina and 
sclera [9]. 
 
 
Fig.1 The Retina – the Neural Layer of the Eye. A Schematic structure of the mammalian eye. 
Sclera and Cornea form the external layer of the eye providing shape and stability. The choroid provides 
nutrition to the retina. To adapt to different light intensities, the iris forms the pupil and determines the light 
incidence by contracting and relaxing. The retina is a neuronal tissue, which forms the internal layer of the 
eye. The eye is filled with the vitreous humor, the lens is required for accommodation to obtain sharp 
images on the retina and the optic nerve transmits the information from the retina to the brain. B 
Schematic (left panel) and real (right panel) structure of the retina, which consist of three nuclear layers: 
The outer nuclear layer (ONL) contains rod (R) and cone (C) photoreceptors, which possess inner 
segments (IS) for energy supply and outer segments (OS) for the photon reception. The tips of the OS are 
engulfed by pigment epithelium cells (PE), which remove photoreceptor debris. The inner nuclear layer 
(INL) contains several cell types: horizontal cells (H), bipolar cells (B) and amacrine cells (A) are required 
for signal transmission from photoreceptors to ganglion cells (G) in the ganglion cell layer (GCL). Müller 
cells (M) are essential to maintain the retinal integrity. ONL, INL and GCL are separated by the inner (IPL) 
and outer plexiform layer (OPL) in which synaptic cell-cell contacts are established. The retinal nerve fiber 
layer (RNFL) bundles ganglion cell axons and transmits information to the optic nerve. The retina is 
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supplied by two separate blood vessel systems (right panel). Photoreceptor cells receive nutrition and 
oxygen via the choroidal vasculature (green); the inner retina is supplied by a branched vessel network, 
which consists of the superficial (red) as well as the inner (yellow) and outer (blue) deeper plexus. 
Figure was adapted from http://www.meei.harvard.edu/patient/images/eye.jpg and 
http://de.wikipedia.org/w/index.php?title=Datei:Retina.jpg&filetimestamp=20080814113451. 
 
1.1.2 Photoreceptor cells 
Photoreceptor cells are primary sensory neurons, which absorb light and convert 
it into an electro-chemical signal. Two distinct types of photoreceptors, differing in size, 
shape and function are known – rods and cones. Rods are required for dim light vision 
and are more numerous than cones, which in turn are essential for color and high 
acuity vision. Mice have a mosaic-like distribution of rods and cones in the entire retina. 
In contrast, primates have a specialized region within the retina – the macula, an area 
where cones outnumber rods [10]. The area with the largest concentration of cones 
near the center of the macula is called fovea and it is required for high acuity vision in 
bright light conditions. 
 
 
Fig.2 Structural and Functional Features of Photoreceptors. A Schematic views of typical rod 
and cone photoreceptor morphology. Both types contain outer segments, which are composed of disc 
membrane like structures. The (connecting) cilium connects the outer segments to the inner segments, 
which contain mitochondria and synthesize new proteins. The nucleus forms the shape of the cell body 
and synapses connect to downstream cells. B Absorption spectrum of rods and cones. Rods have a 
maximal absorbance of light at 498 nm. The spectrum of green (533 nm) and red cones (564 nm) is shifted 
to higher wavelength, whereas blue cones absorb energy-rich light around 437 nm. 
Figure was adapted from http://www.fz-juelich.de/inb/inb-1/datapool/page/24/Figure2.jpg and 
http://webvision.med.utah.edu/imageswv/spectra.jpeg 
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Morphologically, photoreceptors consist of the synaptic ending, the cell body 
yielding the nucleus and the inner and outer segments (IS & OS) (Fig.2.A). 
Mitochondria are located in the IS and guarantee an adequate energy supply for the 
photoreceptors. Outer segments, which are responsible for the photon uptake, contain 
disc like double-membrane structures. Embedded within these membrane structures 
are the visual pigments. The visual pigments are complexes containing the G-protein 
coupled receptor opsin and the covalently bound vitamin A derivative 11-cis-retinal. 
Opsin molecules integrate into the disc like membranes via their seven membrane 
spanning helices [11]. The difference of absorption maxima between rods and cones 
depends on the type of opsin molecule. In rods, opsin and 11-cis-retinal form 
rhodopsin, which has an absorption maximum at 496 nm [12]. Cones express different 
opsin molecules, which shift the absorption maximum to higher wavelength (green 
cone, 533 nm) or lower wavelength (blue cone, 437 nm) (Fig.2.B). In contrast to most 
mammalians, which have blue and green cones, primates possess in addition also red 
cones (564 nm). 
1.1.3 Phototransduction 
The first step to convert the light input into a neuronal response in the brain is the 
phototransduction (Fig.3), which takes place in photoreceptor cells [11]. Unexcited 
photoreceptors are depolarized due to open cGMP gated sodium channels and a 
constant influx of sodium and calcium. This causes constant release of the excitatory 
neurotransmitter glutamate, which stimulates or inhibits different types of downstream 
bipolar cells. 
 
Fig.3 Phototransduction Cascade. Shown is the principle of phototransduction after light 
reception. When a photon hits rhodopsin (R*) a signalling cascade is activated beginning with GTP 
mediated activation of the transducin (G) α-subunit. The activated subunit (G*) binds to the γ-subunits 
phosphodiesterase (PDE**). That causes an activation of the PDE α- and β-subunit and triggers the 
processing of cGMP to GMP, which finally causes the closure of cGMP-gated cation-channels and thereby 
the hyperpolarization of the photoreceptor cell. cGMP is restored by the Guanylyl cyclase (GC). 
Figure: Leskov et al., 2000 Neuron 
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Upon light stimulation, 11-cis isomerizes into all-trans-retinal und thereby induces 
conformational changes in the rhodopsin structure. Activated rhodopsin 
(metarhodopsin II) mediates the rapid replacement of GDP by GTP on the α−subunit of 
transducin, which is a heterotrimeric G-protein. The released GTP-bound α−subunit 
binds the γ-subunit of a heterotrimeric phosphodiesterase (PDE), which activates its 
two catalytic α- and β-subunits. The activated PDE induces the cleavage of cGMP to 
GMP. Thus, cGMP gated sodium channels are closed resulting in a continuing closure 
of voltage-gated channels. This leads to the hyperpolarization of the cell and the drop 
of calcium ions stopping the release of glutamate and reversing inhibition or stimulation 
of bipolar cells [13, 14]. 
1.1.4 The Retina as a Part of the Visual Pathway 
Besides light reception, the retina is required for initial processing of the light-
induced flow of information. In general, photoreceptor cells signal to bipolar cells, which 
transmit the information vertically to ganglion cells. Eventually, the information bundles 
in the optic nerve and is transmitted to the visual cortex in the brain [11]. The vision in 
vertebrates depends on the perception of contrasts between images and background. 
Therefore, two major types of bipolar cells (ON and OFF) respond differently to the 
glutamate release of cone photoreceptors (Fig.4.A). In order to detect dark images on 
a light background, bipolar cells having ionotropic glutamate receptors, depolarize and 
activate the OFF-pathway. In contrast, the ON-pathway is regulated by bipolar cells, 
which harbor inhibitory metabotropic glutamate receptors and are inactive when 
glutamate is released from photoreceptors. These cells are required for the recognition 
of light pattern on dark background. To tune the information, additional cell types are 
required. Horizontal cells are functional modulators signaling horizontally in the INL to 
enhance the contrast between ON- and OFF-pathways in a so-called centre surround 
organization. That means horizontal cells add an opposite signal, surrounding a certain 
bipolar cell signal, by inhibiting all neighboring bipolar cells. In contrast to cones, only 
one type of bipolar cell connects to rods, solely transmitting ON-signals. However, 
unlike cone bipolar cells, rod bipolar cells have no direct connections to ganglion cells 
but employ amacrine cells to mediate the information (Fig.4.B). Two specialized 
subtypes of amacrine cells, AII and A17, are required to transmit a signal from rod 
bipolar cells to ganglion cells. AII amacrine cells signal either directly to ON- and OFF-
ganglion cells or they use ON- and OFF-bipolar cells of cones as a relay to signal to 
ganglion cells. A17 amacrine cells modulate and amplify the AII signals. 
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Fig.4 Signaltransmission in the Retina. A Light stimulates cone photoreceptor cells, which are 
connected to ON- or OFF-bipolar cells. Bipolar cells transmit the signal to ON-centre and to OFF-centre 
ganglion cells. ON- and OFF-ganglion cells have receptive fields. That means that ON-ganglion cells are 
activated when light falls into the centre of the receptive field and OFF-ganglion cells are activated, when 
light falls in the periphery of the receptive filed, leaving their centre dark. To generate a centre-surround 
like receptive field, horizontal cells generate an antagonistic surround signal to bipolar cells and thereby to 
ganglion cells. The receptive field of ganglion cells has a “Sombrero-like” structure integrating opposing 
signals about centre and surround, which helps to sharpen the image boundaries. B Rod photoreceptor 
cells are only connected to ON-bipolar cells and employ AII amacrine cells to mediate the signal to 
ganglion cells. Thereby, amacrine cells collect the signal from many rods and transmit the information 
either directly to ON- or OFF-ganglion cells, or they employ the cone-bipolar cells. 
Figures: Helga Kolb, 2003 American Scientist 
 
All information leaves the retina via the optic nerve to reach the visual cortex [1, 
2] (Fig.5). Visual fibers of both eyes pass the optic chiasm, which is located close to 
the thalamus and hypothalamus. There, fibers of the nasal half of each retina cross to 
the contralateral (opposite side) hemisphere of the brain. In contrast, fibers of temporal 
half of both retinas remain in the ipsilateral (the same side) hemisphere of the brain. 
Optic fibers form the optic tract, which leads to the lateral geniculate nucleus (LGN). 
Both hemispheres of the brain contain a LGN, which is located inside the thalamus and 
acts as the primary processing center for visual information. Typically, the LGN 
consists of six cell-layers containing different types of cells (magnocellular, 
parvocellular and koniocellular cells) and receives input from both eyes. Therefore the 
information is divided alternating among the layers. The LGN signals information to the 
visual cortex (striate cortex) along fibers of the geniculo-calcarine tract. The primary 
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visual cortex (V1) consists of six functionally distinct layers, is located in the occipital 
lobe of the brain and transmits information from the LGN to two separate streams. The 
dorsal stream goes from V1 to areas called V2 and V5 to the posterior parietal cortex, 
which integrates sensory and motor portions of the brain. The ventral stream begins 
with V1 and goes through V2 and V4 to the inferior temporal cortex, which is involved 
in object feature recognition [11]. 
 
 
Fig.5 The Visual Pathway. Shown is the visual pathway, which starts in the retina of the eye. After 
initial signal integration, the information leaves the eye via the optic nerve. In the optic chiasm the optic 
fibres from the nasal part of the retina cross to the contralateral hemisphere (yellow fibres of the right eye 
cross to the left hemisphere and blue fibres of the left eye cross to the right hemisphere), whereas optic 
fibres from the temporal part of the retina are directed to the ipsilateral hemisphere. Nerve fibres are 
directed along the optic tract to the lateral geniculate body (LGN) and further to the primary visual cortex 
via the geniculo-calcarine tract. 
Figure was adapted from http://pal.pearson.com/teams/PALSearch.do. 
 
1.2 Retinal Diseases 
The four most prevalent eye diseases in Europe and North America, which lead 
to legal blindness, are age-related macular degeneration (AMD), cataract, glaucoma 
and diabetic retinopathy [15]. Except for cataracts, all diseases severely impair vision 
or cause blindness by affecting the retina, indicating that retinal degeneration is one of 
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the major reasons for blindness in human patients. Among the group of retinal 
diseases, AMD and retinitis pigmentosa (RP) are mainly responsible for the loss of 
vision by photoreceptor cell death. 
 
1.2.1 Age-Related Macular Degeneration 
AMD is a disease usually occurring in patients with the age of over 50 years and 
impairs or abolishes central vision. During aging, auto fluorescent lipofuscin, which is 
composed of lipids and proteins from photoreceptor debris, progressively accumulates 
in PE cells. The pyridinium bis-retinoid A2E is a highly cytotoxic component of 
lipofuscin and a potent photo-inducible generator of reactive oxygen species (ROS). 
Additionally, deposits of acellular, polymorphous debris accumulate between PE and 
Bruch’s membrane in healthy subjects to form so-called drusen [11]. 
 
 
Fig.6 Different Stages of AMD. Shown are different clinical stages of AMD. During early AMD 
(panel A) small and medium-sized drusen are found by fundus photography and histological analyzes 
(white and black arrows). During intermediate AMD (panel B) large drusen are present (black arrow), 
which appear as enlarged yellowish dots in the fundus (white arrow). During this phase geographic atrophy 
starts but does not extend to the macula centre. The late phase of AMD can be distinguished between dry 
(non-neovascular) AMD and wet (neovascular) AMD. Dry AMD (panel C) is characterized by geographic 
atrophy (white arrow) of the macula centre and the loss of Bruch‘s membrane (black arrow). In wet AMD 
(panel D) abnormal neovascularization of leaky vessels (white and black arrow) causes haemorrhages 
(blue arrow). 
Figure: Jager et al., 2008 New England Journal of Medicine 
 
The first clinical hallmark of AMD is the abnormal increase of drusen-formation, 
which can damage the PE (Fig.6). In combination with a chronic aberrant inflammation, 
this can lead to a geographic atrophy of the retina. Most of the patients develop the 
atrophic (dry) form of AMD. However, 10 to 15% of AMD patients develop an exudative 
(wet) form of AMD, featured by abnormal retinal neovascularization. Although wet AMD 
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is less frequent, it is responsible for 80% of all cases of severe visual impairment and 
blindness among AMD patients [16]. Wet AMD is accompanied by increased vascular 
permeability and fragility and can lead to subretinal hemorrhage, fluid exudation, lipid 
deposition, detachment of the retinal pigment epithelium from the choroid, fibrotic scars 
or a combination of these findings [16]. Due to hemorrhage, wet AMD can lead to a 
rapid loss of vision, whereas dry AMD leads to a gradual loss of vision over a time 
period from month to years. Besides age, several other risk factors like smoking [17-
19], ethnical background [20] or obesity [21] are known to accelerate AMD 
development. Genetically, polymorphisms in factor H [22-25] and in factor B [26] of the 
complement system are associated with AMD development. Further, a polymorphism 
in the promoter of HTRA1, a gene encoding a secreted serine protease, increases the 
risk for AMD development [27, 28]. To reduce the symptoms and the disease 
progression, several strategies are currently employed. An appropriate nutrition with a 
low fat diet and antioxidant supplementation may delay the transition into advanced 
AMD pathology [16]. The intravitreal injection of antiangiogenic components, like 
antibody fragments raised against human vascular endothelial growth factor (Vegf), is 
a successful strategy to attenuate progression of neovascularization in wet AMD [29]. 
Aside from the symptomatic therapy, a cure from the disease is not possible yet. 
 
1.2.2 Retinitis Pigmentosa (RP) 
Retinitis pigmentosa (RP), terms a set of hereditary diseases, which are caused 
by genetic mutations and which are featured by retinal degeneration due to 
photoreceptor cell death [30, 31]. Statistically, 1 in 4000 humans suffer from RP, which 
numbers the total affected humans to more than 1.5 million worldwide. RP can be 
inherited in an autosomal-dominant, an autosomal recessive or in a X-linked manner. 
20 – 30% of all patients suffer from associated, non-ocular diseases, which are 
described by more than 30 different syndromes. The two major forms are Usher and 
Bardet-Biedl syndrome [30]. In Usher syndrome, a cochlea disease resulting in hearing 
defects or deafness can accompany RP. In the Bardet-Biedl syndrome, RP can be 
associated with renal diseases, obesity, polydactyly etc. RP is a variably developing 
disorder, which can lead to loss of vision between childhood/birth and mid-adulthood. 
The classical pattern is characterized by an early night blindness during adolescence 
and the loss of peripheral vision in young adulthood. Typically, intraretinal pigmentation 
appears in the fundus due to the migration of PE cells into the neural retina (Fig.7). The 
degeneration starts in the periphery of the retina. As the disease advances, patients 
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suffer from tunnel vision and eventually from legal blindness – typically in the second 
decade of life [30, 31]. 
 
 
Fig.7 Fundus Photography of a Retinitis Pigmentosa Patient. Shown is the fundus photography 
of a healthy subject (left panel) in comparison to a retinitis pigmentosa patient (right panel). The dark 
lesions represent the pigment of the RPE cells, which migrate into the retina in degenerated regions due to 
the lack of photoreceptor cells. The lesions appear predominantly in the retinal periphery and solely 
progress to the central retina. 
Figure: http://webvision.med.utah.edu/ClinicalERG.html#ERGs%20in%20retinitis%20pigmentosa-
like%20diseases 
 
In most forms of RP, loss of rods precedes loss of cones. However, in some 
cases rods and cones decline is simultaneous and in cone-rod dystrophies cone 
degeneration precedes loss of rods. This form of RP is characterized by early loss of 
visual acuity and impaired color vision [32]. Till 2008, approximately 190 disease-
related genes were mapped and 130 disease-related genes were identified [31]. These 
genes belong to different functional groups like transport, metabolism, photoreceptor 
physiology or ion homeostasis. Mutations in the rhodopsin gene (RHO), in the usher 
syndrome 2A gene (USH2A) and in the retinitis pigmentosa GTPase regulator gene 
(RPGR) account for 30% of all RP cases [30]. However, in about 50% of all patients 
the genes, responsible for RP, are still unknown. 
Although some supplemental nutrition like vitamin A and E as well as 
docosahexaenoic acid (DHA), which is an omega-3 fatty acid, might delay the progress 
of the disease [30], RP is still incurable and leads to legal blindness. 
 
1.3 Models for Retinal Degeneration 
To investigate the pathological changes, the molecular events or possible 
treatment strategies in retinal degeneration, models are required to focus on specific 
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problems. Several models are available with certain advantages or disadvantages. In 
general, two major model systems – inherited and induced – can be distinguished: 
1. Inherited retinal degeneration is based on animal models with an artificially 
introduced or spontaneous genetic modification, which is inherited among the offspring. 
2. Induced retinal degeneration requires an exogenous physically or chemically 
injury stimulus. 
1.3.1 Model for Inherited Retinal Degeneration 
To mimic retinal degeneration a variety of animal-models harboring either 
naturally occurring mutations or artificially introduced genetic modifications are 
available. A variety of different species like cats, dogs, fish, insects, pigs, monkeys or 
rodents exists to investigate inherited retinal diseases [33]. Due to the availability of 
many different mutations or genetic modifications specific models may closely 
resemble a certain human pathology. Mice are excellent tools because they are easily 
and precisely genetically modifiable. Deleting or mutating specific target genes can 
resemble genetic conditions of human patients. To date, more than 90 different mouse 
models exist, which harbor a mutation in a gene relevant for human retinal pathology 
[33]. A model for autosomal recessive RP is the rd1 mouse [34], which harbors a 
retroviral insert in the gene encoding the β-subunit of the phosphodiesterase (PDE). 
This leads to aberrant splicing and a null phenotype causing increased levels of cGMP 
in photoreceptor cells. As a consequence, ion channels remain constantly open, 
leading to increased intracellular Ca2+ concentrations. This leads to a very rapid 
degeneration starting at PND11 and resulting in a complete loss of photoreceptors in 
the central retina with 3 weeks of age. A model for autosomal dominant RP with later 
onset and slower progression is the transgenic VPP mouse [35, 36]. This mouse 
expresses additional copies of rhodopsin with 3 different mutations, which lead to 3 
amino acid substitutions (V20G, P23H, P27L). Among them, P23H is the most 
common cause for autosomal dominant RP in human patients. 
It is rather difficult to find appropriate models for AMD. Only primates have a 
human-like macula and AMD is an age related disease, which means animals need to 
survive a long lifespan. However, there are a couple of mouse models, which feature 
AMD partially. Among them, Ccl2-/- (chemokine (C-C motif) ligand 2) mice develop 
drusen-like deposits in the retina after two years and presenting retinal degeneration, 
which partially resembles AMD pathology [37]. 
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1.3.2 Light Exposure – A Model For Induced Retinal Degeneration 
Retinal Degeneration can be induced by a variety of exogenous stimuli like iron, 
led or calcium overload, by N-methyl-N-nitrosourea (MNU), by autoantibody treatment, 
by oxygen deprivation, etc. [33]. A frequently used tool to induce retinal degeneration is 
light. Light induces photoreceptor cell death, and thereby mimics the key feature of RP 
pathology [38-40]. Furthermore, it is assumed to accelerate the progression of human 
retinal diseases [41, 42]. Compared to models of inherited retinal degeneration, light 
exposure allows a temporal control of induction and a regulation of the severity grad. 
Two different experimental setups of light exposure, with different kinetics and disease 
progression, are established. A long-term exposure to low levels of light induces a 
moderate and slow progression of retinal degeneration [43]. A protocol of short-term 
exposure to high levels of light rapidly initiates retinal degeneration [44] and provides 
highly reproducible results (Fig.8). Due to the short and strong death-stimulus, cells 
respond synchronized either undergoing apoptosis or initiating pro-survival 
mechanisms. This allows an easy quantification of cell death and might raise certain 
(apoptosis/cell survival) markers of interest above the detection threshold. 
 
 
Fig.8 Experimental Setup of Short-Term Light-Induced Retinal Degeneration. Mice are 
exposed to cytotoxic levels of white light, which triggers photoreceptor cell death. Depending on the 
genetic background and on the pigmentation of animals (albino vs. pigmented) light intensities between 
5‘000 and 13‘000 lux are employed for 1 to 2 hours. During the recovery phase apoptosis takes place and 
photoreceptors degenerate. Finally, morphological and biochemical analyses can be performed between 
36 hours and 10 days after illumination. 
Figure: Courtesy of A. Wenzel, C. Remé and C. Grimm 
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Photoreceptor cell death after a short-term exposure to a strong light stimulus 
can be divided into 4 phases [45]. The first step requires repetitive bleaching of 
rhodopsin [46] and causes an accumulation of retinoid metabolites [47] (e.g. all-trans 
retinal). Increased oxidative stress may contribute to the pro-apoptotic mechanisms. In 
the second step – the death-signal transduction-phase I – photoreceptors experience 
an increased calcium influx [48]. Calcium is known to trigger apoptosis in many neural 
systems. Although no cytochrome C is released, a swelling of mitochondria marks this 
phase. In the death-signal transduction-phase II AP-1 is activated 6 – 12 hours after 
light exposure and confers apoptosis [49-51]. AP-1 is a transcription factor formed by 
members of the Jun family proteins or of Jun and Fos family members [49, 50]. The 
termination phase is characterized by DNA fragmentation, cell disintegration and 
clearance of photoreceptor debris [45]. Progressive photoreceptor cell apoptosis 
results in released nucleosomes, which can be measured and quantified. 
Morphologically, photoreceptor cell death can be visualized by disintegration of IS and 
OS, as well as by the occurrence of pycnotic nuclei. After the peak of apoptosis (1 – 3 
days after light exposure) macrophages invade the retina in order to remove 
photoreceptor debris. 
The apoptotic pathways enabled after light exposure are largely unknown and 
classical pathways like activation of effector-caspases and release of cytochrome c 
seem to be not induced [52, 53]. However, caspase-1 is induced (but not activated) 
and might confer apoptosis by an unknown mechanism [51, 52]. Calpains may play a 
major role and may replace the lacking caspase activity after light exposure [53]. 
Further, members of the Jak/STAT signaling pathway seem to be involved in models 
light-induced and inherited retinal degeneration [54]. 
The limitation of the (light-) induced models is, that induced models only partially 
feature the pathology of human diseases and the cell-biological mechanisms might 
severely differ. Nevertheless, these models are easy to handle and might provide 
interesting candidates, which then can be further tested in appropriate inherited 
models. 
 
1.4 Neuroprotection and Mechanisms of Hypoxic 
Preconditioning 
In general, neuroprotection can be defined as any therapeutic approach that 
prevents or retards neuronal cell death. Thereby, the process of cell apoptosis is 
targeted and not the initial pathogenic stimulus. 
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1.4.1 Retinal Neuroprotection 
Neuroprotective approaches have been successfully tested in a variety of animal 
models for neurodegenerative diseases like stroke, Parkinson disease, or Alzheimer 
disease in order to attenuate the pathogenesis and to restore or maintain the function 
of the affected neuronal system. Among the group of neuroprotective compounds, 
which are used to treat retinal degeneration, are: anti-inflammatory substances to 
reduce secondary neuronal cell death, NMDA antagonists to reduce glutamate toxicity, 
sodium channel blockers, nitric oxide synthase inhibitors or free radical scavengers. 
Other strategies are corticosteroids, regulators of ion homeostasis like Ca2+-channel 
blockers or regulators of metabolism [55, 56]. A promising approach to prevent retinal 
apoptosis is the application or overexpression of growth factors [57] like glial cell 
derived neurotrophic factor (GDNF) [58], brain-derived neurotrophic factor (BDNF) [59], 
platelet derived growth factor (PDGF) [60], ciliary neurotrophic factor (CTNF) [61], 
fibroblast growth factor 2 (FGF2) [62], which is remarkable beneficial in models of 
glaucoma and inherited or light induced retinal degeneration. However, a 
neurodegenerative disease includes a complex interplay of several cell types like 
astrocytes, glia cells and neurons and an activation of multiple pro- and anti-apoptotic 
cascades. Therefore, most clinical trials were not satisfying when a single factor 
modulation was tested in brain or in the retina. A multiple drug therapy, which is 
already applied in cancer therapies, might be a promising alternative. Further, the use 
of compounds with multiple biological functions like hormones, corticosteroids, 
progesterone or synthetic drugs like cyclic dipeptides, which protect against oxygen 
dependent, mechanical injury dependent or free radical dependent neuronal cell death 
[63] could replace single factor therapies. 
1.4.2 Hypoxic Preconditioning 
A very successful strategy to attenuate neuro- and retinal degeneration in animal 
models is preconditioning, which is the exposure of a tissue or an organism to sub-
lethal stress conditions. This induces pro-survival pathways to protect against future 
injury. Preconditioning stimuli like hypothermia [64], endotoxin pretreatment [65, 66] or 
light [67] have been shown to activate multiple pro-survival pathways and to prevent 
very efficiently neuronal degeneration. Hypoxic and ischemic preconditioning strongly 
protect the retina against cell death [68-73]. Whereas hypoxic preconditioning reduces 
the oxygen availability, ischemic preconditioning additionally inhibits the blood flow 
preventing nutrition exchange and waste disposal in addition. Although both 
preconditioning protocols induce a response to low oxygen and have similar protective 
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effects, they differ in gene regulation and duration of the protective effect [69, 71, 73, 
74]. 
The exact mechanism of neuroprotection after hypoxic preconditioning is still 
unknown. However, hypoxia causes increased expression of potential neuroprotective 
genes like Vegf [71], heme oxygenase 1 (HO-1) [74], heat shock protein 27 (Hsp27) 
[75] or erythropoietin (Epo) [71] and generates a response that protects the retina 
against high levels of white light – a strong apoptotic stimulus. Photoreceptors of 
normoxic (21% O2) control mice undergo apoptosis when exposed to light. In contrast, 
retinal morphology and function of mice preconditioned by hypoxia (6% O2) for 6 h are 
completely maintained when exposed to light after 4 h of reoxygenation (Fig.9.A). 
Thereby, the level of retinal neuroprotection correlates with the oxygen levels. An 
oxygen concentration of 6 to 10% provides complete protection against light induced 
retinal degeneration. 14% oxygen shows an intermediate level of protection and no 
protection is observed in retinas of mice exposed to 18% oxygen. The protective effect 
lies within a narrow time window. After 16 h of reoxygenation the retina regains light 
damage susceptibility and photoreceptors undergo apoptosis again [71, 72]. This 
implies, that potential neuroprotective factors induced by hypoxic preconditioning are 
short-lived and rapidly degraded or inactivated during reoxygenation. 
 
 
Fig.9 Hypoxic Preconditioning and Epo Administration Protect Against Light-induced 
Retinal Degeneration. Dark control mice have healthy photoreceptor cells with correctly structured outer 
and inner segments. Illuminated normoxic mice completely lack photoreceptor cells 10 days after light 
exposure. A Hypoxic preconditioning completely protects the retina against light damage leaving retinal 
INTRODUCTION  24 
morphology unimpaired. B Epo administration partially protects the retina against light damage. Some 
pycnotic nuclei (red arrows) are present 36 hours after light exposure. Retinas injected with sodium 
chloride (NaCl) as control were damaged after illumination. 
Figure: M. Thiersch and C. Grimm 
 
1.4.3 Epo Partially Protects the Retina 
Epo, one of the most prominent factors differentially regulated by hypoxia, is 
induced in oxygen-deprived retinas [71]. Epo protects retinal cells from apoptosis in a 
variety of degeneration models [71, 76-78]. Intraperitoneal application of recombinant 
human Epo (rhEpo) before and after light exposure reduced light damage susceptibility 
of mice and protected photoreceptors against toxic light insults (Fig.9.B) [71]. The Epo 
receptor (EpoR) is localized in the inner segments of photoreceptors and on ganglion 
cells [71, 79] suggesting that Epo-mediated activation of EpoR directly induces 
protection of visual cells. The protective effect of rhEpo injections is restricted to a time 
window of 1h before to 1 h after light exposure and is less complete than after hypoxic 
preconditioning [71, 72]. Likewise transgenic mice (tg6), which express human Epo 
and have 20-fold increased retinal Epo levels, are protected to a lower extend against 
light damage than mice preconditioned by hypoxia [80]. This suggests that 
pretreatment with low oxygen induces several factors (with Epo being one of them) that 
may need to act in concert to fully protect photoreceptors against light insult. 
Therefore, transcription factors, which control the expression of Epo, Vegf and 
other potential neuroprotective genes, could be targets for future therapeutic 
interventions. One promising candidate of such transcription factors may be hypoxia-
inducible factor 1 (HIF-1). Similar to the correlation between neuroprotection and 
oxygen concentration, HIF-1 is dose-dependently activated by decreasing oxygen 
concentrations. 
 
1.5 The HIF System – Master Regulator of Hypoxia 
Hypoxia-inducible factors (HIFs) are transcription factors essential to maintain 
cellular or systemic oxygen homeostasis. The HIFs are heterodimeric factors 
consisting of a HIF-α subunit and of a constitutively expressed HIF-β subunit named 
aryl hydrocarbon receptor nuclear translocator (ARNT). Three different HIF-α subunits 
are described (HIF-1α, -2α, -3α) [81]. Each α- and β-subunit belongs to the bHLH 
(basic helix-loop-helix)-PAS (Per/ARNT/SIM) family and contains two PAS domains 
(PAS-A and PAS-B) and a bHLH domain (Fig.10) [82]. These domains are essential for 
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DNA binding and for the dimerization of the α- and β-subunits. Additionally, HIF-1α and 
HIF-2α contain a TAD-N and a TAD-C domain (terminal transactivation domains), 
which are required for the recruitment of transcriptional co-activators such as 
p300/CBP [83-85]. The TAD-N domain overlaps with the oxygen-dependent 
degradation domain (ODD), which is required to regulate the stabilization of the HIF-α 
subunit depending on the oxygen concentration [81]. In contrast to HIF-1α and HIF-2α, 
HIF-3α lacks the C-transactivation domain and acts as a suppressor of HIF-1 and HIF-
2 in a dominant negative manner [86]. Three out of six known isoforms of HIF-3α even 
lack the ODD indicating that they might be constantly expressed to counteract HIF-1α. 
 
 
Fig.10 Structure of HIF-1α  and HIF-1β subunits. HIF-1α and HIF-1β contain a basic-helix-loop-
helix structure (bHLH) and two PER-ARNT-SIM (PAS1 and PAS2) domains. Human HIF-1α is 
hydroxylated at proline (P) residue 402 and 564 to recruit von Hippel-Lindau tumour suppressor protein 
(VHL) and to initiate HIF-1α degradation. Hydroxylation of asparagine (N) residue 803 prevents binding of 
transcriptional co-factors. Additional acetylation at lysine (k) residue 532 enhances the binding of VHL. 
HIF-1α contains a N- as well as a C- terminal transactivation domains (N/CTAD) and HIF-1β contains one 
transactivation domain (TAD). 
Figure: adapted from Carroll and Ashcroft, 2005 Molecular Medicine 
 
1.5.1 Oxygen-Dependent Regulation of HIF-1α 
In order to quickly respond to cellular changes in oxygen concentration, HIF-1α is 
constitutively expressed but rapidly degraded under normoxic conditions (Fig.11). To 
target human HIF-1α for proteosomal degradation under normoxic conditions, 
prolylhydroxylases (PHDs) hydroxylate HIF-1α posttranslationally at two specific 
proline residues (Pro402 & Pro564) consisting of an LXXLAP aminoacid motive in the 
ODD [87-90]. Prolyl hydroxylases are Fe(II) dependent dioxygenases, which require 
oxygen and α-ketoglutarate as co-substrates [90, 91]. Additionally, the 
acetyltransferase ARD-1 transfers an acetyl group to the Lys-532 residue of the human 
HIF-1α subunit [92]. The hydroxylation and acetylation steps prepare the binding of the 
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tumor suppressor von Hippel-Lindau protein (VHL). VHL is a part of an E3 ligase 
complex, which initiates the binding of ubiquitin eventually leading to proteasomal 
degradation of HIF-1α [93, 94]. In order to additionally inactivate HIF-α subunits, factor 
inhibiting HIF (FIH) hydroxylates human HIF-1α subunits at an asparagine residue in 
the C-terminal transactivation domain (Asn803) [95-97]. This inhibits the binding of the 
transcriptional co-activators p300 and CBP (CREB binding protein) and reduces the 
transcription activity of HIF-1. 
 
Fig.11 Oxygen-dependent Regulation of HIF-1α. During conditions of normal oxygen (O2) supply 
(left side) HIF-1α is hydroxylated at two proline (Pro) residues by prolylhydroxylases (PHDs). The 
hydroxylation initiates the binding of the von Hippel-Lindau tumour suppressor protein (VHL), which 
triggers the ligation of ubiquitin (Ub) and results in a rapid degeneration of HIF-1α via the proteosomal 
degradation pathway. During hypoxia (right side) PHDs fail to hydroxylate HIF-1α, which thereby becomes 
stabilized. After translocation to the nucleus HIF-1α and HIF-1β dimerize to form HIF-1 and bind to the 
hypoxia-response element (HRE) in promoter regions of target genes. Due to the recruitment of 
transcriptional co-activators p300/CBP HIF-1 differentially expresses genes involved in different pathways 
(e.g. apoptosis or cell survival). 
Figure: adapted from http://www.panomics.com/images/hif_celllineflow.gif and from Carroll and Ashcroft, 
2005 Molecular Medicine 
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1.5.2 Oxygen-Independent Regulation of HIF-1α 
Besides the oxygen dependent regulation of HIF-1α, other mechanisms are 
known to regulate the stabilization or activity of HIF-1α under normoxic or hypoxic 
conditions in an oxygen-independent manner [98]. 
Negative regulators of HIF-1α are CITED2, CITED4 [99, 100] and p53 [101], 
which compete with HIF-1α for the binding of p300 to reduce HIF-1 transcriptional 
activity and/or to facilitate its degradation. HIF-3α4 (IPAS) an isoform of HIF-3α 
harbors a bHLH-PAS domain but lacks the C-TAD domain and diminishes HIF-1 
activity by competing for the binding of HIF-1β [102]. Tumor suppressor, p14ARF binds 
to the ODD of HIF-1α to inhibit its transcriptional activity without affecting the protein 
stability [103]. 
Positive regulators are growth factors and cytokines like epidermal growth factor 
(EGF) [104], insulin-like growth factor (IGF) 1/2, [105-107] hepatocyte growth factor 
(HGF) [108] and PDGF [109]. Via the growth factor signaling pathways Ras/Raf/MAPK 
and PI3K/Akt/PKB they can stabilize HIF-1α under normoxic conditions or boost the 
HIF-1α activation during hypoxia [110]. The second messenger nitric oxide (NO) 
regulates HIF-1α in a concentration dependent manner [111]. High levels of NO 
stimulate HIF-1α accumulation; low levels of NO rather facilitate HIF-1α degradation 
even under hypoxic conditions. Mitochondria act as oxygen sensors and increase the 
reactive oxygen species (ROS) generation during hypoxia. In order to endure hypoxia, 
ROS can activate pathways, which lead to induction of HIF-1α [98]. 
 
1.5.3 HIF-1α Regulates Cell Death and Survival 
Hypoxia and the stabilization of HIF-1α can induce both, cell death and cell 
survival [112]. HIF-1 regulates the expression levels of pro-survival genes (like Epo, 
Vegf, IGF-1, etc. [113-115]) as well as pro-apoptotic genes (p53, Bnip3, caspase-3 etc. 
[116-118]). The pro-survival or pro-death property of HIF-1 depends on the duration 
and severity of hypoxia [119], the different types of pathogenic stimuli [120] and on 
different types of cells [121]. 
The embryonic vascularization and thereby the whole development of an 
organism absolutely requires HIF-1α. The ablation of HIF-1α leads to prenatal mortality 
between embryonic day 8 and 9 due to the complete lack of cephalic vascularization, a 
severely impaired somatic formation and insufficient neural development [122]. A 
growing organism or a developing tissue depends on a sufficient nutrition and oxygen 
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supply, which is warranted via blood vessel networks. HIF-1 induces multiple 
angiogenic factors like Vegf or angiopoietin, which initiate the development of blood 
vessels [123, 124]. To optimize the oxygen supply HIFs stimulate the expression of 
erythropoietin (Epo), which binds to its receptor and enhances the maturation and 
survival of erythroid progenitor cells in bone marrow and spleen [125]. Additionally, Epo 
exhibits strong neuroprotective properties (see chapter 1.4.3). 
Cellular energy is stored as ATP, which is the key-element for a living cell. 
Substrates like glucose are required to generate ATP aerobic via electron transport 
along the respiratory chain in mitochondria (oxidative phosphorylation) or anaerobic via 
glycolysis during oxygen deprivation. In situations of low intracellular oxygen 
concentration the ATP generation via oxidative phosphorylation is constricted. HIF-1 
can enhance the anaerobic metabolism by the differential regulation of metabolic 
genes. The induction of glucose transporter 1 (GLUT1) increases the glucose uptake of 
cells, the expression of glycolytic genes accelerates glucose metabolization to pyruvat 
and the induced expression of lactate dehydrogenase A (LDHA) leads to an enhanced 
pyruvat conversion to lactate [126, 127]. Further, HIF-1 optimizes the respiration 
efficiency under hypoxic conditions by inducing the expression of the COX4-2 subunit, 
which replaces the COX4-1 subunit in the cytochrome c oxidase [128]. The induction of 
pyruvat dehydrogenase kinase 1 (PDK) inactivates the pyruvat dehydrogenase (PDH) 
and thereby prevents the conversion of pyruvat to acetyl coenzyme A, which is the 
substrate for the Krebs cycle [129]. By contributing to an adequate energy supply HIF-1 
can ensure a prolonged cell survival. In fact, the strong pro-survival effects of HIF-1 
can be even harmful for an organism. During cancer progression cells grow 
abnormally. In order to increase beyond microscopic size, tumors need to resist to 
hypoxia. HIF-1 is stabilized in most of human tumors and is directly correlated to the 
pathology in human patients [130-133]. A therapeutic strategy is to target the 
stabilization of HIF-1, which is connected to vascularization and changed expression of 
metabolism-associated genes – both hallmarks for tumor pathogenesis. 
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2 AIMS OF THE THESIS 
 
1. Analyses of the retinal transcriptome after hypoxic preconditioning to 
identify potential neuroprotective factors 
Hypoxic preconditioning protects against light induced retinal degeneration. Low 
oxygen levels result in stabilization of HIF-1α and in induced Epo expression, which 
protects the retina against light damage. However, systemically applied recombinant 
human Epo protects the retina only partially against toxic light insults. Therefore, it is 
likely that additional genes, differentially expressed by hypoxic preconditioning, are 
required for a complete protection of photoreceptors. The identification of genes, which 
are differentially expressed during hypoxic preconditioning, should provide a better 
understanding of the retinal response to hypoxia and of mechanisms of retinal 
neuroprotection. The aim of this study was to analyze the retinal transcriptome after 
hypoxia with the focus on the following points: 
 
I. How does the hypoxic transcriptome compare to the normoxic transcriptome in 
the retina? 
II. Are there candidate genes, which potentially contribute to retinal neuroprotection 
observed after hypoxic preconditioning? 
III. Selection and analysis of a first potential target gene to investigate its impact on 
retinal neuroprotection. 
 
2. The role of HIF-1α in retinal neuroprotection after hypoxic 
preconditioning 
In many systems HIF-1 is associated with cell survival after preconditioning. In 
the retina HIF-1 is induced during hypoxic preconditioning. HIF-1 controls the 
expression of genes involved in apoptosis. Therefore HIF-1 should be an excellent 
candidate for regulating retinal neuroprotection. A systemic knock out of the oxygen 
dependent regulated component HIF-1α is lethal, and cannot be used as a tool to 
analyze the role of HIF-1α. However, a conditional photoreceptor cell specific ablation 
of HIF-1α may help to elucidate its role in retinal neuroprotection against light toxicity. 
The aim of this project was to delete HIF-1α specifically in photoreceptors using the 
Cre-lox technology. We employed two different photoreceptor-specific Cre expressing 
mouse lines (PrpCre and OpnCre) and focused on the following problems: 
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I. Is photoreceptor-specific HIF-1α required to maintain normal retinal morphology 
and function? 
II. Is photoreceptor-specific HIF-1α required to resist short severe hypoxia? 
III. Is photoreceptor-specific HIF-1α the “engine” of retinal neuroprotection after 
hypoxic preconditioning? 
IV. Are there HIF-1α independent mechanisms, which could be responsible for 
retinal neuroprotection 
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3 RESULTS 
3.1 Analysis of the retinal gene expression profile after 
hypoxic preconditioning identifies candidate genes for 
neuroprotection 
 
Markus Thiersch1, Wolfgang Raffelsberger2, Rico Frigg1, Marijana Samardzija1, 
Andreas Wenzel1, Olivier Poch2 and Christian Grimm1 
 
1Lab of Retinal Cell Biology, Dept Ophthalmology, University of Zurich, Switzerland 
2Laboratoire de BioInformatique et Génomique Intégrative, Institut de Genetique et de 
Biologie Moleculaire et Cellulaire, 67404 Illkirch, France 
 
 
Published in BMC Genomics 2008, 9:73 (8 February 2008) 
 
 
 
 
Reference number [134] refers to this paper 
BioMed Central
Page 1 of 14
(page number not for citation purposes)
BMC Genomics
Open AccessResearch article
Analysis of the retinal gene expression profile after hypoxic 
preconditioning identifies candidate genes for neuroprotection
Markus Thiersch1, Wolfgang Raffelsberger2, Rico Frigg1, 
Marijana Samardzija1, Andreas Wenzel1, Olivier Poch2 and 
Christian Grimm*1
Address: 1Lab of Retinal Cell Biology, Dept Ophthalmology, University of Zurich, Switzerland and 2Laboratoire de BioInformatique et Génomique 
Intégrative, Institut de Genetique et de Biologie Moleculaire et Cellulaire, 67404 Illkirch, France
Email: Markus Thiersch - markus.thiersch@usz.ch; Wolfgang Raffelsberger - wraff@titus.u-strasbg.fr; Rico Frigg - enrico.frigg@puk.zh.ch; 
Marijana Samardzija - marijana.samardzija@opht.uzh.ch; Andreas Wenzel - andreas.wenzel@novartis.com; Olivier Poch - poch@igbmc.u-
strasbg.fr; Christian Grimm* - cgrimm@opht.uzh.ch
* Corresponding author    
Abstract
Background: Retinal degeneration is a main cause of blindness in humans. Neuroprotective
therapies may be used to rescue retinal cells and preserve vision. Hypoxic preconditioning
stabilizes the transcription factor HIF-1α in the retina and strongly protects photoreceptors in an
animal model of light-induced retinal degeneration. To address the molecular mechanisms of the
protection, we analyzed the transcriptome of the hypoxic retina using microarrays and real-time
PCR.
Results: Hypoxic exposure induced a marked alteration in the retinal transcriptome with
significantly different expression levels of 431 genes immediately after hypoxic exposure. The
normal expression profile was restored within 16 hours of reoxygenation. Among the differentially
regulated genes, several candidates for neuroprotection were identified like metallothionein-1 and
-2, the HIF-1 target gene adrenomedullin and the gene encoding the antioxidative and
cytoprotective enzyme paraoxonase 1 which was previously not known to be a hypoxia responsive
gene in the retina. The strongly upregulated cyclin dependent kinase inhibitor p21 was excluded
from being essential for neuroprotection.
Conclusion: Our data suggest that neuroprotection after hypoxic preconditioning is the result of
the differential expression of a multitude of genes which may act in concert to protect visual cells
against a toxic insult.
Background
Retinal blinding diseases like retinitis pigmentosa (RP)
and age related macular degeneration (AMD) are charac-
terized by a progressive retinal degeneration which
involves the apoptotic loss of photoreceptor cells.
Although significant progress in the understanding of the
molecular mechanisms leading to AMD and RP has been
made in recent years, efficient treatments to successfully
prevent loss of vision are still not available.
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Neuroprotection is a strategy to preserve retinal function.
It aims at the interference with regulatory mechanisms of
cell death to protect photoreceptor cells. To successfully
target these mechanisms it is necessary to understand the
molecular signalling networks in the degenerating retina.
Since neither an extrinsic (activation of caspases via death
receptors) nor an intrinsic death pathway (release of cyto-
chrome c from mitochondria) seems to be activated dur-
ing retinal degeneration [1], mechanisms of
photoreceptor cell death are still poorly understood. Sev-
eral models of inherited [2] and induced [3] retinal degen-
eration are used to study the molecular events of
photoreceptor apoptosis. Inherited models mostly show a
slow progression of retinal degeneration resulting in con-
stant but low levels of apoptosis. Models of induced reti-
nal degeneration, like the light damage model [3], are easy
to handle and the synchronized response to the apoptotic
stimulus may raise apoptotic factors above detection
threshold allowing their detailed investigation.
Various preconditioning protocols are used as a strategy to
protect tissues from degenerative processes. Especially
ischemic and hypoxic preconditioning successfully
reduced the severity of induced or inherited degeneration
in tissues like brain [4,5] heart [6,7] and the retina [8-12].
Hypoxia describes a state of low oxygen. It appears patho-
logically during several diseases like cancer, stroke or heart
infarction [13] but also physiologically during develop-
ment in many tissues [14]. In the adult retina, increased
oxygen consumption during night time leads to border-
line hypoxic conditions [15]. To cope with the reduced
oxygen availability cells differentially regulate genes
including factors involved in an anti-apoptotic response
[16,17]. A key regulator of the tissue response to hypoxia
is the transcription factor hypoxia inducible factor 1 (HIF-
1), a heterodimeric protein consisting of the constitutively
and stably expressed hypoxia inducible factor 1β (HIF-1β)
and oxygen regulated subunit hypoxia inducible factor 1α
(HIF-1α). During hypoxia HIF-1α is stabilized, enters the
nucleus, recruits HIF-1β and regulates the expression of
target genes involved in different pathways like apoptosis,
metabolism or angiogenesis [18].
Hypoxic preconditioning was shown to stabilize HIF-1α
in the retina [9,12]. Stabilization of this transcription fac-
tor induces the expression of target genes with neuropro-
tective properties like vascular endothelial growth factor
(Vegf) and erythropoietin (Epo) suggesting a link between
HIF-1 driven gene expression and neuroprotection [9,12].
Exogenous application of Epo not only protects retinal
ganglion cells in a model of ischemia-reperfusion injury
[19] but also photoreceptors in the model of light induced
retinal degeneration [20,21]. However, protection of vis-
ual cells from light damage was weaker than after hypoxic
preconditioning suggesting that factors in addition to Epo
contribute to retinal protection by hypoxia. The identifica-
tion of these factors is essential for the development of
efficient neuroprotective strategies focused on the preven-
tion of retinal degeneration.
We used whole genome microarrays and real-time PCR to
detect expression of differentially regulated genes after
hypoxic preconditioning in adult mouse retinas. The anal-
ysis of the hypoxic transcriptome characterized the
response of the retina to low oxygen levels. Cyclin-
dependent kinase inhibitor 1a (p21) was among the most
strongly induced genes and occupied a central position in
a differentially regulated gene network affecting cellular
growth and proliferation. Using p21 gene knockout ani-
mals, we analyzed the impact of this gene on retinal neu-
roprotection in the model of light induced retinal
degeneration.
Results
Time frame of neuroprotection after hypoxic 
preconditioning
In previous experiments we observed an almost complete
protection of photoreceptors against light induced degen-
eration when exposed at 4 hours after hypoxic precondi-
tioning. Protection, however, was lost after prolonged
reoxygenation of 16 hours suggesting a rather short-lived
neuroprotective effect of hypoxic preconditioning [9]. To
analyze the time frame of hypoxia-induced neuroprotec-
tion in more detail, we allowed preconditioned mice to
reoxygenate for 4 h, 8 h, 12 h and 16 h, respectively,
before they were exposed to high levels of white light. As
expected, retinal morphology (Fig. 1A) was almost com-
pletely preserved in mice illuminated after a reoxygena-
tion period of 4 h. Only slight disturbances and
vesiculations in the rod outer segments but no apoptotic
nuclei with condensed chromatin were observed.
Exposure after 8 h of reoxygenation resulted in the appear-
ance of some apoptotic photoreceptor nuclei. 12 h of
reoxygenation further reduced the protection against light
damage as evidenced by the appearance of many nuclei
with condensed chromatin and an almost complete disin-
tegration of rod inner (RIS) and rod outer segments
(ROS). Retinas of mice illuminated 16 hours after hypoxic
preconditioning were as susceptible to light damage as
retinas of normoxic control mice (Fig. 1A).
The retinal response to hypoxic preconditioning
It is well known that hypoxia alters the gene expression
profile in a given tissue [22] in an attempt to cope with the
unfavourable condition. One of the major factors regulat-
ing this response is the transcription factor HIF-1, which
is activated in the hypoxic retina (Fig. 1B) [9]. Similarly,
the pro-survival transcription factor Stat3 [23], which has
been reported to be induced in several hypoxic tissues
BMC Genomics 2008, 9:73 http://www.biomedcentral.com/1471-2164/9/73
Page 3 of 14
(page number not for citation purposes)
[24], was phosphorylated and thus activated in the
hypoxic retina (Fig. 1B). The different levels of activation
(shown are examples of two mice) point to a certain vari-
ability in the response to hypoxia between individual
mice. Nevertheless, the activation of these transcription
factors suggests a differential regulation of a multitude of
potentially neuroprotective genes in the retina by hypoxic
preconditioning. Based on the time frame of neuroprotec-
tion (Fig. 1A), we analyzed the gene expression pattern in
the retina at 0 h, 2 h, 4 h, and at 16 h after hypoxia (see
Methods).
Hierarchical clustering of gene chip data showed strong
similarities of the three replica-chips of a respective time
point after hypoxia [see additional file 1]. Such clustering
was not observed in normoxic samples suggesting that
hypoxia induced a strong and specific response in the ret-
ina. This hypoxic response quickly vanished and at 4 h
Transient protection of retinal morphology by hypoxic preconditioningFigur  1
Transient protection of retinal morphology by hypoxic preconditioning. A) BALB/c mice were preconditioned by 
hypoxia for 6 h. After 4 h, 8 h, 12 h or 16 h of reoxygenation in darkness, mice were exposed to 5'000 lux of white light for 1 
h. Control animals were not preconditioned and were (normoxic) or were not (dark control) exposed to light. Retinal mor-
phology was analyzed 36 h after light exposure. Normoxic animals exposed to light showed a severe disruption of ROS and RIS 
with the appearance of many pycnotic photoreceptor nuclei. Mice exposed to light 4 hours after hypoxic preconditioning were 
almost completely protected and only some ROS vesiculation was observed. The protective effect of hypoxia was progres-
sively weakened with increasing reoxygenation time before illumination as indicated by an increased disruption of ROS and RIS 
and the increased appearance of pycnotic photoreceptor nuclei. 16 h after preconditioning the protection was completely lost. 
Hypoxic preconditioning per se did not affect retinal morphology or function even after prolonged survival (data not shown, 
[9]). Arrowheads: examples of pycnotic nuclei; ROS: rod outer segments; RIS: rod inner segments; ONL: outer nuclear layer, 
scale bar: 25 μm. B) Expression of transcription factors HIF-1α and phospho-STAT3 in the retina was analyzed in normoxic 
mice or immediately after hypoxic preconditioning by Western blotting. β-actin and STAT3 levels verified equal sample loading. 
Both transcription factors were induced immediately after hypoxia with some variability between individuals. Shown are results 
from two normoxic controls and from two mice preconditioned with hypoxia.
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after hypoxic preconditioning the retinal transcriptome
was similar to normoxic controls.
After normalization of the data by GCRMA algorithm to
minimize the theoretical appearance of false positive sig-
nals we detected 431 differentially regulated genes imme-
diately after hypoxia, 227 of which had a fold change
above 2 (0 h, Fig. 2). The number of regulated genes
decreased gradually until 16 h after hypoxia when just 3
genes showed altered expression levels (Fig. 2). The appli-
cation of our statistical filter for a maximal acceptable
FDR suggested that there are (statistically estimated) 25,
23, 6 and 1 false positive genes in the analyzed list of dif-
ferentially regulated genes at 0 h, 2 h, 4 h and 16 h, respec-
tively.
Prominently regulated genes
The genes with the strongest regulation after hypoxic
exposure are listed in Table 1 [for complete gene lists see
additional file 2]. The most significantly upregulated gene
(>118-fold) was found to be Obox6, a homeobox-contain-
ing, putative transcriptional activator of unknown func-
tion mainly expressed in oocytes [25]. The gene with the
strongest downregulation was the cold-inducible RNA
binding motif protein 3 (Rbm3) with a 19-fold reduced
expression immediately after hypoxia (Table 1).
Most interestingly, expression of several genes with a
potential capacity to protect photoreceptors against light-
induced cell death was upregulated (Table 1). To this
group belong p21 and Bcl2l10. In addition, genes belong-
ing to oxidative stress response pathways or lipid metabo-
lism like metallothioneins (Mt1 and Mt2), transthyretin
(Ttr) and paraoxonase1 (Pon1) were induced as was the
expression of adrenomedullin (Adm) which was previ-
ously shown to respond to hypoxic conditions [26] and to
have neuroprotective properties [27].
Some pro-apoptotic genes were downregulated after
hypoxic preconditioning (Table 1) like Mef2c, a transcrip-
tion factor involved in neuronal loss in Parkinson's dis-
ease [28] and in the regulation of apoptosis in
macrophages [29]. The genes belonging to the Rbm fam-
ily of genes are also of high interest since some members
of this family are known to have an impact on apoptosis
regulation [30].
Verification of Affymetrix microarray data
The expression of a total of 32 genes identified by the
microarrays was tested by realtime PCR. Differential
expression in response to hypoxia was verified for 21
(66%) genes (Fig. 3 and additional file 3). Quality control
analysis showed that the integrities of both retinal RNA
and chip surfaces were high [QC analysis, see additional
file 1] and are thus unlikely to be responsible for the
somewhat low confirmation frequency.
Since many of the genes which were not confirmed by
real-time PCR to be differentially regulated had a low
fold-change on the microarrays, we used only genes with
a minimal fold change of 2 for the investigations of func-
tionally related groups (see below). Figure 3 shows the
real-time PCR data of 4 selected genes with potential neu-
roprotective properties (p21, Pon1, Ttr, Adm). Consistent
with the microarray results, these genes were strongly
upregulated immediately after hypoxia and returned
quickly to normal expression levels during reoxygenation.
Biological functional groups and pathway analysis
The bioinformatics resource DAVID was used to study the
impact of differentially expressed genes on known biolog-
ical processes [31]. We obtained 39 functional groups for
upregulated genes and 8 groups for downregulated genes
immediately after hypoxia (H0). Significant functional
groups included 'apoptosis', 'cell cycle' or 'negative regula-
tion of transcription' (note that some genes appear in
more than one group) were found in the list of upregu-
lated genes (Table 2). Lists of all functional related groups
can be found in additional file 4. Gene signalling networks
affected by hypoxic preconditioning were identified using
Ingenuity Pathway analysis and the complete lists of regu-
lated genes (Fig 4 and see additional file 5). The centre of
the strongest affected pathway was occupied by p21, one of
the most strongly upregulated genes by hypoxia (Fig. 4).
All genes belonging to this pathway were differentially reg-
ulated. 70% of the genes were induced indicating that the
pathway was activated rather than repressed. All genes of
Number of genes differentially expressed immediately (0 h), 2 h, 4 h and 16 h after hypoxic preconditioningFigur 2
Number of genes differentially expressed immedi-
ately (0 h), 2 h, 4 h and 16 h after hypoxic precondi-
tioning. Gray bars: total number of significantly regulated 
genes. White bars: number of genes regulated at least 2-fold. 
The number of differentially regulated genes decreased rap-
idly during reoxygenation, indicating a fast return to the gene 
expression pattern of normoxic retinas.
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Table 1: Top 50 differentially regulated genes immediately after hypoxic preconditioning
Affymetrix ID Gene Symbol Gene Name FC pVal
UPREGULATED
1440257_at Obox6 oocyte specific homeobox 6 118.4 2.48E-07
1433837_at 8430408G22Rik RIKEN cDNA 8430408G22 gene 35.6 6.94E-05
1424638_at Cdkn1a cyclin-dependent kinase inhibitor 1A (p21) 30.5 3.00E-05
1454409_at 4833408G04Rik RIKEN cDNA 4833408G04 gene 24.0 2.07E-06
1418190_at Pon1 paraoxonase 1 22.5 1.98E-05
1422832_at Rgr retinal G protein coupled receptor 22.1 6.20E-05
1454608_x_at Ttr transthyretin 20.1 2.67E-04
1455913_x_at Ttr transthyretin 20.0 3.11E-04
1458610_at - --- 17.4 1.95E-04
1416434_at Bcl2l10 Bcl2-like 10 17.0 2.70E-05
1444487_at Lrat lecithin-retinol acyltransferase 16.2 6.54E-06
1441228_at Apold1 apolipoprotein L domain containing 1 11.7 7.21E-05
1438815_at Hist2h2aa2 histone 2, H2aa2 10.7 1.01E-04
1416077_at Adm adrenomedullin 10.6 2.48E-04
1430197_a_at Pitpnm2 phosphatidylinositol transfer protein, membrane-associated 2 10.3 5.36E-05
1428942_at Mt2 metallothionein 2 9.7 5.12E-06
1418808_at Rdh5 retinol dehydrogenase 5 9.7 9.82E-05
1427221_at MGI:2143217 X transporter protein 3 similar 1 gene 9.3 1.29E-04
1430817_at Samd7 sterile alpha motif domain containing 7 8.6 2.66E-04
1447494_at D7Bwg0826e DNA segment, Chr 7, Brigham & Women's Genetics 0826 expressed 7.2 5.77E-06
1428352_at Arrdc2 arrestin domain containing 2 7.1 6.05E-05
1446587_at - Transcribed locus 6.9 2.32E-04
1424838_at A330049M08Ri RIKEN cDNA A330049M08 gene 6.8 1.21E-04
1426117_a_at Slc19a2 solute carrier family 19 (thiamine transporter), member 2 6.8 1.80E-04
1430357_at H3f3b H3 histone, family 3B 6.3 5.84E-05
1422557_s_at Mt1 metallothionein 1 6.3 5.42E-06
1454991_at Slc7a1 solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 1
6.1 1.39E-04
1429348_at Sema3c semaphorin 3C 5.9 3.55E-04
1442366_at 6820408C15Ri RIKEN cDNA 6820408C15 gene (6820408C15Rik), mRNA 5.6 6.15E-05
1441673_at C80120 expressed sequence C80120 5.3 1.39E-04
DOWNREGULATED
1429169_at Rbm3 RNA binding motif protein 3 19.41 2.54E-04
1435692_at LOC622320 similar to retinoic acid, EGF, and NGF upregulated 7.02 3.79E-05
1447363_s_at Bub1b budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) 6.36 8.09E-06
1416961_at Bub1b budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) 5.41 1.20E-06
1444172_at - Transcribed locus 4.72 2.64E-04
1435158_at Rbm12b RNA binding motif protein 12B 4.40 6.09E-05
1425083_at Otor otoraplin 4.03 2.21E-04
1445709_at Mdm1 transformed mouse 3T3 cell double minute 1 3.97 1.64E-04
1450953_at Wdr39A WD repeat domain 39 3.70 1.93E-04
1456723_at Prr14 Proline rich 14 3.49 2.35E-05
1456834_at Ibrdc2 IBR domain containing 2 (Ibrdc2), mRNA 3.45 1.76E-04
1442051_at His2h3cl histone 2, H3c1 3.39 2.63E-04
1437647_at Dido1 death inducer-obliterator 1 3.38 6.54E-05
1421379_at Zfp354b zinc finger protein 354B 3.28 3.41E-04
1424852_at Mef2c myocyte enhancer factor 2C 3.22 1.40E-04
1429655_at Nudcd1 Nudcd1 NudC domain containing 1 3.19 3.84E-04 3.19 3.84E-04
1442249_at - Transcribed locus 3.11 1.03E-04
1416920_at Rbm4 RNA binding motif protein 4 3.11 1.44E-04
1460107_at 1700129I04Rik RIKEN cDNA 1700129I04 gene 3.11 1.74E-04
1453010_at Iws1 IWS1 homolog (S. cerevisiae) 2.98 2.80E-04
FC: fold change; pVal: p-value
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this pathway, which showed at least a two-fold differential
regulation on the chip, were tested by real-time PCR. Ten
of the 16 tested genes were confirmed to be regulated by
hypoxia (Table 3). This suggested that the p21-pathway
was indeed strongly affected by the hypoxic precondition-
ing protocol. Since it is known that p21 not only inhibits
cell cycle but can also repress apoptosis [32], it was consid-
ered as a strong candidate for the involvement in neuro-
protection by hypoxic preconditioning.
The influence of p21 on retinal neuroprotection in the 
model of light induced degeneration
The hypothesis that p21 is important for neuroprotection
in the retina after hypoxic preconditioning was directly
tested using p21 knockout animals. Both, normoxic and
hypoxic preconditioned p21-/- mice were exposed to high
intensity visible light for 2 hours and retinal morphology
was analyzed 10 days thereafter (Fig. 5). As expected, nor-
moxic control p21-/- mice showed strong damage after
light exposure with the loss of all photoreceptors in the
central retina. If p21 was involved in neuroprotection
after hypoxic exposure, preconditioned p21-/- mice should
show an increased susceptibility to light damage as com-
pared to wild type mice. However, photoreceptors of the
p21 knockout mice were completely protected after pre-
conditioning (Fig. 5). The quantification of cell death by
biochemical assays (data not shown) supported our con-
clusion that p21 does not contribute significantly to the
neuroprotective effect observed after hypoxic precondi-
tioning. Furthermore, most genes identified by Ingenuity
Pathway analysis as being part of the p21 signalling net-
work were similarly regulated in the presence or absence
of functional p21. The only exception was Semaphorin 3c
(Sema3c), which showed no hypoxic upregulation in the
absence of p21 (data not shown).
Discussion
Hypoxic preconditioning is strongly neuroprotective and
prevents photoreceptor apoptosis after exposure to high
levels of visible light [9]. The transcription factors HIF-1
and Stat3 are activated. This suggests differential regula-
tion of the expression of various target genes which was
confirmed by the detection of 431 differentially regulated
genes immediately after hypoxia. More than 50% of these
genes showed at least a 2-fold difference in the expression
level as compared to normoxic retinas. Among those were
also Rgr and Lrat, two genes highly expressed in the retinal
pigment epithelium. Genes normally not or only barely
expressed in the neuronal retina may easily reach a high-
fold induction when the tissue is contaminated with
neighbouring cells expressing the respective gene at high
levels. Low levels of oxygen during hypoxic precondition-
ing may have altered the physical interaction properties
between neuronal retina and retinal pigment epithelium
(RPE) leading to an increased contamination rate of the
retina by cells of the RPE during tissue isolation. Thus,
fold inductions have to be interpreted cautiously.
Reoxygenation caused the rapid return to a normal gene
expression pattern. This is in line with a model of hypoxic
preconditioning in brain where it was shown that differ-
ential gene regulation was low between 12 and 18 hours
of reoxygenation [33]. In models of ischemic precondi-
tioning (IPC), however, differential gene expression is
observed immediately after the stimulus until up to 7 days
after preconditioning [34-36]. This goes together with a
long lasting neuroprotective effect of IPC observed in the
retina [10] and in brain [37] suggesting that mechanisms
of IPC may differ from those of acute hypoxic precondi-
tioning. An extended neuroprotection by hypoxic precon-
ditioning may be achieved by the repetitive exposure to
low oxygen [12].
Similarities of hypoxic preconditioning and IPC
Although mechanisms of hypoxic preconditioning and
IPC may differ, few genes were found to be differentially
regulated in both types of preconditioning protocol.
Among those are metallothionein 2 (Mt2), C/ebpd (an
apoptosis-related transcription factor) and p21 [35,38].
The identification of these genes makes them strong candi-
dates for playing a role in general retinal neuroprotection.
Expression of candidate genes analyzed by real-time PCRFigure 3
Expression of candidate genes analyzed by real-time 
PCR. Expression profile of p21 (Cdkn1a), Pon1 (paraoxonase 
1) Ttr (transthyretin) and Adm (adrenomedullin) immediately 
after hypoxic exposure (0 h), or after a period of 2 h, 4 h or 
16 h of reoxygenation as determined by real-time PCR. Fold-
changes are expressed relative to normoxic controls of 
respective time points, which were set to one. n = 5 for each 
treatment and time point. White bars: samples of normoxic 
retinas, grey bars: samples of hypoxic preconditioned retinas; 
*** p ≥ 0.001, ** p ≥ 0.01, * p ≥ 0.05).
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An involvement of p21 was directly tested using the
respective knockout animal. As a HIF-1 target gene [39],
p21 was not only very strongly regulated but was also at
the center of a highly regulated gene network (Fig. 4).
Although p21 can be pro-apoptotic [40] and can trigger
non-apoptotic cell death [41], it is also known to have
antiapoptotic properties [42]. However, the test of p21
knockout mice in the model of light induced degenera-
tion revealed no significant impact of p21 on neuroprotec-
tion against light damage. Despite the lack of p21, all
other genes of the p21 pathway (except for Sema3c)
showed the same response to hypoxic preconditioning as
in wild type mice. This raises the possibility that other
genes of the p21 network might influence retinal neuro-
protection. Specific candidates are Timp3 which has been
reported to be a promoter of apoptosis through the inhi-
bition of metalloproteinases [43] and Egf which has
proven anti-apoptotic properties [44].
Mt2, as a gene also detected in both preconditioning
schemes, may play an important role as a scavenger of free
radicals [45]. It is interesting to note that metal-
lothioneins are also induced after ischemic precondition-
ing of the rat spinal cord [34] and that they have been
reported to be neuro- and cardioprotective, respectively,
in various degenerative models [46,47]. In addition, met-
allothioneins have been shown to be induced in light-
damaged retinas [48] and to protect retinas from oxidative
Table 2: Differentially regulated genes with possible impact on cell survival and neuroprotection; detected and functionally clustered 
by DAVID.
Affymetrix ID Gene Symbol Gene Name FC
Up-regulated
apoptosis (p ≥ 0.032)
1424638_at Cdkn1a cyclin-dependent kinase inhibitor 1a (p21) 30.5
1416434_at Bcl2l10 Bcl2-like 10 17.0
1442025_a_at Zbtb16 zinc finger and btb domain containing 16 3.6
1454109_a_at Ptdsr phosphatidylserine receptor 2.4
1420909_at, 1451959_a_at Vegfa vascular endothelial growth factor a 2.3
1453851_a_at Gadd45g growth arrest and dna-damage-inducible 45 gamma 2.3
1452050_at Camk1d calcium/calmodulin-dependent protein kinase id 2.1
1454903_at Ngfr nerve growth factor receptor (TNFR superfamily, member 16) 2.0
cell cycle (p ≥ 0.013)
1424638_at Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) 30.5
1416309_at Nusap1 nucleolar and spindle associated protein 1 4.4
1454018_at Tlk2 tousled-like kinase 2 (Arabidopsis) 4.3
1449007_at Btg3 B-cell translocation gene 3 4.2
1424143_a_at, 1424144_at Cdt1 retroviral integration site 2 3.4
1419024_at, 1455002_at Ptp4a1 protein tyrosine phosphatase 4a1 2.7
1453851_a_at Gadd45g growth arrest and DNA-damage-inducible 45 gamma 2.3
1420909_at, 1451959_a_at Vegfa vascular endothelial growth factor A 2.3
1459978_x_at - gene model 877 (NCBI) 2.0
1435870_at Sycp3 synaptonemal complex protein 3 2.0
negative regulation of transcription (p ≥ 0.031)
1442025_a_at Zbtb16 zinc finger and btb domain containing 16 3.6
1425809_at Fabp4 Fatty acid binding protein 4, adipocyte (Fabp4), mRNA 3.5
1425895_a_at Id1 inhibitor of DNA binding 1 3.1
1442397_at Nfx1 nuclear transcription factor, X-box binding 1 2.7
1425732_a_at Mxi1 Max interacting protein 1 2.1
Down-regulated
regulation of transcription (p ≥ 0.09)
1440343_at Rps6ka5 ribosomal protein S6 kinase, polypeptide 5 0.42
1450034_at Stat1 signal transducer and activator of transcription 1 0.47
1416826_a_at Trfp Trf (TATA binding protein-related factor)-proximal protein homolog (Drosophila) 0.41
1450953_at Wdr39 WD repeat domain 39 0.27
1421379_at Zfp354b zinc finger protein 354B 0.31
1424852_at Mef2c myocyte enhancer factor 2C 0.31
1437647_at Dido1 death inducer-obliterator 1 0.30
1443952_at Thra thyroid hormone receptor alpha 0.48
1428760_at Snapc3 small nuclear RNA activating complex, polypeptide 3 0.40
1456723_at Prr14 Proline rich 14 0.29
Analysis of the gene expression pattern was immediately after hypoxia; FC: fold change
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The most prominently affected gene network discovered by Ingenuity Pathway AnalysisFigure 4
The most prominently affected gene network discovered by Ingenuity Pathway Analysis. Network was classified 
as: Cellular growth & proliferation, DNA replication, recombination & repair. Pathway contains pro survival genes like Egf, Vegf and 
p21, which occupy central positions in this network. Red: induction; green: repression; white: unaffected; colour intensity cor-
relates with fold change.
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stress caused by the glutamate analogue NMDA [49]. Fur-
ther experiments are clearly needed to evaluate the impact
of this protein in retinal neuroprotection.
The low similarity of the transcriptome after IPC and
hypoxic preconditioning may be surprising but might be
based on the different nature of the preconditioning pro-
tocols. Whereas IPC normally uses a very short (minutes)
ischemic stimulus followed by reperfusion, our protocol
of hypoxic preconditioning uses exposure to 6 hours of
low oxygen concentrations followed by the immediate
analysis. The different length of exposure to low oxygen
and the interrupted supply of nutrients in one (IPC) but
not the other protocol might essentially explain the differ-
ences in the gene expression patterns.
Strong candidate genes for neuroprotection: Adm, Pon1
Adrenomedullin (Adm) is a multifunctional protein
involved in angiogenesis, cancer promotion, host defence
and neuroprotection [50]. Elevated levels of Adm were
found in plasma of patients suffering from retinitis pig-
mentosa [51]. Previous reports identified Adm as a target
gene of HIF-1α [52,53] linking it to a possible HIF – medi-
ated protection mechanism.
Interestingly, some genes which so far were not described
in the context of hypoxia, like paraoxonase 1 (Pon1), were
also highly induced. Pon1 is a high-density lipoprotein
(HDL) associated enzyme which plays a major role in the
prevention of lipid peroxidation [54,55]. Since retinal
degeneration involves oxidative stress and inhibition of
lipid peroxidation protects against light damage [56] Pon1
may have an important role in retinal protection after
hypoxic preconditioning. Recently, Pon1 levels were
found to be reduced in serum of AMD patients whereas a
marker for oxidative stress was elevated [57]. This may
suggest that elevated levels of Pon1 in our model might
reduce oxidative stress and prevent photoreceptor degen-
eration. Interestingly, C57Bl/6 mice which have a reduced
sensitivity to light damage show a higher basal expression
of Pon1 than light sensitive strains (data not shown). If the
anti-oxidative enzyme Paraoxonase 1 was involved in the
protection of the retina against oxidative damage, the dif-
ferent basal expression levels of Pon1 might contribute to
the different light damage susceptibilities of various
mouse strains.
Additional genes with potential neuroprotective function
Bcl2-like 10 (Bcl2l10) is a anti-apoptotic member of the
Bcl2 family [58] acting to suppress cell death by prevent-
ing cytochrome c release, casp-3 activation and mitochon-
drial membrane collapse [59]. However, retinal
degeneration induced by acute light exposure may not
depend on cytochrome c release or caspase activation
[60]. Therefore, upregulation of Bcl2l10 might not be
responsible for photoreceptor protection by hypoxic pre-
conditioning.
Induction of the HIF-1 target gene Vegfa is an attempt to
increase tissue oxygen levels by improving blood circula-
Table 3: Real-Time PCR results of 16 genes belonging to the p21 
pathway compared to the fold change (FC) detected by 
Affymetrix microarrays.
Gene symbol FC Affymetrix 
Chip
FC PCR
Cdkn1a (p21) 30.5 20.3*
Sema3c 5.9 3.9*
Egf 4.7 2.8*
HMGB2 4.1 3.0*
Fabp4 3.5 5.3*
CEBPd 3.5 3.5*
Timp3 3.3 3.7*
ID1 3.1 1.8*
Rad23b 2.6 1.2
Vegf 2.3 2.0*
Stom 2.0 1.3
Hes6 1.9 1.6*
SOS1 1.9 0.9
Stat1 0.5 1.1
Thra 0.5 0.8
IBRDC2 0.3 0.9
Analysis of gene expression was immediately after hypoxia
FC: fold change. * p < 0.05
Role of p21 in hypoxic preconditioningFigure 5
Role of p21 in hypoxic preconditioning. Hypoxic pre-
conditioned (hypoxia) or normoxic (normoxia) p21-/- mice 
were exposed to 13'000 lux of white light for 2 hours and 
retinal morphology was analyzed 10 days thereafter. Dark-
adapted knockout mice served as controls (dark control). 
Hypoxic preconditioning almost completely protected the 
retina of p21-/- mice leading to a retinal morphology indistin-
guishable from controls. Exposure of normoxic mice led to a 
complete degeneration of photoreceptors in the central ret-
ina. Shown are representative samples of control and light 
exposed mice. n = 2 (controls); n = 4 (light exposed mice). 
Abbreviations as in Fig. 1. Scale bar: 25 μm.
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tion through the formation of new vessels [61]. In the ret-
ina Vegfa is also recognized as a pro-survival factor
protecting retinal neurons against ischemic injury [62].
However, Vegfa is discussed to have also pro-apoptotic
properties [63] and its potential role in the precondition-
ing scheme is unclear. Ptdsr encodes a posphatidylserine
receptor involved in the clearance of apoptotic cells [64]
and it has been shown that lack of Ptdsr activity can
increase tissue damage through the stimulation of apop-
tosis in cells neighbouring apoptotic cells [65]. Ptdsr is
also involved in the elimination of apoptotic debris of
dying photoreceptors by macrophage-mediated phagocy-
tosis which is important for the maintenance of retinal tis-
sue integrity [66].
Downregulated genes with a possible impact on cell death
included Mef2c and genes of the Rbm family of protein.
Mef2c triggers apoptosis in macrophages [29] and may be
involved in dopaminergic neuron death in Parkinson's
disease [28]. Because macrophages seem to play an
important role in light induced apoptosis [67,68] a poten-
tial influence on neuroprotection may be possible but
needs further investigation. This is also true for the identi-
fied members of the Rbm family. Although these proteins
have been implicated in the modulation of apoptosis
[30], and downregulation of Rbm3 has been specifically
connected to the regulation of cell cycle progression [69]
and the inhibition of apoptosis [70], their role is still con-
troversial.
Conclusion
Since hypoxia can either lead to adaptation and protec-
tion [71] or to apoptosis [72] it may not be surprising that
we identified several genes which may rather be involved
in promoting apoptosis than in its inhibition. Neuropro-
tection by hypoxic preconditioning may thus depend on
a balance between numerous anti- and proapoptotic fac-
tors. The loss of individual proteins like p21 may not be
sufficient to shift the balance towards apoptosis. Likewise,
it might require several different antiapoptotic factors to
fully protect the retina. Full neuroprotection may only be
achieved by controlling the central regulators of the
hypoxic response like the transcription factors HIF and/or
STAT3.
Methods
Animals, hypoxic preconditioning and light damage
Animals were treated in accordance with the regulations
of the Veterinary Authority of Zurich and with the state-
ment of 'The Association for Research in Vision and Oph-
thalmology' for the use of animals in research. BALB/c
mice were purchased from Harlan (The Netherlands) and
p21-/- mice on a mixed Bl/6;129S2 background were
obtained from Jackson Laboratory (Bar Harbor, USA). All
mice were homozygous for the light sensitive Rpe65450Leu
variant [73]. Hypoxic preconditioning (6% O2 for 6
hours) was performed as described previously [9]. Reoxy-
genation was allowed in darkness for 4 h, 8 h, 12 h and 16
h in normal room air. After reoxygenation BALB/c mice
were exposed to 5'000 lux of white fluorescent light for 1
h and analyzed at time points as indicated.
Pupils of p21-/- animals (pigmented) were dilated in dim
red light using 1% Cyclogyl (Alcon, Cham, Switzerland)
and 5% Phenylephrine (Ciba Vision, Niederwangen,
Switzerland) 45 minutes prior to illumination. Light dose
(13'000 lux) and exposure duration (2 h) was adjusted
according to the decreased light damage susceptibility of
this mouse strain. After light exposure animals remained
in darkness until analyzed or at the most for 36 h.
For morphology mice were sacrificed 36 h or 10 days after
light exposure and eyes were enucleated and processed as
previously described [74].
RNA isolation and Affymetrix microarrays
Retinas were isolated immediately, 2 h, 4 h and 16 h after
hypoxic preconditioning, frozen in liquid nitrogen and
stored at -70°C. Normoxic controls were treated in paral-
lel and collected at the same time points. For Affymetrix
microarrays 3 retinas of 3 different mice were pooled. This
procedure was repeated 3 times to generate independent
biological triplicates. RNA was extracted using the RNeasy
isolation kit (Qiagen, Hilden, Germany), including a
DNase treatment to digest residual genomic DNA. RNA
was processed according to standard procedures and
hybridized to Affymetrix GeneChip® Mouse Genome 430
2.0 microarrays. The 3 experimental replicates were
hybridized independently resulting in three microarray
replicates per condition. In total, 24 Affymetrix gene chips
were hybridized with RNA from 72 retinas of 72 mice.
Quality control (QC) and Affymetrix microarray analysis
To analyze the quality of the results after gene chip hybrid-
ization we employed RReporterGenerator [75] combining
Affymetrix-style QC, RMA and residual QC. The complete
report is available in additional file 1.
Affymetrix raw gene expression data were summarized
and normalized using the GCRMA procedure [76]. The
data were filtered in order to remove probe-sets with con-
stant low-level expression. Probe-sets were removed
which showed replicate means for a given time-point for
both treatments below the threshold separating the two
peaks of the bimodal distribution of signal-intensity val-
ues. This procedure was performed independently for
each of the differential testing procedures. The filtered
data-sets were subsequently subjected to t-tests with mul-
tiple testing correction and control of the false discovery
rate (FDR) using OCplus package [77] available under
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Bioconductor [78]. By comparing the plotted number of
differentially expressed genes at various FDR levels, corre-
sponding threshold values for the maximum acceptable
FDR were chosen with the aim of keeping homogenous
groups with similar FDR together.
To group differentially regulated genes according to their
biological function the Affymetrix IDs were imported into
the Database for Annotation, Visualization and Integrated
Discovery (DAVID) from the National Institute of Allergy
and Infectious Diseases (NIAID), NIH [31,79] and into
Ingenuity Pathway Analyses from Ingenuity Systems [80].
Real-time PCR
cDNA was prepared from equal amounts of total retinal
RNA, using oligo(dT) primers and M-MLV reverse tran-
scriptase (Promega, Madison, WI, USA). 10 ng of cDNA
was amplified in a LightCycler 480 instrument (Roche
Diagnostics AG, Rotkreuz, Switzerland) using LightCycler
480 SYBR Green I Master Mix (Roche Diagnostics AG) and
appropriate primer pairs [see additional file 6]. mRNA
levels were normalized to β-actin and relative values were
calculated using a respective calibrator.
Western blotting
Retinas were homogenized in 0.1 M Tris/HCl (pH 8.0) by
sonification at 4°C. The protein content was determined
using a Bradford assay (Bio-Rad, Munich, Germany). Pro-
tein extracts were mixed with SDS sample buffer and incu-
bated for 10 min at 90°C. Proteins were separated by SDS-
PAGE and blotted onto a nitrocellulose membrane. After
blocking with 5% non-fat dry milk (Bio-Rad, Munich,
Germany) in TBST (Tris/HCl 10 mM, pH 8; 150 mM
NaCl; 0.05% Tween-20) membranes were incubated with
primary antibodies at 4°C over night. Primary antibodies
used were: rabbit anti-HIF-1α (Novus Biologicals NB
100–479; 1:1000), rabbit anti-phospho-STAT3 (Cell Sig-
nalling; 1:500), rabbit anti-STAT3 (Cell Signalling
1:1000) and goat anti-β-actin (Santa Cruz; 1:1000). After
incubation with horseradish peroxidase labelled second-
ary antibodies for 1 h at room temperature the protein
bands were visualized by the application of a chemilumi-
nescent substrate (PerkinElmer, Boston, USA) and expo-
sure to a Super RX film (Fujifilm, Dielsdorf, Switzerland).
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Pathway Analysis and classified as: Cell death, cellular development, 
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Affymetrix Batch QC using RReportGenerator and R
September 21, 2007
This document was generated by Analysis Type File automAffyQC2.Rnw’, Version: 1.0.8
a protocol for automated QC analysis for Affymetrix expression array data.
Written by wolfgang.raffelsberger@igbmc.u-strasbg.fr, LGBI, IGBMC (Strasbourg, France).
QC analysis of 24 cel-files of type Mouse430.2 found in :
[1] "/genomics/g6/CELs/retine/Gri_Hypox/all"
page 3
The blots address original PM values, either as boxplot or as density estimate for the signal distribution (similar to packages
simpleaffy and affyQCReport).
page 4
This figure shows the QC plot from the simpleaffy package. Briefly, these plots show the 3’ to 5’ ratio for spiked-in and
control genes (typically with triangles for b-Actin and squares fro GAPDH). The dot with the vertical line (heading to
0) shows the scaling factor. Finally, the percentage of present calls and value of average background are shown in the left
part of the image.
page 5
This pair of graphs shows the RLE (top) and NUSE (bottom) plots from the affyPLM package. The RLE compares
expression values on each array against median expression values, for a probeset across all arrays, and the NUSE plot
shows the standard errors for each gene standardized across all arrays.
page 6
This page shows false color images for the residuals (from the affyPLM package, with red intensities corresponding to
positive residuals and blue to negative residuals).
page 7
MA plots (from affyPLM package) of each array against a synthetic median array (constructed from probe-wise medians).
The red line represents a lowess fit to the scatter plot and is helpful in indicating non-linear relationships.
page 8
In the top part the RNA degaradation plot shows the average intensity with respect to the sorted 5’ to 3’ position of
the probes in the target-sequence. Depending on the type of microarray specific patters can be observed (see also Bol-
stad and Gentleman et al) . The lower figure shows a density estimate for the signal distribution of data resulting from RMA.
page 9
Similarity between GCRMA summarized samples measured as Eucliedean Distance.
Top: Distance matrix for all pairwise comparisons. Red cells indicate very similar samples.
Bottom: Dendrogram from Hierarchical Clustering with Bootstrap p-Values. Approximately Unbiased (AU) p values are
shown in red, Bootstrap Probability (BP) in green. AU might be a better approximation to unbiased p-value than BP values
(Suzuki et al).
The aim of this report is to provide information on multiple QC aspects for a set of Affymetrix arrays. The interpretation of QC
parameters and QC plots should be done with care since this may lead to delicate decisions. For further information and details
about the plots shown in this report please look at the references section.
The analysis was run on September 21, 2007 , using R version 2.5.1 on a x86-64-unknown-linux-gnu system.
..total computing time : 417.6 min
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time for reading cel-fiels : 212.46 sec
time for figures QC1 and QC2 : 320.76 sec
time for RNA degradation figure : 25.13 sec
time for plm calculation : 72.62 sec
time for RLE and NUSE figures : 14.75 sec
time for residual images : 603.45 sec
time for MA-plots : 800.85 sec
time for calculating RMA : 252.31 sec
time for plot of Sig Dist of RMA treated data : 2.08 sec
time for hierarchical clustering and bootstrap pValues : 138.9 min
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RESULTS  57 
3.1.1.2 Lists of Differentially Regulated Genes (Additional File 2) 
 
TABLE 1 Differentially Regulated Genes by Hypoxic Preconditioning H0 
AffymetrixID p-Value Fold change Gene  
1440257_at 2.48E-07 118.36 oocyte specific homeobox 6 
1433837_at 6.94E-05 35.63 RIKEN cDNA 8430408G22 gene 
1424638_at 3.00E-05 30.48 cyclin-dependent kinase inhibitor 1A (P21) 
1454409_at 2.07E-06 24.02 RIKEN cDNA 4833408G04 gene 
1418190_at 1.98E-05 22.55 paraoxonase 1 
1422832_at 6.20E-05 22.09 retinal G protein coupled receptor 
1454608_x_at 0.00026744 20.11 transthyretin  
1455913_x_at 0.000310957 19.97 transthyretin  
1458610_at 0.000195109 17.40 ---  
1416434_at 2.70E-05 17.02 Bcl2-like 10  
1444487_at 6.54E-06 16.17 ---  
1441228_at 7.21E-05 11.68 PREDICTED: similar to vascular early response 
gene protein [Mus musculus], mRNA sequence 
1438815_at 0.000101469 10.73 histone 2, H2aa2 
1416077_at 0.000248019 10.59 adrenomedullin 
1430197_a_at 5.36E-05 10.27 phosphatidylinositol transfer protein, membrane-
associated 2 
1428942_at 5.12E-06 9.72 metallothionein 2 
1418808_at 9.82E-05 9.72 retinol dehydrogenase 5 
1427221_at 0.000128871 9.33 X transporter protein 3 similar 1 gene 
1430817_at 0.000266245 8.60 sterile alpha motif domain containing 7 
1447494_at 5.77E-06 7.15 RIKEN cDNA 2600013E07 gene 
1428352_at 6.05E-05 7.06 arrestin domain containing 2 
1446587_at 0.000232092 6.93 Transcribed locus 
1424838_at 0.000120631 6.82 RIKEN cDNA A330049M08 gene 
1426117_a_at 0.00018024 6.76 solute carrier family 19 (thiamine transporter), 
member 2 
1430357_at 5.84E-05 6.28 H3 histone, family 3B 
1422557_s_at 5.42E-06 6.26 metallothionein 1 
1454991_at 0.000139272 6.11 solute carrier family 7 (cationic amino acid 
transporter, y+ system), member 1 
1429348_at 0.00035515 5.86 sema domain, immunoglobulin domain (Ig), short 
basic domain, secreted, (semaphorin) 3C 
1442366_at 6.15E-05 5.61 RIKEN cDNA 6820408C15 gene (6820408C15Rik), 
mRNA 
1441673_at 0.000139215 5.28 expressed sequence C80120 
1448231_at 1.89E-06 5.01 FK506 binding protein 5 
1435918_at 0.000181976 4.94 cDNA sequence BC055107 
1418093_a_at 3.96E-06 4.70 epidermal growth factor 
1423785_at 0.00036492 4.44 EGL nine homolog 1 (C. elegans) 
1416309_at 0.000163701 4.43 nucleolar and spindle associated protein 1 
1455385_at 0.000158024 4.40 SEC15-like 1 (S. cerevisiae) 
1454018_at 0.000249767 4.33 tousled-like kinase 2 (Arabidopsis) 
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1428923_at 3.47E-05 4.28 protein phosphatase 1, regulatory (inhibitor) subunit 
3G 
1444528_at 7.25E-05 4.25 Zinc finger protein 316 (Zfp316), mRNA 
1449007_at 0.000123554 4.21 B-cell translocation gene 3 
1455475_at 0.000267688 4.16 RIKEN cDNA 3110057O12 gene 
1452534_a_at 7.43E-05 4.06 high mobility group box 2 
1422803_at 0.000298361 4.04 follistatin-like 3 
1434203_at 0.000193383 3.94 cDNA sequence BC055107 
1453303_at 0.000107858 3.93 RIKEN cDNA 4833417J20 gene 
1431308_at 0.00036618 3.91 RIKEN cDNA 5730557B15 gene 
1427507_at 0.000166537 3.89 tripartite motif protein 17 
1416125_at 1.05E-05 3.85 FK506 binding protein 5 
1458669_at 0.000151183 3.72 Transcribed locus 
1459331_at 0.000195472 3.66 surfeit gene 6 
1442025_a_at 0.000106863 3.61 ---  
1451959_a_at 1.74E-05 3.56 vascular endothelial growth factor A 
1456676_a_at 0.000226291 3.56 6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 3 
1445443_at 0.000133959 3.52 ---  
1425809_at 0.00034519 3.50 Fatty acid binding protein 4, adipocyte (Fabp4), 
mRNA 
1423233_at 0.00038307 3.47 CCAAT/enhancer binding protein (C/EBP), delta 
1440555_at 1.03E-05 3.45 Ras-related GTP binding D 
1436279_at 8.46E-06 3.40 Solute carrier family 26, member 7 (Slc26a7), 
mRNA 
1417887_at 5.87E-05 3.40 RIKEN cDNA 1110055N21 gene 
1424143_a_at 0.000174386 3.37 retroviral integration site 2 
1424144_at 0.00037672 3.28 retroviral integration site 2 
1419089_at 4.49E-05 3.28 tissue inhibitor of metalloproteinase 3 
1451325_at 4.70E-05 3.26 forty-two-three domain containing 1 
1448359_a_at 7.11E-05 3.23 HIG1 domain family, member 1A 
1434202_a_at 0.000112753 3.23 cDNA sequence BC055107 
1436006_at 0.00026245 3.18 eukaryotic translation initiation factor 2 alpha kinase 
1 
1454617_at 5.15E-05 3.15 arrestin domain containing 3 
1454623_at 0.00036572 3.13 similar to Carboxypeptidase A2 precursor 
1427364_a_at 0.000104267 3.13 ornithine decarboxylase, structural 1 /// similar to 
Ornithine decarboxylase (ODC) /// similar to 
Ornithine decarboxylase (ODC) 
1425895_a_at 0.000108139 3.10 inhibitor of DNA binding 1 
1449335_at 8.21E-05 3.10 tissue inhibitor of metalloproteinase 3 
1422885_at 1.33E-05 3.10 small nuclear ribonucleoprotein D3 
1436605_at 0.000112507 3.10 transketolase 
1419029_at 5.21E-05 3.08 ERO1-like (S. cerevisiae) 
1443196_at 5.64E-05 3.03 13 days embryo heart cDNA, RIKEN full-length 
enriched library, clone:D330001J12 
product:unclassifiable, full insert sequence 
1437313_x_at 7.81E-05 3.00 high mobility group box 2 
1433814_at 0.00037743 2.99 Transcribed locus 
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1449324_at 2.01E-05 2.98 ERO1-like (S. cerevisiae) 
1454949_at 0.00035566 2.97 Ubiquitin specific peptidase 7 (Usp7), mRNA 
1437818_at 0.000141517 2.95 RIKEN cDNA 9430016H08 gene 
1419030_at 6.69E-06 2.93 ERO1-like (S. cerevisiae) 
1423865_at 3.18E-05 2.93 solute carrier family 44, member 1 
1429183_at 9.59E-05 2.91 plakophilin 2 
1448607_at 0.000262344 2.90 pre-B-cell colony-enhancing factor 1 
1429050_at 6.50E-05 2.88 cysteine-rich hydrophobic domain 2 
1434570_at 0.000228516 2.84 cDNA sequence AK122525 
1440932_at 0.0003692 2.79 ---  
1457451_at 0.000104526 2.78 ---  
1416432_at 1.39E-05 2.77 6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 3 
1442397_at 6.18E-05 2.74 nuclear transcription factor, X-box binding 1 
1436531_at 0.000293193 2.74 methionine aminopeptidase 2 
1450725_s_at 0.000171891 2.73 carbonic anhydrase 14 
1433674_a_at 0.00011106 2.70 RNA, U22 small nucleolar 
1438681_at 7.67E-05 2.69 alkB, alkylation repair homolog (E. coli) 
1418370_at 9.16E-05 2.69 troponin C, cardiac/slow skeletal 
1452891_at 0.000141048 2.68 RIKEN cDNA 5730568A12 gene 
1428544_at 9.38E-05 2.67 RIKEN cDNA 0610007L01 gene 
1452414_s_at 0.000300782 2.67 DNA segment, Chr 19, ERATO Doi 678, expressed 
1428823_at 0.000153081 2.66 HD domain containing 2 
1419024_at 0.00032058 2.66 protein tyrosine phosphatase 4a1 
1417149_at 0.000108159 2.65 procollagen-proline, 2-oxoglutarate 4-dioxygenase 
(proline 4-hydroxylase), alpha II polypeptide 
1441315_s_at 0.00032571 2.65 solute carrier family 19 (thiamine transporter), 
member 2 
1430746_at 0.000258587 2.64 RIKEN cDNA 1110050P16 gene 
1416039_x_at 0.000107418 2.61 cysteine rich protein 61 
1450412_at 8.83E-05 2.60 transducin (beta)-like 2 
1430798_x_at 0.000201526 2.60 mitochondrial ribosomal protein L15 
1455420_at 5.14E-05 2.59 RAD23b homolog (S. cerevisiae) 
1435875_at 3.18E-06 2.57 protein kinase, AMP-activated, beta 2 non-catalytic 
subunit 
1416481_s_at 0.000298381 2.57 HIG1 domain family, member 1A 
1429089_s_at 0.00029993 2.55 RIKEN cDNA 2900026A02 gene 
1435245_at 5.29E-05 2.53 glutaminase 2 (liver, mitochondrial) 
1455002_at 0.000226722 2.53 protein tyrosine phosphatase 4a1 
1456748_a_at 3.83E-05 2.52 4-nitrophenylphosphatase domain and non-
neuronal SNAP25-like protein homolog 1 (C. 
elegans) 
1437088_at 0.000201662 2.51 SDA1 domain containing 1 
1431212_a_at 0.00010318 2.51 RIKEN cDNA 3300001M20 gene 
1446769_at 3.20E-05 2.49 RIKEN cDNA 2810439F02 gene 
1426417_at 0.00032499 2.46 Yip1 domain family, member 4 
1437785_at 3.66E-05 2.46 a disintegrin-like and metallopeptidase (reprolysin 
type) with thrombospondin type 1 motif, 9 
1416512_at 0.000202856 2.44 nucleotide binding protein 2 
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1454109_a_at 9.54E-05 2.40 phosphatidylserine receptor 
1419087_s_at 0.00033316 2.39 splicing factor 3a, subunit 1 
1438761_a_at 2.95E-05 2.38 ornithine decarboxylase, structural 1 /// similar to 
Ornithine decarboxylase (ODC) /// similar to 
Ornithine decarboxylase (ODC) 
1453851_a_at 0.000308457 2.34 growth arrest and DNA-damage-inducible 45 
gamma 
1455320_at 0.00014932 2.33 expressed sequence AI480535 
1439677_at 0.000133355 2.32 epilepsy, progressive myoclonic epilepsy, type 2 
gene alpha 
1416749_at 0.00038473 2.32 HtrA serine peptidase 1 
1434952_at 0.000246056 2.32 Cytochrome c oxidase subunit IV isoform 1 
(Cox4i1), mRNA 
1438046_at 3.82E-05 2.31 expressed sequence AU019823 
1426727_s_at 0.00037587 2.30 protein phosphatase 1, regulatory subunit 10 /// 
hypothetical protein LOC545202 
1455782_at 9.53E-05 2.29 sterile alpha motif domain containing 7 
1420909_at 0.000304099 2.25 vascular endothelial growth factor A 
1416344_at 0.000278017 2.22 lysosomal membrane glycoprotein 2 
1422476_at 0.000116371 2.21 interferon gamma inducible protein 30 
1426721_s_at 0.00035377 2.21 TCDD-inducible poly(ADP-ribose) polymerase 
1440179_x_at 6.63E-05 2.21 similar to hypothetical protein MGC26996; 
chromosome 6 open reading frame 172 
1438606_a_at 8.03E-05 2.20 chloride intracellular channel 4 (mitochondrial) 
1455254_at 0.000205617 2.13 RIKEN cDNA 4833420G11 gene 
1459897_a_at 0.000230612 2.13 suprabasin  
1425732_a_at 0.00033976 2.12 Max interacting protein 1 
1444241_at 0.000144929 2.10 WW domain containing adaptor with coiled-coil 
1428529_at 7.11E-06 2.09 RIKEN cDNA 2810026P18 gene 
1435351_at 1.85E-06 2.08 RIKEN cDNA 2310026E23 gene 
1458046_at 0.00036917 2.08 ---  
1420138_at 0.000169245 2.07 solute carrier family 19 (sodium/hydrogen 
exchanger), member 1 
1452050_at 6.02E-05 2.06 calcium/calmodulin-dependent protein kinase ID 
1425477_x_at 0.00034286 2.06 histocompatibility 2, class II antigen A, beta 1 
1448654_at 0.000205405 2.04 mitochondrial carrier homolog 2 (C. elegans) 
1438251_x_at 0.000101884 2.04 HtrA serine peptidase 1 
1449341_a_at 1.96E-05 2.03 stomatin  
1454903_at 0.000234716 1.98 nerve growth factor receptor (TNFR superfamily, 
member 16) 
1426600_at 0.000112368 1.98 solute carrier family 2 (facilitated glucose 
transporter), member 1 
1434012_at 0.000266359 1.96 RIKEN cDNA 1110055N21 gene 
1435870_at 0.000120695 1.95 Synaptonemal complex protein 3 (Sycp3), mRNA 
1459978_x_at 5.28E-05 1.95 gene model 877, (NCBI) 
1421884_at 0.000218307 1.92 Son of sevenless homolog 1 (Drosophila) 
1418777_at 0.000267738 1.91 chemokine (C-C motif) ligand 25 
1417288_at 3.45E-05 1.90 pleckstrin homology domain-containing, family A 
(phosphoinositide binding specific) member 2 
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1428754_at 3.70E-05 1.86 RIKEN cDNA 3300001M20 gene 
1436050_x_at 0.000256706 1.86 hairy and enhancer of split 6 (Drosophila) 
1454937_at 0.000241224 1.85 RIKEN cDNA B630005N14 gene 
1419938_s_at 0.000155818 1.85 ---  
1433436_s_at 0.00032398 1.85 thiamine triphosphatase 
1456005_a_at 3.98E-05 1.85 BCL2-like 11 (apoptosis facilitator) 
1426288_at 0.000175909 1.85 low density lipoprotein receptor-related protein 4 
1451893_s_at 0.000246465 1.85 membrane associated guanylate kinase, WW and 
PDZ domain containing 1 
1457275_at 0.000234799 1.84 desmuslin  
1435448_at 0.000131445 1.83 BCL2-like 11 (apoptosis facilitator) 
1455671_at 0.000233252 1.83 COMM domain containing 8 
1426594_at 0.00011977 1.82 FERM domain containing 4B 
1453344_at 0.000116605 1.82 RIKEN cDNA 1810032O08 gene 
1416129_at 0.00035436 1.78 ERBB receptor feedback inhibitor 1 
1456355_s_at 6.90E-05 1.77 sensitivity to red light reduced homolog 
(Arabidopsis) 
1451872_a_at 9.59E-06 1.73 neuralized-like homolog (Drosophila) 
1424526_a_at 0.000123901 1.73 TDP-glucose 4,6-dehydratase 
1423480_at 0.000139804 1.73 nucleolar protein 11 
1448276_at 0.000276959 1.72 tetraspanin 4 
1418561_at 0.0003567 1.72 splicing factor 3b, subunit 1 
1439032_at 9.05E-05 1.71 RIKEN cDNA 2410007P03 gene 
1436209_at 5.69E-05 1.71 DnaJ (Hsp40) homolog, subfamily C, member 16 
1427171_at 0.000130998 1.70 rearranged L-myc fusion sequence 
1434680_at 0.0003249 1.70 pleckstrin homology domain containing, family G 
(with RhoGef domain) member 3 
1422677_at 0.000263535 1.70 diacylglycerol O-acyltransferase 2 
1423337_at 0.00035115 1.68 origin recognition complex, subunit 4-like (S. 
cerevisiae) 
1426474_at 0.000202384 1.68 ATP synthase mitochondrial F1 complex assembly 
factor 2 
1455429_at 1.87E-05 1.66 expressed sequence AI450540 
1455726_at 0.0002984 1.66 gene model 71, (NCBI) 
1437615_s_at 1.06E-05 1.65 Vacuolar protein sorting 37C (yeast), mRNA (cDNA 
clone MGC:32338 IMAGE:5029143) 
1456390_at 7.49E-05 1.64 protein phosphatase 2a, catalytic subunit, alpha 
isoform 
1456775_at 4.29E-05 1.64 RIKEN cDNA 2810013E07 gene 
1450425_a_at 0.000288911 1.63 RIKEN cDNA 2700062C07 gene 
1425054_a_at 2.23E-05 1.63 RIKEN cDNA 2510006D16 gene 
1436100_at 0.000149688 1.62 SH2 domain containing 5 
1454802_x_at 2.41E-05 1.62 ariadne homolog 2 (Drosophila) 
1424197_s_at 0.000194537 1.61 Fanconi anemia, complementation group E 
1451342_at 3.94E-05 1.59 spondin 1, (f-spondin) extracellular matrix protein 
1444682_at 8.34E-05 1.58 cDNA Sequence BC037032 
1416135_at 7.05E-05 1.58 apurinic/apyrimidinic endonuclease 1 
1448769_at 0.000212764 1.57 solute carrier family 35, member B1 
1437630_at 0.00035534 1.57 DNA segment, Chr 16, Brigham & Women's 
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1434011_a_at 7.33E-05 1.57 RIKEN cDNA 1110055N21 gene 
1429080_at 9.62E-05 1.56 M-phase phosphoprotein 10 (U3 small nucleolar 
ribonucleoprotein) 
1417509_at 3.40E-06 1.56 ring finger protein (C3HC4 type) 19 
1431423_a_at 1.44E-05 1.55 mediator of RNA polymerase II transcription, 
subunit 8 homolog (yeast) 
1415723_at 7.89E-05 1.54 eukaryotic translation initiation factor 5 
1441659_at 0.000294139 1.54 D4, zinc and double PHD fingers, family 3 
1449884_at 0.000136622 1.52 EF-hand calcium binding domain 2 
1424892_at 0.00034808 1.51 zinc finger protein 95 
1426999_at 0.000166058 1.51 RIKEN cDNA 2700069A02 gene 
1417900_a_at 0.00037592 1.51 very low density lipoprotein receptor 
1456910_at 0.000247631 1.51 Transcribed locus 
1429083_at 0.000205794 1.50 amylo-1,6-glucosidase, 4-alpha-glucanotransferase 
1448706_at 0.000265081 1.49 Traf and Tnf receptor associated protein 
1425966_x_at 0.000237604 1.48 ubiquitin C  
1455354_at 8.10E-05 1.47 WD repeat domain 22 
1434465_x_at 0.000109228 1.46 very low density lipoprotein receptor 
1452771_s_at 4.31E-05 1.46 acyl-CoA synthetase long-chain family member 3 
1417508_at 0.000138096 1.44 ring finger protein (C3HC4 type) 19 
1421528_a_at 0.000221108 1.43 surfeit gene 5 
1449702_at 0.000302957 1.43 zinc finger, AN1-type domain 2A 
1452691_at 8.70E-05 1.42 RNA binding motif protein 17 
1458218_s_at 0.00032951 1.41 phosphodiesterase 7A 
1452693_at 0.00035691 1.41 DEAH (Asp-Glu-Ala-His) box polypeptide 35 
1460109_at 0.000163871 1.37 DNA segment, Chr 8, ERATO Doi 325, expressed, 
mRNA (cDNA clone MGC:36794 IMAGE:3498003) 
1435715_x_at 0.00033561 1.37 thymine DNA glycosylase /// similar to Thymine 
DNA glycosylase /// similar to Thymine DNA 
glycosylase 
1448744_at 0.000114888 1.35 galactosamine (N-acetyl)-6-sulfate sulfatase 
1429667_at 8.30E-05 1.35 RIKEN cDNA E130119J07 gene 
1423699_at 0.000231602 1.35 DNA segment, Chr 15, ERATO Doi 785, expressed 
1452784_at 0.000283203 1.35 integrin alpha V 
1423059_at 0.000132421 1.34 PTK2 protein tyrosine kinase 2 
1437087_at 0.000198435 1.34 Expressed sequence R75581 (R75581), mRNA 
1438446_x_at 9.82E-05 1.34 putative phosphatase 
1436223_at 0.00033255 1.34 PREDICTED: integrin beta 8 [Mus musculus], 
mRNA sequence 
1438040_a_at 0.00019203 1.33 tumor rejection antigen gp96 
1450015_x_at 0.00037043 1.31 sphingosine-1-phosphate phosphatase 1 
1428153_at 7.37E-05 1.30 mitochondrial ribosomal protein S10 
1434314_s_at 6.55E-05 1.28 RAB11 family interacting protein 5 (class I) 
1423447_at 0.00033514 1.28 caseinolytic peptidase X (E.coli) 
1455959_s_at 0.00036529 1.27 glutamate-cysteine ligase, catalytic subunit 
1429615_at 0.000124321 1.26 zinc finger protein 91 
1423181_s_at 0.000154371 1.26 chloride channel, nucleotide-sensitive, 1A 
1417349_at 0.000124108 1.23 pallidin  
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1423255_at 0.00034569 1.22 ATPase, H+ transporting, V1 subunit G isoform 1 
1431826_a_at 1.13E-05 1.22 BR serine/threonine kinase 2 
1438218_at 7.22E-05 1.20 zinc finger and BTB domain containing 24 
1415749_a_at 3.42E-06 1.19 Ras-related GTP binding C 
1434995_s_at 3.30E-05 1.09 death effector domain-containing 
1419377_at 0.00032354 1.08 ---  
1420828_s_at 0.000201853 0.90 tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, theta 
polypeptide 
1423187_at 4.24E-05 0.86 gamma-aminobutyric acid (GABA-A) receptor-
associated protein-like 2 
1454641_at 0.00037164 0.85 CGG triplet repeat binding protein 1 
1448484_at 6.75E-05 0.85 S-adenosylmethionine decarboxylase 1 
1415683_at 0.000165936 0.84 N-myristoyltransferase 1 
1423132_a_at 0.000171638 0.83 RIKEN cDNA 5730427N09 gene /// similar to TGF 
beta-inducible nuclear protein 1 (L-name related 
LNR42) 
1435767_at 0.000102555 0.81 sodium channel, voltage-gated, type III, beta 
1420871_at 0.00033192 0.81 guanylate cyclase 1, soluble, beta 3 
1456377_x_at 5.70E-05 0.81 RIKEN cDNA 0610025L06 gene 
1437309_a_at 0.000193657 0.81 replication protein A1 
1424002_at 0.000281601 0.80 phosducin-like 3 
1416628_at 0.000123932 0.80 RIKEN cDNA 0610006I08 gene 
1422568_at 2.14E-05 0.79 nuclear distribution gene E-like homolog 1 (A. 
nidulans) 
1417206_at 0.000282478 0.79 uroporphyrinogen decarboxylase 
1420872_at 0.000272629 0.78 guanylate cyclase 1, soluble, beta 3 
1428374_at 0.000193233 0.78 glucuronyl C5-epimerase 
1417660_s_at 0.000267853 0.77 vacuolar protein sorting 29 (S. pombe) 
1425020_at 2.46E-05 0.77 UBX domain containing 4 /// similar to Ubxd4 
protein 
1455126_x_at 0.000158685 0.77 RIKEN cDNA 2310028O11 gene 
1415772_at 0.000189561 0.77 nucleolin  
1416153_at 0.00034836 0.77 signal recognition particle 54 
1423709_s_at 0.00038122 0.76 phenylalanine-tRNA synthetase-like, beta subunit 
1418792_at 0.000165235 0.76 SH3-domain GRB2-like 2 
1448357_at 0.00036854 0.76 small nuclear ribonucleoprotein polypeptide G 
1436101_at 0.000178128 0.75 ring finger protein 24 
1448761_a_at 0.000231828 0.75 coatomer protein complex, subunit gamma 2 
1455940_x_at 0.00020585 0.74 WD repeat domain 6 
1448809_at 0.00032438 0.74 chromosome segregation 1-like (S. cerevisiae) 
1448203_at 0.000234022 0.74 ATP synthase, H+ transporting, mitochondrial F0 
complex, subunit g 
1423655_a_at 7.16E-05 0.73 RIKEN cDNA 1500010J02 gene 
1452754_at 9.59E-05 0.73 RIKEN cDNA 5730592L21 gene 
1434955_at 2.93E-07 0.73 membrane-associated ring finger (C3HC4) 1 
1424828_a_at 0.000127627 0.73 fumarate hydratase 1 
1450258_a_at 0.000308638 0.73 ELAV (embryonic lethal, abnormal vision, 
Drosophila)-like 4 (Hu antigen D) 
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1436889_at 0.00012079 0.73 gamma-aminobutyric acid (GABA-A) receptor, 
subunit alpha 1 
1433794_at 8.85E-05 0.73 amyotrophic lateral sclerosis 4 homolog (human) 
1428503_a_at 7.91E-06 0.71 NFKB inhibitor interacting Ras-like protein 1 
1451202_at 0.000104819 0.71 RIKEN cDNA C330007P06 gene 
1448100_at 0.000112153 0.71 RIKEN cDNA 4833439L19 gene 
1418383_at 0.00024715 0.71 adenomatosis polyposis coli down-regulated 1 
1426783_at 8.33E-05 0.70 GCN5 general control of amino acid synthesis-like 2 
(yeast) 
1419522_at 0.00037263 0.70 zinc finger, MYND domain containing 19 
1424348_at 0.00036461 0.70 RIKEN cDNA 1110007A13 gene 
1448483_a_at 0.000212503 0.70 NADH dehydrogenase (ubiquinone) 1 beta 
subcomplex, 2 
1459749_s_at 0.00033687 0.70 FAT tumor suppressor homolog 4 (Drosophila) 
1437742_at 0.000223517 0.69 RAB21, member RAS oncogene family 
1455159_at 0.00038107 0.69 RIKEN cDNA 2900057D21 gene 
1428331_at 0.00034975 0.69 RIKEN cDNA 2210016F16 gene 
1424223_at 0.000149413 0.68 RIKEN cDNA 1700020C11 gene 
1455465_at 0.000217527 0.68 Adult male medulla oblongata cDNA, RIKEN full-
length enriched library, clone:6330504I23 
product:unclassifiable, full insert sequence 
1448429_at 0.000157653 0.68 glycogenin 1  
1424679_at 0.00017743 0.68 mab-21-like 1 (C. elegans) 
1436325_at 6.96E-06 0.68 RAR-related orphan receptor alpha 
1426736_at 0.000291976 0.68 G1 to S phase transition 1 
1424548_at 4.53E-05 0.67 zinc finger, CCCH-type with G patch domain 
1424501_at 0.000266472 0.67 RIKEN cDNA 4732497O03 gene 
1428906_at 8.33E-06 0.67 general transcription factor IIH, polypeptide 5 
1436266_x_at 1.86E-05 0.67 chromobox homolog 1 (Drosophila HP1 beta) 
1420616_at 2.67E-06 0.67 ash2 (absent, small, or homeotic)-like (Drosophila) 
1441969_at 5.26E-05 0.66 tripartite motif-containing 36 
1418902_at 3.51E-05 0.65 RIKEN cDNA 3110023E09 gene 
1424895_at 5.80E-05 0.65 G-protein signalling modulator 2 (AGS3-like, C. 
elegans) 
1416549_at 6.34E-05 0.65 solute carrier family 35, member B4 
1454814_s_at 0.000152026 0.65 expressed sequence AU021838 
1421882_a_at 0.00034826 0.65 ELAV (embryonic lethal, abnormal vision, 
Drosophila)-like 2 (Hu antigen B) 
1417555_at 0.000157641 0.65 ATPase family, AAA domain containing 1 
1425981_a_at 2.28E-05 0.64 retinoblastoma-like 2 
1431163_at 0.00011715 0.64 RIKEN cDNA 2700046G09 gene 
1429252_at 0.000159177 0.64 RIKEN cDNA 0610010K14 gene (0610010K14Rik), 
mRNA 
1421369_a_at 0.00036578 0.64 mab-21-like 1 (C. elegans) 
1423109_s_at 0.000162733 0.64 solute carrier family 25 (mitochondrial 
carnitine/acylcarnitine translocase), member 20 
1434552_at 0.000193604 0.64 WD repeat domain 77 
1448672_a_at 0.00037638 0.64 zinc finger protein 289 
1425531_at 0.000298986 0.64 zinc finger, HIT domain containing 1 
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1448372_a_at 4.72E-05 0.64 transmembrane protein 4 
1423482_at 4.26E-05 0.63 uroporphyrinogen III synthase 
1452284_at 5.62E-05 0.63 protein tyrosine phosphatase, receptor type Z, 
polypeptide 1 
1450966_at 0.000123501 0.63 carnitine O-octanoyltransferase 
1423410_at 0.000111604 0.63 meiosis expressed gene 1 
1430889_a_at 0.000180387 0.63 thiopurine methyltransferase 
1433748_at 9.56E-05 0.63 zinc finger, DHHC domain containing 18 
1418148_at 4.54E-05 0.62 abhydrolase domain containing 1 
1433953_at 0.000277467 0.62 zinc finger protein 277 
1416991_at 3.28E-05 0.61 mitochondrial translation optimization 1 homolog (S. 
cerevisiae) 
1422561_at 0.000150297 0.61 a disintegrin-like and metallopeptidase (reprolysin 
type) with thrombospondin type 1 motif, 5 
(aggrecanase-2) 
1429364_at 0.00021382 0.61 RIKEN cDNA 4930579G24 gene 
1448287_at 4.32E-05 0.61 RNA polymerase 1-3 
1417847_at 0.000216243 0.60 Unc-51 like kinase 2 (C. elegans) 
1428620_at 0.000142209 0.60 endosulfine alpha 
1425114_at 0.0003375 0.60 retinoblastoma binding protein 6 
1460041_at 0.000288987 0.59 RIKEN cDNA D630040I23 gene 
1424646_at 8.21E-05 0.59 uridine-cytidine kinase 1-like 1 
1452440_at 0.000106035 0.59 tumor necrosis factor (ligand) superfamily, member 
12 /// tumor necrosis factor (ligand) superfamily, 
member 12-member 13 
1452883_a_at 0.00038041 0.59 RIKEN cDNA 2310002J21 gene 
1426111_x_at 0.00038149 0.58 interferon regulatory factor 3 
1427326_at 0.000217915 0.58 RIKEN cDNA 4732471D19 gene 
1428636_at 0.0003671 0.58 six transmembrane epithelial antigen of prostate 2 
1455337_at 0.000305282 0.58 RIKEN cDNA 9030023J02 gene 
1460465_at 0.000145719 0.57 RIKEN cDNA A930038C07 gene 
1440215_at 0.000158117 0.57 hypothetical protein C130086A10 
1417609_at 0.00035402 0.57 ubiquitin-conjugating enzyme E2A, RAD6 homolog 
(S. cerevisiae) 
1419078_at 1.83E-05 0.56 ninein  
1437783_x_at 0.000100968 0.56 transmembrane protein 4 
1457708_at 0.000184157 0.56 methyl-CpG binding domain protein 4 
1438197_at 0.000141909 0.56 expressed sequence AI854408 
1424946_a_at 0.000148187 0.55 mitochondrial fission regulator 1 
1418516_at 0.00026168 0.55 metal response element binding transcription factor 
2 
1422819_at 6.97E-05 0.55 mitochondrial ribosomal protein L36 
1450980_at 0.000103876 0.55 GTP binding protein 3 
1428975_at 0.000117113 0.55 sushi domain containing 3 
1448858_at 0.000303964 0.54 Unc-51 like kinase 2 (C. elegans) 
1435096_at 0.000201171 0.54 resistance to inhibitors of cholinesterase 8 homolog 
B (C. elegans) 
1449393_at 0.000311101 0.54 SH2 domain protein 1A 
1424575_at 0.000219434 0.54 RAB, member of RAS oncogene family-like 5 
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1441945_s_at 8.07E-05 0.54 abhydrolase domain containing 14A 
1456789_at 3.90E-05 0.54 ---  
1424896_at 0.0001937 0.54 G protein-coupled receptor 85 
1448943_at 0.000273847 0.54 neuropilin 1  
1455472_at 0.0003464 0.54 RIKEN cDNA A630071D13 gene 
1437872_at 0.000267925 0.53 cDNA sequence AB112350 
1426364_at 7.83E-05 0.53 ---  
1434771_at 0.000186056 0.52 RIKEN cDNA 0610011F06 gene 
1427401_at 1.69E-05 0.52 cholinergic receptor, nicotinic, alpha polypeptide 5 
1456378_s_at 9.41E-05 0.51 F-box and leucine-rich repeat protein 20 
1455906_at 8.18E-05 0.51 RIKEN cDNA 6030446N20 gene 
1436833_x_at 0.000289796 0.51 tubulin tyrosine ligase-like 1 
1433620_at 0.000189197 0.51 WD repeat domain 41 
1433495_at 0.000297816 0.51 glycosyltransferase 25 domain containing 1 
1451991_at 0.000237475 0.49 Eph receptor A7 
1457686_at 2.88E-05 0.48 RIKEN cDNA B230333C21 gene /// similar to DNA 
segment on chromosome X and Y (unique) 155 
expressed sequence isoform 1 
1443952_at 0.000252875 0.48 thyroid hormone receptor alpha 
1451271_a_at 2.13E-05 0.47 acetyl-Coenzyme A acetyltransferase 1 
1455213_at 7.91E-05 0.47 RIKEN cDNA 4930488E11 gene 
1449749_s_at 0.000113813 0.47 transcription factor B1, mitochondrial 
1450034_at 3.76E-05 0.47 signal transducer and activator of transcription 1 
1418045_at 9.25E-05 0.46 inositol polyphosphate-1-phosphatase 
1423923_a_at 0.000211421 0.46 WD repeat domain 8 
1418529_at 1.40E-05 0.46 O-sialoglycoprotein endopeptidase 
1429059_s_at 0.000231783 0.44 RIKEN cDNA 1110004B13 gene 
1416349_at 0.000115826 0.44 mitochondrial ribosomal protein L34 
1435668_at 0.00024082 0.44 ---  
1453128_at 5.34E-05 0.43 extra cellular link domain-containing 1 
1448905_at 0.000173644 0.43 expressed in non-metastatic cells 3 
1440343_at 0.000189249 0.42 ribosomal protein S6 kinase, polypeptide 5 
1433831_at 0.00038315 0.42 RIKEN cDNA 4833418A01 gene 
1417859_at 0.00032746 0.42 growth arrest specific 7 
1444139_at 0.000174918 0.41 DNA-damage-inducible transcript 4-like 
1440485_at 0.00011189 0.41 ---  
1416826_a_at 6.07E-05 0.41 Trf (TATA binding protein-related factor)-proximal 
protein homolog (Drosophila) 
1417680_at 2.47E-05 0.41 potassium voltage-gated channel, shaker-related 
subfamily, member 5 
1428760_at 1.94E-05 0.40 small nuclear RNA activating complex, polypeptide 
3 
1438285_at 1.68E-05 0.40 RIKEN cDNA 2210015D19 gene 
1438407_at 8.20E-05 0.40 RIKEN cDNA 9330132E09 gene 
1457969_at 0.000312548 0.40 RAB interacting factor 
1451297_at 0.00037322 0.39 gulonolactone (L-) oxidase 
1456904_at 6.14E-05 0.39 Transcribed locus 
1417834_at 1.19E-05 0.38 synaptojanin 2 binding protein 
1436382_at 4.48E-05 0.38 zinc finger and BTB domain containing 12 
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1433547_s_at 0.000190494 0.37 NudC domain containing 1 
1454681_at 3.80E-05 0.37 RNA binding motif protein 35A 
1434837_at 5.81E-05 0.37 mediator of DNA damage checkpoint 1 
1423343_at 1.53E-05 0.37 solute carrier organic anion transporter family, 
member 1c1 
1452388_at 7.58E-05 0.35 heat shock protein 1A 
1439078_at 4.16E-06 0.34 kelch-like 4 (Drosophila) 
1453010_at 0.000279593 0.34 RIKEN cDNA 1700069O15 gene 
1460107_at 0.000174203 0.32 RIKEN cDNA 1700129I04 gene 
1442249_at 0.000103219 0.32 Transcribed locus 
1416920_at 0.000143858 0.32 RNA binding motif protein 4 
1429655_at 0.000384 0.31 NudC domain containing 1 
1424852_at 0.000140109 0.31 myocyte enhancer factor 2C 
1421379_at 0.00034147 0.31 zinc finger protein 354B 
1437647_at 6.54E-05 0.30 death inducer-obliterator 1 
1442051_at 0.00026252 0.30 histone 2, H3c1 
1456834_at 0.000176314 0.29 IBR domain containing 2 (Ibrdc2), mRNA 
1456723_at 2.35E-05 0.29 Zinc finger protein 689, mRNA (cDNA clone 
IMAGE:1263742) 
1450953_at 0.000192568 0.27 WD repeat domain 39 
1445709_at 0.000163529 0.25 transformed mouse 3T3 cell double minute 1 
1425083_at 0.000221231 0.25 otoraplin  
1435158_at 6.09E-05 0.23 RNA binding motif protein 12B 
1444172_at 0.00026394 0.21 Transcribed locus 
1416961_at 1.20E-06 0.18 budding uninhibited by benzimidazoles 1 homolog, 
beta (S. cerevisiae) 
1447363_s_at 8.09E-06 0.16 budding uninhibited by benzimidazoles 1 homolog, 
beta (S. cerevisiae) 
1435692_at 3.79E-05 0.14 Adult male hippocampus cDNA, RIKEN full-length 
enriched library, clone:C630017C20 
product:hypothetical K+ channel 
tetramerisation/BTB/POZ/BTB domain profile 
containing protein, full insert sequence 
1429169_at 0.000254317 0.05 RNA binding motif protein 3 
 
 
TABLE 2 Differentially Regulated Genes by Hypoxic Preconditioning H2 
AffymetrixID pValue Fold change Gene  
1440257_at 0.00041684 22.63 oocyte specific homeobox 6 
1450692_at 0.00038942 8.91 kinesin family member 4 
1422557_s_at 0.00050407 6.11 metallothionein 1 
1454409_at 0.00039689 5.90 RIKEN cDNA 4833408G04 gene 
1455385_at 0.00060015 5.55 SEC15-like 1 (S. cerevisiae) 
1442366_at 0.00032571 4.35 RIKEN cDNA 6820408C15 gene (6820408C15Rik), 
mRNA 
1441430_at 0.000593 4.25 Transcribed locus  
1456653_a_at 0.00076918 3.50 methylenetetrahydrofolate dehydrogenase 
(NADP+ dependent) 1-like 
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1449007_at 0.00042528 3.37 B-cell translocation gene 3  
1416125_at 2.35508E-05 3.27 FK506 binding protein 5  
1417042_at 0.000167361 3.22 solute carrier family 37 (glycerol-6-phosphate 
transporter), member 4 
 
1448231_at 0.000194797 3.12 FK506 binding protein 5 
1441935_at 0.00014658 2.99 ankyrin repeat, family A (RFXANK-like), 2 
1422885_at 0.000111381 2.58 small nuclear ribonucleoprotein D3 
1436605_at 1.33921E-05 2.54 transketolase 
1426389_at 0.000122515 2.53 calcium/calmodulin-dependent protein kinase ID 
1427364_a_at 0.000276494 2.47 ornithine decarboxylase, structural 1 /// similar to 
Ornithine decarboxylase (ODC) /// similar to 
Ornithine decarboxylase (ODC) 
1453522_at 0.00065951 2.47 RIKEN cDNA 6530401N04 gene 
1439912_at 0.00059301 2.46 RIKEN cDNA 9430098F02 gene 
1452050_at 0.000066249 2.41 calcium/calmodulin-dependent protein kinase ID 
1453429_at 0.00065894 2.36 RIKEN cDNA 9530057J20 gene 
1425607_at 0.00065431 2.26 holocarboxylase synthetase (biotin- [propriony-
Coenzyme A-carboxylase (ATP-hydrolysing)] 
ligase) 
1424834_s_at 0.00062738 2.18 inositol 1,4,5-triphosphate receptor 2 
1424149_at 0.000178513 2.02 RIKEN cDNA 1110014D18 gene 
1434952_at 0.00057342 1.96 Cytochrome c oxidase subunit IV isoform 1 
(Cox4i1), mRNA 
1435647_at 0.00054926 1.94 inhibitor of kappaB kinase gamma 
1436108_at 0.000088128 1.92 thioredoxin domain containing 9 
1450648_s_at 0.00033116 1.82 histocompatibility 2, class II antigen A, beta 1 
1417096_at 0.00032979 1.80 RIKEN cDNA 2810430M08 gene 
1425024_at 0.00068655 1.80 RIKEN cDNA E430018J23 gene 
1423980_at 0.000128141 1.80 solute carrier family 25 (mitochondrial carrier, 
palmitoylcarnitine transporter), member 29 
1437076_at 0.00071934 1.80 RIKEN cDNA A930017M01 gene 
1447944_at 0.00034731 1.79 zinc finger with KRAB and SCAN domains 1 
1448359_a_at 0.00053321 1.79 HIG1 domain family, member 1A 
1460473_at 0.00042559 1.78 RIKEN cDNA 6230400D17 gene 
1428832_at 0.000102193 1.77 RIKEN cDNA 1600002H07 gene 
1448765_at 0.000039349 1.75 Fyn proto-oncogene 
1416155_at 0.00078399 1.73 high mobility group box 3 
1435881_at 0.00042308 1.72 poly(rC) binding protein 2 
1416595_at 0.00035816 1.71 mitochondrial ribosomal protein S22 
1457949_at 0.00069063 1.70 Transcribed locus 
1452835_a_at 0.0007643 1.69 polymerase (RNA) mitochondrial (DNA directed) 
1417742_a_at 0.00020495 1.63 DNA methyltransferase 1-associated protein 1 
1448607_at 0.00059606 1.63 pre-B-cell colony-enhancing factor 1 
1429337_at 0.00056578 1.62 RIKEN cDNA 2610301K12 gene 
1423981_x_at 2.87152E-06 1.61 solute carrier family 25 (mitochondrial carrier, 
palmitoylcarnitine transporter), member 29 
1455027_at 0.00066007 1.61 DNA segment, Chr 5, Brigham & Women's Genetics 
0860 expressed 
1436886_x_at 0.00077386 1.61 XPA binding protein 2 
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1455320_at 0.0007447 1.59 expressed sequence AI480535 
1418284_at 0.00075021 1.57 vacuolar protein sorting 72 (yeast) 
1449039_a_at 0.000103588 1.56 heterogeneous nuclear ribonucleoprotein D-like  
1452515_a_at 0.000239423 1.55 xylosyltransferase II 
1454690_at 0.000154256 1.55 inhibitor of kappaB kinase gamma 
1416890_at 0.000036626 1.53 WD repeat domain 74  
1428375_at 0.000142557 1.53 --- 
1454913_at 0.000298883 1.52 RIKEN cDNA 9930104L06 gene 
1435187_at 0.000247526 1.50 Translocase of outer mitochondrial membrane 20 
homolog (yeast) (Tomm20), mRNA 
1442002_at 0.00048741 1.49 RIKEN cDNA 7030402D04 gene 
1447027_s_at 0.00068279 1.47 lipoic acid synthetase 
1432384_a_at 0.00060644 1.47 RIKEN cDNA 1600013P15 gene 
1423970_at 0.00054272 1.46 THO complex 3 
1428927_at 0.000274764 1.46 SHQ1 homolog (S. cerevisiae) 
1451163_at 0.000189693 1.45 Terf1 (TRF1)-interacting nuclear factor 2 
1417875_at 0.000114952 1.45 DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 
1426510_at 0.000080706 1.44 saccharopine dehydrogenase (putative) 
1423811_at 0.000235167 1.44 splicing factor 3a, subunit 3 
1423218_a_at 0.000236316 1.44 mitochondrial ribosomal protein L49 
1435544_at 0.00065469 1.44 exosome component 6 
1418789_at 0.000203658 1.44 syntrophin, gamma 2 
1455339_at 0.000191371 1.43 RIKEN cDNA C430014M02 gene 
1450172_at 0.0003594 1.42 Pbx/knotted 1 homeobox 
1426845_at 0.000090318 1.42 RIKEN cDNA 6030457N17 gene 
1426987_at 0.000150698 1.42 RIKEN cDNA 5430417L22 gene 
1423197_a_at 0.000046991 1.42 expressed sequence AW011752 
1452148_at 0.000211751 1.41 low density lipoprotein receptor-related protein 
associated protein 1 
1428274_s_at 0.000088279 1.41 RIKEN cDNA 1110065L07 gene 
1428407_at 1.05742E-05 1.41 heterogeneous nuclear ribonucleoprotein A0 /// 
similar to heterogeneous nuclear ribonucleoprotein 
A0 
1416110_at 0.00054473 1.40 solute carrier family 35, member A4 
1435464_at 0.00032156 1.39 RIKEN cDNA 1110003E01 gene 
1427158_at 0.00056069 1.39 mitochondrial ribosomal protein S30 
1455354_at 0.00050665 1.38 WD repeat domain 22 
1432488_a_at 0.00041313 1.38 splicing factor 3a, subunit 3 
1427879_at 0.0001698 1.38 RIKEN cDNA 1810031K17 gene 
1425830_a_at 0.00071648 1.37 RIKEN cDNA 2810452K22 gene 
1416308_at 0.000067326 1.37 UDP-glucose dehydrogenase 
1421756_a_at 0.00039787 1.37 G protein-coupled receptor 19 
1438397_a_at 0.00047047 1.37 RNA-binding region (RNP1, RRM) containing 2  
1433993_at 0.00047468 1.36 RIKEN cDNA 4931406P16 gene  
1423112_at 0.000234545 1.36 ubiquitin-conjugating enzyme E2D 3 (UBC4/5 
homolog, yeast) 
1426789_s_at 0.000165419 1.35 structure specific recognition protein 1 
1433554_at 0.00049141 1.35 expressed sequence AU022870 
1431784_a_at 0.000120005 1.34 brix domain containing 5 
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1415715_at 0.000223839 1.34 RIKEN cDNA 0610039G24 gene 
1424887_at 0.00057766 1.33 kelch domain containing 4 
1422712_a_at 0.00063827 1.33 ubiquitin-conjugating enzyme E2I 
1415985_at 0.00064683 1.32 splicing factor 3b, subunit 3 
1452978_at 0.00065586 1.32 RIKEN cDNA 2900055D14 gene 
1427080_at 0.0005302 1.32 RIKEN cDNA 2610036D13 gene 
1454669_at 0.00076603 1.32 transmembrane protein 11 
1426644_at 0.00067247 1.31 TBC1 domain family, member 20 
1437071_at 0.00071196 1.31 eukaryotic translation initiation factor 1A, Y-linked 
1434088_at 0.00038948 1.31 zinc finger protein 496 
1455430_at 0.000201884 1.31 RIKEN cDNA 3200001K10 gene 
1424036_at 0.00017426 1.30 RIKEN cDNA 2610031L17 gene 
1417264_at 0.000098384 1.30 DNA segment, Chr 5, ERATO Doi 33, expressed 
1416866_at 0.00050974 1.29 blocked early in transport 1 homolog (S. cerevisiae) 
1416096_at 0.00078368 1.29 expressed sequence AI413782 
1450891_at 0.000102644 1.29 signal recognition particle 19 
1416341_at 0.00071176 1.29 polymerase (RNA) II (DNA directed) polypeptide C 
1451267_at 0.00036524 1.28 SHANK-associated RH domain interacting protein 
1424787_a_at 0.00075464 1.28 nuclear respiratory factor 1 
1426790_at 0.000302831 1.27 structure specific recognition protein 1 
1438771_at 1.91437E-05 1.27 bromodomain containing 1 
1451587_a_at 1.79119E-05 1.27 TIP41, TOR signalling pathway regulator-like (S. 
cerevisiae) 
1448711_at 0.000156469 1.27 minichromosome maintenance deficient 3 (S. 
cerevisiae) associated protein 
1435469_at 0.00075773 1.27 quiescin Q6-like 1 
1434233_at 0.000263258 1.25 --- 
1422795_at 0.00035914 1.25 cullin 3 
1418648_at 0.0005135 1.25 EGL nine homolog 3 (C. elegans) 
1452765_at 0.0000607 1.25 solute carrier family 39 (zinc transporter), member 9 
1421135_a_at 0.00025818 1.24 CCR4-NOT transcription complex, subunit 8 
1460360_at 0.00042751 1.24 asparaginase like 1 
1455898_x_at 0.00056659 1.24 solute carrier family 2 (facilitated glucose 
transporter), member 3 
1427916_at 0.000266575 1.24 suppression of tumorigenicity 7-like 
1424251_a_at 0.00067173 1.24 heterogeneous nuclear ribonucleoprotein D-like 
1418974_at 0.00032603 1.23 basic leucine zipper nuclear factor 1 
1426871_at 0.000084881 1.23 F-box only protein 33 
1460171_at 0.00063067 1.23 COP9 (constitutive photomorphogenic) homolog, 
subunit 5 (Arabidopsis thaliana) 
1436828_a_at 0.00072521 1.23 tumor protein D52-like 2 
1436028_at 2.20041E-05 1.23 transmembrane protein 33 
1435249_at 0.0002232 1.22 BTAF1 RNA polymerase II, B-TFIID transcription 
factor-associated, 170kDa (Mot1 homolog, S. 
cerevisiae) 
1448970_at 0.00006227 1.22 RIKEN cDNA 1200007B05 gene 
1434884_at 0.000103 1.21 Metadherin 
1456746_a_at 0.00062566 1.21 Cd99 antigen-like 2 
1426939_at 0.00062415 1.20 RIKEN cDNA 2310007F12 gene 
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1418014_a_at 0.000190135 1.19 UDP-Gal:betaGlcNAc beta 1,4- 
galactosyltransferase, polypeptide 1 
1423573_at 0.00052182 1.19 steroid 5 alpha-reductase 2-like 
1447931_at 0.000113849 1.19 Wolf-Hirschhorn syndrome candidate 1-like 1 
(human) 
 
1439044_at 0.00055504 1.19 zinc finger protein 354C 
1451315_at 0.00057924 1.18 RIKEN cDNA 2610511E22 gene 
1426256_at 0.000299568 1.17 translocase of inner mitochondrial membrane 17a 
1434289_at 0.00074721 1.17 NOL1/NOP2/Sun domain family, member 5 
1453928_a_at 0.00054048 1.16 Sjogren syndrome antigen B  
1448488_at 0.00049978 1.14 mitochondrial ribosomal protein S5 
1418198_a_at 0.00033672 1.13 transmembrane 9 superfamily member 1 
1452039_a_at 0.000307184 1.12 Brca1 associated protein 1 
1425572_a_at 0.000078574 1.10 development and differentiation enhancing 
1453055_at 0.00068191 0.94 sema domain, transmembrane domain (TM), and 
cytoplasmic domain, (semaphorin) 6D 
1416180_a_at 0.00060015 0.85 radixin  
1452603_at 0.000040406 0.85 RIKEN cDNA 5330431N19 gene 
1425100_a_at 0.00035585 0.83 phosphodiesterase 6G, cGMP-specific, rod, gamma 
1423906_at 0.000062875 0.82 heat shock factor binding protein 1 
1455042_at 0.000255739 0.81 Transducin (beta)-like 1 X-linked (Tbl1x), mRNA 
1418497_at 0.00048397 0.80 fibroblast growth factor 13 
1430713_s_at 0.00033778 0.79 NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex, 13 
1426716_at 0.000294417 0.78 tudor domain containing 7 
1417663_a_at 0.00060094 0.78 N-myc downstream regulated gene 3 
1422895_at 0.00042365 0.78 vesicle-associated membrane protein 4 
1440795_x_at 0.00068297 0.78 rabaptin, RAB GTPase binding effector protein 2 
1448788_at 0.00068826 0.78 Cd200 antigen 
1420623_x_at 0.00062057 0.77 heat shock protein 8  
1422593_at 0.000017666 0.77 adaptor-related protein complex 3, sigma 1 subunit 
1435695_a_at 0.00070538 0.77 RIKEN cDNA A030007L17 gene 
1452740_at 0.000051796 0.76 myosin, heavy polypeptide 10, non-muscle 
1424089_a_at 0.00071507 0.74 transcription factor 4 
1454708_at 0.00035905 0.74 actin-binding LIM protein 1  
1424813_at 0.00076327 0.74 expressed sequence AA536717 
1434260_at 0.00036935 0.73 FCH and double SH3 domains 2 
1426957_at 0.00034571 0.73 transformation related protein 53 binding protein 1 
1431593_a_at 3.4515E-06 0.72 tRNA splicing endonuclease 34 homolog (SEN34, 
S. cerevisiae) 
1438664_at 0.000256784 0.72 protein kinase, cAMP dependent regulatory, type II 
beta 
1430583_at 0.00058341 0.72 RIKEN cDNA C130076O07 gene 
1416394_at 0.00005655 0.71 Bcl2-associated athanogene 1 
1415772_at 0.0001464 0.71 nucleolin 
1437533_at 0.000267709 0.71 baculoviral IAP repeat-containing 4 
1438477_a_at 0.00050285 0.71 methylmalonyl CoA epimerase 
1428540_at 0.00044296 0.71 RIKEN cDNA 3321401G04 gene 
1436657_at 0.000251579 0.70 16 days neonate cerebellum cDNA, RIKEN full-
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length enriched library, clone:9630002G20 
product:hypothetical protein, full insert sequence 
1419449_a_at 0.00075818 0.70 guanine nucleotide binding protein, alpha inhibiting 
2 
1433583_at 0.000084596 0.70 zinc finger protein 365 
1449314_at 0.00052148 0.70 zinc finger protein, multitype 2 
1435194_at 0.000195651 0.70 Heat shock protein 4, mRNA (cDNA clone 
MGC:5961 IMAGE:3494648) 
1438430_at 0.000102246 0.69 high mobility group box transcription factor 1 
1433482_a_at 0.000276507 0.69 far upstream element (FUSE) binding protein 1 
1445850_at 0.00063118 0.69 RIKEN cDNA 9530009M10 gene 
1437807_x_at 0.00063803 0.69 catenin (cadherin associated protein), alpha 1 
1433504_at 0.000039219 0.69 brain glycogen phosphorylase 
1440402_at 0.00064376 0.68 RIKEN cDNA 4831426I19 gene 
1451047_at 0.00064808 0.68 integral membrane protein 2A 
1436560_at 0.000314327 0.68 expressed sequence AW124694 
1416156_at 0.00050387 0.67 vinculin 
1455700_at 0.00065476 0.67 MTERF domain containing 3 
1436833_x_at 0.000113345 0.67 tubulin tyrosine ligase-like 1 
1428487_s_at 0.00042433 0.67 RIKEN cDNA 1500041J02 gene 
1418716_at 0.000167078 0.67 mitochondrial ribosomal protein S25 
1437657_at 0.00078 0.66 zinc finger protein 291 
1452284_at 0.00027223 0.65 protein tyrosine phosphatase, receptor type Z, 
polypeptide 1 
1421883_at 0.000192019 0.65 ELAV (embryonic lethal, abnormal vision, 
Drosophila)-like 2 (Hu antigen B) 
1434674_at 0.0006771 0.65 lysosomal trafficking regulator 
1424121_at 0.000159114 0.64 COMM domain containing 1 
1417605_s_at 2.79936E-05 0.64 calcium/calmodulin-dependent protein kinase I 
1450215_at 0.000261052 0.64 recoverin 
1435204_at 0.00068621 0.63 heterogeneous nuclear ribonucleoprotein 
methyltransferase-like 4 (S. cerevisiae) 
1420113_s_at 0.0006 0.63 RIKEN cDNA 2410022L05 gene 
1427674_a_at 0.000055249 0.63 seizure related gene 6 
1456387_at 0.00046616 0.63 nucleolar protein 4 
1417830_at 9.6302E-06 0.62 SMC (structural maintenance of chromosomes 1)-
like 1 (S. cerevisiae) 
1439815_at 0.00071928 0.62 RIKEN cDNA A230048G03 gene 
1429119_at 0.000161092 0.62 RIKEN cDNA 4833421E05 gene 
1426090_a_at 0.000258489 0.61 fer (fms/fps related) protein kinase, testis specific 2 
1429055_at 0.0005368 0.61 RIKEN cDNA 4930506M07 gene 
1448657_a_at 0.00069407 0.61 DnaJ (Hsp40) homolog, subfamily B, member 10 
1420886_a_at 0.00064077 0.61 X-box binding protein 1  
1453398_at 0.00073895 0.60 RIKEN cDNA A930009A15 gene 
1417774_at 0.000143992 0.59 N-acetylneuraminic acid synthase (sialic acid 
synthase) 
1416844_at 0.00078285 0.59 heterogeneous nuclear ribonucleoprotein 
methyltransferase-like 1 (S. cerevisiae) 
1428232_at 0.00044938 0.59 cleavage and polyadenylation specific factor 6 
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1417970_at 0.00066353 0.57 ATP synthase, H+ transporting, mitochondrial F0 
complex, subunit s 
1428683_at 0.00077926 0.57 RIKEN cDNA A930016P21 gene 
1452955_at 0.00048071 0.57 general transcription factor IIH, polypeptide 5 
1452923_at 0.00049036 0.56 RIKEN cDNA 1810058I14 gene 
1451063_at 0.00069857 0.55 syntaxin binding protein 4 
1425757_a_at 0.00077391 0.54 interphotoreceptor matrix proteoglycan 1 
1451822_a_at 0.000255811 0.53 secernin 2 
1429036_at 0.00037557 0.53 otopetrin 3 
1427126_at 0.00070566 0.52 heat shock protein 1A 
1455187_at 0.00070079 0.52 zinc finger and BTB domain containing 40 
1434577_at 0.000148256 0.49 cDNA sequence BC052040 
1422155_at 0.00057822 0.48 histone 2, H3c2 
1452318_a_at 1.02611E-05 0.48 heat shock protein 1A 
1430245_at 0.00053063 0.47 --- 
1417604_at 0.000135427 0.47 calcium/calmodulin-dependent protein kinase I 
1440928_at 0.000227124 0.47 RIKEN cDNA D630037F22 gene 
1428329_a_at 0.00056601 0.45 WD repeat domain 56 
1427127_x_at 0.00048937 0.44 heat shock protein 1A 
1436203_a_at 0.00065869 0.44 RIKEN cDNA 1110059G02 gene 
1439622_at 0.000086218 0.42 Ras association (RalGDS/AF-6) domain family 4 
1428550_at 0.000221568 0.40 RIKEN cDNA 1810015A11 gene 
1456532_at 0.000115953 0.39 --- 
1439078_at 4.4327E-06 0.37 kelch-like 4 (Drosophila) 
 
TABLE 3 Differentially Regulated Genes by Hypoxic Preconditioning H4 
AffymetrixID pValue Fold change Gene  
1450692_at 0.000070106 13.94 kinesin family member 4 
1435234_at 0.000033914 1.49 nuclear receptor coactivator 2 
1447500_at 0.000038109 1.48 cut-like 2 (Drosophila) 
1417551_at 4.2285E-06 1.43 ceroid lipofuscinosis, neuronal 3, juvenile (Batten, 
Spielmeyer-Vogt disease) 
1416821_at 0.000062761 1.33 expressed sequence 2 embryonic lethal 
1452197_at 1.42316E-05 1.29 SMC4 structural maintenance of chromosomes 4-
like 1 (yeast) 
1456056_a_at 0.000066635 1.20 DNA segment, Chr 6, Wayne State University 
116, expressed 
 
1415749_a_at 1.36054E-05 1.18 Ras-related GTP binding C  
1418345_at 0.000039922 1.15 tumor necrosis factor (ligand) superfamily, 
member 13 /// tumor necrosis factor (ligand) 
superfamily, member 12-member 13 
 
1425265_a_at 2.44588E-05 1.14 prion protein interacting protein 1  
1435066_at 0.000055061 0.86 phosphatidylinositol transfer protein, cytoplasmic 
1 
 
1428306_at 0.000068874 0.83 DNA-damage-inducible transcript 4 
1416064_a_at 2.17324E-05 0.76 heat shock 70kD protein 5 (glucose-regulated 
protein) 
1433444_at 0.000067983 0.75 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 
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1452814_at 2.62974E-05 0.75 copine III 
1455265_a_at 3.02218E-05 0.73 regulator of G-protein signaling 16 
1438504_x_at 0.000051975 0.71 Transmembrane 7 superfamily member 3 (Tm7sf3), 
mRNA 
1423078_a_at 0.000036291 0.70 sterol-C4-methyl oxidase-like 
1439006_x_at 6.7052E-06 0.65 RIKEN cDNA 6430550H21 gene 
1419225_at 0.000054204 0.63 calcium channel, voltage-dependent, alpha2/delta 
subunit 3 
1443134_at 0.000068282 0.61 Adult retina cDNA, RIKEN full-length enriched 
library, clone:A930005G22 product:unclassifiable, 
full insert sequence 
1418186_at 2.53811E-05 0.58 glutathione S-transferase, theta 1 
1444603_at 0.000045006 0.51 10, 11 days embryo whole body cDNA, RIKEN full-
length enriched library, clone:2810030D12 
product:unclassifiable, full insert sequence 
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3.1.1.3 Total List of Real-time PCR Results (Additional File 3) 
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3.1.1.4 List of Genes Functionally Clustered by DAVID (Additional File 4) 
 
TABLE 5 Differentially up-regulated genes functionally clustered by DAVID. 
Term Category: cellular physiological process; 75 genes (49.02%); pValue 5.11E-04 
Affymetrix ID Gene 
1426727_s_at PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1416432_at, 1456676_a_at 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BIPHOSPHATASE 3 
1426600_at 
SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 
1 
1430798_x_at MITOCHONDRIAL RIBOSOMAL PROTEIN L15 
1454623_at SIMILAR TO CARBOXYPEPTIDASE A2 PRECURSOR 
1423233_at CCAAT/ENHANCER BINDING PROTEIN (C/EBP), DELTA 
1454018_at TOUSLED-LIKE KINASE 2 (ARABIDOPSIS) 
1435245_at GLUTAMINASE 2 (LIVER, MITOCHONDRIAL) 
1416434_at BCL2-LIKE 10 
1437785_at 
A DISINTEGRIN-LIKE AND METALLOPEPTIDASE (REPROLYSIN TYPE) WITH 
THROMBOSPONDIN TYPE 1 MOTIF, 9 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1459331_at SURFEIT GENE 6 
1433814_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1426721_s_at TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE 
1448607_at PRE-B-CELL COLONY-ENHANCING FACTOR 1 
1419087_s_at SPLICING FACTOR 3A, SUBUNIT 1 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1427221_at X TRANSPORTER PROTEIN 3 SIMILAR 1 GENE 
1426117_a_at, 
1441315_s_at 
SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1454991_at 
SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, Y+ 
SYSTEM), MEMBER 1 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1430357_at H3 HISTONE, FAMILY 3A 
1440555_at RAS-RELATED GTP BINDING D 
1430197_a_at PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED 2 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1425732_a_at MAX INTERACTING PROTEIN 1 
1422832_at RETINAL G PROTEIN COUPLED RECEPTOR 
1416309_at EXPRESSED SEQUENCE AW547774 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1422885_at SMALL NUCLEAR RIBONUCLEOPROTEIN D3 
1416039_x_at CYSTEINE RICH PROTEIN 61 
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1422557_s_at METALLOTHIONEIN 1 
1450725_s_at CARBONIC ANHYDRASE 14 
1447494_at RIKEN CDNA 2600013E07 GENE 
1454949_at RIKEN CDNA 2210010O09 GENE 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1438606_a_at CHLORIDE INTRACELLULAR CHANNEL 4 (MITOCHONDRIAL) 
1436279_at SOLUTE CARRIER FAMILY 26, MEMBER 7 
1418190_at PARAOXONASE 1 
1419029_at, 1419030_at, 
1449324_at 
ERO1-LIKE (S. CEREVISIAE) 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1416125_at, 1448231_at FK506 BINDING PROTEIN 5 
1449007_at B-CELL TRANSLOCATION GENE 3 
1429050_at CYSTEINE-RICH HYDROPHOBIC DOMAIN 2 
1439677_at EPILEPSY, PROGRESSIVE MYOCLONIC EPILEPSY, TYPE 2 GENE ALPHA 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1454608_x_at, 
1455913_x_at 
TRANSTHYRETIN 
1454109_a_at PHOSPHATIDYLSERINE RECEPTOR 
1434952_at CYTOCHROME C OXIDASE SUBUNIT IV ISOFORM 1 
1457451_at ACTIVIN RECEPTOR IIA 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1459978_x_at GENE MODEL 877, (NCBI) 
1444487_at 
LECITHIN-RETINOL ACYLTRANSFERASE (PHOSPHATIDYLCHOLINE-RETINOL-O-
ACYLTRANSFERASE) 
1455385_at EXOCYST COMPLEX COMPONENT 6 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1436531_at METHIONINE AMINOPEPTIDASE 2 
1435870_at SYNAPTONEMAL COMPLEX PROTEIN 3 
1438815_at HISTONE 2, H2AA1 
1448654_at MITOCHONDRIAL CARRIER HOMOLOG 2 (C. ELEGANS) 
1435875_at PROTEIN KINASE, AMP-ACTIVATED, BETA 2 NON-CATALYTIC SUBUNIT 
1440257_at OOCYTE SPECIFIC HOMEOBOX 6 
1444528_at ZINC FINGER PROTEIN 316 
1420138_at SOLUTE CARRIER FAMILY 19 (SODIUM/HYDROGEN EXCHANGER), MEMBER 1 
1455420_at RAD23B HOMOLOG (S. CEREVISIAE) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1423865_at SOLUTE CARRIER FAMILY 44, MEMBER 1 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
1428942_at METALLOTHIONEIN 2 
Term Category: negative regulation of biological process; 13 genes (8.5%); pValue 0.0015 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
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1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1449007_at B-CELL TRANSLOCATION GENE 3 
1416434_at BCL2-LIKE 10 
1425732_a_at MAX INTERACTING PROTEIN 1 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: enzyme linked receptor protein signaling pathway; 7 genes (4.58%); pValue 0.0025 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1419089_at, 1449335_at TISSUE INHIBITOR OF METALLOPROTEINASE 3 
1429348_at 
SEMA DOMAIN, IMMUNOGLOBULIN DOMAIN (IG), SHORT BASIC DOMAIN, 
SECRETED, (SEMAPHORIN) 3C 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1457451_at ACTIVIN RECEPTOR IIA 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: negative regulation of cellular process; 12 genes (7.84%); pValue 0.0025 
Affymetrix ID Gene 
1449007_at B-CELL TRANSLOCATION GENE 3 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425732_a_at MAX INTERACTING PROTEIN 1 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: protein metabolism; 30 genes (19.61%); pValue 0.0037 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1454949_at RIKEN CDNA 2210010O09 GENE 
1423785_at EGL NINE HOMOLOG 1 (C. ELEGANS) 
1419029_at, 1419030_at, 
1449324_at 
ERO1-LIKE (S. CEREVISIAE) 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1416125_at, 1448231_at FK506 BINDING PROTEIN 5 
1430798_x_at MITOCHONDRIAL RIBOSOMAL PROTEIN L15 
1454018_at TOUSLED-LIKE KINASE 2 (ARABIDOPSIS) 
1454623_at SIMILAR TO CARBOXYPEPTIDASE A2 PRECURSOR 
1439677_at EPILEPSY, PROGRESSIVE MYOCLONIC EPILEPSY, TYPE 2 GENE ALPHA 
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1437785_at 
A DISINTEGRIN-LIKE AND METALLOPEPTIDASE (REPROLYSIN TYPE) WITH 
THROMBOSPONDIN TYPE 1 MOTIF, 9 
1459331_at SURFEIT GENE 6 
1433814_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1426721_s_at TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE 
1457451_at ACTIVIN RECEPTOR IIA 
1419087_s_at SPLICING FACTOR 3A, SUBUNIT 1 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1436531_at METHIONINE AMINOPEPTIDASE 2 
1438815_at HISTONE 2, H2AA1 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1430357_at H3 HISTONE, FAMILY 3A 
1455420_at RAD23B HOMOLOG (S. CEREVISIAE) 
1422832_at RETINAL G PROTEIN COUPLED RECEPTOR 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: regulation of cell proliferation; 7 genes (4.58%); pValue 0.0038 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1449007_at B-CELL TRANSLOCATION GENE 3 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: positive regulation of physiological process; 10 genes (6.54%); pValue 0.0059 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1416309_at EXPRESSED SEQUENCE AW547774 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: positive regulation of biological process; 11 genes (7.19%); pValue 0.0078 
RESULTS  80 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1416309_at EXPRESSED SEQUENCE AW547774 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: negative regulation of cellular physiological process; 10 genes (6.54%); pValue 0.0078 
Affymetrix ID Gene 
1449007_at B-CELL TRANSLOCATION GENE 3 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425732_a_at MAX INTERACTING PROTEIN 1 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: transmembrane receptor protein serine/threonine kinase signaling pathway; 4 genes (2.61%); 
pValue 0.01 
Affymetrix ID Gene 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1457451_at ACTIVIN RECEPTOR IIA 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: negative regulation of physiological process; 10 genes (6.54%); pValue 0.01 
Affymetrix ID Gene 
1449007_at B-CELL TRANSLOCATION GENE 3 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425732_a_at MAX INTERACTING PROTEIN 1 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: BMP signaling pathway; 3 genes (1.96%); pValue 0.01 
Affymetrix ID Gene 
RESULTS  81 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: cell cycle; 10 genes (6.54%); pValue 0.013 
Affymetrix ID Gene 
1454018_at TOUSLED-LIKE KINASE 2 (ARABIDOPSIS) 
1449007_at B-CELL TRANSLOCATION GENE 3 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1459978_x_at GENE MODEL 877, (NCBI) 
1416309_at EXPRESSED SEQUENCE AW547774 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1435870_at SYNAPTONEMAL COMPLEX PROTEIN 3 
Term Category: positive regulation of cellular physiological process; 9 genes (5.88%); pValue 0.014 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1416309_at EXPRESSED SEQUENCE AW547774 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: negative regulation of cellular metabolism; 6 genes (3.92%); pValue 0.014 
Affymetrix ID Gene 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425732_a_at MAX INTERACTING PROTEIN 1 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: negative regulation of protein kinase activity; 3 genes (1.96%); pValue 0.016 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
Term Category: negative regulation of transferase activity; 3 genes (1.96%); pValue 0.017 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
RESULTS  82 
Term Category: negative regulation of cell proliferation; 4 genes (2.61%); pValue 0.018 
Affymetrix ID Gene 
1449007_at B-CELL TRANSLOCATION GENE 3 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
Term Category: negative regulation of enzyme activity; 3 genes (1.96%); pValue 0.019 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
Term Category: regulation of progression through cell cycle; 7 genes (4.58%); pValue 0.019 
Affymetrix ID Gene 
1449007_at B-CELL TRANSLOCATION GENE 3 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1459978_x_at GENE MODEL 877, (NCBI) 
1416309_at EXPRESSED SEQUENCE AW547774 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: regulation of cell cycle; 7 genes (4.58%); pValue 0.019 
Affymetrix ID Gene 
1449007_at B-CELL TRANSLOCATION GENE 3 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1459978_x_at GENE MODEL 877, (NCBI) 
1416309_at EXPRESSED SEQUENCE AW547774 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: positive regulation of cellular process; 9 genes (5.88%); pValue 0.022 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1416309_at EXPRESSED SEQUENCE AW547774 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: nitric oxide mediated signal transduction; 2 genes (1.31%); pValue 0.024 
Affymetrix ID Gene 
1428942_at METALLOTHIONEIN 2 
RESULTS  83 
1422557_s_at METALLOTHIONEIN 1 
Term Category: amino acid and derivative metabolism; 6 genes (3.92%); pValue 0.025 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1435245_at GLUTAMINASE 2 (LIVER, MITOCHONDRIAL) 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1454608_x_at, 
1455913_x_at 
TRANSTHYRETIN 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
Term Category: cell proliferation; 7 genes (4.58%); pValue 0.025 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1449007_at B-CELL TRANSLOCATION GENE 3 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: negative regulation of metabolism; 6 genes (3.92%); pValue 0.026 
Affymetrix ID Gene 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425732_a_at MAX INTERACTING PROTEIN 1 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: zinc ion homeostasis; 2 genes (1.31%); pValue 0.03 
Affymetrix ID Gene 
1428942_at METALLOTHIONEIN 2 
1422557_s_at METALLOTHIONEIN 1 
Term Category: negative regulation of transcription; 5 genes (3.27%); pValue 0.031 
Affymetrix ID Gene 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425732_a_at MAX INTERACTING PROTEIN 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: positive regulation of cell proliferation; 4 genes (2.61%); pValue 0.031 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
RESULTS  84 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: apoptosis; 8 genes (5.23%); pValue 0.032 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1454109_a_at PHOSPHATIDYLSERINE RECEPTOR 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: programmed cell death; 8 genes (5.23%); pValue 0.035 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1454109_a_at PHOSPHATIDYLSERINE RECEPTOR 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: macromolecule metabolism; 33 genes (21.57%); pValue 0.035 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1454949_at RIKEN CDNA 2210010O09 GENE 
1423785_at EGL NINE HOMOLOG 1 (C. ELEGANS) 
1416432_at, 1456676_a_at 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BIPHOSPHATASE 3 
1419029_at, 1419030_at, 
1449324_at 
ERO1-LIKE (S. CEREVISIAE) 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1430798_x_at MITOCHONDRIAL RIBOSOMAL PROTEIN L15 
1416125_at, 1448231_at FK506 BINDING PROTEIN 5 
1454018_at TOUSLED-LIKE KINASE 2 (ARABIDOPSIS) 
1454623_at SIMILAR TO CARBOXYPEPTIDASE A2 PRECURSOR 
1439677_at EPILEPSY, PROGRESSIVE MYOCLONIC EPILEPSY, TYPE 2 GENE ALPHA 
1437785_at 
A DISINTEGRIN-LIKE AND METALLOPEPTIDASE (REPROLYSIN TYPE) WITH 
THROMBOSPONDIN TYPE 1 MOTIF, 9 
1433814_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14 
1459331_at SURFEIT GENE 6 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1426721_s_at TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE 
RESULTS  85 
1457451_at ACTIVIN RECEPTOR IIA 
1419087_s_at SPLICING FACTOR 3A, SUBUNIT 1 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1436531_at METHIONINE AMINOPEPTIDASE 2 
1438815_at HISTONE 2, H2AA1 
1430357_at H3 HISTONE, FAMILY 3A 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1455420_at RAD23B HOMOLOG (S. CEREVISIAE) 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1422832_at RETINAL G PROTEIN COUPLED RECEPTOR 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
1422885_at SMALL NUCLEAR RIBONUCLEOPROTEIN D3 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism; 5 
genes (3.27%); pValue 0.037 
Affymetrix ID Gene 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425732_a_at MAX INTERACTING PROTEIN 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: cellular protein metabolism; 25 genes (16.34%); pValue 0.039 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1454949_at RIKEN CDNA 2210010O09 GENE 
1419029_at, 1419030_at, 
1449324_at 
ERO1-LIKE (S. CEREVISIAE) 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1416125_at, 1448231_at FK506 BINDING PROTEIN 5 
1430798_x_at MITOCHONDRIAL RIBOSOMAL PROTEIN L15 
1454623_at SIMILAR TO CARBOXYPEPTIDASE A2 PRECURSOR 
1454018_at TOUSLED-LIKE KINASE 2 (ARABIDOPSIS) 
1439677_at EPILEPSY, PROGRESSIVE MYOCLONIC EPILEPSY, TYPE 2 GENE ALPHA 
1437785_at 
A DISINTEGRIN-LIKE AND METALLOPEPTIDASE (REPROLYSIN TYPE) WITH 
THROMBOSPONDIN TYPE 1 MOTIF, 9 
1433814_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1426721_s_at TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE 
1457451_at ACTIVIN RECEPTOR IIA 
1419087_s_at SPLICING FACTOR 3A, SUBUNIT 1 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
RESULTS  86 
1436531_at METHIONINE AMINOPEPTIDASE 2 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1455420_at RAD23B HOMOLOG (S. CEREVISIAE) 
1422832_at RETINAL G PROTEIN COUPLED RECEPTOR 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: amine metabolism; 6 genes (3.92%); pValue 0.042 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1435245_at GLUTAMINASE 2 (LIVER, MITOCHONDRIAL) 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1454608_x_at, 
1455913_x_at 
TRANSTHYRETIN 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
Term Category: cell death; 8 genes (5.23%); pValue 0.044 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1454109_a_at PHOSPHATIDYLSERINE RECEPTOR 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: cellular macromolecule metabolism; 25 genes (16.34%); pValue 0.045 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1454949_at RIKEN CDNA 2210010O09 GENE 
1419029_at, 1419030_at, 
1449324_at 
ERO1-LIKE (S. CEREVISIAE) 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1416125_at, 1448231_at FK506 BINDING PROTEIN 5 
1430798_x_at MITOCHONDRIAL RIBOSOMAL PROTEIN L15 
1454623_at SIMILAR TO CARBOXYPEPTIDASE A2 PRECURSOR 
1454018_at TOUSLED-LIKE KINASE 2 (ARABIDOPSIS) 
1439677_at EPILEPSY, PROGRESSIVE MYOCLONIC EPILEPSY, TYPE 2 GENE ALPHA 
1437785_at 
A DISINTEGRIN-LIKE AND METALLOPEPTIDASE (REPROLYSIN TYPE) WITH 
THROMBOSPONDIN TYPE 1 MOTIF, 9 
1433814_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1426721_s_at TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE 
RESULTS  87 
1457451_at ACTIVIN RECEPTOR IIA 
1419087_s_at SPLICING FACTOR 3A, SUBUNIT 1 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1436531_at METHIONINE AMINOPEPTIDASE 2 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1455420_at RAD23B HOMOLOG (S. CEREVISIAE) 
1422832_at RETINAL G PROTEIN COUPLED RECEPTOR 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: death; 8 genes (5.23%); pValue 0.047 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1454109_a_at PHOSPHATIDYLSERINE RECEPTOR 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: regulation of apoptosis; 6 genes (3.92%); pValue 0.047 
Affymetrix ID Gene 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: regulation of programmed cell death; 6 genes (3.92%); pValue 0.051 
Affymetrix ID Gene 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
Term Category: nitrogen compound metabolism; 6 genes (3.92%); pValue 0.052 
Affymetrix ID Gene 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1435245_at GLUTAMINASE 2 (LIVER, MITOCHONDRIAL) 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1454608_x_at, 
1455913_x_at 
TRANSTHYRETIN 
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1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
Term Category: negative regulation of transcription, DNA-dependent; 4 genes (2.61%); pValue 0.058 
Affymetrix ID Gene 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1425732_a_at MAX INTERACTING PROTEIN 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: amino acid derivative metabolism, DNA-dependent; 3 genes (1.96%); pValue 0.058 
Affymetrix ID Gene 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1454608_x_at, 
1455913_x_at 
TRANSTHYRETIN 
Term Category: positive regulation of programmed cell death; 4 genes (2.61%); pValue 0.06 
Affymetrix ID Gene 
1416434_at BCL2-LIKE 10 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
Term Category: primary metabolism; 48 genes (31.37%); pValue 0.061 
Affymetrix ID Gene 
1426727_s_at PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1454949_at RIKEN CDNA 2210010O09 GENE 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1423785_at EGL NINE HOMOLOG 1 (C. ELEGANS) 
1418190_at PARAOXONASE 1 
1416432_at, 1456676_a_at 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BIPHOSPHATASE 3 
1419029_at, 1419030_at, 
1449324_at 
ERO1-LIKE (S. CEREVISIAE) 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1430798_x_at MITOCHONDRIAL RIBOSOMAL PROTEIN L15 
1416125_at, 1448231_at FK506 BINDING PROTEIN 5 
1423233_at CCAAT/ENHANCER BINDING PROTEIN (C/EBP), DELTA 
1454623_at SIMILAR TO CARBOXYPEPTIDASE A2 PRECURSOR 
1454018_at TOUSLED-LIKE KINASE 2 (ARABIDOPSIS) 
1435245_at GLUTAMINASE 2 (LIVER, MITOCHONDRIAL) 
1439677_at EPILEPSY, PROGRESSIVE MYOCLONIC EPILEPSY, TYPE 2 GENE ALPHA 
1437785_at 
A DISINTEGRIN-LIKE AND METALLOPEPTIDASE (REPROLYSIN TYPE) WITH 
THROMBOSPONDIN TYPE 1 MOTIF, 9 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1433814_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14 
1459331_at SURFEIT GENE 6 
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1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1454608_x_at, 
1455913_x_at 
TRANSTHYRETIN 
1426721_s_at TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE 
1448607_at PRE-B-CELL COLONY-ENHANCING FACTOR 1 
1457451_at ACTIVIN RECEPTOR IIA 
1419087_s_at SPLICING FACTOR 3A, SUBUNIT 1 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1444487_at 
LECITHIN-RETINOL ACYLTRANSFERASE (PHOSPHATIDYLCHOLINE-RETINOL-O-
ACYLTRANSFERASE) 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1436531_at METHIONINE AMINOPEPTIDASE 2 
1438815_at HISTONE 2, H2AA1 
1435875_at PROTEIN KINASE, AMP-ACTIVATED, BETA 2 NON-CATALYTIC SUBUNIT 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1430357_at H3 HISTONE, FAMILY 3A 
1440257_at OOCYTE SPECIFIC HOMEOBOX 6 
1455420_at RAD23B HOMOLOG (S. CEREVISIAE) 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1425732_a_at MAX INTERACTING PROTEIN 1 
1422832_at RETINAL G PROTEIN COUPLED RECEPTOR 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
1422885_at SMALL NUCLEAR RIBONUCLEOPROTEIN D3 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: nucleosome assembly; 3 genes (1.96%); pValue 0.065 
Affymetrix ID Gene 
1430357_at H3 HISTONE, FAMILY 3A 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1438815_at HISTONE 2, H2AA1 
Term Category: regulation of biological process; 28 genes (18.3%); pValue 0.066 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1449007_at B-CELL TRANSLOCATION GENE 3 
1423233_at CCAAT/ENHANCER BINDING PROTEIN (C/EBP), DELTA 
1416434_at BCL2-LIKE 10 
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1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1436605_at TRANSKETOLASE 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1459978_x_at GENE MODEL 877, (NCBI) 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1440257_at OOCYTE SPECIFIC HOMEOBOX 6 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1425732_a_at MAX INTERACTING PROTEIN 1 
1416309_at EXPRESSED SEQUENCE AW547774 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1418370_at TROPONIN C, CARDIAC/SLOW SKELETAL 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1416039_x_at CYSTEINE RICH PROTEIN 61 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: protein complex assembly; 4 genes (2.61%); pValue 0.068 
Affymetrix ID Gene 
1430357_at H3 HISTONE, FAMILY 3A 
1459331_at SURFEIT GENE 6 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1438815_at HISTONE 2, H2AA1 
Term Category: blood vessel development; 4 genes (2.61%); pValue 0.07 
Affymetrix ID Gene 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1454109_a_at PHOSPHATIDYLSERINE RECEPTOR 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1416039_x_at CYSTEINE RICH PROTEIN 61 
Term Category: regulation of physiological process; 36 genes (16.99%); pValue 0.07 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1449007_at B-CELL TRANSLOCATION GENE 3 
1423233_at CCAAT/ENHANCER BINDING PROTEIN (C/EBP), DELTA 
1416434_at BCL2-LIKE 10 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
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1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1459978_x_at GENE MODEL 877, (NCBI) 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1440257_at OOCYTE SPECIFIC HOMEOBOX 6 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1425732_a_at MAX INTERACTING PROTEIN 1 
1416309_at EXPRESSED SEQUENCE AW547774 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1418370_at TROPONIN C, CARDIAC/SLOW SKELETAL 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1416039_x_at CYSTEINE RICH PROTEIN 61 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: negative regulation of BMP signaling pathway; 2 genes (1.31%); pValue 0.07 
Affymetrix ID Gene 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: vasculature development; 4 genes (2.61%); pValue 0.073 
Affymetrix ID Gene 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1454109_a_at PHOSPHATIDYLSERINE RECEPTOR 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1416039_x_at CYSTEINE RICH PROTEIN 61 
Term Category: regulation of cellular process; 26 Genes (16.99%); pValue 0.078 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1449007_at B-CELL TRANSLOCATION GENE 3 
1423233_at CCAAT/ENHANCER BINDING PROTEIN (C/EBP), DELTA 
1416434_at BCL2-LIKE 10 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1459978_x_at GENE MODEL 877, (NCBI) 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
RESULTS  92 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1440257_at OOCYTE SPECIFIC HOMEOBOX 6 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1425732_a_at MAX INTERACTING PROTEIN 1 
1416309_at EXPRESSED SEQUENCE AW547774 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1416039_x_at CYSTEINE RICH PROTEIN 61 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: regulation of cellular physiological process; 25 genes (16.34%); pValue 0.079 
Affymetrix ID Gene 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1449007_at B-CELL TRANSLOCATION GENE 3 
1423233_at CCAAT/ENHANCER BINDING PROTEIN (C/EBP), DELTA 
1416434_at BCL2-LIKE 10 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1459978_x_at GENE MODEL 877, (NCBI) 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1424638_at CYCLIN-DEPENDENT KINASE INHIBITOR 1A (P21) 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1440257_at OOCYTE SPECIFIC HOMEOBOX 6 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1425732_a_at MAX INTERACTING PROTEIN 1 
1416309_at EXPRESSED SEQUENCE AW547774 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1420909_at, 1451959_a_at VASCULAR ENDOTHELIAL GROWTH FACTOR A 
1416039_x_at CYSTEINE RICH PROTEIN 61 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
Term Category: regulation of BMP signaling pathway; 2 genes (1.31%); pValue 0.08 
Affymetrix ID Gene 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1422803_at FOLLISTATIN-LIKE 3 
Term Category: chromatin assembly; 3 genes (1.96%); pValue 0.084 
Affymetrix ID Gene 
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1430357_at H3 HISTONE, FAMILY 3A 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1438815_at HISTONE 2, H2AA1 
Term Category: metabolism; 52 genes (33.9%); pValue 0.088 
Affymetrix ID Gene 
1426727_s_at PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10 
1453851_a_at GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 GAMMA 
1423785_at EGL NINE HOMOLOG 1 (C. ELEGANS) 
1416432_at, 1456676_a_at 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BIPHOSPHATASE 3 
1430798_x_at MITOCHONDRIAL RIBOSOMAL PROTEIN L15 
1454018_at TOUSLED-LIKE KINASE 2 (ARABIDOPSIS) 
1423233_at CCAAT/ENHANCER BINDING PROTEIN (C/EBP), DELTA 
1454623_at SIMILAR TO CARBOXYPEPTIDASE A2 PRECURSOR 
1435245_at GLUTAMINASE 2 (LIVER, MITOCHONDRIAL) 
1437785_at 
A DISINTEGRIN-LIKE AND METALLOPEPTIDASE (REPROLYSIN TYPE) WITH 
THROMBOSPONDIN TYPE 1 MOTIF, 9 
1459331_at SURFEIT GENE 6 
1433814_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14 
1436006_at EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 
1417149_at 
PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE 4-DIOXYGENASE (PROLINE 4-
HYDROXYLASE), ALPHA II POLYPEPTIDE 
1425895_a_at INHIBITOR OF DNA BINDING 1 
1426721_s_at TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE 
1448607_at PRE-B-CELL COLONY-ENHANCING FACTOR 1 
1419087_s_at SPLICING FACTOR 3A, SUBUNIT 1 
1442025_a_at ZINC FINGER AND BTB DOMAIN CONTAINING 16 
1431212_a_at RIKEN CDNA 3300001M20 GENE 
1425809_at FATTY ACID BINDING PROTEIN 4, ADIPOCYTE 
1430357_at H3 HISTONE, FAMILY 3A 
1418093_a_at EPIDERMAL GROWTH FACTOR 
1430197_a_at PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED 2 
1424143_a_at, 1424144_at RETROVIRAL INTEGRATION SITE 2 
1425732_a_at MAX INTERACTING PROTEIN 1 
1422832_at RETINAL G PROTEIN COUPLED RECEPTOR 
1437313_x_at, 
1452534_a_at 
HIGH MOBILITY GROUP BOX 2 
1422885_at SMALL NUCLEAR RIBONUCLEOPROTEIN D3 
1450725_s_at CARBONIC ANHYDRASE 14 
1454949_at RIKEN CDNA 2210010O09 GENE 
1418808_at RETINOL DEHYDROGENASE 5 
1427364_a_at, 
1438761_a_at 
ORNITHINE DECARBOXYLASE, STRUCTURAL 1 
1418190_at PARAOXONASE 1 
1419029_at, 1419030_at, 
1449324_at 
ERO1-LIKE (S. CEREVISIAE) 
1416749_at, 1438251_x_at HTRA SERINE PEPTIDASE 1 
1416125_at, 1448231_at FK506 BINDING PROTEIN 5 
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1439677_at EPILEPSY, PROGRESSIVE MYOCLONIC EPILEPSY, TYPE 2 GENE ALPHA 
1419024_at, 1455002_at PROTEIN TYROSINE PHOSPHATASE 4A1 
1454608_x_at, 
1455913_x_at 
TRANSTHYRETIN 
1434952_at CYTOCHROME C OXIDASE SUBUNIT IV ISOFORM 1 
1457451_at ACTIVIN RECEPTOR IIA 
1452050_at CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE ID 
1444487_at 
LECITHIN-RETINOL ACYLTRANSFERASE (PHOSPHATIDYLCHOLINE-RETINOL-O-
ACYLTRANSFERASE) 
1436531_at METHIONINE AMINOPEPTIDASE 2 
1438815_at HISTONE 2, H2AA1 
1435875_at PROTEIN KINASE, AMP-ACTIVATED, BETA 2 NON-CATALYTIC SUBUNIT 
1440257_at OOCYTE SPECIFIC HOMEOBOX 6 
1455420_at RAD23B HOMOLOG (S. CEREVISIAE) 
1454903_at NERVE GROWTH FACTOR RECEPTOR (TNFR SUPERFAMILY, MEMBER 16) 
1416344_at LYSOSOMAL MEMBRANE GLYCOPROTEIN 2 
1442397_at NUCLEAR X BOX BINDING FACTOR 1 
 
TABLE 6 Differentially down-regulated genes functionally clustered by DAVID. 
Term Category: cellular metabolism; 30 genes (41.67%); pValue 0.002 
Affymetrix ID Gene 
1424852_at MYOCYTE ENHANCER FACTOR 2C 
1428760_at RIKEN CDNA 4930558A07 GENE 
1429169_at RNA BINDING MOTIF PROTEIN 3 
1456723_at ZINC FINGER PROTEIN 689 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1450034_at SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 
1451991_at EPH RECEPTOR A7 
1416349_at MITOCHONDRIAL RIBOSOMAL PROTEIN L34 
1450953_at WD REPEAT DOMAIN 39 
1449749_s_at TRANSCRIPTION FACTOR B1, MITOCHONDRIAL 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
1434837_at MEDIATOR OF DNA DAMAGE CHECKPOINT 1 
1433495_at GLYCOSYLTRANSFERASE 25 DOMAIN CONTAINING 1 
1426364_at MITOCHONDRIAL RIBOSOME RECYCLING FACTOR 
1421379_at ZINC FINGER PROTEIN 354B 
1418529_at O-SIALOGLYCOPROTEIN ENDOPEPTIDASE 
1436833_x_at TUBULIN TYROSINE LIGASE-LIKE 1 
1453128_at EXTRA CELLULAR LINK DOMAIN-CONTAINING 1 
1417859_at GROWTH ARREST SPECIFIC 7 
1451297_at GULONOLACTONE (L-) OXIDASE 
1448905_at RIKEN CDNA 1810009F08 GENE 
1416961_at, 
1447363_s_at 
BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 HOMOLOG, BETA (S. 
CEREVISIAE) 
1453010_at RIKEN CDNA 1700069O15 GENE 
1416920_at RNA BINDING MOTIF PROTEIN 4 
1416826_a_at 
TRF (TATA BINDING PROTEIN-RELATED FACTOR)-PROXIMAL PROTEIN 
HOMOLOG (DROSOPHILA) 
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1456378_s_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20 
1456834_at IBR DOMAIN CONTAINING 2 
1437647_at DEATH INDUCER-OBLITERATOR 1 
1452388_at HEAT SHOCK PROTEIN 1B 
1442051_at HISTONE 2, H3C1 
Term Category: cellular physiological process; 37 genes (51.39%); pValue 0.003 
Affymetrix ID Gene 
1424852_at MYOCYTE ENHANCER FACTOR 2C 
1428760_at RIKEN CDNA 4930558A07 GENE 
1429169_at RNA BINDING MOTIF PROTEIN 3 
1456723_at ZINC FINGER PROTEIN 689 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1450034_at SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 
1451991_at EPH RECEPTOR A7 
1423343_at SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1C1 
1455213_at RIKEN CDNA 4930488E11 GENE 
1416349_at MITOCHONDRIAL RIBOSOMAL PROTEIN L34 
1450953_at WD REPEAT DOMAIN 39 
1449749_s_at TRANSCRIPTION FACTOR B1, MITOCHONDRIAL 
1434837_at MEDIATOR OF DNA DAMAGE CHECKPOINT 1 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
1433495_at GLYCOSYLTRANSFERASE 25 DOMAIN CONTAINING 1 
1457969_at RAB INTERACTING FACTOR 
1417834_at SYNAPTOJANIN 2 BINDING PROTEIN 
1426364_at MITOCHONDRIAL RIBOSOME RECYCLING FACTOR 
1421379_at ZINC FINGER PROTEIN 354B 
1418529_at O-SIALOGLYCOPROTEIN ENDOPEPTIDASE 
1448943_at NEUROPILIN 1 
1451297_at GULONOLACTONE (L-) OXIDASE 
1417859_at GROWTH ARREST SPECIFIC 7 
1436833_x_at TUBULIN TYROSINE LIGASE-LIKE 1 
1453128_at EXTRA CELLULAR LINK DOMAIN-CONTAINING 1 
1448905_at RIKEN CDNA 1810009F08 GENE 
1416961_at, 
1447363_s_at 
BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 HOMOLOG, BETA (S. 
CEREVISIAE) 
1453010_at RIKEN CDNA 1700069O15 GENE 
1416920_at RNA BINDING MOTIF PROTEIN 4 
1416826_a_at 
TRF (TATA BINDING PROTEIN-RELATED FACTOR)-PROXIMAL PROTEIN 
HOMOLOG (DROSOPHILA) 
1456378_s_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20 
1456834_at IBR DOMAIN CONTAINING 2 
1437647_at DEATH INDUCER-OBLITERATOR 1 
1452388_at HEAT SHOCK PROTEIN 1B 
1427401_at CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 5 
1442051_at HISTONE 2, H3C1 
1417680_at 
POTASSIUM VOLTAGE-GATED CHANNEL, SHAKER-RELATED SUBFAMILY, 
MEMBER 5 
Term Category: primary metabolism; 28 genes (38.89%); pValue 0.005 
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Affymetrix ID Gene 
1424852_at MYOCYTE ENHANCER FACTOR 2C 
1428760_at RIKEN CDNA 4930558A07 GENE 
1429169_at RNA BINDING MOTIF PROTEIN 3 
1456723_at ZINC FINGER PROTEIN 689 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1450034_at SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 
1451991_at EPH RECEPTOR A7 
1416349_at MITOCHONDRIAL RIBOSOMAL PROTEIN L34 
1450953_at WD REPEAT DOMAIN 39 
1449749_s_at TRANSCRIPTION FACTOR B1, MITOCHONDRIAL 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
1434837_at MEDIATOR OF DNA DAMAGE CHECKPOINT 1 
1433495_at GLYCOSYLTRANSFERASE 25 DOMAIN CONTAINING 1 
1426364_at MITOCHONDRIAL RIBOSOME RECYCLING FACTOR 
1421379_at ZINC FINGER PROTEIN 354B 
1418529_at O-SIALOGLYCOPROTEIN ENDOPEPTIDASE 
1436833_x_at TUBULIN TYROSINE LIGASE-LIKE 1 
1453128_at EXTRA CELLULAR LINK DOMAIN-CONTAINING 1 
1417859_at GROWTH ARREST SPECIFIC 7 
1448905_at RIKEN CDNA 1810009F08 GENE 
1416961_at, 
1447363_s_at 
BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 HOMOLOG, BETA (S. 
CEREVISIAE) 
1416920_at RNA BINDING MOTIF PROTEIN 4 
1416826_a_at 
TRF (TATA BINDING PROTEIN-RELATED FACTOR)-PROXIMAL PROTEIN 
HOMOLOG (DROSOPHILA) 
1456378_s_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20 
1456834_at IBR DOMAIN CONTAINING 2 
1437647_at DEATH INDUCER-OBLITERATOR 1 
1452388_at HEAT SHOCK PROTEIN 1B 
1442051_at HISTONE 2, H3C1 
Term Category: metabolism; 30 genes (41.67%); pValue 0.006 
Affymetrix ID Gene 
1424852_at MYOCYTE ENHANCER FACTOR 2C 
1428760_at RIKEN CDNA 4930558A07 GENE 
1429169_at RNA BINDING MOTIF PROTEIN 3 
1456723_at ZINC FINGER PROTEIN 689 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1450034_at SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 
1451991_at EPH RECEPTOR A7 
1416349_at MITOCHONDRIAL RIBOSOMAL PROTEIN L34 
1450953_at WD REPEAT DOMAIN 39 
1449749_s_at TRANSCRIPTION FACTOR B1, MITOCHONDRIAL 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
1434837_at MEDIATOR OF DNA DAMAGE CHECKPOINT 1 
1433495_at GLYCOSYLTRANSFERASE 25 DOMAIN CONTAINING 1 
1426364_at MITOCHONDRIAL RIBOSOME RECYCLING FACTOR 
1421379_at ZINC FINGER PROTEIN 354B 
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1418529_at O-SIALOGLYCOPROTEIN ENDOPEPTIDASE 
1436833_x_at TUBULIN TYROSINE LIGASE-LIKE 1 
1453128_at EXTRA CELLULAR LINK DOMAIN-CONTAINING 1 
1417859_at GROWTH ARREST SPECIFIC 7 
1451297_at GULONOLACTONE (L-) OXIDASE 
1448905_at RIKEN CDNA 1810009F08 GENE 
1416961_at, 
1447363_s_at 
BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 HOMOLOG, BETA (S. 
CEREVISIAE) 
1453010_at RIKEN CDNA 1700069O15 GENE 
1416920_at RNA BINDING MOTIF PROTEIN 4 
1416826_a_at 
TRF (TATA BINDING PROTEIN-RELATED FACTOR)-PROXIMAL PROTEIN 
HOMOLOG (DROSOPHILA) 
1456378_s_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20 
1456834_at IBR DOMAIN CONTAINING 2 
1437647_at DEATH INDUCER-OBLITERATOR 1 
1452388_at HEAT SHOCK PROTEIN 1B 
1442051_at HISTONE 2, H3C1 
Term Category: nucleobase, nucleoside, nucleotide and nucleic acid metabolism; 17 genes (23.61%); pValue 
0.006 
Affymetrix ID Gene 
1421379_at ZINC FINGER PROTEIN 354B 
1424852_at MYOCYTE ENHANCER FACTOR 2C 
1428760_at RIKEN CDNA 4930558A07 GENE 
1456723_at ZINC FINGER PROTEIN 689 
1429169_at RNA BINDING MOTIF PROTEIN 3 
1450034_at SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1448905_at RIKEN CDNA 1810009F08 GENE 
1416920_at RNA BINDING MOTIF PROTEIN 4 
1416826_a_at 
TRF (TATA BINDING PROTEIN-RELATED FACTOR)-PROXIMAL PROTEIN 
HOMOLOG (DROSOPHILA) 
1450953_at WD REPEAT DOMAIN 39 
1437647_at DEATH INDUCER-OBLITERATOR 1 
1452388_at HEAT SHOCK PROTEIN 1B 
1449749_s_at TRANSCRIPTION FACTOR B1, MITOCHONDRIAL 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
1434837_at MEDIATOR OF DNA DAMAGE CHECKPOINT 1 
1442051_at HISTONE 2, H3C1 
Term Category: cartilage condensation; 2 genes (2.78%); pValue 0.028 
Affymetrix ID Gene 
1425083_at OTORAPLIN 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
Term Category: macromolecule metabolism; 18 genes (25%); pValue 0.03 
Affymetrix ID Gene 
1433495_at GLYCOSYLTRANSFERASE 25 DOMAIN CONTAINING 1 
1426364_at MITOCHONDRIAL RIBOSOME RECYCLING FACTOR 
1418529_at O-SIALOGLYCOPROTEIN ENDOPEPTIDASE 
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1429169_at RNA BINDING MOTIF PROTEIN 3 
1453128_at EXTRA CELLULAR LINK DOMAIN-CONTAINING 1 
1436833_x_at TUBULIN TYROSINE LIGASE-LIKE 1 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1417859_at GROWTH ARREST SPECIFIC 7 
1416961_at, 
1447363_s_at 
BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 HOMOLOG, BETA (S. 
CEREVISIAE) 
1451991_at EPH RECEPTOR A7 
1416920_at RNA BINDING MOTIF PROTEIN 4 
1456378_s_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20 
1456834_at IBR DOMAIN CONTAINING 2 
1416349_at MITOCHONDRIAL RIBOSOMAL PROTEIN L34 
1452388_at HEAT SHOCK PROTEIN 1B 
1449749_s_at TRANSCRIPTION FACTOR B1, MITOCHONDRIAL 
1434837_at MEDIATOR OF DNA DAMAGE CHECKPOINT 1 
1442051_at HISTONE 2, H3C1 
Term Category: biopolymer metabolism; 13 genes (18.06%); pValue 0.04 
Affymetrix ID Gene 
1433495_at GLYCOSYLTRANSFERASE 25 DOMAIN CONTAINING 1 
1429169_at RNA BINDING MOTIF PROTEIN 3 
1436833_x_at TUBULIN TYROSINE LIGASE-LIKE 1 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1416961_at, 
1447363_s_at 
BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 HOMOLOG, BETA (S. 
CEREVISIAE) 
1451991_at EPH RECEPTOR A7 
1416920_at RNA BINDING MOTIF PROTEIN 4 
1456378_s_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20 
1456834_at IBR DOMAIN CONTAINING 2 
1452388_at HEAT SHOCK PROTEIN 1B 
1449749_s_at TRANSCRIPTION FACTOR B1, MITOCHONDRIAL 
1434837_at MEDIATOR OF DNA DAMAGE CHECKPOINT 1 
1442051_at HISTONE 2, H3C1 
Term Category: cartilage development; 2 genes (2.78%); pValue 0.078 
Affymetrix ID Gene 
1425083_at OTORAPLIN 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
Term Category: cellular macromolecule metabolism; 13 genes (18.06%); pValue 0.08 
Affymetrix ID Gene 
1433495_at GLYCOSYLTRANSFERASE 25 DOMAIN CONTAINING 1 
1426364_at MITOCHONDRIAL RIBOSOME RECYCLING FACTOR 
1418529_at O-SIALOGLYCOPROTEIN ENDOPEPTIDASE 
1429169_at RNA BINDING MOTIF PROTEIN 3 
1436833_x_at TUBULIN TYROSINE LIGASE-LIKE 1 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1417859_at GROWTH ARREST SPECIFIC 7 
1416961_at, 
1447363_s_at 
BUDDING UNINHIBITED BY BENZIMIDAZOLES 1 HOMOLOG, BETA (S. 
CEREVISIAE) 
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1451991_at EPH RECEPTOR A7 
1456378_s_at F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20 
1456834_at IBR DOMAIN CONTAINING 2 
1416349_at MITOCHONDRIAL RIBOSOMAL PROTEIN L34 
1452388_at HEAT SHOCK PROTEIN 1B 
Term Category: regulation of transcription, DNA-dependent; 10 genes (13.89%); pValue 0.09 
Affymetrix ID Gene 
1450034_at SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1416826_a_at 
TRF (TATA BINDING PROTEIN-RELATED FACTOR)-PROXIMAL PROTEIN 
HOMOLOG (DROSOPHILA) 
1450953_at WD REPEAT DOMAIN 39 
1424852_at MYOCYTE ENHANCER FACTOR 2C 
1421379_at ZINC FINGER PROTEIN 354B 
1437647_at DEATH INDUCER-OBLITERATOR 1 
1428760_at RIKEN CDNA 4930558A07 GENE 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
1456723_at ZINC FINGER PROTEIN 689 
Term Category: transcription, DNA-dependent; 10 genes (13.89%); pValue 0.099 
Affymetrix ID Gene 
1450034_at SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 
1440343_at RIBOSOMAL PROTEIN S6 KINASE, POLYPEPTIDE 5 
1416826_a_at 
TRF (TATA BINDING PROTEIN-RELATED FACTOR)-PROXIMAL PROTEIN 
HOMOLOG (DROSOPHILA) 
1450953_at WD REPEAT DOMAIN 39 
1424852_at MYOCYTE ENHANCER FACTOR 2C 
1421379_at ZINC FINGER PROTEIN 354B 
1437647_at DEATH INDUCER-OBLITERATOR 1 
1428760_at RIKEN CDNA 4930558A07 GENE 
1443952_at THYROID HORMONE RECEPTOR ALPHA 
1456723_at ZINC FINGER PROTEIN 689 
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3.1.1.5 Hypoxic Preconditioning Gene Networks Discovered by Ingenuity Pathway 
Analysis (Additional File 5) 
 
 
 
Supplemental Fig.2 A prominent affected gene network discovered by Ingenuity Pathway 
Analysis. Network was classified as: DNA replication, recombination, cell cycle and cancer. 
Pathway is centrally occupied by Myc and contains the pro survival gene Adm. Note that Myc itself 
is not differentially regulated. (red = induction; green = repression; white = unaffected; color 
intensity correlates with fold change) 
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Supplemental Fig.3 An affected gene network discovered by Ingenuity Pathway Analysis. 
Network was classified as: Cell death, cellular development, hematological system development & 
function. Some genes related to TGF-b are induced after hypoxic preconditioning (red = Induction; 
green = repression; white = unaffected; color intensity correlates with fold change) 
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3.1.1.6 Primer Sequences and Product Sizes (Additional File 6) 
 
TABLE 7 Primer pairs used for real time PCR. 
Gene Primer forward Primer reverse Product bp 
Adm TTCGCAGTTCCGAAAGAAGT GGTAGCTGCTGGATGCTTGTA 77 
Bcl2l10 GAACTTTCTGTATAATCTGCTCATGG TGAAGAAGCGGCAAAAGC 89 
Cdkn1a CGGTGTCAGAGTCTAGGGGAATTG CGTGACGAAGTCAAAGTTCCACC 238 
Cebpd CTTTTAGGTGGTTGCCGAAG GCAACGAGGAATCAAGTTTCA 70 
Dido1 (Iso1/3) CTCTATATCCGTGGTAGCTCTGG TGGGGACTGCCTCTTAAACA 76 
Dido1 (Iso2) GACTGAGTTCGAAACGAAGGA CGAACAACCAAAGGGACAGT 63 
Egf CATGCCCCACAGGATTTG GGGCAGGAAACAAGTTCGT 64 
Egln1 CATTGTTGGCAGAAGGTGTG CAAAGGACTACAGGGTCTCCA 70 
Fabp4 GAAAACGAGATGGTGACAAGC TTGTGGAAGTCACGCCTTT 60 
H3f3B CGATTGCGGCTCTTGTTC CTTGGTTCGGGCCATTTT 96 
Hes6 GCACGGATCAACGAGAGTC CGGCGTTCTCTAGCTTGG 76 
Hmgb2 GATTGCGTTACGAGAAACCAG GTCACCCTTGCCCATGAC 126 
Ibrdc2 AGGCTGTGGCTCAGACCTTA ACACTGGAGCCCATCGAC 75 
Id1 GCGAGATCAGTGCCTTGG CTCCTGAAGGGCTGGAGTC 111 
Kif4 GCATGACTGCAACCATTGAT TATCTGGGCTGCTTTGCACT 63 
Mef2c TCTGCCCTCAGTCAGTTGG CGTGGTGTGTTGTGGGTATC 63 
Metap2 GGAGAGAGATGACGACGATGA CTTCTTCCCAGTTGCACCAT 61 
Mt1 GAATGGACCCCAACTGCTC GCAGCAGCTCTTCTTGCAG 104 
Pon1 AATGCTTTCCGTGAAGTAACGC TCTAACTCTGACACTGCTGGCTCC 218 
Rad23b CCCTGACAGAGCTGTGGAAT GTCAACCACAGCCTGACTTTC 70 
Sema3c ATGGCCACTCTTGCTCTAGG CATCTTGTCTTCGGCTCCTC 60 
Slc2A1 ATGGATCCCAGCAGCAAG CCAGTGTTATAGCCGAACTGC 92 
Sos1 TCGGCAACTCACTTTACTTGAA TGTCCACACACTTCCAACTAATTC 76 
Stat1 TTGTGTTGAATCCCGAACCT TCGAACCACTGTGACATCCT 95 
Stom CCAGTGCAGCTCCAGAGAG CGCATTCATTTCCCCTTC 93 
Thra AAGGTGGAGTGTGGGTCAGA TTTTTCGCTTTCCATCTGGT 64 
Timp3 GCCTCAAGCTAGAAGTCAACAAA TGTACATCTTGCCTTCATACACG 69 
Ttr AATGTCCTCTGATGGTCAAAGTCC TGGAACGGGGAAATGCCAAG 238 
Vegf_all ACTTGTGTTGGGAGGAGGATGTC AATGGGTTTGTCGTGTTTCTGG 171 
Vegf164 (Iso1) CATCTTCAAGCCGTCCTGTGTG TGACCCTTTCCCTTTCCTCG 240 
Vegf120 (Iso2) GCCAGAAAATCACTGTGAGCC TCTACAGGAATCCCAGAAACAACC 478 
Vegf188 (Iso3) CAGAAAAATGTGACAAGCCAAGG TCTACAGGAATCCCAGAAACAACC 344 
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Abstract 
Hypoxic preconditioning stabilizes hypoxia-inducible-factor 1α (HIF-1α) in the 
retina and protects photoreceptors against light-induced cell death. HIF-1α is one of the 
major transcription factors responding to low oxygen tension and can differentially 
regulate a large number of target genes. To analyze whether photoreceptor specific 
expression of HIF-1α is essential to protect photoreceptors by hypoxic preconditioning, 
we knocked down expression of HIF-1α specifically in photoreceptor cells using the 
cre-lox system. The cre-mediated knockdown caused a 20-fold reduced expression of 
HIF-1α in the photoreceptor cell layer. In the total retina, RNA expression was reduced 
by 65% and hypoxic preconditioning did only lead to a small increase in HIF-1α protein 
levels. Accordingly, HIF-1 target gene expression after hypoxia was significantly 
diminished. Retinas of HIF-1α knockdown animals did not show any pathological 
alterations and tolerated hypoxic exposure comparable to wild type retinas. 
Importantly, the strong neuroprotective effect of hypoxic preconditioning against light-
induced photoreceptor degeneration persisted in knockdown mice suggesting that 
hypoxia-mediated survival of light exposure does not depend on an autocrine action of 
HIF-1α in photoreceptor cells. Hypoxia-mediated stabilization of HIF-2α and 
phosphorylation of STAT3 was not affected in the retinas of HIF-1α knockdown mice. 
Thus, these factors are candidates for regulating the resistance of photoreceptors 
against light damage after hypoxic preconditioning along with several potentially 
neuroprotective genes which were similarly induced in hypoxic knockdown and control 
mice.  
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Introduction 
Photoreceptor degeneration is common to many blinding diseases including 
Retinitis Pigmentosa (RP) and age related macular degeneration (AMD). Whereas RP 
is a monogenetic disorder affecting primarily photoreceptors, the pathology of AMD is 
complex and involves death of cells of the retinal pigment epithelium (RPE) and of 
photoreceptors, changes in the Bruch’s membrane, formation of Drusen and – in the 
wet form of the disease - neovascularization. To mimic photoreceptor degeneration as 
part of the retinal pathology in these diseases, mice are exposed to cytotoxic levels of 
white light, which triggers apoptosis in photoreceptors (Wenzel et al. 2005). Different 
strategies such as hypoxic and ischemic preconditioning have been shown to inhibit 
cell death and to protect non-neuronal as well as neuronal tissues – including the retina 
– from apoptosis (Gage & Stanton 1996; Barone et al. 1998; Roth et al. 1998; Gidday 
et al. 1999; Grimm et al. 2002; Tanaka et al. 2002; Zhang et al. 2002; Sharp et al. 
2004; Zhu et al. 2007). The underlying pro-survival mechanisms are not completely 
understood. However, it is clear that cells respond to hypoxia with the differential 
regulation of genes driven by several major transcription factors. Among those, hypoxia 
inducible factors (HIFs) are the most prominent proteins regulating the tissue response 
to low oxygen levels. The HIF family consists of 3 identified members with HIF-1 being 
the best-characterized protein (Bruick & McKnight 2002). It is a heterodimeric 
transcription factor, which consists of the HIF-1α and HIF-1β subunits. Both proteins 
are ubiquitously expressed with HIF-1α being posttranslationally regulated by oxygen 
availability (Wang & Semenza 1993; 1995). Under normoxic conditions 
prolylhydroxylases (PHDs) hydroxylate HIF-1α at specific prolin residues (Bruick & 
McKnight 2001; Ivan et al. 2001; Jaakkola et al. 2001) providing the substrate for the 
von-Hippel-Lindau protein (VHL), which initiates the accumulative binding of ubiquitin 
to the protein. This finally results in the efficient degradation of HIF-1α via the 
proteosomal degradation pathway (Salceda & Caro 1997; Huang et al. 1998). 
Additionally, factor inhibiting HIF (FIH) hydroxylates HIF-1α at an asparagine residue in 
the transactivation domain to inhibit the binding of transcriptional cofactors (Mahon et 
al. 2001). Under hypoxic conditions the hydroxylases fail to hydroxylate HIF-1α 
resulting in its stabilization and activation. Stabilized HIF-1α is transferred into the 
nucleus where it binds its partner hypoxia inducible factor-1β (HIF-1β) to form HIF-1, 
which differentially regulates the expression of many genes involved in apoptosis, cell 
survival, angiogenesis and metabolism (Bruick & McKnight 2002).  
Many reports have connected HIF-1α to tissue- and neuro-protection (Ran et al. 
2005; Siddiq et al. 2005; Hill et al. 2008; Rosenberger et al. 2008). Recently, it was 
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reported that cardioprotection against ischemia/reperfusion after ischemic 
preconditioning requires HIF-1α expression (Cai et al. 2008) and that neuronal ablation 
of HIF-1α enhances pathological effects after cerebral ischemia (Baranova et al. 2007). 
In the retina HIF-1α was found in association with heat shock protein 27 (Hsp27), nitric 
oxide synthase (NOS) or heme oxygenase-1 (HO-1) to protect from ischemia after 
ischemic preconditioning (Whitlock et al. 2005; Kaur et al. 2006; Zhu et al. 2007). 
Additionally, the level of HIF-1α stabilization after hypoxic preconditioning correlated 
with the degree of photoreceptor protection against light-induced degeneration (Grimm 
et al. 2002). Part of this neuroprotective response was attributed to erythropoietin (Epo) 
(Grimm et al. 2002), which, as newer data indicate, may mainly be regulated by HIF-2 
and not by HIF-1 (Rankin et al. 2007). This suggests that HIF-2 may have 
neuroprotective activity affecting cell survival after a toxic insult. To date the impact of 
HIF-1α on retinal neuroprotection after hypoxic preconditioning has not been analyzed 
in detail. Using tissue-specific knockdown mice, we analyzed whether photoreceptors 
require intrinsic activity of HIF-1α to survive light exposure after hypoxic 
preconditioning.  
 
Material and Methods 
 
Animals 
Animals were treated in accordance with the regulations of the Veterinary 
Authority of Zurich and with the statement of ‘The Association for Research in Vision 
and Ophthalmology’ for the use of animals in research. Mice carrying a floxed exon 2 
of HIF-1α (HIF-1αF/F) (Ryan et al. 2000) were kindly provided by Randall Johnson 
(UCSD San Diego, USA)/Max Gassmann (University of Zurich, Switzerland) and PrP-
Cre-ERT(28.4) mice (Weber et al. 2001) were obtained from Pierre Chambon (IGBMC, 
Strasbourg, France). LMOPC1 mice (expressing Cre under the control of the rod opsin 
promoter) have been published before (Le et al. 2006). To generate conditional 
knockdown mice HIF-1αF/F mice were bred to PrP-Cre-ERT(28.4) mice or to LMOPC1 
according to classical breeding schemes. All mouse strains analyzed were maintained 
on a homozygous Rpe65450Leu background (Wenzel et al. 2003). To simplify matters 
LMOPC1:HIF-1αΔ/Δ mice were named OpnCre(HIF-Δ) and HIF-1αF/F control mice were 
named OpnCre(HIF-wt). PrP-Cre-ERT(28.4) mice required tamoxifen (TAM) to induce Cre 
activity. TAM was dissolved in sunflower oil (Sigma-Aldrich, Buchs, Switzerland) to 
obtain a concentration of 10 mg/ml. TAM (1mg/40g) was injected intraperitoneally in 
three week old animals twice a day for 5 consecutive days. Control injections were 
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done with oil only. After injections mice were allowed to recover for 2 weeks before 
experiments were performed. In keeping with the above nomenclature, TAM treated 
knockdown animals (PrP-Cre-ERT(28.4):HIFΔ/Δ) were named PrpCre(HIF-Δ) and oil 
treated PrP-Cre-ERT(28.4):HIFF/F control mice were named PrpCre(HIF-wt). For tissue 
isolation and analysis, mice were sacrificed by CO2 anesthesia followed by cervical 
dislocation. 
 
Hypoxic preconditioning and light exposure 
Hypoxic preconditioning (6-7% O2 for 6 hours) was performed as described 
previously (Grimm et al. 2002). After hypoxia, mice were sacrificed at indicated time 
points for tissue collection or were dark adapted for 4 h before light onset. For light 
exposure, pupils of mice were dilated in dim red light using 1% Cyclogyl (Alcon, Cham, 
Switzerland) and 5% Phenylephrine (Ciba Vision, Niederwangen, Switzerland) 45 
minutes prior to illumination. After light exposure (13‘000 lux; 2 h) animals remained in 
darkness over night and were analyzed after 36 h or at the time points indicated. 
 
Morphology and cell death detection 
To analyze morphology, mice were sacrificed 36 h after light exposure. Eyes 
were enucleated and processed for light microscopy as previously described 
(Samardzija et al. 2006). A digitalized Axiovision microscope (Carl Zeiss Microscopy, 
Jena, Germany) using 40x objective lenses with numerical aperture of 1.3 was used to 
examine slides. Representative images were taken from the inferior temporal retina. To 
balance for staining variabilities, contrast and brightness were sometimes slightly 
adjusted. As semi-quantitative assessment of apoptosis, nucleosomal release was 
determined at 36 h after light exposure using a cell death detection kit (Roche 
Diagnostics, Basel, Switzerland) according to the manufacturer’s recommendation.  
 
RNA isolation and real time PCR 
Retinas were isolated immediately after hypoxic preconditioning, frozen in liquid 
nitrogen and stored at -80 °C. Normoxic controls were treated in parallel and collected 
at the same time points. Total retinal RNA was extracted using the RNeasy isolation kit 
(Qiagen, Hilden, Germany), including a DNase treatment to digest residual genomic 
DNA. cDNA was prepared from equal amounts of total retinal RNA using oligo(dT) 
primers and M-MLV reverse transcriptase (Promega, Madison, WI, USA). 5 ng of 
cDNA was amplified in a LightCycler 480 instrument (Roche Diagnostics AG, Rotkreuz, 
Switzerland) using LightCycler 480 SYBR Green I Master Mix (Roche Diagnostics AG, 
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Rotkreuz, Switzerland) and appropriate primer pairs (Table 1). cDNA levels were 
normalized to β-actin and relative values were calculated using a respective calibrator. 
At least eight independent samples were used for each condition in PrpCre mice and 
five in OpnCre mice.  
 
Western blotting 
Retinas were sonified in 0.1 M Tris/HCl (pH 8.0) at 4 °C and protein content was 
determined using BCATM Protein Assay Kit (Pierce, Rockford, USA). Protein extracts 
were mixed with SDS sample buffer and incubated for 10 min at 95 °C. Proteins were 
separated by SDS-PAGE and blotted onto a nitrocellulose membrane. After blocking 
with 5% non-fat dry milk (Bio-Rad, Munich, Germany) in TBST (Tris/HCl 10 mM, pH 8; 
150 mM NaCl; 0.05% Tween-20) membranes were incubated with primary antibodies 
at 4 °C overnight. Primary antibodies used were: rabbit anti-HIF-1α (Novus Biologicals 
NB, Littleton, CA, USA; 100-479; 1:1000), rabbit anti-phospho-STAT3 (Cell Signaling, 
Danvers, MA, USA; #9131; 1:500), rabbit anti-STAT3 (Cell Signalling, Danvers, MA, 
USA; #9132; 1:1000), rabbit anti-HIF-2α (Novus Biologicals NB, Littleton, CA, USA; 
100-480; 1:500) and goat anti-β-actin (Santa Cruz, Santa Cruz, CA, USA; sc1616; 
1:1000). After incubation with horseradish peroxidase labeled secondary antibodies for 
1 h at room temperature, the protein bands were visualized by the application of a 
chemiluminescent substrate (PerkinElmer, Boston, USA) and exposure to a Super RX 
film (Fujifilm, Dielsdorf, Switzerland). 
For protein analyzes at least four individual samples were used for each 
condition. 
 
Immunofluorescence 
Eyes were isolated and incubated for 10 min in PBS containing 4% PFA. Cornea 
and lens were removed and the remaining tissue including the retina was incubated for 
another 15 min in 4% PFA. Afterwards, eyecups were kept in 30% sucrose and 
embedded in cryoprotective medium (Jung, Nussloch, Germany). 12 µm sections were 
cut and cryoslides were blocked in a humid chamber with PBS containing 3% normal 
goat serum (NGS) and 0.3% Triton X100. Slides were incubated with rabbit anti HIF-1α 
antibody (Novus Biologicals NB, Littleton, CA, USA; 100-654; 1:100). After washing 
with PBS, slides were incubated with Cy3 labeled secondary antibodies (Jackson 
ImmunoResearch Europe, Suffolk, England), for 1 h at room temperature, washed with 
PBS, counterstained with 4',6-diamidino-2-phenylindole dilactate (DAPI, Molecular 
Probes) and mounted with Mowiol 4-88 Reagent (VWR International AG, Lucerna, 
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Switzerland). Immunofluorescent stainings were analyzed with a digitalized Axiovision 
microscope (Carl Zeiss Microscopy, Jena, Germany) using 20x objective lenses with a 
numerical aperture of 0.5. Stainings on normoxic and hypoxic samples were done in 
parallel on the same slide. 
 
Laser capture microdissection 
For laser capture microdissection (LCM) eyes were enucleated, embedded in 
RNase free cryoprotective medium (Jung, Nussloch, Germany) and stored at -80 °C. 
Samples were cut (12 µm) and transferred to nuclease and human nucleic acid free 
membrane slides (Molecular Machines & Industries, Glattbrugg, Switzerland). Prior to 
LCM samples were incubated with acetone (5 min), 99.9% ethanol (30 sec) and xylol 
(5 min). After aceton and xylol incubation slides were dried for 5 min and 30 min, 
respectively. Laser captured tissues were collected in tubes with an adhesive lid 
(Molecular Machines & Industries, Glattbrugg, Switzerland) and stored at -80 °C. RNA 
was isolated using the RNeasy Micro Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s recommendations, including a DNase treatment to digest residual 
genomic DNA. cDNA synthesis and analyzes were performed as described above. 
 
Statistical Analyzes 
For statistical validations of gene expression we used unpaired, two-tailed 
students t-tests for the individual comparison between wild type and knockdown mice 
in normoxia or hypoxia, respectively. F-value, t-ratios (t), degrees of freedom (df) and 
number of samples (n) are given for each analysis in the body of the main text. One-
way analysis of variance (ANOVA) with Bonferroni posttests was used to compare cell 
death of normoxic and hypoxic wild type or knockdown mice, respectively, to controls. 
F-values, total (treatment plus residual) degrees of freedom (df), t-ratios (t) for each 
posttest, number of samples (n) as well as whether P values were above or below level 
of significance (P>0.05 or P<0.05) are given within the main text of the results section. 
All calculations were done using Prism Software (GraphPad Prism Software Inc. San 
Diego, CA, USA). 
 
Results 
 
HIF-1α is expressed in all retinal cell layers 
The HIF-1α gene is ubiquitously expressed in almost all eukaryotic cells. To 
analyze the mRNA expression of HIF-1α and its family member HIF-2α in the different 
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layers of the mouse retina we isolated the outer nuclear layer (ONL), the inner nuclear 
layer (INL) and the ganglion cell layer (GCL) by LCM of normoxic adult PrpCre(HIF-wt) 
mice and analyzed gene expression by reverse transcription PCR. Whereas mRNAs of 
the control genes Gnat1 (ONL), Chx10 (INL) and Opn4 (GCL) were mainly detected in 
their expected layers, HIF-1α as well as HIF-2α were expressed in all layers of the 
retina (Fig. 1A). 
To analyze protein distribution of HIF-1α we performed immunostaining on 
normoxic and hypoxic retinas. In normoxic mice HIF-1α protein is rapidly degraded and 
therefore hardly detectable. Nevertheless, immunostaining for HIF-1α showed some 
residual protein in the normoxic GCL (Fig. 1B; Normoxia). During hypoxia HIF-1α 
protein is stabilized and a strong accumulation of HIF-1α was observed in the GCL and 
INL (Fig. 1B; Hypoxia) as reported previously (Ozaki et al. 1999; Zhu et al. 2007). In 
addition, we also observed an intense HIF-1α staining in the ONL supporting our RNA 
data that HIF-1α is expressed in all retinal cell layers. 
 
Deletion of HIF-1α in photoreceptor cells 
The stabilization of HIF-1α in the ONL during hypoxia suggests that it might be 
needed by photoreceptors to cope with hypoxic stress. To test for the role of HIF-1α in 
photoreceptor cells, we generated two mouse strains with photoreceptor-specific 
deletions of HIF-1α (see Materials and Methods). PrpCre mice express tamoxifen 
(TAM) inducible Cre under the control of the prion protein promoter (Prp) whereas 
OpnCre mice express Cre under the control of the rod opsin promoter. Both mouse 
lines were reported to express Cre specifically in photoreceptor cells (Weber et al. 
2001; Le et al. 2006). To generate PrpCre(HIF-Δ) mice, PrpCre(HIF-wt) were treated with 
TAM to delete HIF-1α in the adult retina leaving postnatal retinal development 
undisturbed. Oil treated PrpCre(HIF-wt) mice served as controls. After a recovery phase 
of 2 weeks after the last TAM (or oil) injection we performed experiments in PrpCre(HIF-
Δ) and PrpCre(HIF-wt) mice at 6 weeks of age. Likewise, OpnCre(HIF-Δ) mice, which start to 
delete the floxed target sequence at postnatal day 7 (Le et al. 2006) and OpnCre(HIF-wt) 
control mice were 6 weeks of age when used for experiments.  
To determine the knockdown efficiency in the two strains we isolated total retinal 
mRNA and protein of at least 5 independent mice. In normoxic OpnCre(HIF-Δ) mice HIF-
1α mRNA levels were significantly (P=0.019, F=3.409, t=2.919, df=8, n=5 for each 
strain) reduced to nearly 50% of control mice (Fig. 2A, left panel).  
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Since this analysis included RNA from cells of the INL and GCL, which do not (or 
not strongly) express cre recombinase, most of the detected HIF-1α mRNA in retinas 
of OpnCre(HIF-Δ) mice was likely to be expressed in cells different from photoreceptors. 
Under hypoxic conditions HIF-1α RNA levels were not significantly (P=0.117, F=2.470, 
t=1.756, df=8, n=5 for each strain) different from controls suggesting an incomplete 
deletion of the HIF-1α gene in photoreceptors. In PrpCre(HIF-Δ) mice, HIF-1α RNA levels 
were strongly and significantly reduced to 35% of controls in both normoxic (P=0.0003, 
F=6.263, t=4.810, df=14, n=8 for each strain) and hypoxic (P=0.0001, F=2.355, 
t=8.655, df=14, n=8 for each strain) retinas (Fig. 2A, right panel). LCM was used to test 
the specificity of HIF-1α deletion in retinas of PrpCre(HIF-Δ) mice. The ONL had 20-fold 
reduced HIF-1α RNA levels as compared to controls (Fig. 2B). Since expression of 
HIF-1α is not regulated on the gene level, these data indicate that only between 5% 
and 10% of the cells in the ONL still express both or one allele of HIF-1α, respectively. 
Thus, at least 90% of photoreceptors are genuine HIF-1α knockout cells whereas the 
other cells are either heterozygous or wild type for HIF-1α. In contrast, cells of the INL 
and GCL of PrpCre(HIF-Δ) mice showed only a 2-fold reduced expression of HIF-1α 
mRNA indicating that HIF-1α deletion was restricted mainly but not exclusively to 
photoreceptor cells. Although most cells in the ONL are knockouts, on a tissue level 
(whole retina) PrpCre(HIF-Δ) mice are rather knockdowns for HIF-1α. The reason for the 
reduced HIF-1α RNA levels in INL and GCL is not known but may be due to cre activity 
in some cells different from photoreceptors. The general integrity of gene expression in 
cre expressing PrpCre(HIF-Δ) mice was not affected as suggested by the normal RNA 
levels of Chx10 in the INL and Gnat1 in the ONL (data not shown).  
To test the effect of the HIF-1α deletion on protein levels we performed Western 
blotting of normoxic or hypoxic preconditioned PrpCre(HIF) and OpnCre(HIF) mice (Fig. 
2C). As expected, we observed only very faint bands in normoxic and a strong 
stabilization of HIF-1α in hypoxic control animals. The comparison between hypoxic 
PrpCre(HIF-wt) and PrpCre(HIF-Δ) mice showed that the HIF-1α protein levels were 
dramatically reduced in knockdown mice (Fig. 2C). In fact, they seemed to reach 
almost the basal levels of normoxic mice indicating that the knockdown efficiency was 
very high on the protein level. In contrast, OpnCre(HIF-Δ) mice showed a less 
pronounced reduction of HIF-1α protein expression during hypoxia when compared to 
control levels.  
In conclusion, PrpCre(HIF-Δ) mice showed a very strong reduction of HIF-1α 
expression predominantly in photoreceptor cells. OpnCre(HIF-Δ) mice presented a less 
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severe reduction with more HIF-1α protein remaining in the retina after hypoxic 
exposure. 
 
Reduced HIF-1α target gene expression in knockdown mice 
HIF-1α regulates the expression of many genes during hypoxia. To analyze the 
effect of reduced HIF-1α protein levels on HIF-1α target gene expression after hypoxic 
preconditioning, we determined mRNA expression levels in normoxic and hypoxic 
retinas (Fig. 3). Egln1 encodes the prolylhydroxylase PHD2, which is required for the 
oxygen dependent degradation of HIF-1α (Bruick & McKnight 2001; Ivan et al. 2001; 
Jaakkola et al. 2001). In PrpCre(HIF-wt) mice and OpnCre(HIF-wt) mice Egln1 RNA levels 
were induced 5-6 times immediately after hypoxia (Fig. 3). The Egln1 induction was 
significantly suppressed by more than 50% in PrpCre(HIF-Δ) (P<0.0001, t=7.142, 
F=1.501, df=14, n=8 for each strain) and by about 30% in OpnCre(HIF-Δ) mice 
(P=0.0072, F=2.562, t=3.579, df=8, n=5 for each strain), respectively. Similarly reduced 
mRNA levels after hypoxia were found in the PrpCre(HIF-Δ) strain for other HIF-1α target 
genes like the pro-apoptotic gene Bnip3 (P=0.0001,F=2.981, t=6.261, df=14, n=8 for 
each strain), the potentially anti-apoptotic genes vascular endothelial growth factor 
(Vegf; P=0.0011, F=2.980, t=4.085, df=14, n=8 for each strain) and adrenomedullin 
(Adm; P=0.0002, F=1.284, t=4.884, df=14, n=8 for each strain) as well as the glucose 
transporter Glut1 (P<0.0001, F=1.157, t=9.052, df=14, n=8 for each strain). RNA levels 
were also reduced in the hypoxic OpnCre(HIF-Δ) mice but reached significance only for 
Egln1 (see above) and Glut1 (P=0.0362, F=2.023, t=2.514, df=8, n=5 for each strain). 
The milder reduction of hypoxic mRNA expression in OpnCre(HIF-Δ) mice as compared 
to PrpCre(HIF-Δ) mice nicely reflects the different knockdown efficiencies in the two 
strains. 
 
Normal retinal development and retinal resistance to hypoxia in mice with 
reduced HIF-1α levels 
It has been reported that TAM treatment in patients after breast cancer surgery 
can very seldom cause mild pathogenic changes in the retina (Heier et al. 1994; Tang 
et al. 1997; Bourla et al. 2007). On the other hand small dosages of TAM have been 
shown to promote neuroprotection (Zhang et al. 2007; Wakade et al. 2008). However, 
neither TAM nor oil treatment had an obvious effect on retinal morphology in control 
mice up to 4 months post injections (Fig. 4A). Additionally, oil and TAM treated wild 
type mice were equally susceptible to light induced retinal degeneration 2 weeks after 
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TAM application (data not shown) indicating that TAM neither impaired normal retinal 
morphology nor per se protected the retina against a toxic light insult. 
Since HIF-1α has been shown to be important to cope with hypoxic conditions in 
neurons (Vangeison et al. 2008) and since the retina becomes borderline hypoxic 
during dark phases (Cringle et al. 2002), we analyzed whether the absence of HIF-1α 
from photoreceptors in PrpCre(HIF-Δ) mice during normoxia or hypoxia would be harmful 
to the retina even without subsequent exposure to damaging light. PrpCre(HIF-wt) and 
PrpCre(HIF-Δ) mice were kept in a standard animal facility with a 12:12 hour day-night-
cycle for 4 months. During this time no obvious morphological alterations appeared and 
the retinas of control and knockdown mice were similar (Fig. 4B upper panels). 
Surprisingly, even a short period of severe hypoxia (6%, 6 h) followed by a recovery 
period of 4 weeks did not induce any noticable changes in the retina of PrpCre(HIF-Δ) 
mice (Fig. 4B lower panels). 
During postnatal development HIF-1α is strongly up regulated from PND5 to 
PND14 (Ozaki et al. 1999; Grimm et al. 2005). Although excision of a large percentage 
of floxed sequences by the opsin-driven cre requires several weeks, recombination in 
OpnCre mice starts already around PND7 (Le et al. 2006). We therefore asked 
whether early loss of HIF-1α in some photoreceptors might influence retinal 
development. However, we could not observe any changes in the retinal morphology of 
OpnCre(HIF-Δ) mice at 6 weeks of age (Fig. 4C). Also retinal susceptibility to light 
damage seemed to be unimpaired (Fig. 5). 
We conclude that photoreceptors can cope with acute (6% oxygen for 6 hours) or 
mild (normal light-dark-cycle) hypoxic stress in the almost complete absence of  their 
own HIF-1α. We next tested the influence of photoreceptor-specific HIF-1α in a 
pathological situation by analyzing photoreceptor survival after hypoxic preconditioning 
and light exposure. 
 
Neuroprotection after hypoxic preconditioning is independent of HIF-1α  
stabilization in photoreceptor cells 
To analyze whether HIF-1α in photoreceptor cells is required to establish the 
neuroprotective effect of hypoxic preconditioning, we compared light-induced 
photoreceptor death in hypoxic preconditioned control and knockdown mice. To 
quantify apoptosis, we measured the release of nucleosomes as indicators of ongoing 
apoptosis at 36 hours after the toxic light insult (Fig. 5A,B). Non-exposed dark control 
mice of all strains showed only basal levels of free nucleosomes (Fig. 5A,B). Similarly, 
retinal morphology was normal (Fig. 5C, upper panels). Normoxic PrpCre(HIF-wt) 
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(P<0.05, F=6.349, df=15, t=2.903, n=3 (control), n=7 (normoxia)) and PrpCre(HIF-Δ) 
(P<0.0001, F=264.4, df=12, t=18.18, n=3 (control), n=5 (normoxia)) showed significant 
cell death when compared to their respective controls. Thus, these mice were 
susceptible to light damage, as expected (Fig. 5A). Hypoxic preconditioning protected 
against light-induced apoptosis independently of the presence of HIF-1α in 
photoreceptors. Cell death in both, light-exposed PrpCre(HIF-wt) (P>0.05, F= 6.349, 
df=15, t=0.4745, n=3 (control), n=6 (hypoxia)) as well as light-exposed PrpCre(HIF-Δ) 
(P>0.05, F=264.4, df=12, t=0.3677, n=3 (control), n=5 (hypoxia)) was not significantly 
different from dark control. Similar results were obtained with the OpnCre mice. Again, 
light exposure did not cause significantly elevated levels of free nucleosomes in 
hypoxic preconditioned OpnCre(HIF-wt) (P>0.05, F=3.541, df=15, t=0.002733, n=3 
(control), n=4 (hypoxia)) or OpnCre(HIF-Δ) (P>0.05, F=2.745, df=13, t=0.008509, n=3 
(control), n=4 (hypoxia)) mice as compared to controls (Fig. 5B). These data were 
morphologically confirmed by the presence of a large number of pycnotic 
photoreceptor nuclei (Fig. 5C , middle panels, arrowheads) and disintegrated outer and 
inner segments in light-exposed normoxic wild type and knockdown mice. Hypoxic 
preconditioning, however, strongly protected retinal morphology against light damage 
independently of the presence of HIF-1α in photoreceptors. Only few scattered 
pycnotic nuclei were present leaving the majority of photoreceptor cells unaffected by 
light exposure (Fig. 5C, lower panels). Analyses of heterozygous HIF-1α knockout mice 
lacking 50% of total HIF-1α RNA and protein in the retina showed similar results (data 
not shown). 
Although, we successfully deleted HIF-1α from most photoreceptor cells, hypoxic 
preconditioning still conferred a strong neuroprotective effect rescuing photoreceptors 
from light damage. This indicates, that protection of visual cells by hypoxic 
preconditioning does not depend on HIF-1α stabilization in photoreceptors. 
 
Alternative mechanisms for neuroprotection after hypoxic preconditioning 
Hypoxia activates several transcription factors in addition to HIF-1α (Kenneth & 
Rocha 2008) leading to the potential regulation of a variety of HIF-1α independent 
genes. Here we analyzed selected genes with potential neuroprotective properties, 
which were found to be differentially regulated during hypoxia in the wild type retina 
(Thiersch et al. 2008). In HIF-1α wild type mice we found a strong, hypoxia-driven 
induction of the anti-apoptotic gene Bcl2l10 (B-cell lymphoma 2 like 10), of Mt1/2 
(metallothionein 1 and 2), Egf (endothelial growth factor) and Epo (erythropoietin) (Fig. 
6A, white bars). This induction was not affected in HIF-1α knockdown mice (Fig. 6A, 
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grey bars). The only exception was Egf, which expression was even slightly induced in 
hypoxic PrpCre(HIF-Δ) mice (P=0.0156, F=2.332, t=2.751, df=14, n=8 for each strain). 
This suggests that these genes might be controlled by transcription factors different 
from HIF-1. Potential candidates are HIF-2 or STAT3, which were activated by hypoxic 
exposure in both control and knockdown mice (Fig. 6B). Metal-regulatory transcription 
factor 1 (Mtf-1), which is strongly expressed in the normoxic and hypoxic retina 
(supporting information) might be involved in the hypoxic regulation of Mt1 and Mt2 
expression (see discussion). The genes not affected by the HIF-1α knockdown 
included Epo, which was particularly reported to have strong neuroprotective properties 
(Sakanaka et al. 1998; Bernaudin et al. 1999; Brines et al. 2000; Siren et al. 2001; 
Grimm et al. 2002) and to be controlled mainly by HIF-2α (Morita et al. 2003; Gruber et 
al. 2007; Rankin et al. 2007). Therefore, Epo might function in photoreceptor protection 
also in the absence of HIF-1α in photoreceptors. In conclusion, the knockdown of HIF-
1α in photoreceptors reduced the induction of HIF-1α target genes during hypoxia 
without affecting the neuroprotective capacity of hypoxic preconditioning. Several 
genes with neuroprotective potential (e.g. metallothionein 1 and 2; Bcl2l10, Egf; Fig. 
6A), which are not affected by the HIF-1α knockdown could potentially participate in the 
protection of the retina against light induced retinal degeneration. 
 
Discussion 
Hypoxic preconditioning is a successful strategy to inhibit tissue degeneration. 
The reported correlation between HIF-1α stabilization and retinal neuroprotection 
(Grimm et al. 2002; Zhu et al. 2007) suggested that the activation of HIF-1α plays an 
important role in pro-survival mechanisms activated by hypoxic preconditioning. Here 
we analyzed the impact of the transcription factor HIF-1α on neuroprotection using 
HIF-1α knockdown mice. 
 
Characterization of photoreceptor specific HIF-1α knockdown mice 
Consistent with a previous report (Zhu et al. 2007) we found HIF-1α to be 
expressed and stabilized in all retinal layers during hypoxic preconditioning. To delete 
HIF-1α predominantly in photoreceptor cells, we employed two different mouse strains 
expressing Cre recombinase under different promoters. TAM inducible PrpCre deleter 
mice activate Cre recombinase efficiently and predominantly in photoreceptor cells 
(Weber et al. 2001). In our hands, this strain almost completely deleted HIF-1α in 
photoreceptors, which was also evidenced by highly reduced HIF-1α target gene 
transcription after hypoxia. Deletion with the OpnCre line was less effective resulting in 
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higher HIF-1α levels and less reduced target gene transcription after hypoxia. The 
knockdown of HIF-1α had no influence on retinal morphology of untreated or hypoxic 
preconditioned mice. Since different studies showed a correlation of HIF-1α induction 
and retinal neuroprotection (Grimm et al. 2002; Whitlock et al. 2005; Zhu et al. 2007), 
we used these mice to analyze the role of HIF-1α in hypoxic preconditioning-mediated 
protection and survival of photoreceptor cells after exposure to high levels of white 
light.  
 
HIF-1α in photoreceptor cells is not essential to cope with severe hypoxia or to 
drive retinal neuroprotection after hypoxic preconditioning 
Our experiments show that photoreceptors do not need to express HIF-1α to be 
protected against light exposure after hypoxic preconditioning. With our approach, 
however, we cannot exclude the possibility that HIF-1α in cells of the INL and / or GCL 
might contribute to the protection of photoreceptors through the expression of diffusible 
factors. 
The exact role of HIF-1α in neuronal tissues during severe hypoxia or ischemia is 
controversial. Two studies with a brain specific deletion of HIF-1α demonstrated 
somewhat contradictory effects. Whereas Helton (Helton et al. 2005) showed that lack 
of HIF-1α in cortex and hippocampus was rather protective against global ischemia, 
Baranova (Baranova et al. 2007) reported that the reduction of HIF-1α increased the 
damage after cerebral ischemia. The knockdowns used in these studies differed in the 
extent of HIF-1α ablation. Baranova used a neuron-specific knockdown, whereas in the 
mice reported by Helton HIF-1α deletion affected additional cell types, including 
astrocytes. Of note, a recent report showed that induction of HIF-1α in astrocytes 
accelerated hypoxia-induced neuronal cell death, whereas an induction of HIF-1α in 
neurons was beneficial for resistance to severe hypoxia (Vangeison et al. 2008). 
In contrast to the neuronal HIF-1α deletion in brain, which showed an increased 
injury after cerebral ischemia (Baranova et al. 2007), PrpCre(HIF-Δ) mice showed no 
retinal abnormalities after exposure to hypoxia. One explanation for this difference may 
be that hypoxia is less severe than ischemia/reperfusion. Furthermore, hypoxia allows 
a substrate exchange and removal of toxic waste products due to the maintained blood 
flow. Another reason that could explain the retinal resistance to hypoxia is that the 
retina might have specific mechanisms to deal with low oxygen even in the absence of 
HIF-1α. The retina is a tissue with a high metabolic rate and becomes borderline 
hypoxic especially during the night (Cringle et al. 2002). The constant exposure to mild 
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hypoxia during nighttime might activate basic hypoxia-response mechanisms that are 
not exclusively HIF-1α dependent and that have the potential to protect against severe 
hypoxia. 
 
Alternative mechanisms for hypoxia induced neuroprotection 
Recently, a similar HIF-1α independent protection of brain neurons against 
cerebral ischemia after hypoxic preconditioning was reported (Baranova et al. 2007). In 
that study HIF-2α was discussed as a possible alternative mechanism to HIF-1α 
mediated neuroprotection. In the retina, we also found elevated levels of HIF-2α after 
hypoxia in control and knockdown mice (Fig. 6B). Recently it was shown that HIF-2α 
and not HIF-1α may regulate the expression of Epo in vivo (Morita et al. 2003; Gruber 
et al. 2007; Rankin et al. 2007) and in cell culture experiments (Chavez et al. 2006). In 
line with these findings, we observed no or only a small decrease in the induction of 
Epo expression in our knockdown strains after hypoxic preconditioning. Since Epo has 
proven neuroprotective properties in the brain and the retina (Bernaudin et al. 1999; 
Brines et al. 2000; Digicaylioglu & Lipton 2001; Grimm et al. 2002; Weishaupt et al. 
2004), Epo may part of the neuroprotective response in the HIF-1α knockdown strains.  
In addition to HIF-2α, other transcription factors like STAT3 and MTF-1 may 
contribute to the observed protection. STAT3 was strongly phosphorylated after 
hypoxic preconditioning and is usually connected to anti-apoptotic activities 
(Stephanou 2004). Recently, Ueki and coworkers suggested a prominent role of 
STAT3 in LIF-mediated protection of photoreceptors from light induced degeneration 
(Ueki et al. 2008). Mtf-1 controls expression of Mt-1 and Mt-2 (Heuchel et al. 1994) 
which are expressed in all retinal layers (supporting information). Both, Mt-1 and Mt-2 
were reported to be upregulated in the hypoxic brain suggesting that expression of 
these metallothioneins might be part of a general response to hypoxic exposure 
(Bernaudin et al. 2002; Tang et al. 2006). Protecting against oxidative stress (Chen et 
al. 2004; Suemori et al. 2006; Nachman-Clewner et al. 2008), Mt1 and Mt2 may thus 
participate in the hypoxia-induced resistance against light damage. Interestingly, it has 
recently been suggested that hypoxic induction of Mt-1 and Mt-2 requires a cooperative 
interaction between Mtf-1 and HIF-1α (Murphy et al. 2008). Since the HIF-1α 
knockdown did not affect expression of Mt-1 and Mt-2, our results may suggest that 
Mtf-1 does not strictly depend on HIF-1α but might use alternative factors like HIF-2α 
for hypoxic gene expression. 
In our earlier analysis of the hypoxic transcriptome of the retina (Thiersch et al. 
2008), we found several additional potential pro-survival factors which have been 
RESULTS  119 
connected to cell survival and/or protection of the retina against toxic insults. Among 
those Bcl2l10 (Song et al. 1999), Adm (Garayoa et al. 2000; Miyashita et al. 2006), 
Vegf (Jin et al. 2000; Nishijima et al. 2007) and Egf (Hicks et al. 1998) were tested in 
addition to Epo, Mt1 and Mt2 for their hypoxic regulation in the HIF-1α knockdown 
retinas. Only the expression of Vegf and Adm was affected in the PrpCre(HIF-Δ) mouse. 
However, since both genes encode secreted factors, we cannot exclude that their 
production in cells of the INL and/or GCL contributed to the protection of photoreceptor 
cells after hypoxic preconditioning. All of these genes were expressed either 
independently of HIF-1α or in cell layers where HIF-1α has not been knocked down. 
Although a detailed investigation of these genes is still needed, these factors are good 
candidates to play an active role in protecting photoreceptors against light damage. 
The cell-type specific deletion of HIF-1α is an excellent tool to address the role 
and function of HIF-1α exclusively in photoreceptor cells. However, the neuronal retina 
consists of three cell layers, which form a functional unit with the retinal pigment 
epithelium. During hypoxia HIF-1α is also strongly stabilized in the GCL and INL where 
it might drive expression of neuroprotective factors which could directly or indirectly 
protect photoreceptor cells. Nevertheless, our results demonstrate that photoreceptors 
do not need to express their own HIF-1α to maintain the structural integrity of the retina 
despite the borderline hypoxic conditions experienced by retinal cells during each dark 
period. Photoreceptors do also not need to express and stabilize HIF-1α to survive a 
toxic light exposure after hypoxic preconditioning. Other factors like HIF-2α, STAT3 
and/or Mtf-1 may play a role in photoreceptor protection and it will be of importance to 
characterize these factors to develop efficient neuroprotective strategies. 
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Table 1 Primer pairs used for PCR. 
Gene Primer forward Primer reverse Product bp 
β-Actin CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153 
Adm TTCGCAGTTCCGAAAGAAGT GGTAGCTGCTGGATGCTTGTA 77 
Bcl2l10 GAACTTTCTGTATAATCTGCTCATGG TGAAGAAGCGGCAAAAGC 89 
Bnip3 CCTGTCGCAGTTGGGTTC GAAGTGCAGTTCTACCCAGGAG 93 
Chx10 CCAGAAGACAGGATACAGGTG GGCTCCATAGAGACCATACT 111 
Egf CATGCCCCACAGGATTTG GGGCAGGAAACAAGTTCGT 64 
Egln1 CATTGTTGGCAGAAGGTGTG CAAAGGACTACAGGGTCTCCA 70 
Epo GCCCTGCTAGCCAATTCC GGCGACATCAATTCCTTCTG 128 
Glut1 ATGGATCCCAGCAGCAAG CCAGTGTTATAGCCGAACTGC 92 
Gnat1 GAGGATGCTGAGAAGGATGC TGAATGTTGAGCGTGGTCAT 209 
HIF-1α TCATCAGTTGCCACTTCCCCAC CCGTCATCTGTTAGCACCATCAC 198 
HIF-2α GGAGCTCAAAAGGTGTCAGG CAGGTAAGGCTCGAACGATG 61 
Mt1 GAATGGACCCCAACTGCTC GCAGCAGCTCTTCTTGCAG 104 
Mt2 TCTTCAAACCGATCTCTCGTCG CAGCAGCTTTTCTTGCAGGAAG 94 
Opn4 CCAGCTTCACAACCAGTCCT CAGCCTGATGTGCAGATGTC 111 
Vegf ACTTGTGTTGGGAGGAGGATGTC AATGGGTTTGTCGTGTTTCTGG 171 
 
Figure legends 
 
Fig. 1. Distribution of HIF-1α mRNA and protein in the retina. 
A) HIF-1α and HIF-2α mRNA expression in the ONL, INL and GCL isolated by 
laser capture microdissection (LCM). Captured fragments of 3 mice were pooled and 
analyzed by conventional RT-PCR. HIF-1α and HIF-2α expression was observed in all 
retinal cell layers. Gnat1 (ONL marker), Chx10 (INL marker) and Opn4 (GCL marker) 
served as indicators for the purity of the isolated tissue fragments (note that minor 
cross-contaminations were detected). Total retinal RNA was used as positive control. 
B) Protein distribution of HIF-1α in the retina of normoxic mice and immediately after 
hypoxia (6% O2; 6 h). Immunofluorescence staining indicates stable HIF-1α protein in 
the GCL during normoxia and the stabilization of HIF-1α protein in the whole retina 
during hypoxia. As a negative control served a normoxic retina, incubated with the 
secondary antibody (Cy3 anti-rabbit) alone. 
ONL: outer nuclear layer; INL: inner nuclear layer; GCL: ganglion cell layer; Scale 
bar: 25 µm 
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Fig. 2. Efficiency of HIF-1α knockdown in the ONL. 
Gene and protein expression was analyzed in mice held in normoxia or in mice 
immediately after exposure to hypoxia (6% O2; 6 h) A) Total retinal levels of HIF-1α 
mRNA was analyzed by real time PCR in Opsin-cre (left panel) and Prp-cre (right 
panel) mediated HIF-1α knockdowns (grey bars) and compared to their respective wild 
type controls (white bars). β-actin served as reference and data were normalized to 
levels of normoxic Cre(HIF-wt)  mice (first bar of each panel).  Under normoxic conditions 
OpnCre(HIF-Δ) mice displayed HIF-1α mRNA levels which were significantly (*, 
P=0.0193, n=5) reduced by 50%. After hypoxia no significant (P=0.117, n=5) 
differences were detectable. HIF-1α deletion in PrpCre(HIF-Δ) mice was very efficient and 
significantly reduced expression of HIF-1α to 35% of control levels under both 
normoxic (***, P=0.0003, n=8) and hypoxic (***, P=0.0001, n=8) conditions. Given are 
means ± SD. Statistical validations were performed using unpaired, two-tailed t-tests. 
B) HIF-1α RNA expression in normoxic PrpCre(HIF-Δ) (grey bars) mice compared to 
normoxic PrpCre(HIF-wt) (white bar) mice in ONL, INL and GCL after LCM. For each 
retinal layer, tissue was pooled from three individual mice. β-Actin expression served 
as reference and data were normalized to expression levels of PrpCre(HIF-wt) in each 
individual layer (set to 1). HIF-1α RNA expression was 20-fold reduced in the ONL of 
PrpCre(HIF-Δ) mice but only 2-fold in INL and GCL. Shown are mean values ± SD of n=3. 
C) Western blot analysis of retinal HIF-1α protein expression in normoxic and hypoxic 
HIF-1α knockdown and wild type mice as indicated. Only faint protein bands were 
observed under normoxic conditions. After hypoxia, HIF-1α protein expression was 
increased in retinas of control OpnCre(HIF-wt) and PrpCre(HIF-wt) mice. In hypoxic 
OpnCre(HIF-Δ) mice HIF-1α protein levels were only slightly diminished but hypoxic 
PrpCre(HIF-Δ) mice showed severely reduced HIF-1α protein expression. Shown are 
representative blots of n=4.  
LCM: laser capture microdissection, other abbreviations as in Figure 1.  
 
Fig. 3. Expression of HIF-1α target genes in total retina. 
mRNA levels of HIF-1α target genes were determined immediately after hypoxia 
or in normoxic controls in total retinal RNA. mRNA expression in OpnCre(HIF-Δ) and 
PrpCre(HIF-Δ) mice (grey bars) were compared to OpnCre(HIF-wt) and PrpCre(HIF-wt) control 
mice (white bars). Expression levels of normoxic (N) Cre(HIF-wt) mice (first bars) were set 
to “1”. β-actin expression served as reference. Expression levels in normoxic Cre(HIF-wt) 
and Cre(HIF-Δ) mice were comparable. During hypoxia (H) all tested HIF-1α target genes 
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were induced in control mice. In hypoxic PrpCre(HIF-Δ) mice the induction of all tested 
HIF-1α target genes was significantly repressed (***P≤0.0002; **P=0.0011; n=5). 
Hypoxic OpnCre(HIF-Δ) mice showed a milder effect and reached significance only for 
Egln1 (**P=0.0072, n=5) and Glut1 (*P=0.0362, n=5). Shown are means ± SD. 
Statistical validations were performed using unpaired, two-tailed t-tests. 
 
Fig. 4. Intraperitoneal TAM application and the ablation of HIF-1α  in photo-
receptor cells has no effect on the retina of normoxic and hypoxic mice. 
A) Mice, carrying the floxed exon 2 of HIF-1α without Cre (HIF-1αF/F), were 
intraperitoneally injected with oil or tamoxifen (TAM) as indicated. The treatment did 
not result in any morphological alterations up to 4 months post-application. B) PrpCre-
mediated knockdown of HIF-1α did not affect retinal morphology in normoxic mice or 
after 6 hours of hypoxia (6% O2). Shown are representative panels of control 
(PrpCre(HIF-wt)) and knockdown (PrpCre(HIF-Δ)) mice kept in normoxia for 4 months after 
treatment (upper panels) or of mice at 4 weeks after exposure to hypoxia (lower 
panels). 
C) An early but moderate deletion of HIF-1α during development did not interfere 
with retinal development and mice showed normal retinal morphology at 6 weeks of 
age. ROS: rod outer segments, RIS: rod inner segments. Other abbreviations as in 
Figure 1; Scale bar: 25 µm 
 
Fig. 5. Role of HIF-1α in retinal neuroprotection. 
Normoxic or hypoxic-pretreated mice were exposed to 13‘000 lux for 2 h and 
analyzed after 36 h. Dark-adapted, normoxic mice served as negative controls. 
A) Relative nucleosomal release was measured as an indicator for apoptotic 
processes in the retina. Values are expressed relative to PrpCre(HIF-wt) mice, which were 
set to “1”. Both, normoxic PrpCre(HIF-wt) and normoxic PrpCre(HIF-Δ) mice were 
susceptible (*P<0.05, ***P<0.001; n=3 for dark control, n=7 for normoxic PrpCre(HIF-wt) 
mice, n= 5 for normoxic PrpCre(HIF-Δ) mice, one-way ANOVA with Bonferroni posttest) to 
light damage as indicated by the increased release of nucleosomes (grey bars). 
Hypoxic preconditioned PrpCre(HIF-Δ) mice showed no increased apoptosis after light 
exposure. (n.s., P>0.05, n=3 for dark control, n=6 for hypoxic PrpCre(HIF-wt) mice, n= 5 
for hypoxic PrpCre(HIF-Δ) mice, one-way ANOVA with Bonferroni posttest). B) OpnCre 
mice were analyzed as in A. Hypoxic preconditioning resulted in full protection of 
OpnCre(HIF-wt) and OpnCre(HIF-Δ) mice (white bars) with no increased cell death as 
compared to controls (n.s., P>0.05, n=3 for dark control, n=4 for hypoxic OpnCre(HIF-wt) 
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mice, n= 4 for hypoxic OpnCre(HIF-Δ) mice, one-way ANOVA with Bonferroni posttest)  
C) Retinal morphology after light exposure. Dark controls (upper panels) showed 
normal retinal structure before light exposure. Normoxic PrpCre(HIF-wt), PrpCre(HIF-Δ) and 
OpnCre(HIF-Δ) mice exposed to light (middle panels) showed severe degeneration of 
photoreceptor cells as indicated by the presence of pycnotic nuclei (arrowheads) and 
the complete disruption of inner and outer segments. All hypoxic preconditioned mice 
(lower panel) were strongly protected against light damage. 
Shown are means ± SD; number of samples (n) are indicated above. 
Abbreviations as in Figures 1 and 4; Scale Bar 25 µm. 
 
Fig. 6. Hypoxia-mediated upregulation of pro-survival genes and transcription 
factors in retinas of HIF-1α knockdown retinas. 
Mice were (H) or were not (N) exposed to hypoxia and mRNA or protein 
expression was analyzed immediately after hypoxia. 
A) Expression of selected potential pro-survival genes analyzed by real time 
PCR. Expression levels of normoxic (N) Cre(HIF-wt) mice of each strain were set to “1” 
(first bar). β-actin served as reference. Expression levels of normoxic Cre(HIF-wt) and 
Cre(HIF-Δ) mice were comparable. All genes were strongly induced after hypoxia (H) in 
control mice as well as in PrpCre(HIF-Δ) and OpnCre(HIF-Δ) mice with only slight 
differences (*, P=0.0156, n=8; unpaired, two-tailed t-tests). Shown are means ± SD of 
n=8 (PrpCre strains) or of n=5 (OpnCre strains). B) Protein extracts were analyzed by 
Western blotting. A comparable induction of HIF-2α and pSTAT3 in OpnCre(HIF-Δ) and 
PrpCre(HIF-Δ) mice as well as in OpnCre(HIF-wt) and PrpCre(HIF-Δ) control mice was 
observed in hypoxic pretreated mice. β-actin and STAT3 were used as loading 
controls. Shown are representative blots of n=4.  
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3.2.1 Supplemental Data for accepted manuscript Thiersch et. al (EJN) 
3.2.1.1 Supporting information MTF-1 
 
 
 
 
 
 
 
 
 
 
Retinal expression of MTF-1.  
A) Expression of MTF-1 was analyzed in retinas of normoxic and hypoxic 
PrpCre(HIF-wt) (white bars) and PrpCre(HIF-Δ) (grey bars) mice by semi quantitative real-
time PCR. Expression levels of normoxic PrpCre(HIF-wt) mice were set to “1” and β-actin 
served as reference. The level of MTF-1 expression in PrpCre(HIF-Δ) mice was slightly 
elevated in normoxia (**P<0.01, t=3.884, df=3, n=8). Hypoxia slightly reduced 
expression of MTF-1 in wild types (*P<0.05, t=3.301, df=3, n=8) and knockdowns 
(*P<0.05, t=3.172, df=3, n=8) compared to normoxic wild type control mice. Statistical 
analysis was done using one-way ANOVA  (F=22.91, total df=31) with Bonferroni 
posttests for the comparison between groups.  
B) Expression of Mt1, Mt2 and MTF-1 in the different retinal layers of the 
normoxic mouse retina. Laser capture microdissection was used to isolate the outer 
nuclear layer (ONL), the inner nuclear layer (INL) and the ganglion cell layer (GCL). 
RNA was isolated and cDNA prepared (see Material and Methods). cDNA from three 
individual mice were pooled for PCR amplification. Gnat2 (cone transducin), CHX10 
and Opn4 (melanopsin) were used as markers for the ONL, INL and GCL, respectively. 
Although some cross-contamination from the ONL to the INL (see Gnat2 amplification) 
and from the INL to the ONL and to the GCL (see CHX10 amplification) was 
detectable, the uniform intensities of the amplified signals for Mt1, Mt2 and MTF-1 
support their expression in all retinal layers. 
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Reactions were done using specific primer pairs as listed in Table 1. Primers for 
MTF-1 were: forward: 5’-GTGGGAAAGCGTTTGCAG-3’; reverse: 5’-
CAGAAGAAGGGTCTTTCACCA-3’. 
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4 GENERAL DISCUSSION 
Hypoxic preconditioning strongly protects the retina against light induced 
photoreceptor cell death. Gene expression of the neuroprotective factor Epo is induced 
during hypoxia and Epo administration protects the retina against toxic light insults [71]. 
However, in contrast to hypoxic preconditioning, which completely protects the mouse 
retina against light damage, Epo alone is only partially protective [71]. Therefore, we 
hypothesized that the neuroprotective effect after hypoxic preconditioning depends on 
the co-expression of several genes, which might act in concert. To identify further 
potential neuroprotective target genes, we analyzed the global gene expression pattern 
of the mouse retina after hypoxic preconditioning by employing micro-array analyzes 
[134]. The retina responded to the exposure of low oxygen with the differential 
expression of more than 400 genes. This response involved genes with different 
biological functions like metabolism, transport etc. but included also cell-survival and 
apoptosis related genes. Among the large number of potentially protective genes, we 
selected the strongly induced gene cyclin-dependent kinase inhibitor 1a (Cdkn1a), 
which encodes for p21, to investigate its role in hypoxia mediated retinal 
neuroprotection. Employing p21-/- mice we showed that p21 is not essential to protect 
the retina against light damage. Besides p21, our study revealed a potential role of 
metallothioneins, which might reduce the oxidative stress evoked by light exposure. 
Additionally, we discovered CCAAT/enhancer binding protein delta (Cebpd), a 
transcriptional regulator with apoptosis interfering properties. 
The large number of differentially regulated genes after hypoxic preconditioning 
suggested that different transcription factors are activated during hypoxia. Among 
those transcription factors, HIF-1 was strongly induced in the hypoxic retina [71, 134]. 
HIF-1 is one of the key-regulators of hypoxia and potentially regulates pro-survival and 
neuroprotective genes [71, 72, 112, 134]. We hypothesized that activation of HIF-1 in 
photoreceptor cells is essential to protect the retina against light induced apoptosis in 
an autocrine fashion. That means that HIF-1 should stimulate the differential 
expression of neuroprotective factors in photoreceptor cells. The factors may act 
intrinsically or may be secreted to act on neighboring photoreceptors (or other retinal) 
cells, respectively. To study the impact of HIF-1 on retinal neuroprotection, HIF-1α (the 
oxygen dependent regulated component of HIF-1) was efficiently ablated in mouse 
photoreceptor cells [135]. In accordance with the level of HIF-1α deletion, the HIF-1 
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target gene expression was clearly reduced after hypoxia. Our results indicate that an 
activation of HIF-1 in photoreceptor cells is not required to protect the retina against 
light induced retinal degeneration. In addition, adaptation to short severe hypoxia does 
not depend on HIF-1 activation in photoreceptor cells. 
 
4.1 Retinal gene expression after hypoxic preconditioning 
In our first project [134], we describe the differential regulation of more than 400 
genes in the mouse retina immediately after hypoxia. Among them, more than 50% 
were at least 2-fold regulated. Of interest, the majority of genes (68% of at least 2-fold 
regulated genes) were induced after hypoxic preconditioning. This suggests, that 
hypoxic preconditioning induces de novo protein synthesis in the retina – an indication, 
that retinal cells induce mechanisms to resist against future injury (and hypoxia per se). 
The differential gene expression due to hypoxia vanished quickly during reoxygenation 
to reach normal levels 4 h after hypoxia. This pattern of a strong transcriptional 
response during hypoxia followed by a fast restoration of normal gene expression 
levels during reoxygenation is characteristic for hypoxic preconditioned tissues. Hence, 
hypoxic preconditioning of brain [136, 137] similarly induces a fast differential gene 
expression and a short-term neuroprotective effect. However, hypoxic preconditioned 
mice (preconditioning with similar protocol than used here) experienced a second 
boost of differential gene regulation 24 hours after hypoxia in the brain with an 
extended protection against ischemic injury [136]. In comparison, ischemic 
preconditioning of the retina seems to induce a rather mild but longer lasting answer on 
the transcriptional level (up to 7 days) [138, 139] and a prolonged tissue protection [68-
70, 73]. This suggests, that mechanisms of ischemic preconditioning differ from those 
of hypoxic preconditioning. Nevertheless, it seems possible to extend the duration of 
retinal neuroprotection after hypoxic preconditioning by repetitive exposure to hypoxia 
[74] to keep up with the longer-lasting neuroprotective effects of ischemic 
preconditioning. 
 
4.1.1 Limitation of the Analysis 
The analysis of retinal gene expression in hypoxic preconditioned mice by micro-
arrays provided an overview of the global transcriptional response. Thereby, we 
achieved insights into affected gene-networks, which were altered during hypoxia and 
discovered potentially neuroprotective genes. However, we are aware that 
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transcriptomic analyses with micro-arrays have certain limitations – functional, 
technical and statistical. 
Functionally, this analysis method is restricted due to the fact that there are many 
steps like differential splicing, protein synthesis and functional processing regulating 
cellular physiology and metabolism beyond gene expression. Differential splicing as a 
posttranscriptional regulatory step is only partially covered by micro-array analyses. 
Posttranslational modification or regulation includes glycosylation, protein-protein-
interactions or phosphorylation etc. that cannot be detected by gene expression 
analyses. Very recently, microRNAs were discovered to bind mRNAs, forming a hairpin 
structure and to silence gene expression by repression of protein biosynthesis [140-
144]. Therefore, micro-array data reflect the cell response to hypoxia only partially. 
Technical, our approach was determined by the micro-array design, the 
sensitivity of the detection system and the sample preparation. Although an increased 
retinal expression of Epo was clearly shown after hypoxic preconditioning [71], we did 
not detect an Epo induction by our micro-array analyzes – simply due to the fact that 
Epo oligos were not spotted on the chip. That indicates, that it might be possible that 
other genes may have escaped the detection as well. Additionally, it cannot be 
completely ruled out that this approach caught up false positive genes. Among the 20 
strongest induced genes, Rpe65 and Lrat are not expressed in the neuronal retina but 
in the retinal pigment epithelium (PE) [145-147] – the single cell layer bordering the 
retina. This suggests, that tissue cross contamination with PE cells could alter the 
micro-array output data. Therefore, relevant micro-array raw data were considered 
carefully and confirmed by real-time PCR. 
Furthermore, the detection of a functional subset of genes among 400 
differentially regulated genes requires an efficient statistical pre-selection. To identify 
potential neuroprotective genes, we employed two strategies. On one hand, we used 
the tool DAVID (Database for Annotation, Visualization and Integrated Discovery) [148-
150], which classifies genes according to their known or predicted biological function. 
Thereby, clustering revealed gene subsets potentially related to apoptosis or other 
biological functions. However, functional clustering was not sufficient to select 
appropriate target genes for further analyzes. Many genes can have multiple biological 
functions complicating the determination of their role in biochemical processes. 
Additionally, interactions between the gene products were not considered. This might 
be essential since most biological processes depend on a complex interplay of several 
factors. In order to complement our target gene screen we additionally performed 
Ingenuity pathway analysis (IPA) [151] to identify pathways affected by hypoxic 
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preconditioning. This strategy considered each possible interaction between 
differentially regulated genes on the level of DNA, mRNA or protein. Among the 
multitude of discovered pathways, the “Cellular growth & proliferation, DNA replication, 
recombination and repair” network was the most affected by hypoxic preconditioning. 
Due to the presence of pro-survival genes in this gene network with cyclin-dependent 
kinase inhibitor 1a (p21) occupying a very central position, this pathway was 
considered as potentially involved in retinal neuroprotection after hypoxic 
preconditioning. However, despite its prominent placement in this network, p21 did not 
play an essential role in neuroprotection (see below 4.1.3). This clearly demonstrates 
that results of in silico analyses do not necessarily reflect the biological situation, even 
though the algorithms used are quite sophisticated. 
 
4.1.2 Hypoxic and Ischemic Preconditioning 
Hypoxic and ischemic preconditioning protects tissues – including the retina – 
against apoptosis [68-73]. Thereby, both preconditioning protocols provoke somewhat 
different physiological alterations. Whereas exposure to hypoxia reduces the partial 
pressure of oxygen and therefore the tissue oxygen concentration, ischemia prevents 
blood flow partially or completely in a certain tissue. This results not only in tissue 
hypoxia but also in insufficient nutrient supply and a lack of toxic metabolite removal. 
However, both protocols share oxygen deprivation as a feature. Although duration and 
severity differs, tissues respond with the induction of hypoxia inducible factors (HIFs) 
and differential gene regulation [71, 72, 75, 139, 152] in both preconditioning protocols. 
It is believed that de novo protein synthesis is required for retinal neuroprotection after 
hypoxic [71, 74, 80, 153] and ischemic preconditioning [69, 70]. Although protein 
synthesis does not necessarily depend on altered gene expression, genes differentially 
regulated in both preconditioning strategies might be interesting targets for retinal 
neuroprotection. Solute carrier family 7, member 1 (Slc7a1), Cebpd, p21 and 
metallothionein 2 (Mt2) were differentially regulated in retinas of ischemia treated rats 
[139, 154]. We observed that hypoxic preconditioning caused a comparable regulation 
of these genes in the mouse retina. Functional clustering identified p21 and Cebpd as 
potential apoptosis related genes and Mt1/2 as genes responding to oxidative stress. 
Likewise, we compared our retinal gene expression data to the differential gene 
expression in brain of mice treated with an identical protocol of hypoxic preconditioning 
[136] and discovered a comparable regulation of adrenomedullin (Adm), p21, Vegf, 
Mt2, glucose transporter 1 (Glut1) or Cebpd. The similarity of gene regulation in retina 
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and brain could be explained by two hypotheses: I.) Comparable types of cells 
(neurons, glia cells, etc.) populate both – brain and the retina (which itself is a part of 
the brain) and respond comparable to hypoxia or II.) Hypoxia initiates similar pattern of 
gene expression in different cells because the adaptation to a critical lack of oxygen 
requires a specific set of genes and factors. In fact, evidence for both hypotheses can 
be found: e.g. astrocytes or fibroblasts respond to hypoxia with an induction of genes 
regulating carbohydrate metabolism [155, 156]. In the retina, such genes were not 
affected by hypoxia except for a slight induction of 6-Phosphofructo-2-kinase/fructose-
2,6-biphosphate-3. Furthermore, expression of collagen and cytoskeletal genes was 
induced in hypoxia exposed endothelial cells [157, 158] but not detected in the hypoxic 
retina. This strongly suggests, that distinct cells and tissues respond differently to 
hypoxic exposure. However, genes like Adm, Vegf, Bnip3 or Cebpd are induced after 
hypoxia in many tissues [136, 137, 155, 158, 159] including the retina. This indicates 
that several pathways like the HIF pathway are activated commonly during hypoxia. 
Since hypoxic and ischemic preconditioning results in cytoprotection in different tissues 
like brain, retina, heart or kidney [68, 69, 71, 160-165], it is likely that a common 
hypoxia/ischemia activated pathway is responsible for the pro-survival effect. Hence, to 
identify appropriate neuroprotective target genes for further analyzes, we selected 
genes, which were induced after hypoxic and ischemic preconditioning in the retina as 
well as in brain (Fig.12). Besides Cebpd and Mt2, the cyclin dependent kinase inhibitor 
p21 was affected in all 3 different experimental setups [136, 154]. Considering that p21 
was highly induced in the hypoxic retina and occupied a central role in a mainly 
affected gene network (as discussed in 4.1.1), it was the first candidate gene to be 
analyzed for its neuroprotective impact. 
 
4.1.3 Cell Cycle Inhibitor Cdkn1a (p21) is not Essential for Neuroprotection 
p21 encodes for a protein, which acts as an inhibitor of the cell cycle by acting on 
cyclin-dependent kinases (CDKs) 2, 4 and 5 [166-169]. However, besides this 
biological role in cell nuclei, p21 can act on signaling pathways in the cytosol and has 
been shown to inhibit apoptosis in a p53 dependent and independent fashion [170-
175]. Furthermore, p21 is a target gene of HIF-1α [176, 177], protects cell-cycle 
independent against oxidative cell damage [178, 179] and was shown to inhibit 
apoptosis by preventing DNA cleavage [180]. 
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Fig.12 Different Setups of Neuroprotective Preconditioning Partially Induce Expression of 
Similar Genes. Three different neuroprotective preconditioning setups (hypoxic preconditioning of retina 
and brain and ischemic preconditioned with or without additional ischemia) show an induction of p21 
(cyclin-dependent kinase inhibitor 1A), Cebpd (CCAAT/enhancer binding protein) and Mt2 (metallothionein 
2) gene expression. This suggests, that these genes might be part of a general protection response. 
Further, hypoxic preconditioning triggers the expression of typical HIF-1α target genes like adrenomedullin 
(Adm), vascular endothelial growth factor (Vegf) and glucose transporter 1 (Glut1) in the retina and in 
brain. A solute carrier (Slc7a1) is induced in the retina after hypoxic preconditioning or after ischemic 
preconditioning. Activating transcription factor 3 (ATF3) and glial fibrillary acidic protein (GFAP) are 
induced in brains of hypoxic preconditioned mice and in retinas of ischemic preconditioned rats; [ ] 
indicates reference number. 
Figure: M. Thiersch 
 
We observed an induction of p21 after hypoxic exposure in the retina and 
hypothesized that p21 contributes to retinal neuroprotection after hypoxia. Therefore, 
we analyzed light induced retinal degeneration after hypoxic preconditioning in p21-/- 
mice. However, hypoxic preconditioned p21-/- mice were completely protected against 
light induced retinal degeneration, indicating that p21 is not essential for retinal 
neuroprotection. Nevertheless, this does not exclude the possibility that p21 can 
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contribute to retinal neuroprotection. Recently it was shown that p21 is induced during 
HDAC-inhibition but was not essential for HDAC-inhibition mediated neuroprotection of 
cortical cells [178]. Nevertheless, an over expression of p21 was sufficient to provide a 
similar protection to these cells [178]. Hypoxic preconditioning of mice activates pro-
survival transcription factors like STAT3 and HIF-1 in the retina and leads to the 
differential expression of more than 400 genes. It could be possible that several 
overlapping pro-survival pathways are activated in the retina of hypoxic preconditioned 
mice. Therefore, p21 might be sufficient but not essential to protect the retina against 
light induced retinal degeneration. Other genes of this pathway could compensate for 
the lack of p21 and confer retinal neuroprotection. The possible impact on retinal 
neuroprotection by Timp3, a pro-apoptotic metalloproteinase inhibitor [181, 182] 
belonging to the p21 network, was tested in Timp3-/- mice (see unpublished data 
chapter 5.1.1). Similar to p21, Timp3 ablation had no effect on retinal neuroprotection 
after hypoxic preconditioning. 
 
4.1.4 Additional Potential Neuroprotective Candidate Genes 
4.1.4.1 Cebpd 
The transcriptional regulator CCAAT/enhancer binding protein delta (Cebpd) can 
impact on a multitude of biological functions – including pro- and anti-apoptotic 
processes [183-185] – and is associated to the p21 pathway [134]. Similar to p21, 
Cebpd is induced in the retina and in brain of hypoxic preconditioned mice [134, 136] 
as well as in ischemic preconditioned retinas [139]. Furthermore, leukemia inhibitor 
factor (LIF) or other members of the Il-6 family were shown to differentially regulate 
Cebpd expression via the gp130-signaling pathway [186]. LIF and the gp130 receptor 
system provide strong retinal neuroprotection via the Jak/STAT pathway [187, 188]. 
Especially the pro-survival transcription factor STAT3 [189], which is activated in the 
retina of hypoxic preconditioned mice [134], seems to be involved in Cebpd gene 
expression [190]. These evidences suggest that Cebpd might be an interesting 
candidate gene for retinal neuroprotection as a downstream target of the pro-survival 
Jak/STAT pathway. 
4.1.4.2 Metallothioneins 
Retinal metallothionein 2 mRNA levels were elevated after hypoxic 
preconditioning [134] and after ischemic preconditioning [139, 154]. Additionally, 
metallothionein 1 was induced in the retina of hypoxic preconditioned mice [134]. Both 
GENERAL DISCUSSION  147 
metallothioneins are induced in light damaged retinas [191] and protect the retina 
against NMDA induced toxicity [192]. Furthermore, Mt1 and Mt2 mRNA levels are 
elevated in spinal cord after ischemic preconditioning and mediate neuro- and 
cardioprotection [193, 194]. Thereby, Mt1 and Mt2 act as free radical scavengers and 
counteract oxidative stress [191, 195, 196] – a trigger of light induced retinal 
degeneration [197-200] and of inherited retinal disorders [201-203]. Although 
metallothioneins are predominantly regulated by the metal response element-binding 
transcription factor-1 [204], Mt1 and Mt2 can be also induced by the pro-survival 
transcription factor STAT3 [205] and are interesting target genes for retinal 
neuroprotection. 
4.1.4.3 Vegf 
The vascular endothelial growth factor (Vegf) is a HIF-1 target gene [206-210] 
and expression levels in the retina are elevated after hypoxic preconditioning of mice 
[71, 134]. VEGF acts on endothelial cells and stimulates proliferation, migration and 
tube formation leading to the growth of new blood vessels [211]. However, the role of 
Vegf in the retina remains controversial. It is considered to be a pro-survival factor for 
neuronal and endothelial cells [211-216]. Additionally, the development of the retina 
depends on Vegf signaling [217, 218], which determines neural progenitor cell 
proliferation and commitment. However, abnormally increased levels of Vegf are 
connected to retinal diseases like diabetic retinopathy (DR), retinopathy of prematurity 
(ROP) and wet AMD. Among other symptoms, these retinal disorders are featured by 
neovascularization, vessel leakiness and retinal degeneration due to hemorrhages 
[219-230]. It seems that the retinal integrity depends on accurately balanced VEGF 
levels. Further, three different isoforms (VEGF120, VEGF164, VEGF188 [231]) of 
VEGF are induced in the retina after hypoxic preconditioning (see unpublished data 
chapter 5.1.2). Therefore, it is difficult to predict the impact of VEGF (or of a specific 
isoform) on retinal neuroprotection after hypoxic preconditioning. Mice, which lack HIF-
1α in photoreceptor cells, show a significantly lower Vegf induction after hypoxia than 
respective control mice. Still, these mice are completely protected against light induced 
retinal degeneration after hypoxic preconditioning [135]. However, cells of the INL and 
GCL most likely continue to express and secrete VEGF, which might be sufficient to 
protect photoreceptors against light damage. Certainly, the complex role of VEGF 
signaling in the retina requires further, detailed analyzes. 
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4.1.4.4 Adrenomedullin 
Adrenomedullin (Adm) is a secreted regulatory peptide with multiple biological 
impacts. Among other functions, Adm has vasodilatory effects, regulates the water-
electrolyte balance in kidneys, stimulates or inhibits cell proliferation or possesses 
antimicrobial properties [232, 233]. Adm mRNA levels are induced in the retina [134] 
and the brain [136] of hypoxic preconditioned mice but quickly return to normal 
expression levels after reoxygenation. Of interest, Adm was reported to offer 
neuroprotective properties in ischemic brains and to protect neurons against oxygen 
glucose deprivation [234-236]. Adm is a target gene of HIF-1α [237, 238] and retinal 
neuroprotection by desferroxamine (DFO) preconditioning was shown to correlate with 
elevated HIF-1α and Adm levels [239]. Further, elevated Adm serum levels, found in 
patients suffering from retinitis pigmentosa, could be a response to photoreceptor cell 
death [240]. Therefore, Adm should be considered as a target gene for retinal 
neuroprotection. 
 
4.1.4.5 Paraoxonase 
Paraoxonase (Pon1) as a member of the paraoxonase gene family, is a high-
density lipoprotein (HDL) associated enzyme, which is predominately expressed in liver 
and secreted into the serum [241]. Pon1 levels seemed to be induced in retinas of 
hypoxic preconditioned mice [134]. However, the expression pattern analysis of 
paraoxonase family genes in retina and eyecup indicates that Pon1 is predominantly 
expressed in the eyecup (see unpublished data chapter 5.1.3). This challenges the 
observed induction of Pon1 in the retina of hypoxic preconditioned mice and points to 
possible contamination effects. However, Pon1 is a risk factor for atherosclerosis [242, 
243] and has a biological impact on cholesterol transport, on the prevention of lipid 
peroxidation and on the reduction of oxidative stress [244, 245]. Considering, that 
retinal degeneration involves oxidative stress and lipid peroxidation [246], Pon1 could 
play an important role in retinal neuroprotection and in retinal disease progression. 
Moreover, Pon1 was reported to be reduced in serum of AMD patients as well as in 
smokers and aged people (both risk factor for AMD) [247-250]. This suggests a 
potential link of Pon1 to AMD – the most frequent retinal disorder. 
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4.1.4.6 Bcl2-like 10 
Bcl2-like 10 (Bcl2l10), which is also named Diva/Boo, is an apoptosis-regulating 
member of the Bcl2 family and was strongly induced immediately after hypoxia [134]. It 
was reported to promote apoptosis by interaction with apoptotic peptidase activating 
factor 1 (Apaf1), an adapter molecule that activates the initiator caspase-9 [251]. 
Additionally, it was shown that Bcl2l10 could prevent CD95 ligand dependent apoptosis 
by interfering with the apoptosome downstream of cytochrome c release [252, 253]. 
However, light induced retinal apoptosis is independent of classical apoptotic pathways 
and neither includes cytochrome c release nor caspase activation [45, 48, 52, 53, 254]. 
Since to little is known about the cell-biological impact of Bcl2l10, it is speculative 
whether its induction contributes to retinal neuroprotection after hypoxic 
preconditioning. 
 
4.1.4.7 Kif4 
Kinesin family member 4 (Kif4) is an apoptosis-regulating gene, which is induced 
in the retina after hypoxic preconditioning (see supplemental data 3.1.1.3) peaking 4 h 
after hypoxia - exactly correlating with the time point of complete protection against 
light induced retinal degeneration [71]. Kif4 is involved in DNA damage/repair pathways 
[255, 256] and was shown to regulate neuronal survival by suppressing poly (ADP-
ribose) polymerase family, member 1 (Parp1) enzyme activity [257]. Under 
physiological conditions, Parp1 maintains cell homeostasis through DNA repair, 
controlling the energy balance and serving as a transcriptional regulator [258, 259]. 
However, over-stimulation of Parp-1 by excessive oxidant-induced DNA damage 
induces cell death [45] and pharmacological inhibition of Parp-1 activity protects 
against cerebral ischemia or myocardial infarction [260]. Recently, it was shown that 
attenuation of Parp1 activity by Casp3 is essential to mediate neuroprotection against 
zinc and NMDA toxicity [261]. Whether Kif4 and its target Parp-1 have an impact on 
retinal neuroprotection after hypoxic preconditioning remains to be analyzed. However, 
it was shown that Parp-1 inhibition leads to partial retinal protection in an inherited 
model (rd1 mouse) [262] as well as in different models of induced retinal degeneration 
(ischemia, NMDA toxicity and N-methyl-N-nitrosourea-induced photoreceptor cell 
apoptosis) [263-265]. This indicates, that Parp-1 activity may contribute to retinal 
degeneration and suggests Kif4 as an interesting candidate gene for retinal 
neuroprotection. 
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4.1.4.8 Mef2c and Rbm family members 
Among the few downregulated genes with potential impact on cell death, Mef2c 
and members of the Rbm family could be of interest. The role of Mef2c is controversial: 
On one hand it was shown that the Mef2 transcription factors are required for neuronal 
development [266] and Mef2c increases the resistance against apoptosis in neuronal 
progenitor cells [267]. On the other hand, Mef2c might also be involved in 
dopaminergic neuron death in Parkinson’s disease [268] and is an inducer of apoptosis 
in macrophages [269]. Macrophages play an important role in light induced retinal 
degeneration [270, 271] to ensure a rapid and efficient clearance of cell debris. This 
reduces secondary apoptotic effects and pro-inflammatory processes and is required to 
maintain the retinal integrity. A downregulation of Mef2c could be a response to 
maintain macrophage activity and to efficiently clear up cells that die after light 
exposure. 
Among the members of the RNA-binding-motif protein family (RBM), gene 
expression of Rbm3, Rbm4 and Rbm12b was repressed. Members of the Rbm family 
were shown to be associated with apoptotic processes [272]. Rbm3 has been 
specifically linked to apoptosis [273] and to proliferation [274]. However, little is known 
about the biological functions of Rbm proteins in the retina and whether they play a role 
in retinal degeneration. 
 
4.2 The role of HIF-1α 
HIF-1α is expressed in the entire retina [74, 135]. We hypothesized that HIF-1α 
stabilization is required to protect photoreceptor cells against light induced cell death. 
To test this, HIF-1α was ablated in photoreceptor cells. We employed a conditional 
knock out system breeding mice carrying loxP-flanked alleles of HIF-1α [275] with two 
different Cre-expressing mouse strains. PrpCre deleter mice [276] ablated HIF-1α very 
efficiently in photoreceptor cells whereas OpnCre mice [277] caused only a partial 
reduction of HIF-1α in photoreceptor cells. Especially PrpCre mice showed strongly 
reduced HIF-1α protein levels. Further, typical HIF-1α target genes like Bnip3 [278], 
Egln1 [279, 280], Vegf [206-210], Adm [237, 238] and Glut1 [281] showed a reduced 
retinal expression after hypoxic preconditioning especially in PrpCre mice and partially 
in OpnCre mice. Retinal development and physiology remained normal when HIF-1α  
was ablated in photoreceptors and no pathological changes were detected in retinas of 
hypoxic preconditioned knock out mice. Additionally, neuroprotection by hypoxic 
preconditioning seems to be independent of HIF-1α stabilization in photoreceptors. The 
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induction of other transcription factors like HIF-2α or STAT3 in control and in knock out 
mice suggests that other mechanisms might exist to protect photoreceptor cells against 
toxic insults. 
 
4.2.1 Physiological Role of HIF-1α in the Retina 
A systemic knock out of HIF-1α was shown to be lethal between embryonic day 9 
and 10 [122, 127]. Thereby, the blood vessel formation is severely impaired in the 
absence of HIF-1α. That indicates, that HIF-1α stabilization is absolutely required for 
the embryonic development of mice. In the retina, HIF-1α is induced between postnatal 
day (PND) 5 and 14, which correlates with an induction of Vegf [72] and the 
development of the inner retinal blood vessel system [9]. Considering the potential role 
of HIF-1α in retinal blood vessel formation, a retinal deletion of HIF-1α during eye 
development might severely impair retinal function and morphology. To avoid potential 
vascular deficits and a resultant abnormal retinal development, two different 
photoreceptor specific Cre expressing mouse lines were compared. Cre activity in 
PrpCre mice [276] can be temporally controlled by tamoxifen (TAM). Inducing Cre 
activity in adult mice should allow a normal retinal development similarly to wild type 
mice. In contrast, OpnCre mice activate Cre around PND 7 [277] – the time point when 
HIF-1α is stabilized in developing retinas of wild type mice [72]. However, the early 
ablation of HIF-1α did not result in pathological changes of morphology. A possible 
explanation could be that OpnCre only partially deleted HIF-1α in photoreceptor cells 
[135]. Furthermore, the three inter-connected blood vessel networks, located in the 
nerve fiber layer and in both plexiform layers, arise from the inner surface of the retina 
[9]. HIF-1α expression in ganglion cells and the inner nuclear layer of OpnCre mice 
might be sufficient to ensure a proper network establishment. 
The retina is a high energy demanding tissue with dropping oxygen 
concentrations during the dark phases [282]. During this phase the retina becomes 
borderline hypoxic and might require HIF-1α for adaptation. In retinas of adult mice 
HIF-1α protein is hardly detectable under physiological conditions [71, 134] except for 
ganglion cells, which show a slight HIF-1α protein signal [135]. In adult PrpCre mice, 
HIF-1α was efficiently deleted in photoreceptor cells [135]. Nevertheless, no 
morphological alterations could be observed PrpCre mice over a period of 4 month, 
suggesting that HIF-1α in photoreceptor cells is not required to maintain retinal integrity 
of adult mice under physiological conditions. 
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PrpCre and OpnCre mice deleted HIF-1α photoreceptor cells specific in mature 
and in developing retinas. Both deleter strains revealed no obvious retinal impairment 
after HIF-1α ablation and were therefore used for analyzing the impact of HIF-1α 
deletion during short but severe hypoxia. 
4.2.2 HIF-1α and Hypoxia 
Almost all types of cells and tissues respond to low levels of oxygen with the 
stabilization of HIF-1α and differential gene expression [283, 284]. The role of HIF-1α 
in neuronal tissue during severe hypoxia or ischemia is controversial. Two independent 
studies showed contradictory effects after brain specific HIF-1α ablation. Baranova et 
al. showed that a neuron specific deletion of HIF-1α increased brain injury after 
cerebral ischemia [285]. In contrast, Helton et al. observed even an increased 
resistance against hypoxic-ischemic damage after HIF-1α ablation in cortex and 
hippocampus [286]. The difference in both studies could be explained by different 
extent of HIF-1α ablation. Whereas Baranova reported a neuron specific knock out 
[285], Helton et al. described mice with HIF-1α deletion in additional cell types, like 
astrocytes [286]. Interestingly, it was shown that an induction of HIF-1α in astrocytes 
accelerated hypoxia-induced cell death. In contrast, an induction of HIF-1α in neurons 
promoted survival and increased the resistance to hypoxia [121]. This suggests a 
beneficial role for HIF-1α stabilization in neurons. However, the ablation of HIF-1α in 
photoreceptor cells – the primary neurons within the retina  – did not induce retinal 
degeneration after sever hypoxia (6-7% O2) in both Cre deleter strains (PrpCre and 
OpnCre) up to 4 weeks after exposure [135]. The differences between the decreased 
tolerance against cerebral ischemia in neuron specific HIF-1α deletion in brain [285] 
and the resistance to severe hypoxia in our model of photoreceptor cell specific HIF-1α 
ablation [135] could be explained by the different treatments. The oxygen deprivation 
during hypoxic exposure (6% O2) of mice as used in our study [135] might be less 
intense than during ischemia as used by Baranova et al. [285]. Ischemia suppresses 
blood flow and prevents nutrition supply as well as the removal of toxic metabolites, 
which might contribute to the cytotoxic effect. Additionally, the retina experiences 
constant exposure to borderline levels of hypoxia during the night [282]. This might 
activate general hypoxia-resistance mechanisms, which do not necessarily require 
HIF-1α in photoreceptor cells and which are sufficient to protect the retina against 
hypoxia induced damage. 
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Both, PrpCre and OpnCre mice were protected against hypoxia induced retinal 
degeneration. Therefore, both mouse models were employed to investigate the role of 
HIF-1α in retinal neuroprotection after hypoxic preconditioning. 
 
4.2.3 HIF-1α and Retinal Neuroprotection 
To analyze the impact of HIF-1α on hypoxia-mediated neuroprotection of the 
retina, both deleter strains (PrpCre [276] and OpnCre [277]) with photoreceptor cell 
specific HIF-1α deletion were hypoxic preconditioned and exposed to toxic levels of 
white light. The results showed that the retinas of mice lacking HIF-1α in photoreceptor 
cells were (like wild type mice) completely protected against light induced retinal 
degeneration after hypoxic preconditioning [135]. This finding is perfectly in line with a 
recent report showing that protection against cerebral ischemia after hypoxic 
preconditioning is independent from HIF-1α stabilization in neurons [285]. 
Nevertheless, both findings are somewhat surprising considering that cardio- and 
nephroprotection after ischemic/hypoxic preconditioning depends on HIF-1α [165, 287-
291]. Moreover, several hypoxia-mimicking compounds like the iron-chelators 
dimethyloxaloylglycine (DMOG), desferroxamine (DFO) etc. or cobalt chloride (CoCl2) 
were shown to stabilize HIF-1α and to confer cell-, tissue- or neuroprotection [292-
298]. Especially the protection of the retina after hypoxic exposure was shown to 
correlate with the stabilization of HIF-1α and the expression of potentially 
neuroprotective HIF-1 target genes [71, 74, 75, 134]. Specific HIF-1α deletion in 
photoreceptor cells – the cells that undergo apoptosis due to light exposure – was used 
to analyze the impact of HIF-1α on photoreceptor cell survival after hypoxic 
preconditioning. However, with the employed model we cannot exclude the possibility 
that remaining HIF-1α in the INL and GCL confers retinal neuroprotection by the 
expression of secreted factors. Among HIF-1α target genes with a potential 
neuroprotective impact, Adm [237, 238] and Vegf [206-210] were only partially reduced 
in HIF-1α ablated mice [135]. This suggests a remaining HIF-1α activity in the INL and 
GCL and that Adm and Vegf as secreted factors could still contribute to retinal 
neuroprotection. To date, there are no Cre deleter strains available that express Cre in 
the entire retina to delete HIF-1α tissue- and not only photoreceptor-specific. 
Nevertheless, our experiments showed clearly, that an intrinsic activation of the 
transcription factor HIF-1 in photoreceptor cells is not essential to protect these cells 
against toxic light insults. 
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4.2.4 Possible Alternative Mechanisms for Hypoxia-induced Retinal 
Neuroprotection 
Analyzing the retinal transcriptome after hypoxia revealed several potential 
neuroprotective target genes [134]. Among them, the induction of Bcl2l10, Adm, Vegf, 
Mt1, Mt2, Epo and Egf was tested in the retina of hypoxic preconditioned HIF-1α knock 
out mice. Except for Vegf and Adm, which showed reduced expression in hypoxic 
preconditioned PrpCre mice; all genes seemed to be expressed either in cell layers 
where HIF-1α was not deleted (INL and GCL) or independently of HIF-1α. This 
suggests the involvement of other transcription factors. Besides HIF-1α, hypoxia 
induces or activates additional transcription factors like HIF-2α, STAT3, p53 and 
members of the Myc- or the NF-κB-family [134, 299-301]. Especially HIF-2α was 
discussed to mediate neuroprotection in a HIF-1α independent protection of brain 
neurons against cerebral ischemia after hypoxic preconditioning [285]. Likewise, we 
observed an induction of HIF-2α after hypoxic preconditioning in the retina of HIF-1α 
ablated and control mice [135]. Very recently a study suggested that HIF-2α and not 
HIF-1α is required to mediate neuroprotection against NGF-deprivation-induced cell 
death in developing neurons [302]. Furthermore, it was shown that HIF-2α instead of 
HIF-1α regulates the expression of Epo in vivo [303-305] and in vitro [306]. Epo acts as 
a strong neuroprotective factor in the brain [114, 307, 308] and in the retina [76, 309] 
and protects against light induced retinal degeneration [71, 72]. In our conditional HIF-
1α knock out mice, Epo mRNA levels were not reduced after hypoxic preconditioning 
when compared to control animals [135] – an effect, which might be responsible for the 
sustained strong neuroprotective effect. Several reasons might account for the 
unaffected Epo expression in the retinas of HIF-1α ablated mice: 1. Retinal Epo 
expression is indeed regulated by HIF-2α instead of HIF-1α as suggested by Morita et 
al. [304] and/or 2. Epo is predominantly expressed in cells of the INL and GCL as 
suggested by García-Ramírez et al. [79]. If Epo is regulated by HIF-2α to confer 
neuroprotection in the retina, then HIF-2α rather than HIF-1α could be one of the 
essential components of retinal neuroprotection after hypoxic preconditioning. 
In addition to HIF-2α other transcription factors like STAT3, which was 
phosphorylated (pSTAT3) and thereby activated in retinas of hypoxic preconditioned 
mice [135], could contribute to retinal neuroprotection. STAT3 is a pro-survival factor 
[189], which is also activated after light exposure [54] – probably as an attempt to 
rescue cells. Recently it was suggested that LIF application mediated protection 
against light induced retinal degeneration in a STAT3 dependent manner [187]. Of 
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interest, Epo was shown to activate STAT3 via Janus kinase 2 (Jak2) [310] in retinal 
ganglion cells and it was shown that Jak2/STAT3 promote neuroprotection in a rat 
model of stroke [311]. This would suggest a link between HIF/Epo induction after 
hypoxic preconditioning and the activation of the pro-survival transcription factor 
STAT3. Among potential STAT3 target genes, Mt1 and Mt2 were reported to mediate 
cardioprotection in a STAT3 dependent fashion [205]. Both metallothioneins act as free 
radical scavengers [191, 195, 196] and were induced in retinas of both, HIF-1α ablated 
and control mice after hypoxic preconditioning [135]. This supports the potential impact 
of STAT3 on retinal neuroprotection. However, metallothioneins are predominately 
regulated by the metal-regulatory transcription factor 1 (MTF1) [204], which was not 
analyzed in our model. That indicates, that there are certainly more potential 
neuroprotective transcription factors activated in the hypoxic retina. To pinpoint the 
molecular mechanisms of retinal neuroprotection by hypoxic preconditioning further 
and detailed investigations are clearly required. 
 
4.3 Conclusion 
We aimed to analyze mechanisms, which are responsible for retinal 
neuroprotection after hypoxic preconditioning. Employing micro-arrays we analyzed the 
retinal transcriptome after hypoxic preconditioning and discovered potential 
neuroprotective genes. Among them was p21 – the cyclin-dependent kinase inhibitor 
1a with potential impact on apoptosis regulation, Cebpd – a downstream target of the 
strong pro-survival transcription factor STAT3; and Mt2 a free radical scavenger that 
might counteract oxidative stress. As a first candidate, we selected p21 and analyzed 
its role by employing p21-/- mice. We showed that p21 is not essential for retinal 
neuroprotection after hypoxic preconditioning. The persistence of the strong 
neuroprotective effect after hypoxic preconditioning could be explained by the 
possibility that hypoxia induces several cell-survival pathways, which partially overlap. 
If that proves to be true, neuroprotective intervention should not target anti-apoptotic 
“effector” genes but upstream factors (like transcription factors), which govern the 
expression of various pro-survival genes or pro-survival pathways. To verify this 
hypothesis, we specifically investigated the role of HIF-1 – one of the main transcription 
factors responding to hypoxia – in retinal neuroprotection after hypoxic preconditioning. 
The photoreceptor-specific deletion of HIF-1α in retinas of developing mice (OpnCre) 
and retinas of adult mice (PrpCre) impaired neither retinal development nor the 
maintenance of retinal integrity. Surprisingly, exposure of HIF-1α ablated mice to short, 
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severe hypoxia caused no functional or morphological abnormalities in the retina. 
Finally, this study clearly showed that retinal neuroprotection against light damage after 
hypoxic preconditioning is independent of HIF-1α stabilization in photoreceptor cells. 
However, the retina is a functional unit consisting of three different neuronal cell layers 
(ONL, INL and GCL) and a single pigment epithelium cell layer. We discussed the 
possibility that the remaining HIF-1α protein in INL and GCL might be sufficient to 
protect the retina by the induction of secreted factors in a paracrine fashion. Further, 
we observed the activation of additional transcription factors like HIF-2α and the pro-
survival transcription factor STAT3. The expression of potentially neuroprotective 
genes like metallothioneins, Bcl2l10 or Egf was not affected by HIF-1α ablation. 
Likewise, the induction of the strong neuroprotective factor Epo after hypoxic 
preconditioning was hardly affected in HIF-1α ablated mice. 
Therefore, we hypothesize that HIF-2α rather than HIF-1α regulates the 
expression of Epo in the retina during hypoxia and as such might be an important 
factor for retinal neuroprotection. Epo is linked to STAT3 and STAT5 signaling [310-
312] and STAT3 has been reported to promote cell survival in the retina [187]. 
Although Epo-induced STAT5 can provide neuroprotection [312], we observed no 
phosphorylation of STAT5 after hypoxic preconditioning (not shown). Additionally, Jak2 
remained inactive after hypoxic preconditioning (not shown). Nevertheless, Epo might 
activate STAT3 in retinas of hypoxic preconditioned mice via an unknown mechanism, 
which could result in the expression of potential STAT3 target genes with 
neuroprotective properties (Mt1, Mt2 [205] and Cebpd [190]). We assume that retinal 
neuroprotection could partially depend on a HIF-2α – Epo – STAT3 axis and might 
require the expression of potential STAT3 target genes – like metallothioneins and 
Cebpd (Fig.13). 
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Fig.13 Hypothesized Major Signalling Cascade Induced by Hypoxic Preconditioning to 
Protect Photoreceptor Cells Against Light-induced Retinal Degeneration. During hypoxia hypoxia-
inducible factor alpha subunits (HIFα) accumulate in the retina and dimerize with HIF-β subunits in the 
nucleus. This induces the gene expression and release of erythropoietin (Epo) (most likely HIF-2α 
dependent). Epo binds to its receptor, which is localized on photoreceptor cells and mediates 
neuroprotection in an autocrine fashion (photoreceptor cells produce Epo themselves) or in a paracrine 
fashion (Epo is not produced by photoreceptor cells but by other cells of the retina). The ligation of Epo to 
its receptor activates STAT3 via an unknown Jak2-independent mechanism, which induces the expression 
of neuroprotective genes like metallothionein 2 (Mt2) and CCAAT/enhancer binding protein (Cebpd) and 
thereby protects the retina against light-induced retinal degeneration. 
Figure: M. Thiersch 
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5 APPENDIX 
5.1 Unpublished Data 
5.1.1 Hypoxic Preconditioning Protects Timp3-/- Mice Against Light-induced 
Retinal Degeneration 
Analyzing the retinal transcriptome after hypoxic preconditioning suggested that 
several networks of genes might confer protection against light induced retinal 
degeneration. Among those genes we tested p21 and showed that it is not essential for 
retinal neuroprotection. Timp3 belongs to the same gene network and was induced 
after hypoxic preconditioning. Because Timp3 is a regulator of apoptosis [181, 182], we 
employed Timp3-/- to analyze the effect of Timp3 ablation on hypoxic preconditioning 
dependent retinal neuroprotection. The exposure of Timp3+/- control mice and Timp3-/- 
mice to light caused retinal degeneration, indicated by reduced rhodopsin levels ten 
days after illumination (Fig.14). Hypoxic preconditioning protected both, Timp3+/- and 
Timp3-/- mice against light induced retinal degeneration, suggesting that Timp3 is not 
essential for hypoxia mediated neuroprotection. 
 
Fig.14 Rhodopsin levels in normoxic or hypoxic preconditioned Timp3-/- mice and Timp3+/- 
control mice ten days after light exposure. Shown are levels of rhodopsin as indicator for the presence 
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of photoreceptor cells. A physiological normal retina contains approximately 500 pmol of rhodopsin per 
retina (indicated by dashed line). Both Timp3+/- and Timp3-/- mice showed reduced levels of rhodopsin after 
illumination, suggesting that they were susceptible to light and underwent retinal degeneration. Hypoxic 
preconditioned Timp3+/- and Timp3-/- mice were completely protected against light induced retinal 
degeneration and reveal normal levels of rhodopsin. Shown are means ±SD of n=3 
 
5.1.2 Differential Expression of Vegf Isoforms in the Retina After Hypoxia 
Hypoxic preconditioning induces the expression of Vegf [71, 134]. However, at 
least three different isoforms of Vegf (VEGF120, VEGF164, VEGF188 [231]) are 
expressed in the retina. It might be possible that the induction of a specific isoform 
confers to retinal neuroprotection. Therefore, we used real time PCR and isoform 
specific primer to analyze whether the Vegf isoforms in the retina were similarly 
induced by hypoxia or whether alternative splicing preferentially activated a specific 
isoform during hypoxia. Real time PCR confirmed the general expression of Vegf and a 
rapid return to normal expression levels. Further we observed that all isoforms (Vegf 
164, 120 and 188) showed a similar pattern of induction between 2 – 3 fold and a quick 
restoration of the normoxic gene expression levels (Fig.15). This suggests that Vegf 
isoforms are similarly regulated in the hypoxic retina. 
 
Fig.15 Differential Expression of Vegf Isoforms after Hypoxic Preconditioning in the Retina. 
Expression levels of total Vegf mRNA and of the isoforms Vegf 164, 120 and 188 in normoxic mice (white 
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bar) and after 0, 2, 4 and 16 hours of hypoxia (grey bars). Data were normalized to normoxic mice which 
were set to “1” for each time point. Statistical significance was estimated with student‘s t-test (n = 4): *p ≤ 
0.05; **p ≤ 0.01. 
 
5.1.3 Expression of Paraoxonase Family Genes in Retina and Eyecup 
Analyzing the retinal transcriptome in response to hypoxia revealed a few 
interesting candidate genes, which could be implicated in retinal neuroprotection. 
Among those genes, we found Paraoxonase 1 (Pon1), which could be potentially 
involved in oxidative stress response of the retina. Further it was shown, that reduced 
Pon1 activity is correlated with the development of AMD [247-250]. In order to estimate 
retinal expression levels of all three paraoxonase family genes, we analyzed mRNA of 
the retina and compared it to eyecup and liver (the major Pon1 producing tissue) 
(Fig.16). 
 
 
Fig.16 Pon1 Expression in Retina compared to Eyecup and Liver. Relative expression levels of 
paraoxonase 1, 2, 3 (Pon1, 2, 3) mRNA in the retina (white bar), eyecup (grey bar) and liver (black bar) 
are logarithmically presented. Data were normalized to retinal expression levels, which were set to “1”. 
(n=4) 
 
Pon2 was equally expressed in retina, eyecup and liver. In contrast, Pon1 and 
Pon3 were predominantly expressed in the liver. Of note, the gene expression levels of 
Pon1 and Pon3 in eyecup strongly exceeded the retinal expression levels, suggesting 
a potential biological role in the eyecup or even in RPE cells. 
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5.3 List of Abbreviations 
(N/C)TAD N/C-terminal transactivation domain 
(rh)Epo recombinant human Epo 
A amacrine cell 
Adm adrenomedullin 
AMD age related macular degeneration  
Apaf-1 apoptotic peptidase activating factor 1 
ARNT aryl hydrocarbon receptor nuclear translocator 
ATP adenosine triphosphate 
Bcl2l10 Bcl2-like 10 
BDNF brain-derived neurotrophic factor 
bHLH basic-helix-loop-helix domain 
Bnip3 BCL2/adenovirus E1B 19 kDa interacting protein 3 
C cone 
Ccl2 chemokine C-C motif ligand 2 
CDK cycline dependent kinase 
Cdkn1a / p21 cycline dependent kinase inhibitor 1a 
Cebpd CCAAT/enhancer binding protein (C/EBP), delta 
cGMP cyclic guanosine monophosphate 
Cox2/4 cytochrome c oxidase subunit 2/4 
CTNF ciliary neurotrophic factor 
DAVID Database for Annotation, Visualization and Integrated Discovery 
DFO desferroxamine 
DHA docosahexaenoic acid 
DMOG dimethyloxaloylglycine 
DNA deoxyribonucleic acid 
DR diabetic retinopathy 
EGF epidermal growth factor 
Epo erythropoietin 
EpoR erythropoietin receptor 
FGF-2 fibroblast growth factor 2 
FIH factor inhibiting HIF 
G ganglion cell 
GCL ganglion cell layer 
GDNF glial cell derived neurotrophic factor 
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GDP guanosine diphosphate 
Glut1 glucose transporter 1 
GTP guanosine triphosphate 
H horizontal cell 
HDL high density lipoprotein 
HGF hepatocyte growth factor 
HIF hypoxia inducible factor 
HO-1 heme oxygenase 1 
Hsp27 heat shock protein 2 
IGF 1/2 insulin-like growth facto 1/2 
INL inner nuclear layer 
IPA Ingenuity Pathway Analysis 
IPAS hypoxia inducible factor 3 
IPL inner plexiform layer 
IS inner segments 
Jak2 janus kinase 2 
Kif-4 kinesin family member 4 
LdhA lactate dehydrogenase A 
LGN laterale geniculate nucleus 
LIF leukemia inhibitor factor 
M müller cell 
MNU N-methyl-N-nitrosourea 
Mt1/2 metallothionein 1/2 
MTF-1 metal response element binding transcription factor 1 
Myc myelocytomatosis oncogene 
NMDA N-methyl-D-aspartic acid 
NO nitric oxide 
O2 oxygen 
ODD oxygen-dependent degradation domain 
ONL outer nuclear layer 
OPL outer plexiform layer 
OS outer segments 
p53 transformation related protein 53 
Parp1 poly (ADP-ribose) polymerase family, member 1 
PAS1/2 Per-Arnt-Sim domain 
PDE phosphodiesterase / transducin 
PDGF platelet derived growth factor 
PDH pyruvat dehydrogenase 
PDK pyruvat dehydrogenase kinase 
PE retinal pigment epithelium 
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PHD prolylhydroxylase 
PND postnatal day 
Pon1 /2/3 paraoxonase 1/2/3 
Pro proline 
R rod 
Rbm RNA binding motif protein 
RNA ribonucleic acid 
Rho rhodopsin 
RMA robust multi-array average 
RNFL retinal nerve fiber layer 
ROP retinopathy of prematurity 
ROS reactive oxygen species 
RP retinitis pigmentosa 
Rpgr retinitis pigmentosa GTPase regulator 
Slc7a1 solute carrier family 7, member 1 
STAT3 signal transducer and activator of transcription 3 
TAM tamoxifen 
Ush2a usher syndrome 2a homolog 
Vegf vascular endothelial growth factor 
VHL von Hippel-Lindau disease tumor suppressor 
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6.1.2 Summary 
The mechanisms of retinal degeneration are largely unknown. In this paper 
signaling pathways were analyzed in light induced retinal degeneration and in inherited 
models for autosomal recessive (rd1 mouse) and for autosomal dominant (VPP 
mouse) retinitis pigmentosa. Expression and activation of proteins was death-stimulus 
specific. Erk1/2 was induced in light damaged retinas. In contrast, Akt was specifically 
activated in the inherited models. Nevertheless, as a common response to retinal 
injury, all models differentially expressed LIF and CLC – members of the interleukin 
(IL)-6 family – in the degenerating retina. These cytokines are known to signal via the 
Jak/STAT pathway, which is potentially involved in the regulation neurodegeneration 
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and neuroprotection.  Indeed, in all models of degeneration Jak2, STAT1 and STAT3 
were activated and cytokine-signaling suppressors CIS, SOCS1 and SOCS3 were 
induced as a negative feedback loop. In the model of light induced retinal 
degeneration, the cytokines LIF and CLC as well as the Jak/STAT signaling was 
activated between 6 and 24 h after illumination – prior to retinal apoptosis (peaks 36 h 
after light exposure). Further we showed, that a sub-lethal exposure to light was not 
sufficient to activate the Jak/STAT signaling, which suggests a potential role of the 
Jak/STAT pathway in retinal apoptosis. Application of AG-490 – a Jak family specific 
tyrosine kinase inhibitor – protected the retina against light induced retinal 
degeneration but failed to protect the retina against inherited retinal degeneration in the 
VPP mouse. AG-490 inactivated Jak2 in the protected, light exposed retinas and the 
degenerating retinas of the VPP mouse. Likewise, the potential Jak2 downstream 
target STAT1 remained inactive in both models. In contrast, STAT3 was activated in 
the degenerating VPP mouse but not in the protected retinas after light exposure. We 
concluded that Jak2 and the activation of the pro-apoptotic transcription factor STAT1 
might be involved in light induced retinal degeneration but not in the inherited models. 
Further, we speculated that the activation of STAT3 – presumably a pro-survival factor 
– might occur via a different, Jak2 independent pathway and is an attempt to protect 
the retina. Because AG-490 treated mice were protected against light induced retinal 
degeneration, STAT3 activation might have been not required under these 
circumstances. Because Jak2, STAT1 and STAT3 were predominantly expressed in 
the INL and GCL, we hypothesized that photoreceptor injury initiates a response in the 
INL or GCL, which attempts to either minimize and/or accelerates photoreceptor cell 
death. 
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Differential role of Jak-STAT signaling in retinal
degenerations
Marijana Samardzija, Andreas Wenzel, Svenja Aufenberg, Markus Thiersch,
Charlotte Reme´, and Christian Grimm1
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Physiology (CIHP) and Neuroscience Center Zurich (ZNZ), University Hospital, Zu¨rich, Switzerland
ABSTRACT Retinal degeneration is a major cause of
severe visual impairment or blindness. Understanding
the underlying molecular mechanisms is a prerequisite
to develop therapeutic approaches for human patients.
We show in three mouse models that induced and
inherited retinal degeneration induces LIF and CLC as
members of the interleukin (IL)-6 family of proteins,
activates proteins of the Jak-STAT signaling pathway,
and up-regulates suppressors of cytokine signaling as a
negative feedback loop. Inhibition of Jak2 leads to
protection of photoreceptors in a model of induced but
not in a model of inherited retinal degeneration. Dif-
ferential activation of Akt suggests alternative pathways
for cell death and/or survival in different models.
Proteins induced during photoreceptor degeneration
are not mainly expressed in photoreceptors but in cells
of other retinal layers. This suggests a model in which
photoreceptor injury is signaled to cells of the inner
retina, which in turn initiate a response either to
support viability or accelerate death of injured cells.—
Samardzija, M., Wenzel, A., Aufenberg, S., Thiersch,
M., Reme´, C., Grimm, C. Differential role of Jak-STAT
signaling in retinal degenerations. FASEB J. 20,
E1790–E1801 (2006)
Key Words: apoptosis  neuroprotection  photoreceptor
The neuronal retina is designed to absorb photons
and convert the information into electrical signals that
are transmitted to the brain. Due to their high special-
ization, photoreceptors are highly vulnerable to any
endogenous or exogenous disturbances. So far more
than 150 genes are known to cause some form of retinal
disorder when mutated (http://www.sph.uth.tmc.edu/
Retnet/). Retinitis pigmentosa (RP) and age-related
macular degeneration (AMD), two frequent causes of
severe visual impairment or blindness in patients, are
characterized by the progressive loss of visual cells by
apoptosis. Various animal models have been generated
and used to investigate the molecular mechanisms of
disease induction and progression. Besides genetically
modified animals, the model of light-induced photore-
ceptor apoptosis is widely used to analyze signaling
pathways during retinal cell death and to test the
efficacy of neuroprotective substances (1–8).
Inhibition of photoreceptor apoptosis is one possible
strategy to protect morphology and function of the
retina and to prolong the period of useful vision in
patients. Several compounds, including cytokines like
fibroblast growth factor-2 (FGF-2), pigment epithelium-
derived factor (PEDF), and ciliary neurotrophic factor
(CNTF), have been shown to be protective in light
damage and in models of inherited retinal degenera-
tion; other factors protect photoreceptors only in in-
duced but not inherited models (2, 5, 9–13). The
mechanisms of protection are still largely unknown but
may involve differential intracellular signaling cascades.
CNTF, for example, is suggested to activate the Janus
kinase signal transducer and activator of transcription
(Jak-STAT) signaling pathway in ganglion cells and
Muller cells. Such activated Muller cells may initiate a
secondary, neuroprotective activity to preserve photo-
receptor viability (14). FGF-2 and glial-derived neuro-
trophic factor (GDNF) might be such factors produced
and released by Muller cells upon proper stimulation
(15). In addition to Jak-STAT signaling, CNTF may also
stimulate cell survival through phosphatidylinositol-3
phosphate kinase (PI3K)-mediated Akt signaling (16, 17).
Upon binding to the heterodimeric receptor com-
plex containing gp130, members of the IL-6 family of
cytokines induce autophosphorylation of cytoplasmic
Jak kinases, which then phosphorylate downstream
molecules such as transcription factors of the signal
transducer and activator of transcription (STAT) family
of proteins. In addition to the IL-6 family of cytokines
that consists of seven members (leukemia inhibitory
factor, LIF; cardiotrophin-1, CT-1; CNTF; cardiotro-
phin-like cytokine, CLC; oncostatin M, OSM; neuropo-
etin, NP; interleukin-6 (IL-6), IFN alpha and gamma
are similarly strong activators of the Jak-STAT pathway
(18). Of particular interest is the fact that Jak-STAT
signaling has been implicated in both pro- and anti-
apoptotic mechanisms. STAT1 is frequently described
as being proapoptotic whereas STAT3 is often found in
proliferating tumor cells and is suspected to be anti-
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ikstrasse 24, 8091 Zürich, Switzerland. E-mail: cgrimm@
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apoptotic (19–21). This signaling cascade is controlled
by a negative feedback loop involving members of the
suppressor of cytokine signaling (SOCS) family of
proteins (22).
Here we show that retinal degeneration in three
different mouse models of induced and inherited pho-
toreceptor apoptosis activates expression of several
proteins of the IL-6 family of cytokines. This leads to
the phosphorylation of members of the Jak-STAT sig-
naling pathway and to the activation of a negative
feedback loop by the increased expression of several
members of the SOCS family. Interference with this
pathway protects the retinal tissue against an acute
toxic insult but not against photoreceptor degenera-
tion in an inherited model. Our results suggest that
Jak-STAT-mediated regulation of an intracellular re-
sponse to photoreceptor degeneration is of differential
importance for the retina depending on the nature of
the insult.
RESULTS
Induction of LIF and CLC by acute light exposure
Injury or stress to the retina or to the optic nerve
induces the expression of several neurotrophic factors,
including CNTF and FGF-2. These molecules may act as
survival factors protecting photoreceptors and other
retinal cells from further damage (23–28). In the
search for additional factors relevant for retinal injury,
we tested expression of cytokines of the IL-6 family in
BALB/c mice after exposure to high levels of white
light, a treatment that represents a strong retinal insult
leading to rapid photoreceptor apoptosis. Whereas
CLC and LIF where highly up-regulated, peaking 12 h
after light exposure, expression CNTF showed a slow
response with a slight increase after 36 h (Fig. 1A, B;
Supplemental Table 1). CT-1 remained unchanged
throughout the period investigated. TGF-, another
cytokine involved in many regulatory and inflammatory
processes in the retina, increased slightly 48 h after
light exposure. Increased expression of LIF and CLC
well preceded the light-induced release of free nucleo-
somes, which peaks 36 h after exposure and indicates
a late stage of apoptosis (Fig. 1B) (2). Increased CNTF
expression largely coincided with the apoptotic wave as
detected by the biochemical detection of free nucleo-
somes.
Induction of the janus-activated kinase (JAK)-STAT
pathway by acute light exposure
Upon binding to their respective receptors, members
of the IL-6 family of cytokines activate the Jak/STAT
signaling pathway. Functional receptors are het-
erodimeric complexes consisting of a common gp130
protein and of specific proteins like CNTF receptor or
LIF receptor, all of which are expressed in the mam-
malian retina (Fig. 2; see Fig. 6) (29). In extracts of
untreated retinas, activated (phosphorylated) Jak2,
STAT1, and STAT3 were not or were only barely
(p-STAT3) detectable, in contrast to p-Akt473 and p-
Erk1,2 (Fig. 2). After light exposure, phosphorylation
of Jak2, STAT1, STAT3, and Erk1,2 strongly increased,
peaking  6 to 12 h postillumination. The level of
p-Akt473 remained largely unchanged, as did expres-
sion of gp130. GFAP expression, a marker for activated
Muller glia cells, increased slightly over time as it was
observed earlier (30). Total levels of individual proteins
remained largely constant, although STAT1 and STAT3
showed a slight increase with time.
Not only activation of proteins by a specific stimulus
but also a timely controlled attenuation of the response
Figure 1. Members of the IL-6 family of cytokines are induced upon exposure to damaging light. BALB/c mice were not (dark
control, d) or were exposed to 5000 lux of white light for 1 h and retinal RNA was prepared immediately (i) or 6 to 72 h after
light exposure, as indicated. After isolation, identical amounts of RNA were reverse transcribed. Equal amounts of cDNAs from
three different animals of a particular condition were pooled and used for exponential PCR. PCR amplifications were done in
triplicate. Thus, each signal represents the average RNA level of three mice. A) Radiolabeled products after exponential RT-PCR
were separated by nondenaturing PAGE. B) Signal intensities were determined on a PhosphorImager. Gene expression is shown
semiquantitatively and relative to -Act RNA levels. Dark control levels were set to 1. The dotted line represents the time course
of apoptosis (release of nucleosomes) after light treatment. These data were published before (2) and are shown here for
informative purposes.
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is essential for an appropriate cellular reaction. The
SOCS family of inhibitory proteins consists of eight
members (CIS and SOCS1–7). CIS, SOCS1, and SOCS3
showed a distinct induction at the gene expression
level, peaking 6 (SOCS1) or 12 h after illumination,
respectively. Expression of SOCS4, SOCS5, SOCS6, and
SOCS7 was slightly (2-fold) and transiently reduced.
Levels of SOCS2 RNA remained constant throughout
the experiment (Fig. 3A, B; Supplemental Table 1).
Correlation with photoreceptor injury
Light-induced phosphorylation of the Jak-STAT pro-
teins in the retina might be a physiological response to
the light pulse after dark adaptation or it might be
associated with retinal injury. We tested these possibil-
ities by analyzing three mouse strains that are differen-
tially susceptible to light damage. The mice exposed to
high levels of light were 1) mice deficient for c-Fos
expressing the RPE65450Met variant (resistant to light
damage, ref. 31), 2) mice deficient for c-Fos expressing
the RPE65450Leu variant (susceptible to light damage,
ref. 32), and 3) control mice expressing the
RPE65450Met variant (susceptible to light damage, ref.
33). A comparison of the phosphorylation pattern in
these three mouse strains should reveal whether Jak-
STAT activation is a general response to light (if so,
activation should be detected in all three lines) or
whether activation is associated with damage (up-regu-
lation in strains 2 and 3 only). The influence of c-Fos
can be assessed by comparing strains 1 and 3, and a
potential role for the leucine-methionine variant in
RPE65 can be analyzed by a comparison of strains 1 and
2 (Fig. 4). Exposure to excessive light-induced phos-
phorylation of Jak2, STAT1, STAT3 in strains suscepti-
ble to light damage (strains 2 and 3) but not in the
resistant strain 1, as shown by the phosphorylation
pattern at 6 h after light exposure. This demonstrates
that activation of Jak/STAT correlates with light dam-
Figure 2. Induction of the Jak-STAT pathway in the retina
after acute light exposure. A) BALB/c mice were not (dark
control, d) or were exposed to 5000 lux of white light for 1 h.
After light exposure, mice were sacrificed immediately (i) or
after 2 to 96 h in darkness, as indicated. Proteins were
extracted from isolated retinas and detected by Western blot.
Figure 3. Members of the suppressor of cytokine signaling family are induced upon exposure to damaging light. BALB/c mice
were not (dark control, d) or were exposed to 5000 lux of white light for 1 h and retinal RNA was prepared immediately (i) or
after 6 to 72 h, as indicated. After isolation, identical amounts of RNA were reverse transcribed. Equal amounts of cDNAs from
three different animals of a particular condition were pooled and used for exponential PCR. PCR amplifications were done in
triplicate. Thus, each signal represents the average RNA level of three mice. A) Radiolabeled products after exponential RT-PCR
were separated by nondenaturing PAGE. B) Signal intensities were determined on a PhosphorImager. Gene expression is shown
semiquantitatively and relative to -Act RNA levels. Dark control levels were set to 1. See also Supplemental Table 1.
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age and not with light absorption per se. Furthermore,
activation is not directly influenced by the presence or
absence of c-Fos and/or the Leu450Met variant in
RPE65. In contrast, increased phosphorylation of
Erk1,2 was detected in all mouse strains after light
exposure. Thus, activation of Jak2, STAT1, and STAT3
may be part of the degenerative pathway induced by
excessive light whereas phosphorylation of Erk1,2 is
not, and may represent a physiological response of the
retina to light or perhaps be part of a protective
pathway.
The Jak-STAT pathway in inherited retinal
degenerations
We used a model for autosomal recessive RP (rd1; ref.
34) and a model for autosomal dominant RP (VPP; ref.
35) to test whether the signaling pathway activated in
the light-induced model of photoreceptor apoptosis
might also play a role in inherited retinal degeneration.
Since the degeneration in VPP mice proceeds slower
than in rd1 mice (12), the time frame of analysis was
adjusted accordingly. As in the light damage model,
p-STAT3 levels were up-regulated during the phase of
photoreceptor degeneration in both inherited models
(Fig. 5), as were levels of total STAT3 protein. Similarly,
total levels of STAT1 protein were elevated although
p-STAT1 was not (rd1, Fig. 5A) or barely (VPP, Fig. 5B)
detectable. In contrast to the induced model, levels of
phosphorylated Jak2 were not or were only marginally
elevated, and levels of p-Erk1,2 remained constant.
Instead, levels of p-Akt473 remained high in the inher-
ited models and declined at the end of postnatal retinal
development in wild-type (WT) mice. The strong in-
duction of GFAP may reflect activation of Muller glia
cells and the process of retinal remodeling (36, 37). At
PND 37, when there are hardly any photoreceptors left
in the rd1 retina (12, 38), all analyzed proteins were
expressed at higher or at similar levels as in WT mice.
This argues that these proteins are not predominantly
expressed in photoreceptors, an interpretation that is
in line with the results of the immunofluorescent
stainings for Jak2, STAT1, and STAT3 (Fig. 7A).
As in the light damage model, expression of LIF,
CLC, and SOCS3 was robustly induced in the two
inherited models of retinal degeneration. SOCS1 was
up-regulated slightly in both models and CIS was in-
duced in VPP mice only during the initial phase of
degeneration (Fig. 6A, B). CNTF was up-regulated late
in the light damage model (Fig. 1) and was moderately
induced in the rd1 mouse retina. FGF-2 was strongly
up-regulated in the VPP mouse but not or only margin-
ally in the rd1 retina. Again, expression of these genes
did not decline with loss of photoreceptors, whereas
expression of the rod-specific gene rhodopsin did (Fig.
6A). These results suggest that different models of
retinal degeneration differentially activate members of
the Jak-STAT signaling pathway.
Figure 4. Induction of the Jak-STAT signaling pathway is
associated with retinal damage. Three strains of mice were or
were not (dark control, d) exposed to 13,000 lux of white
fluorescent light for 2 h. Retinal proteins were isolated at 6 h
after illumination and analyzed by Western blot, as indicated.
Retinas of c-fos/ mice on the Rpe65450M background
(strain 1) are resistant to light exposure whereas retinas of
c-fos/ mice on the Rpe65450L genetic background (strain
2) are susceptible. WT mice (SV129BL/6) on the Rpe65450M
background (strain 3) are susceptible. Phosphorylation of
Jak-STAT was only induced in mice susceptible to light
damage. ERK1,2 was induced in all strains of mice on light
exposure. The phosphorylation pattern of one dark control
and of one (strain 3) or of two different animals exposed to
light (strains 1 and 2) is shown.
Figure 5. Members of the Jak-STAT signaling pathway are
differentially induced in inherited retinal degeneration. A)
Retinal proteins of rd1 and corresponding WT (wt) mice
were extracted at indicated postnatal days and analyzed by
Western blot. B) Same analysis as in panel A, but using VPP
mice as an autosomal dominant model for retinal degenera-
tion. Time points for analysis were chosen according to the
different time frame of degeneration in the two models.
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Retinal localization of Jak/STAT proteins and
photoreceptor degeneration
We used immunofluorescence to investigate the retinal
localization of Jak/STAT proteins in the models of
induced (light damage) and inherited (VPP) retinal
degeneration (Fig. 7A). In untreated mice, Jak2 and
STAT3 localized to some but not all cells of the inner
nuclear layer and of the ganglion cell layer. Some
STAT3 staining could also be detected in inner seg-
ments of photoreceptor cells and in the outer plexi-
form layer (OPL). STAT1 localized mainly to the inner
plexiform layer (IPL) and OPL as well as to the
ganglion cells. The pattern of the STAT1 staining in the
IPL may reflect stratification within the layer and
therefore the synaptic complexes between bipolar, am-
acrine, and ganglion cells. Light treatment of the
retinas did not alter the distribution of STAT1 and
STAT3 but seemed to have caused a shift of Jak2
localization mainly to the IPL and OPL (between ONL
and INL). Note that a similar shift of Jak2 localization
to the IPL was detected in degenerating VPP retinas.
Most important, however, no increased localization to
the ONL was found in light-damaged retinas even
though light exposure induced cell death exclusively in
this cell layer (Fig. 7B).
An increased immunofluorescence for STAT3 was
detected in the ONL of 28-day-old VPP mice whereas
STAT1 staining remained largely unaffected. STAT3
was also the main protein that was differentially ex-
pressed in the VPP mice when analyzed by Western blot
(Fig. 5). However, increased immunofluorescence did
not seem to correlate with the few apoptotic photore-
ceptors present in the ONL at the time point analyzed
(Fig. 7B).
Inhibition of Jak-STAT signaling pathway protects
against induced but not inherited retinal degeneration
The differential activation of members of the Jak-STAT
pathway in the induced and inherited models of retinal
degeneration may suggest that interference with this
signaling may lead to different effects. We used AG-490,
a tyrosine kinase inhibitor specific for the Jak family
kinases (39–41), in an attempt to dissect the role of the
Jak/STAT signaling pathway in the different models of
retinal degeneration. AG-490 was injected intraperito-
neally (i.p.) immediately before onset of light expo-
sure. The phosphorylation pattern of Jak2, STAT1, and
STAT3 was analyzed 18 h thereafter (Fig. 8A). In
contrast to mice injected with carrier or to uninjected
mice, AG-490-treated mice did not show increased
protein phosphorylation. Furthermore, AG-490 treat-
ment, and thus interference with the Jak-STAT path-
way, significantly reduced light damage susceptibility of
photoreceptors as indicated by reduced internucleoso-
mal DNA cleavage (Fig. 8B). AG-490-treated mice had
only few scattered photoreceptor nuclei showing con-
densed chromatin (pyknotic nuclei) as a classical sign
of apoptosis (Fig. 8C, middle panel), whereas mice
treated with carrier showed a highly increased number
of pyknotic nuclei (Fig. 8C, bottom panel).
To assess a potential role for Jak2 in STAT3 activation
and retinal degeneration in the VPP mouse as a model
for inherited retinal degeneration, we treated VPP mice
with daily injections of AG-490, starting at PND 15 and
ending at PND 27. Analysis was at PND 28. The retina
of 15-day-old VPP mice had 7 to 9 rows of photorecep-
tor nuclei and distinct (but shortened) inner and outer
segments (not shown). AG-490 treatment slightly re-
Figure 6. Expression of members of the IL-6 family of
cytokines and of the SOCS family is induced in models of
inherited retinal degeneration. A) Retinal RNA of rd1 and
corresponding WT (wt) mice was isolated at indicated post-
natal days. After isolation, identical amounts of RNA from
three different animals were pooled, reverse transcribed and
the resulting cDNA was used for exponential PCR. Thus, each
signal represents the average RNA level of three mice. B)
Same as in panel A, but using VPP mice as an autosomal
dominant model for retinal degeneration.
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duced phosphorylation levels of Jak2. Levels of p-
STAT3, however, were still elevated and comparable to
untreated VPP mice (Fig. 9A). The amount of rhodop-
sin per retina was measured to quantify photoreceptor
degeneration. Four-wk-old WT mice had 0.43  0.083
(n3) nmol rhodopsin whereas untreated VPP mice of
the same age had only 0.071  0.015 (n3) nmol and
AG-490-treated mice had 0.065  0.014 (n4) rhodop-
sin left. Thus, despite AG-490 treatment, 80% of the
photoreceptors were lost (Fig. 9B). Morphological eval-
uation of retinas from 4-wk-old animals showed that
control VPP and AG-490-treated VPP mice had retained
about three rows of photoreceptor nuclei compared
with 12 rows in a WT retina (Fig. 9C).
Figure 7. Immunofluorescent stainings detecting Jak-STAT proteins (A) or apoptotic cells (B). A) Cryosections of WT (left
column), light-exposed WT mice at 12 h after exposure (middle column) and VPP mice at 28 days of age (right column) were
stained with antibodies, as indicated. The panels in the left column are merged pictures of fluorescent (antibody staining, red)
and Nomarski images (for a better visualization of retinal structures). The middle and right columns show fluorescent images
only. B) Staining for apoptotic cells (TUNEL staining). No TUNEL-positive cells are detected in WT control retinas. Light
exposure of WT cells induced apoptosis and TUNEL-positive stainings in a large number of cells in the ONL but not in other
cell layers. Arrowheads point to TUNEL-positive cells in the ONL of VPP mice. RPE: retinal pigment epithelium; ONL: outer
nuclear layer; INL: inner nuclear layer; IPL: inner plexiform layer; GCL: ganglion cell layer.
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To test whether the lack of an effect of AG-490
treatment on STAT3 phosphorylation was due to an
adaptational response of the retina to the long-term
treatment, we analyzed phosphorylation pattern 19 h
after the injection of a single dose of AG-490. The
timing and treatment are comparable to the experi-
mental protocol of AG-490 application and analysis in
the light damage experiments (Fig. 8). However,
STAT3 phosphorylation was not reduced after this
treatment (Fig 9D). In addition, there was no obvious
reduction in Jak2 phosphorylation. Thus, the continu-
ously present stimulus in the VPP mouse (the mutant
protein) may require several repetitive applications of
AG-490 to establish an effect on Jak2 phosphorylation.
MATERIALS AND METHODS
Mice and light exposure
Animals were treated in accordance with the regulations of
the Veterinary Authority of Zurich and with the statement of
‘The Association for Research in Vision and Ophthalmology’
for the use of animals in research. c-fos WT and c-fos
knockout (c-fos/) mice were on mixed SV129BL/6 back-
ground. Genotyping for c-fos and for the Rpe65 variant at
position 450 was done as described (12, 32). VPP mice were
kept on a mixed SV129BL/6 background and genotyped
using upstream primer 5-AGA CTG ACA TGG GGA GGA
ATT CCC AGA-3 and downstream primer 5-CAG CTG CTC
GAA GTG ACT CCG ACC-3. Rd1 (C3H) and BALB/c mice
were from Harlan (Netherlands). Six to 8-wk-old male
BALB/c mice were dark-adapted overnight (16 h) and ex-
posed to 5000 lux of white fluorescent light for 1 h. After
exposure, mice were returned to darkness for 24 h before
they were returned to cyclic (12 h:12 h) light. Pigmented
c-fos/ or c-fos/ mice were dark adapted as above, their
pupils dilated (1% Cyclogyl, Alcon, Cham, Switzerland; and
Figure 8. Inhibition of Jak signaling prevents retinal degen-
eration after bright light exposure. A) BALB/c mice received
immediately before light exposure no (not injected) or a
single injection of 800 	g AG-490 (ag) or of carrier DMSO
(dm), as indicated. Mice were not (dark) or were subse-
quently exposed for 1 h to 5000 lux and phosphorylation of
proteins was tested 18 h after exposure. Retinal proteins from
separate animals were loaded in each lane. B) Retinas of
animals not exposed to light (dark) or of animals pretreated
either with AG-490 (ag) or DMSO (dm) and exposed for 1 h
to 5000 lux were used to quantify apoptosis by ELISA. *P 
0.003, two-tailed t test; n  10 mice for each condition. C)
Light microscopy 18 h after light exposure. Retinas of dark
control mice showed regular photoreceptors (upper panel).
Retinas of AG-490 (ag) -treated mice exhibited few apoptotic
photoreceptor nuclei (arrowheads, middle panel) and retinas
of carrier (DMSO, dm) -treated mice had significantly more
dying photoreceptors (arrowheads, lower panel). ROS: rod
outer segments; RIS: rod inner segments. Other abbreviations
as in Fig. 7.
Figure 9. AG-490 treatment does not prevent photoreceptor degeneration in the VPP mouse. VPP mice received 12 i.p. injections
on 12 consecutive days (A–C) or one single (D) injections of 800 	g AG-490. Daily injected mice were treated starting at PND15 and
ending at PND 27. Mice were sacrificed for analysis at PND 28. A) Western blot analysis of total retinal protein of VPP or WT (wt) mice
that were (ag) or were not (n) repetitively treated with AG-490. AG-490 treatment reduced Jak2 phosphorylation in VPP mice to
similar levels as in wt mice. Phosphorylation of STAT3 was still prominent. Shown are two different mice treated with AG-490. B)
Photoreceptor loss at PND 28 was quantified by measurement of retinal rhodopsin in wt (n3), VPP (n3) and AG-490-treated VPP
mice (n4). C) Morphological evaluation of retinal degeneration in WT (left panel), VPP (middle panel) and AG-490-treated VPP
mice (right panel) at PND 28. Abbreviations as in Fig. 7. D) Western blot analysis of total retinal protein of 28-day-old VPP or WT (wt)
mice that were not treated (n) or were treated with either DMSO (dm) or a single injection of 800 	g AG-490 (ag). Analysis was 19 h
after injection. Shown are four different mice treated with AG-490 and a single mouse for each control.
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5% phenylephrine, Ciba Vision, Niederwangen, Switzerland)
1 h prior to light exposure, and exposed to 13,000 lux of
white light for 2 h.
Microscopy, immunofluorescence, and TUNEL staining
For light microscopy, eyes were fixed in 2.5% glutaraldehyde
in 0.1 M cacodylate buffer, pH 7.3, at 4°C overnight. For each
eye, the superior and inferior retina were prepared, washed
in cacodylate buffer, incubated in osmium tetroxide for 1 h,
dehydrated, and embedded in Epon 812. Sections (0.5 	m)
were prepared from the lower central retina (most affected in
our light damage model) and counterstained with methylene
blue.
For immunofluorescence and TUNEL staining, eyes of
adult WT control or light exposed (2 h at 13,000 lux, analysis
was at12 h) mice, respectively, or of 28-day-old VPP mice of
the Rpe65450M background (64) were enucleated, embedded
in Tissue Tec OCT compound (Mioles Inc., Elkhart, IN,
USA), and frozen in liquid nitrogen. Sections (10 	) were
dried and fixed in acetone for 10 min at 4°C. Sections were
washed in PBST (PBS0.05% Triton X-100) for 2 
 5 min at
room temperature. After blocking in PBST  10% normal
goat serum (NGS) for 1 h at room temperature, sections were
incubated with the respective primary antibodies (anti-Jak2,
Biosource; Camarillo, CA, USA; anti-STAT1 and anti-STAT3,
Cell Signaling; Beverly, MA, USA). Sections were washed 3 

10 min in PBST and Cy3-conjugated secondary anti-rabbit
antibodies (Jackson ImmunoResesarch, Soham, UK) were
added in PBST 3% NGS (dilution 1/500) for 1–2 h at room
temperature. Sections were washed 2 
 10 min in PBST and
1 
 in PBS. TUNEL staining was done according to the
manufacturer’s recommendation (Roche diagnostics, Basel,
Switzerland).
Western blot
Retinas were homogenized in 100 mM Tris/HCl, pH 8.0, and
analyzed for protein content using Bradford reagent. Stan-
dard SDS-PAGE and Western blot were performed. For
immunodetection, the following antibodies were used: anti-
Jak2 (#44–406, Biosource), anti-STAT1 (#9172, Cell Signal-
ing), anti-STAT3 (#9132, Cell Signaling), anti-ERK1,2 (#9102,
NEB), anti-Akt (#9272, Cell Signaling), anti-gp130 (sc-656,
Santa Cruz), anti-GFAP (G-3893, Sigma), anti--actin (sc-
1616, Santa Cruz), anti-phospho-Jak2pYpY1007/1008 (#44–426,
Biosource), anti-phospho-STAT1Tyr701 (#9171, Cell Signal-
ing), anti-phospho-STAT3Tyr705 (#9131, Cell Signaling), anti-
phospho-ERK1,2Thr202/Tyr204 (#9101, NEB), anti-phospho-
AktTyr473 (#9271, Cell Signaling). Blots were incubated
overnight at 4°C with primary antibodies followed by a 1 h
incubation at room temperature with HRP-conjugated sec-
ondary antibodies. Immunoreactivity was visualized using the
Renaissance-Western blot detection kit (Perkin Elmer Life
Sciences, Emeryville, CA, USA).
RNA preparation and RT-polymerase chain
reaction (RT-PCR)
Retinas were removed through a slit in the cornea and
immediately frozen in liquid nitrogen. Total retinal RNA was
prepared using the RNeasy RNA isolation kit (Qiagen,
Hilden, Germany), including DNase treatment to digest
residual genomic DNA. Identical amounts of RNA were used
for reverse transcription using oligo(dT) and M-MLV reverse
transcriptase (Promega, Madison, WI, USA). cDNAs from
three different animals were pooled and amplified with
specific primers (Table 1). Amplification was stopped at cycle
numbers ensuring analysis of products in the linear am-
plification phase of the polymerase chain reaction (PCR)
(numbers of cycles were determined in pre-ex-
periments). Downstream primers were 32P-end-labeled. Am-
plification products were resolved on a 6% native polyacryl-
amide gel, quantified on a PhosphorImager, and normalized
to -actin expression. In experiments without quantification,
PCR products were resolved on a 1.5% agarose gel.
AG-490 injections, ELISA cell death assay, rhodopsin
measurements
AG-490 (LC Laboratories, Woburn, MA, USA) was dissolved
in 56% DMSO. AG-490 (40 	g/g) (65, 66) was injected i.p.
immediately before light exposure or daily  10 AM, respec-
tively. Control animals were injected with 56% DMSO. Cell
death was quantified 18 h after light exposure using the
ELISA-based Cell Death Detection Kit (Roche Diagnostics,
Basel, Switzerland) according to the manufacturer’s recom-
mendation. The rhodopsin content was determined as de-
scribed (67).
TABLE 1. PCR primers used for amplifications
Gene Upstream Downstream Product
CIS GCTACCTGTTCACACTGTCA GACTAGCCGACACAGATGTT 350 bp
SOCS1 CTCCGTGACTACCTGAGTTC CCAGACACAAGCTGCTACAA 278 bp
SOCS2 CTGTTCACCTGTACCTGACCA CACATAGCTGCATTCGGAGA 240 bp
SOCS3 GGAGACAGATGAGGCTGGTGA GGACCTACTGACCGAGAGAT 349 bp
SOCS4 GTCATAACTGCCAACAGTGC CTGAAGGAGGTCTGGAACAAG 252 bp
SOCS5 GCGAGAGAAGACGGCTTAGT GACCTGTTGTAGCGGCGGAA 481 bp
SOCS6 CCTTGCTGGTGACTTCGTGA CACTCGCATCTCCATCTTGA 361 bp
SOCS7 GCCTCAGCCTCCTAGATGAT CACCACCGACTGACAGCGAT 473 bp
CLC GCATCAACTCCGCAGCTTAG CTGAACGCCATAGCCAGGTCT 443 bp
LIF AATGCCACCTGTGCCATACG CAACTTGGTCTTCTCTGTCCCG 216 bp
Ct-1 TTTCTGTCTCTCCATCTGTGTCCTG GTGGGAAGGTCCTAAGGTGAATG 492 bp
CNTF AGCCTTGACTCAGTGGATGGTG ATCAGCCTCTTTTTCAGGGACC 276 bp
FGF-2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG 158 bp
Tgf- GCAACAATTCCTGGCGTTAC CTGTGGAGCTGAAGCAATAG 345 bp
-Actin CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153 bp
LIFR TGGCTGTCATTGTTGGCGTG CTTACCCTCTTCATCTTCTGCTGC 536 bp
Rho TTTTATGTGCCCTTCTCCAACG TTTTATGTGCCCTTCTCCAACG 440 bp
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DISCUSSION
Retinal degeneration is a leading cause of blindness in
human patients. Here we investigated signaling path-
ways in an induced, an autosomal recessive, and an
autosomal dominant model for the disease in humans.
We show that proteins of the Jak-STAT pathway were
induced in all models but that the individual activation
patterns were death stimulus-specific. Differentially ac-
tivated proteins include cytokine ligands, STAT tran-
scription factors, and molecules of a negative feedback
loop. The neuroprotective effect of the inhibition of
Jak2 in induced but not in inherited cell death suggests
that this signaling cascade is of differential importance
depending on the death stimulus.
The Jak-STAT signaling pathway, and especially
STAT1 and STAT3 proteins have been implicated in
neurodegenerative as well as neuroprotective mecha-
nisms (42). In the light-treated retina, STAT1 and
STAT3 proteins were both activated, suggesting that
cell death as well as cell survival pathways were induced.
We speculate that the retina generates death factors
promoting apoptosis of photoreceptors that are dam-
aged beyond rescue and survival factors that help to
rescue damaged photoreceptors that are still viable.
The nature of such factors remains to be determined,
but their production may be differentially controlled by
STAT1 and STAT3, respectively.
Jak2, STAT1, and STAT3 proteins were found mainly
in the INL, GCL, IPL, and OPL but rarely in photore-
ceptors (Fig. 7), which agrees with previous reports (14,
43, 44). However, photoreceptors are the cells primar-
ily affected in all models of retinal degeneration used
here. Thus, the fate of photoreceptors might be deter-
mined by other cell types through STAT1/STAT3-
regulated production and release of growth factors
and/or cytokines. Recently, injection of CT-1 (a mem-
ber of the IL-6 family of cytokines) into the eyes of a rat
model for inherited retinal disease increased phosphor-
ylation of STAT3 and STAT1 and protected photore-
ceptors. Increased phosphorylation colocalized with
Muller cells, implicating these cells in the regulation of
photoreceptor apoptosis in a paracrine fashion (45).
Evidence suggests that the neuroprotective effect of
CNTF on photoreceptors and ganglion cells may be
mediated through induction of STAT3 (14, 46). Our
results here are in line with such a conclusion.
Peak activation of the Jak-STAT pathway was at 12 h
postillumination whereas the peak of apoptotic release
of nucleosomes was found  36 h after exposure (2),
supporting the notion that Jak-STAT signaling is an
early event that may regulate the fate of photoreceptor
cells. Thus, it is conceivable that interference with such
an early event can influence the progression of the
degeneration. The tyrosine kinase inhibitor AG-490
interferes with Jak kinases, including Jak2 (39–41).
Thus, reduced activation of STAT1 and STAT3 may
have been through inhibition of Jak2, although we
cannot completely rule out an involvement of other
AG-490-responsive kinases. Since the presumable pro-
apoptotic pathway (STAT1) was blocked, the simulta-
neous reduction of the presumable antiapoptotic
STAT3 pathway was not disastrous for the retina, and
the net result of the treatment was protection of
photoreceptors.
In the case of the analyzed models for inherited
photoreceptor degeneration, mainly STAT3 but not
STAT1 was activated throughout the degenerative pe-
riod. Although STAT1 may be an important death
mediator in the light damage model, it may not be
involved in the inherited models. Also, phosphoryla-
tion of Jak2 was at best slightly increased in the VPP
mouse and remained at basal levels in the rd1 retina.
Since cell death in the inherited models stretches over
an extended period, activation of the proteins may only
occur in a small number of cells simultaneously and
may therefore go undetected in Western blot experi-
ments. However, the immunofluorescent stainings did
not give evidence that the proteins colocalize with
dying (TUNEL-positive) cells. This suggests that photo-
receptor degeneration in the inherited models may be
independent of Jak2, a conclusion corroborated by the
ineffectiveness of AG-490 treatment of VPP mice. The
strong activation of STAT3 in these mice therefore may
be by an alternative pathway, which may include, for
example, an oxidative stress response (47, 48). Never-
theless, activation of the (presumably) protective
STAT3 signaling obviously is not sufficient for rescuing
photoreceptors in the inherited model. Although
STAT3 is activated in induced and inherited models,
the signaling system through which STAT3 is activated
may be different. The differential effectiveness of many
factors on induction and progression of induced or
inherited retinal degeneration (2) also argues for the
existence of multiple signaling systems that lead to
photoreceptor cell death. To develop therapeutic strat-
egies for a large variety of diseases, it will be important
to identify and understand these signaling events.
The sustained phosphorylation of Akt in both models
of inherited retinal degeneration argues for molecular
mechanisms in addition to STAT3 signaling. The PI3K-
Akt pathway has been shown to be important for the
survival of several neuronal cell types (49–51), and Akt
has been suggested to be part of a retinal defense
mechanism in response to toxic insults (52), perhaps
through the activation of CNTF expression (17). At
least in the rd1 retina, steady-state levels of CNTF
mRNA were moderately elevated in the late phase of
degeneration, as has been reported by others (53). In
the rd1 retina, Akt and pAkt expression did not decline
at P37, a time point when the rd1 mouse has lost almost
all photoreceptors. This indicates that the majority of
Akt is not expressed in photoreceptors. The same holds
true for the other genes tested (Figs. 5, 6) as judged by
their expression pattern during aging. The immunoflu-
orescent studies (Fig. 7) support this conclusion.
Therefore, induction of the genes and proteins shown
here might be a response of cells in the INL and/or
GCL to photoreceptor injury. The protection of pho-
toreceptors against light damage by inhibition of Jak2
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may thus suggest a model in which photoreceptors
signal injury to cells in the INL, which then initiate the
appropriate response to either support survival or
promote death of the injured photoreceptors. In addi-
tion, induction of a general defense mechanism may
ensure survival of cells not directly damaged by the
applied toxic stimulus. Such a defense mechanism may
involve CNTF in the rd1 mouse and FGF-2 in the VPP
mouse. Chronic up-regulation of FGF-2 may slow down
the progression of photoreceptor degeneration in the
VPP mouse as has been suggested for other models
(54).
It is tempting to speculate that the cells that “rule”
over the fate of other cells might be the Muller glia
cells. These cells have been shown to react strongly to
retinal injury and they seem to release neurotrophic
factors, including the protective cytokines FGF-2 and
CNTF, in protocols of preconditioning and neuropro-
tection (14, 15, 26, 55–58).
The role of LIF
The role of CLC and LIF, the two members of the IL-6
family of cytokines that were induced in all models of
retinal degeneration, is unclear. They may act in an
autocrine or paracrine fashion. In the rd1 mouse,
expression of CLC and LIF was still up-regulated even
after most photoreceptors had died and were cleared
from the subretinal space. The same long-lasting stim-
ulation was observed for p-STAT3, p-Akt473, and GFAP.
This may suggest that these factors play a role in the
retina even after photoreceptor degeneration—for ex-
ample, in the remodeling of second order neurons,
which begins as early as PND10 in the rd1 retina (36,
37). LIF may be of particular interest in this respect
since this factor was shown to keep cells in an undiffer-
entiated state to modulate stem cell renewal (59, 60). In
the postnatal retina, LIF blocks expression of Nrl and
Crx transcription factors (61), disrupts synaptic organi-
zation (62), and arrests developing photoreceptors in a
pre-rod stage (63). Increased expression of LIF in a
degenerating retina may therefore be required for the
adjustment of the remaining cells of the INL and GCL
to the new retinal architecture.
In summary, we show the differential regulation of
the IL-6 family of cytokines and of the Jak-STAT
signaling pathway in different models of retinal degen-
eration. Interference with this signaling protects a
model of induced but not a model of inherited photo-
receptor apoptosis, suggesting that regulation/execu-
tion of cell death of visual cells strongly depends on the
particular apoptotic stimulus. The expression pattern
of the various factors supports a pivotal regulatory role
of the INL and/or GCL in photoreceptor apoptosis.
Treatment strategies to prevent photoreceptor degen-
eration in human blinding diseases may thus need to
target the regulatory molecular response of cells apart
from photoreceptors.
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SPECIFIC AIMS
Photoreceptor apoptosis is a hallmark of blinding dis-
eases caused by retinal degeneration. Neuroprotective
strategies may protect photoreceptors from cell death
and thus prolong the period of useful vision in patients.
For the development of such strategies it is essential to
understand the molecular signaling pathways involved
in the degeneration of the retina. Molecules of the
Jak-STAT pathway have been implicated in the control
of cell survival, cell progression, and cell death. We
analyzed a potential role of Jak-STAT signaling in three
models of induced and inherited retinal degeneration.
Using an inhibitor of Jak2, we tested whether the
Jak-STAT pathway might be a potential target for
therapeutic approaches, with the goal to prevent pho-
toreceptor apoptosis.
PRINCIPAL FINDINGS
1. Induction of the Jak-STAT signaling pathway in a
model of light-induced retinal degeneration
Retinal expression of leukemia inhibitory factor (LIF)
and cardiotrophin like cytokine (CLC), members of the
interleukin (IL)-6 family of cytokines, was strongly
up-regulated during photoreceptor degeneration in-
duced by exposure to bright white light. Peak expres-
sion of LIF and CLC occurred 12 h after light exposure,
declining to near-basal levels in 3 days.
Concomitant with the induction of the cytokines,
Janus kinase-2 (Jak2) as well as signal transducer and
activator of transcription-1 (STAT1) and STAT3, both
targets of Jak2, were activated by phosphorylation (Fig.
1). Extracellular-regulated kinase 1,2 (ERK1,2) was
phosphorylated but Akt was not. This suggests that LIF
and/or CLC were binding to their respective mem-
brane receptors, leading to the activation of the intra-
cellular Jak-STAT signaling pathway.
Jak2 and STAT-3 localized mainly to cells of the inner
nuclear layer (INL) and the ganglion cell layer (GCL)
with a weaker signal of STAT-3 in the inner segments of
photoreceptors. STAT-1 localized mainly to the inner
and outer plexiform layers (IPL and OPL) as well as to
the GCL. This localization agrees with earlier publica-
tions and suggests that cells of the INL and GCL may
respond to photoreceptor cell death.
The family of suppressors of cytokine signaling
(SOCS) constitute a negative feedback loop for the
regulation of Jak-STAT signaling. Expression analysis of
all eight members of the SOCS family revealed a strong
induction of SOCS3 (13-fold) and, to a lesser extent,
of SOCS1 (6-fold) and of CIS (2-fold).
2. Light-induced activation of the Jak-STAT pathway
is damage dependent
To evaluate the significance of the activation of the
Jak-STAT pathway for retinal degeneration, we tested
phosphorylation of Jak2, STAT1, STAT3, and ERK1,2
in mouse strains differentially susceptible to light-in-
duced retinal degeneration. Retinas of mice lacking the
c-Fos protein on a genetic background expressing the
methionine variant of the Rpe65 gene (c-fos/;
Rpe65450M) are not susceptible to light damage
whereas photoreceptors of c-fos/ mice expressing
the leucine variant of the Rpe65 gene (Rpe65450L)
undergo rapid apoptosis after acute light exposure.
Phosphorylation of ERK1,2 was increased after expo-
sure in all strains, suggesting that ERK1,2 is activated by
light per se and so may be involved in a physiological
response to increased lighting conditions. In contrast,
Jak2, STAT1, and STAT3 were activated exclusively in
strains that are susceptible to light damage. No activa-
tion could be detected in the resistant strain. Thus, the
Jak-STAT signaling pathway may be important for the
induction of cell death after the light stimulus, an
interpretation supported by the peak of activation at
12 h postillumination, 24 h before the maximal release
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of free nucleosomes, which was analyzed as a biochem-
ical marker for apoptosis.
3. Induction of members of the Jak-STAT pathway in
inherited retinal degeneration
We used the rd1 mouse as a model for autosomal
recessive retinitis pigmentosa (arRP) and the trans-
genic VPP mouse as a model for autosomal dominant
RP (adRP) to test whether the pathway activated by
acute light exposure may also be involved in photore-
ceptor apoptosis in inherited retinal degeneration. A
mutation in the -subunit of phosphodiesterase causes
the rapid degeneration of photoreceptors in the rd1
mouse, with an early onset around postnatal day (PND)
11 and almost complete degeneration at 3 wk of age.
The transgene in the VPP mouse expresses a mutant
rhodopsin protein with three amino acid substitutions.
Degeneration induced by the transgene has a later
onset and is slowly progressing. As in the light damage
model, p-STAT3 levels were up-regulated during the
phase of photoreceptor degeneration in both inherited
models. Although levels of total STAT1 protein were
elevated in both inherited models, p-STAT1 was not
(rd1) or was only barely (VPP) detectable. In contrast
to the induced model, p-Jak2 was not (rd1) or only
marginally (VPP) activated, and levels of p-ERK1,2
remained constant. Instead, levels of p-Akt were ele-
vated in the adult retinas of both models.
Exponential RT-polymerase chain reaction (RT-
PCR) showed that LIF and CLC cytokines were also
induced in both inherited models, as was SOCS3. CIS
was slightly elevated in the VPP model but not in the
rd1 mouse. SOCS1, however, remained at basal levels in
both models. These results suggest that a degeneration-
inducing stimulus causes a specific expression and/or
activation of members of the Jak-STAT pathway. This is
further supported by our observation that ciliary neu-
rotrophic factor (CNTF) was moderately induced in
the rd1 mouse retina and that fibroblast growth factor-2
(FGF-2) was strongly up-regulated in the VPP mouse
but only marginally in the rd1 retina.
Figure 1. Induction of the Jak-STAT pathway in the retina
after acute light exposure. BALB/c mice were not (dark
control, d) or were exposed to 5000 lux of white light for 1 h.
After light exposure, mice were sacrificed immediately (i) or
after two 96 h of recovery in darkness as indicated. Proteins
were extracted from isolated retinas and tested by Western
blot.
Figure 2. Inhibition of Jak signaling prevents retinal degen-
eration after bright light exposure. A) Immediately before
light exposure, BALB/c mice received a single injection of
800 g AG-490 (ag) or carrier DMSO (dm) or were not
injected. Mice were subsequently exposed for 1 h to 5000 lux
or not (dark) and phosphorylation of proteins was tested 18 h
postexposure. Retinal proteins from separate animals were
loaded in each lane. B) Retinas of animals not exposed to
light (dark) or of animals pretreated with AG-490 (ag) of
DMSO (dm) and exposed for 1 h to 5000 lux were used to
quantify apoptosis by ELISA. *P 0.003, 2-tailed t test; n 10
mice for each condition. C) Light microscopy 18 h after light
exposure. Retinas of dark control mice showed regular pho-
toreceptors (upper panel). Retinas of AG-490 (ag)-treated
mice exhibited few apoptotic photoreceptor nuclei (arrow-
heads, middle panel); retinas of carrier (DMSO, dm)-treated
mice had significantly more dying photoreceptors (arrow-
heads, lower panel). RPE: retinal pigment epithelium; reac-
tive oxygen species (ROS): rod outer segments; RIS: rod
inner segments; ONL outer nuclear layer.
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4. Inhibition of Jak-STAT signaling protects against
induced but not inherited retinal degeneration
AG-490, an inhibitor of Jak2 activity, was injected i.p.
immediately before the onset of light exposure. In
contrast to control mice injected with carrier or ones
that did not receive an injection, AG-490-treated mice
did not show increased protein phosphorylation (Fig.
2). Furthermore, AG-490 treatment, and thus interfer-
ence with the Jak-STAT pathway, significantly reduced
light damage susceptibility of photoreceptors as indi-
cated by reduced internucleosomal DNA cleavage (Fig.
2B). AG-490-treated mice had only a few scattered
photoreceptor nuclei showing condensed chromatin as
a classical sign of apoptosis (Fig. 2C, middle panel),
whereas mice treated with carrier only showed a highly
increased number of pyknotic nuclei (Fig. 2C, bottom
panel).
To assess the potential role of Jak2 in STAT3 activa-
tion and retinal degeneration in the VPP mouse, we
treated VPP mice with daily injections of AG-490,
starting at PND 15 and ending at PND 27. Analysis was
at PND 28. The retina of 15-day-old VPP mice had 7 to
9 rows of photoreceptor nuclei and distinct (but short-
ened) inner and outer segments. AG-490 treatment
reduced phosphorylation of Jak2 to levels found in
wild-type (WT) animals. Levels of p-STAT3, however,
were still elevated and clearly above WT levels. The
amount of rhodopsin per retina was measured to
quantify photoreceptor degeneration. Four-wk-old WT
mice had 0.43 0.083 (n3) nmol rhodopsin, whereas
untreated VPP mice of the same age had only 0.071 
0.015 (n3) nmol and AG-490-treated mice had
0.065 0.014 (n4) rhodopsin left. Thus, regardless of
the AG-490 treatment, 80% of the photoreceptors
were lost.
CONCLUSIONS AND SIGNIFICANCE
In this work we show that members of the Jak-STAT
pathway are induced in three different models of
retinal degeneration. The individual activation pat-
terns, however, are death stimulus specific. Differen-
tially activated proteins include cytokine ligands, STAT
transcription factors, and molecules of a negative feed-
back loop. The neuroprotective effect of the inhibition
of Jak2 in induced but not in inherited cell death,
supports the conclusion of different molecular path-
ways in retinal degenerations.
The Jak-STAT signaling pathway has been implicated
in neurodegenerative as well as neuroprotective mech-
anisms. Activation of STAT1 is mostly proapoptotic
whereas phosphorylation of STAT3 is commonly ac-
cepted as antiapoptotic. In the light-treated retina,
STAT1 and STAT3 proteins were both activated, imply-
ing that cell death as well as cell survival mechanisms
were induced. We speculate that the retina responds to
an insult by generating both death factors promoting
apoptosis of photoreceptors that are damaged beyond
rescue and survival factors which help to rescue dam-
aged photoreceptors that are still viable (Fig. 3). The
production of such factors may be differentially con-
trolled by STAT1 and STAT3, respectively. Jak2,
STAT1, and STAT3 proteins were found mainly in cells
of the INL and GCL and in the inner and outer
plexiform layers. However, photoreceptors are the cells
primarily affected in all models of retinal degeneration
used here. Thus, the fate of photoreceptors might be
determined by other cell types through STAT1/STAT3-
regulated production and release of growth factors
and/or cytokines.
Treatment with AG-490 did not rescue photorecep-
tors in the VPP mouse, which suggests that different
mechanisms are involved in inherited retinal degener-
ations. The differential activation of STAT3 and STAT1
proteins, and especially the sustained phosphorylation
of Akt in both inherited but not the induced model,
support this conclusion. To find treatment strategies
for a broad range of retinal degeneration, it is of
outmost importance to analyze the different signaling
cascades in order to identify common molecules as
potential treatment targets.
Figure 3. Schematic representation of the signaling pathways
involved in the models of retinal degeneration.
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6.2.2 Summary 
In this paper we investigated the role of caspase-1 (Casp-1), which was induced 
on the transcriptional level during light-induced retinal degeneration. We assumed that 
caspase-1 might trigger apoptosis and tested our hypothesis in a model for light 
induced retinal degeneration and in inherited models for autosomal recessive (rd1 
mouse) and for autosomal dominant (VPP mouse) retinal degeneration. Apoptosis 
induced by light was measured by nucleosomal release, which peaked 36 h after 
illumination. The uncleaved pro-from of caspase-1 started to accumulate 6 h after light. 
In correlation with the nucleosomal release, pro-caspase-1 protein levels reached a 
plateau between 36 h and 72 h after light exposure. In a second boost, it peaked again 
5 days after light and reached basal levels 20 days after light exposure. In contrast, 
protein levels of initiator caspase-9 and effector-caspase-3, -6 and –7 pro-forms were 
not induced. IL-1β encodes for a precursor protein, which has to be proteolytic 
processed to the mature form by activated Casp-1. IL-1β mRNA levels were 
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upregulated after light exposure with a maximal induction 12 h after illumination. 
However, neither was IL-1β processed nor was the pro-form of Casp-1 cleaved and 
thereby activated. We observed a similar induction of Casp-1 pro-form but no cleavage 
or Casp-1 activity in rd1 and VPP mice – both models for inherited retinal 
degeneration. Nevertheless, we speculated that the pro-form of Casp-1 might initiate 
apoptosis via an unknown mechanism. Therefore, we compared the light susceptibility 
of Casp-1-/- mice to wild type control mice. The ablation of Casp-1 did not notably 
influence light induced retinal degeneration. IL-1R1-/- mice lack the IL-1 receptor type 1, 
which is the target receptor for Casp-1-activated IL-1β. However, IL-1R1-/- mice and 
control mice similarly degenerated after light exposure – supporting the finding of a 
Casp-1 independent apoptosis mechanism. To test a potential Casp-1 impact in 
models for inherited retinal degeneration, we generated double-mutant rd1/Casp-1-/- 
and VPP/Casp-1-/- mice. Casp-1 ablation neither impaired progression nor severity of 
retinal pathogenesis in rd1 mice. In contrast, Casp-1 ablation substantially protected 
retinal morphology in VPP mice. VPP/Casp-1-/- mice had twice as high rhodopsin levels 
(a marker for the survival of photoreceptor cells) as single mutant VPP mice. To test, 
whether Casp-1 facilitates cell death via its classical downstream target IL-1β in VPP 
mice, we analyzed VPP/IL-1R1-/- double-mutant mice. However, the lack of IL-1R1 did 
not influence retinal degeneration, suggesting a role of Casp-1 independent from its 
classical function as an IL-1β processor. We assumed that cytokine and chemokine 
signaling might be required for a non-conventional Casp-1 function. Therefore, we 
analyzed Casp-1, speck-like protein (asc), CNTF, FGF-2 and monocyte 
chemoattractant protein (MCP-1) gene expression in wild type, Casp-1-/-, VPP and 
VPP/Casp-1-/- mice (Note: primers for Casp-1 aligned upstream the neomycin cassette 
and therefore detected expression levels of the disrupted, nonfunctional Casp-1 gene). 
Casp-1 gene expression remained steady state during postnatal development (PND11 
– PND56) but was induced in VPP mice, which correlated with the Casp-1 protein 
expression. Nonfunctional Casp-1 gene expression was induced in Casp-1-/- mice and 
even more pronounced in VPP/Casp-1-/- mice. We speculated that Casp-1 might 
regulates its own gene activity in a feedback loop. Expression levels of asc – a CARD 
(caspase recruiting domain) containing protein, involved in Casp-1 activation – 
declined in wild type mice but were elevated in VPP mice. This further supports an 
impact of Casp-1 in retinal degeneration of VPP mice. However, Casp-1-/- and 
VPP/Casp-1-/- mice showed hardly any asc expression, suggesting that asc is Casp-1 
dependent regulated. CNTF was elevated in VPP and VPP/Casp-1-/- mice during the 
late phase of retinal degeneration (PND42 – PND56). FGF-2 was strongly induced in 
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VPP and VPP/Casp-1-/- mice. However, FGF-2 expression was slightly reduced in 
VPP/Casp-1-/- mice compared to VPP mice, which possibly reflects the milder and/or 
delayed retinal degeneration in Casp-1 ablated mice. MCP-1 is involved in the 
recruitment of macrophages to the side of injury, which is essential to minimize 
secondary apoptosis or necrosis. Because MCP-1 expression levels were induced in 
VPP mice and even more in VPP/Casp-1-/- mice, we suggested that it might be 
required for the improved retinal maintenance in Casp-1 ablated VPP mice. In 
conclusion, we discovered that light-induced retinal degeneration and inherited retinal 
degeneration in rd1 mice is caspase-1 independent. In VPP mice, casp-1 is partially 
involved in retinal degeneration via a non-classical pathway. However, ablation of 
Casp-1 did not completely protect the retina of VPP mice, suggesting further pro-
apoptotic pathways. 
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Caspase-1 Ablation Protects Photoreceptors in a Model
of Autosomal Dominant Retinitis Pigmentosa
Marijana Samardzija, Andreas Wenzel, Markus Thiersch, Rico Frigg, Charlotte Reme´, and
Christian Grimm
PURPOSE. Caspase-1 gene expression has been reported to be
upregulated during light-induced retinal degeneration and to
be reduced after neuroprotective treatments. Thus, caspase-1
may be proapoptotic in the retina. To test directly the role of
caspase-1 in photoreceptor apoptosis, three mouse models
were analyzed for retinal degeneration in the presence or
absence of caspase-1.
METHODS. Photoreceptor apoptosis was monitored in one
model of induced (exposure to light) and in two models of
inherited (rd1, VPP) retinal degeneration. Retinal degeneration
was assessed qualitatively by light microscopy and quantita-
tively by the determination of free nucleosomes with ELISA or
by rhodopsin measurements. Gene expression and protein
levels were assessed by real-time RT-PCR and by Western blot
analysis, respectively.
RESULTS. Levels of caspase-1 proenzyme increased in all models
of retinal degeneration concomitantly with the onset of cell
death. Maturation or classic activity of caspase-1 was not de-
tected in the retina. Ablation of caspase-1 was protective in the
model of adRP (VPP mouse), but not in the two other models.
Ablation of interleukin-1 receptor type 1 was without effect.
Expression of monocyte chemoattractant protein (MCP)-1 in-
creased in the model protected by caspase-1 ablation.
CONCLUSIONS. Increased retinal expression of caspase-1 proen-
zyme may be a common marker for photoreceptor degenera-
tion. The differential effects of caspase-1 ablation suggests a
modulatory role of caspase-1 for photoreceptor apoptosis in
some but not all models. Such a modulatory activity may
involve a caspase-1 function different from the classic activa-
tion of interleukin-1. (Invest Ophthalmol Vis Sci. 2006;47:
5181–5190) DOI:10.1167/iovs.06-0556
Photoreceptor cell death is a hallmark of most retinal dys-trophies. Dying photoreceptors share all the major mor-
phologic features of apoptosis including nuclear condensation
and nucleosomal DNA fragmentation, cytosolic condensation,
and cell shrinkage as well as the formation of apoptotic bodies.
Apoptosis has been considered as the final common pathway
of cell death in retinal degenerations.1–3 The intracellular sig-
nals that lead to apoptosis of the visual cells are still far from
conclusive. The caspases, a family of cysteine proteases, have
been implicated in the regulation of apoptotic cell death in a
variety of systems. Caspase-dependent cell death is regulated
via one of three major pathways: the receptor- or the mito-
chondria-mediated cell signaling pathway or by an endoplas-
mic reticulum stress response. One of the key events triggering
caspase-dependent apoptosis is the activation of initiator
caspases by oligomerization of the inactive cellular precursors
in response to death stimuli. Once activated, initiator caspases
induce a tightly regulated cascade of events propagating the
death signal by activation of downstream effector caspases
leading to cleavage of various cellular substrates in a process
that culminates in cell death (reviewed in Ref. 4).
In experimental models developed to study cell death in the
retina, several different caspases—in particular, caspase-3—
have been reported to be activated during apoptosis. These
models include cell death induced by ischemia,5 excitotoxic-
ity,6 treatment with autoantibodies,7 and lead and calcium
overload.8 Caspase activation has also been demonstrated in
some animal models of inherited retinal degeneration such as
rhodopsin S334ter rats,9 Royal College of Surgeon (RCS) rats,10
tubby mice,11 and rds mice.12 For retinal degeneration in the
rd1 mouse, which carries a mutation in the gene encoding the
phosphodiesterase -subunit (PDE6)13 contradictory data re-
garding the involvement of caspase-3 have been reported. Both
caspase-dependent14–17 and -independent18 photoreceptor
cell death have been described.
Caspase (Casp)-1 has been identified as the mammalian
homologue to the nematode ced-3 gene19 and has been impli-
cated in programmed cell death. Today, Casp-1 is mainly asso-
ciated with inflammation, for its ability to cleave the inactive
31-kDa cytokine pro-interleukin-1- (pro-IL-1) into an active
17-kDa mature form.20,21 However, evidence of an involve-
ment of Casp-1 also in apoptosis has been demonstrated in
several in vitro and in vivo systems.22–25 Using the model of
light-induced retinal degeneration, we and others have shown
that Casp-1 gene expression is increased in retinas injured by
exposure to light26–28 and that treatments that increase the
resistance against light-induced damage (e.g., hypoxic precon-
ditioning) prevent increased Casp-1 expression.29 These find-
ings suggest that Casp-1 is involved in the mediation or regu-
lation of photoreceptor apoptosis after a light-induced insult.
In the present study, we tested whether Casp-1 was in-
duced in other models of retinal degeneration as well and
whether ablation of Casp-1 would influence the degenerative
process. For this purpose, we used the rd1 mouse as a model
for autosomal recessive retinitis pigmentosa (arRP) and the
VPP mouse, representing a model for autosomal dominant RP
(adRP). The rd1 mouse develops a fast and light-independent
degeneration of photoreceptors starting around postnatal day
(PND)10.13 The VPP mouse expresses a mutant rhodopsin
transgene encoding a protein with three amino acid substitu-
tions (V20G, P23H, and P27L)30 one of which (P23H) repre-
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sents the most common cause for adRP in the United States.
The expression of the transgene leads to photoreceptor death
with loss of function.30,31 Retinal degeneration in the VPP
mouse is accelerated by light32,33 but proceeds slower than in
the rd1 mouse. We analyzed the course of retinal degeneration
in the light-induced and the two inherited models in the pres-
ence and absence of functional Casp-1 and showed that the
lack of Casp-1 activity affected the retina differentially in the
three models.
MATERIALS AND METHODS
Animals
All procedures concerning animals were in accordance with the reg-
ulations of the Veterinary Authority of Zurich and with the ARVO
Statement for the use of Animals in Ophthalmic and Vision Research.
All animals were raised in cyclic light (12:12 hours; 60 lux at cage
level).
BALB/c mice were purchased from Harlan (Horst, The Nether-
lands). Casp-1-deficient mice (Casp1–/–) are described elsewhere34 and
were generously provided by Winnie Wong (BASF Bioresearch,
Worcester, MA). VPP mice (generously provided by Muna Naash,
University of Oklahoma, Oklahoma City, OK) and wild-type mice (both
on a 129.B6 background) and rd1 mice (C3H/HeJ) were maintained at
the University Hospital Zurich. The IL-1R1–/– mice, backcrossed onto
BALB/c background for more than eight generations,35,36 were kindly
provided by Manfred Kopf (ETH, Zurich, CH). The double mutants
rd1/Casp1–/–, VPP/Casp1–/–, and VPP/IL-1R1–/– were generated by clas-
sic breeding schemes. Genotyping was performed by PCR on genomic
DNA, using the primers shown in Table 1. For rd1 genotyping, PCR
products were digested with DdeI, as described elsewhere.37 All
mouse strains were homozygous for the Rpe65450Leu variant.
38
Exposure to Light and Assessment of
Retinal Damage
Light damage was induced in dark-adapted 6- to 8-week-old mice
placed in cages with reflective interior by exposure to 5 klux/1 hour
(albino strains) or to 13 klux/2 hours (pigmented, with dilated pupils)
of diffuse white fluorescent light, as described elsewhere.39 The extent
of light-induced damage in the retinas after different recovery periods
in darkness was quantified by the ELISA-based determination of free
nucleosomes in the cytoplasm (generated after internucleosomal cleav-
age of genomic DNA during the course of apoptosis), with a cell
viability kit (Cell Death Detection Kit no. 1920685; Roche Diagnostics,
Basel, Switzerland) according to the manufacturer’s recommendation
or by the determination of the rhodopsin content after 16 hours of dark
adaptation as described.40
Qualitative assessment of retinal tissue was performed by light
microscopic viewing of sections from the lower temporal retina of
2.5% glutaraldehyde-fixed and Epon 812-embedded eyes, as has been
described.39
Semiquantitative RT-PCR Analysis
RNA isolation from retinas and cDNA synthesis were performed as
described previously.26 Primer pairs used for specific amplifications
were designed to span intronic sequences or cover exon–intron
boundaries (Table 1). Gene expression was analyzed by real-time
RT-PCR with a polymerase ready mix (SYBR Green JumpStart Taq
ReadyMix; Sigma-Aldrich, Munich, Germany) and a thermocycler
(LightCycler; Roche Diagnostics). Amplification specificity was con-
trolled by performing a melting curve analysis of the amplified PCR
fragments and by visualizing amplified products on agarose gels. For
relative quantification of gene expression, mRNA levels were normal-
ized to -actin using the CT (comparative threshold cycle) method
and relative values were calculated with a respective control sample
used for calibration, as indicated in the Results section. Each reaction
was run in triplicate.
Western Blot Analysis
Retinas were homogenized in 100 mM Tris/HCl (pH 8.0) and analyzed
for protein content by using the Bradford method. Standard SDS-PAGE
and Western blot analysis were performed. Polyclonal rabbit anti-
casp-1, -3, -6, -7, (kindly provided by Peter Vandenabeele, Ghent Uni-
versity, Belgium), anti-casp-1 (p10) (sc-514; Santa Cruz Biotechnology,
Santa Cruz, CA), anti-casp-9 (no. 9504; Cell Signaling, Danvers, MA) and
sheep anti-IL1 (S329/B4b, kind gift from Stephen Poole; NIBSC [In-
stitute for Biological Standards and Control], Potters Bar, UK) antibod-
ies were applied, followed by a horseradish peroxidase (HRP)-conju-
gated secondary anti-rabbit (no. NA934; GE Healthcare, Munich,
Germany) or anti-sheep/goat (STAR88P; Serotec, Oxford, UK) anti-
body. To control for equal protein loading, membranes were reprobed
with goat anti-actin antibody (sc-1616; Santa Cruz Biotechnology).
Immunoreactivity was visualized using a Western blot detection kit
(Renaissance; PerkinElmer Life Sciences, Emeryville, CA).
Determination of WEHD-pNA Cleavage
Retinas were dissected and homogenized in 120 L of cold lysis buffer
(BF14100; R&D Systems, Minneapolis, MN) followed by incubation on
ice for 30 minutes. The retinal homogenates were centrifuged at
15,000g for 10 minutes at 4°C. The protein content of supernates was
determined by a protein assay (Bio-Rad, Hercules, CA) using bovine
serum albumin as the standard. An equal quantity (150 g) of retinal
protein was loaded into each well of a microtiter plate. Lysates were
incubated with an equal volume of 1 reaction buffer and Casp-1
TABLE 1. Primer Sequences
Gene Forward Primer Reverse Primer
Genotyping
Casp1 wt CTGTGGTGACTAACCGATAA CATGCCTGAATAATGATCACC
Casp1/ CTGTGGTGACTAACCGATAA GCGCCTCCCCTACCCGG
rd1 CATCCCACCTGAGCTCACAGAAAG GCCTACAACAGAGGAGCTTCTAGC
IL-1R1 wt GAGTTACCCGAGGTCCAG GAAGAAGCTCACGTTGTC
IL-1R1/ GAGTTACCCGAGGTCCAG GCGAATGGGCTGACCCGCT
VPP AGACTGACATGGGGAGGAATTCCCAGA CAGCTGCTCGAAGTGACTCCGACC
RT-PCR
-Actin CAACGGCTCGGCATGTG CTCTTGCTCTGGGCCTCG
Casp-1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC
IL-1 GCAGGCAGTATCACTCATTG CGTTGCTTGGTTCTCCTTGT
Asc ACGCCATAGATCTCACTGAC CACAGCTCCAGACTCTTCTT
FGF-2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG
MCP-1 GGCTCAGCCAGATGCAGTTA CTGCTGCTGGTGATCCTCTT
CNTF CTCTGTAGCCGCTCTATCTG GGTACACCATCCACTGAGTC
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FIGURE 1. Retinal apoptosis and
expression of caspases after expo-
sure to light. Dark-adapted BALB/c
(A, C, D) or 129.B6 (B) mice were
not exposed (dark) or were ex-
posed to 5 klux of white fluores-
cent light for 1 hour (A, C, D) or to
13 klux for 2 hours (B). Retinas
were harvested immediately (I) or
at different time points as indi-
cated. (A) Cell death in the retina
was detected by ELISA-based mea-
surement of free nucleosomes in
cytoplasmic extracts. Release of nu-
cleosomes was detected as early as
6 hours after exposure and peaked
at 36 hours. Data points represent
the OD405 of retinas of individual
mice. Note the logarithmic scale on
the y-axis. (B) Retinal morphology
of 129.B6 mice at the indicated
time points before (dark) or after
exposure to light. (C) Apoptotic
cell death was associated with ac-
cumulation of the Casp-1 proform.
Western blots show proforms of in-
dividual caspases at different time
points after exposure to light as in-
dicated. Levels of Casp-1 increased
steadily, whereas expression of
other tested caspases remained
constant. Representative Western
blot analyses from at least three in-
dependent experiments are shown.
Membranes were reprobed with -actin to control for equal protein load. (D) Long-term follow-up of Casp-1 expression after exposure to
light. Expression of Casp-1 peaked at 5 days after illumination before basal levels were reached after 20 days. -Actin was tested as loading
control.
FIGURE 2. Caspase-1 activity was
not detected after exposure to light.
Dark-adapted BALB/c mice were not
exposed (dark) or were exposed for
1 hour to 5 klux, and retinas were
harvested immediately (I) or at differ-
ent time points thereafter as indi-
cated. (A) Levels of IL-1 mRNA in-
creased after exposure and peaked at
12 hours after illumination. Relative
mRNA levels were assessed by expo-
nential RT-PCR (mean  SD of three
reactions performed on a pool of
RNAs from three retinas isolated
from three different animals per time
point). (B) Il-1 was not processed
after light-induced damage. Increas-
ing pro-IL-1 levels were detected by
Western blot analysis with increasing
time (as indicated) after exposure to
light (top). Mouse recombinant ma-
ture IL-1 (17 kDa) was used as a
positive control (pos) for immuno-
blot analysis. Mature IL-1 was not
detected in retinal extracts. *31 kDa
proform of Il-1, **unspecific signal,
***mature form of Il-1. -Actin
served as the loading control (bot-
tom). (C) Casp-1 was not enzymati-
cally active after light-induced dam-
age. WEHD-pNA cleavage was determined spetrophotometrically in vitro using an ELISA-based method on retinal extracts prepared from control
(dark) or from retinas isolated at different time points after exposure to light, as indicated. pos: recombinant active Casp-1 as the positive control
(the mean  SD of three retinas from three different animals). (D) Pro-Casp-1 was not processed after exposure to light. Retinal extracts prepared
at 72 hours after exposure to light were tested with two antibodies recognizing the Casp-1 proform and p20 active form (left) or the Casp-1 proform
and the p10 active form (right). Extract of Casp-1 knockout mice (KO) was loaded for specificity control, and -actin served as the loading control
(bottom). pos: recombinant active Casp-1 as positive control for antibodies.
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substrate, according to the manufacturer’s instructions at 37°C for 18
hours. Cleavage of the peptide substrate WEHD-pNA was monitored by
liberation of the chromogenic pNA measuring absorption at 405 nm.
Three animals were analyzed per condition.
RESULTS
To establish the time course of light-induced photoreceptor
apoptosis, we used two different methods. To quantify the
amount of cells, which irreversibly entered the process of
apoptotic cell death, that is cells in the phase of internucleo-
somal DNA cleavage, we measured the release of free nucleo-
somes in retinal cell lysates by ELISA. To assess cell loss and
morphologic changes by apoptosis in the retina, we used
classic histologic methods.
Nucleosomal release above background was detectable at 6
hours after illumination and peaked at 36 hours after exposure
to light (Fig. 1A) as described earlier.41 Signal intensity de-
clined slowly thereafter, but relatively high levels remained up
to 3 days after illumination (the last time point tested). Mor-
phologic changes in light-exposed retinas were detectable by
light microscopy at 1 day after exposure (Fig. 1B). Rod outer
segments (ROS) and rod inner segments (RIS) were severely
disturbed, and many photoreceptor nuclei in the outer nuclear
layer (ONL) showed condensed chromatin. At 2 days after
illumination, the ONL was thinned and contained predomi-
nantly nuclei with condensed chromatin. The area of ROS and
RIS showed complete devastation. The gap between ONL and
pigment epithelium (PE) at days 2 and 5 may be preparation
artifacts resulting from the weakened retinal structures. Be-
tween 2 and 5 days after exposure, most photoreceptor nuclei
were lost. Between 5 and 10 days, debris of dead cells was
removed, and no further change was obvious up to day 30 after
the exposure.
DNA cleavage, as detected by the cell death detection ELISA
assay, precedes the removal of the affected cell. Its peak was
detected between 1 and 3 days after the insult, whereas phys-
ical loss of cells followed after a delay of approximately 1 day
(peak between 2 and 5 days). Accordingly, we focused on the
first 3 days after exposure to light for the analysis of biochem-
ical events in the signaling cascades leading to cell death.
Expression and Activity of Caspase-1 in
Retinal Degeneration
In many systems, apoptotic cell death is mediated by caspases.
In the light-induced damage system, however, Western blot
analysis revealed that the amount of the proenzymatic forms of
caspase-3, -6, -7, and -9 remained unchanged over a period of 3
days after the exposure to light (Fig. 1C). In addition, cleaved
(activated) fragments of these caspases remained undetectable.
Together with results from others,18,42 this suggests that light-
induced damage is independent of these caspases. In contrast,
increasing Casp-1 proenzyme levels were detected after light
treatment (Fig 1C). Induction of Casp-1 followed the initial
time course of nucleosomal release (Fig. 1A) starting at 6 hours
after illumination. In contrast to the release of nucleosomes,
Casp-1 proenzyme increased continuously, reaching a maxi-
mum at 5 days. Thereafter, pro-Casp-1 levels declined to base-
line (Figs. 1C, 1D). Thus, elevated Casp-1 levels were present
beyond the peak of apoptosis.
The major known role of active Casp-1 is proteolytic pro-
cessing of IL-1 from a 33-kDa precursor protein to the 17-kDa
mature form. Light exposure induced expression of IL-1, with
peak mRNA levels at 12 hours (Fig. 2A) and maximum protein
(proform) levels at 24 to 72 hours after illumination (Fig. 2B).
Although both Casp-1 protease and IL-1 substrate were in-
duced and present in high amounts at 72 hours after illumina-
tion, we did not observe mature IL-1 by Western blot analysis
(Fig. 2B) or ELISA (not shown). Using an in vitro assay for
WEHD-pNA substrate cleavage, we also did not detect in-
creased Casp-1 activity in retinal extracts after exposure to
light (Fig. 2C). Because Casp-1 has to be cleaved to become
active, we tested for the presence of the mature form of Casp-1
in retinal extracts prepared 72 hours after illumination. Using
two different antibodies that recognized cleaved Casp-1 prod-
ucts in control experiments (p20 and p10, respectively), we
did not detect any cleaved products of Casp-1 in retinal ex-
tracts (Fig. 2D). The lack of IL-1 substrate cleavage and of the
cleaved Casp-1 mature form suggests that Casp-1 did not ma-
ture and was therefore not activated, despite the increased
expression of the proform.
To test whether increased Casp-1 levels is be a general
phenomenon of retinal degeneration, we also analyzed its
expression in two models of inherited retinal degeneration.
FIGURE 3. Induction of Casp-1 ex-
pression in inherited models of ret-
inal degeneration. rd1 (A) and VPP
(B) mice were raised in dim cyclic
light, and retinas were harvested on
different postnatal days, as indi-
cated. Each time point was com-
pared with age-matched wild-type
mice. Casp-1 expression was tested
in total retinal homogenates by
Western blot analysis. Extracts
from Casp1–/– mice served as the
control for antibody specificity.
Casp-1 activation was monitored by
the WEHD-pNA substrate cleavage
assay as in Fig. 2C. (A) Casp-1 levels
increased in retinas of rd1 mice
starting at PND14. (B) Casp-1 lev-
els increased in retinas of VPP mice
starting at PND21. Mature Casp-1
was not detected at any age in any
genotype tested (not shown). (C)
No classic Casp-1 activity was de-
tected in extracts from retinas of VPP mice. WEHD-pNA cleavage was measured spectrophotometrically in retinal extracts from 4-week-old
VPP mice and corresponding wild-type control animals. pos: activity of recombinant active Casp-1 as positive control. The mean  SD of
three independent retinas from three different animals.
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The rd1 mouse is characterized by fast photoreceptor degen-
eration, beginning at approximately postnatal day 10 (PND10)
and peaking atPND13,43 whereas retinal degeneration in the
transgenic VPP mouse30,31 has a later onset, and degeneration
proceeds more slowly44 (compare the images in Figs. 5A and
5B). Although retinal degeneration in the rd1 mouse may14–17
or may not18 involve Casp-3, the molecular pathways of pho-
toreceptor apoptosis in the VPP mouse have not been investi-
gated so far. Whereas wild-type animals expressed low
amounts of Casp-1 protein that remained unchanged at all
time-points, increased levels of Casp-1 were found early after
onset of degeneration in rd1 and VPP retinas (Figs. 3A, 3B). In
both models of inherited retinal degeneration, Casp-1 levels
increased further with age. Of note, Casp-1 levels in the rd1
retina where highest at PND37, at a time point when loss of
photoreceptors was nearly complete (see Fig. 5A). This sug-
gests that Casp-1 was expressed in cells different from photo-
receptors.
Similar to the light-damage model, we did not observe
cleaved mature Casp-1 (not shown). Furthermore, in vitro
cleavage assays using retinal extracts from wild-type and VPP
mice at PND28 again pointed to the absence of classic Casp-1
activity (Fig 3C).
In each of the three models of retinal degeneration, in-
creased levels of Casp-1 coincided with the onset of photore-
ceptor apoptosis. Levels of Casp-1 remained high, at least until
the degenerative process was completed.
Role of Casp-1 in Retinal Degeneration
Previously, we have shown that hypoxic preconditioning sup-
presses transcriptional upregulation of Casp-1 after exposure
to light and protects photoreceptors from light-induced dam-
age. These findings suggest that pretreatment may protect
retinal morphology and function by interfering with a Casp-1–
dependent pathway.29 To test the suggested role of Casp-1 in
light-induced photoreceptor apoptosis, we exposed Casp1–/–
and wild-type control mice, both on a mixed 129/Sv-B6 genetic
background, to high levels of white light (2 hours, 13 klux) and
analyzed their retinal morphology at 5 and 10 days after expo-
sure. Absence of Casp-1 did not notably influence light-induced
retinal degeneration, as progression and extent of degenera-
tion was comparable to wild-type mice (Figs. 4A, 4B). Retinas
of both genotypes, analyzed 5 days after exposure to light,
were characterized by a thinned ONL and a complete disinte-
gration of RIS and ROS. Most of the remaining photoreceptor
nuclei were pyknotic, indicating ongoing cell death. Photore-
ceptor cells were mostly cleared from the retina 10 days after
illumination. During all times, the inner retinal structures were
well preserved.
As the biochemical assays used to detect mature Casp-1 and
IL-1 (Figs. 1, 2) may not have been sensitive enough to detect
small amounts of active proteins, we addressed a potential role
of IL-1 in retinal degeneration by using IL-1 receptor type 1
knockout mice (IL-1R1–/–) on a BALB/c background. BALB/c
wild-type mice served as the control. As IL-1R1 is the only
identified signaling receptor mediating the effects of IL-1,45,46
its absence should completely prevent any IL-1 signaling,
FIGURE 4. Ablation of Casp-1 did not protect retinal morphology
against light-induced damage. Dark-adapted, pigmented (wild-type,
Casp1–/–), and albino (BALB/c, IL-1R1–/–) mice were exposed for 2
hours to13 klux or for 1 hour to 5 klux of light, respectively. Retinal
morphology of mice not exposed to light (dark, left) or of mice
exposed to light and analyzed after 5 (5d, middle) or 10 (10d, right) d
was analyzed by light microscopy. Shown are images of light-induced
retinal degeneration in (A) pigmented wild-type animals, (B) pig-
mented Casp1–/– animals, (C) albino wild-type (BALB/c) mice, and (D)
IL-1R1–/– knockout mice on an BALB/c genetic background. All mouse
strains analyzed showed severe loss of photoreceptor nuclei and de-
struction of outer and inner segments at 5 days after exposure. At 10
days after exposure, most photoreceptor nuclei were lost. Shown are
representative sections of the most affected retinal regions of two to
four animals per time point and genotype. The large gap between ONL
and RPE in some sections is due to a preparational artifact of the
injured tissue.
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although the potential existence of alternative signaling mech-
anisms has been discussed.47,48 Wild-type and IL-1R1–/– mice
were exposed to 5 klux of light for 1 hour and analyzed 5 and
10 days after exposure. Retinal degeneration was comparably
severe in both types of mice (Figs. 4C, 4D).
These experiments show that lack of Casp-1 did not prevent
light-induced photoreceptor degeneration and suggest that
IL-1 signaling may not be involved in the degenerative pro-
cess.
Several molecular pathways exist for cell death in different
forms of retinal degeneration.2,41 Therefore, we also tested the
potential effect of Casp-1 ablation in the two models of inher-
ited retinal degeneration. For this purpose, we generated rd1/
Casp1–/– and VPP/Casp1–/– double-mutant mice and investi-
gated retinal morphology at different postnatal days. Retinas of
Casp1–/– mice, used as controls in this experiment, showed a
normal morphologic appearance (Fig. 5A, top). Ablation of
Casp-1 did not affect the course of retinal degeneration in rd1
mice, as the process proceeded without notable differences in
rd1 (Fig. 5A, middle) and rd1/Casp1–/– double-mutant mice
(Fig. 5A, bottom). Both rd1 and rd1/Casp1–/– retinas showed
scattered apoptotic nuclei at PND11 and almost complete loss
of photoreceptors by PND21.
In contrast, ablation of Casp-1 substantially protected retinal
morphology in VPP mice (Fig. 5B). At PND21, the ONL thick-
ness in retinas of VPP mice was about half that of Casp1–/–
(compare top rows of Figs. 5A and 5B) or of wild-type mice.
Most of the outer segments were severely disturbed. Accord-
ingly, reduced levels of rhodopsin (17% compared with
wild-type or Casp1–/–) were detected at this age (Table 2).
VPP/Casp1–/– double mutant mice, however, had more photo-
receptor nuclei, better preserved outer segments and higher
levels of rhodopsin (twice as much) than VPP mice. Preserva-
tion of retinal morphology and higher rhodopsin contents
persisted until at least PND42 (Fig. 5B, Table 2). At PND56, the
ONL was still thicker in double-mutant mice, but the structure
of the outer segments was severely disturbed, which was
reflected by a rhodopsin content similar to that of VPP mice.
Although lack of Casp-1 protected the retina of VPP mice,
morphology and rhodopsin content did not reach the quality
or the amount, respectively, of wild-type or Casp1–/– animals.
The continuous expression of mutant rhodopsin obviously
prevented a complete protection.
Because lack of Casp-1 protected the VPP retina even
though we did not observe Casp-1 cleavage activity in VPP
mice in in vitro assays (Fig. 3C), we also analyzed VPP/IL-1R1–/–
double mutant animals to address a potential role IL-1 signal-
ing for VPP mediated retinal degeneration. Lack of IL-1R1 did
not influence the degeneration in the VPP mouse retina as
judged by the amount of rhodopsin at PND21 and PND42
(Table 2) and retinal morphology (not shown). This finding
supports the conclusion that Casp-1 may influence retinal de-
generation in the VPP mouse independent from its classic
function as activator of IL-1 signaling.
Signaling Mechanisms
To address potential signaling mechanisms involved in such a
nonconventional Casp-1 function, we tested expression of sev-
eral genes involved in cytokine or chemokine signaling by
real-time PCR. In retinas of wild-type animals, Casp-1 gene
expression remained stable and at low levels during postnatal
development and aging (Fig. 6). In VPP mice, however, in-
creased Casp-1 gene expression was detected from PND21
(4-fold) to PND56 (10-fold), which is in line with the increased
levels of Casp-1 protein detected by Western blot analysis (Fig.
3B). The oligonucleotides used for real-time PCR hybridize
upstream of the neomycin insertion (exon 6,34) in the Casp-1
knockout allele and can therefore detect its expression. Ex-
pression of the disrupted gene in the Casp1–/– retinas was
increased compared with that in wild-type. This elevated ex-
pression was even more pronounced in the VPP/Casp1–/– mice
(Fig. 6). Obviously, lack of Casp-1 protein caused an increased
transcription rate of the Casp-1 gene. This increase could be
because of the lack of a negative feedback inhibition that may
normally be imposed by the Casp-1 protein. The highly in-
creased Casp-1 gene expression in the VPP/Casp1–/– retina may
be an attempt to produce the protease in response to the injury
(as in the VPP mouse with wild-type Casp-1). Because the
protein cannot be generated, the putative regulatory feedback
signal may be missing, resulting in a vicious cycle and a steady
increase of gene expression.
Apoptosis-associated speck-like protein (asc) is a CARD
(caspase recruiting domain) containing protein that is mainly
FIGURE 5. Differential effect of Casp-1 gene ablation in models of
inherited retinal degeneration. (A) Absence of Casp-1 in rd1 mice did
not alter the progression of photoreceptor degeneration. Retinal mor-
phology was assessed at the PNDs indicated. Casp1–/– mice had a
normal retinal morphology (top). Photoreceptor degeneration pro-
ceeded similarly in rd1 and rd1/Casp–/– retinas (middle and bottom).
Both showed thinning of the ONL at PND14 and almost complete loss
of photoreceptors at PND21 and -37. (B) Ablation of Casp-1 delayed
retinal degeneration in VPP mice. VPP and VPP/Casp1–/– double-mu-
tant were analyzed at the PNDs indicated. Compared with VPP retinas
(top), the VPP/Casp1–/– mice (bottom) showed an increased number of
photoreceptor nuclei in the ONL and better preservation of photore-
ceptor segments. Representative sections of the most affected areas of
two to four animals per time point and genotype are presented.
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involved in the activation of pro-Casp-1.49 Recently, asc has also
been implicated in the activation of Casp-8.50 In contrast to the
decreasing expression in wild-type mice, VPP mice show a two-
fold increase of asc expression with time (Fig. 6). In mice lacking
functional Casp-1, asc expression is almost undetectable (Fig. 6)
suggesting that Casp-1 protein is necessary to stimulate asc gene
expression. The increase of asc in VPP mice also further supports
an involvement of Casp-1 in the degenerative process.
Ciliary neurotrophic factor (CNTF) and fibroblast growth
factor (FGF)-2 have been implicated in retinal neuroprotection
(reviewed in Ref. 41). Expression levels of CNTF were similar
in all four strains tested (Fig. 6). Only at PND56, both VPP and
TABLE 2. Rhodopsin Content in Retinas of Dark-Adapted Mice with Different Genotypes
Mouse Strain PND21 PND28 PND42 PND56
wt 0.43  0.02 nmol 0.43  0.08 nmol 0.47  0.05 nmol 0.50  0.02 nmol
100% 100% 100% 100%
3/3 3/3 7/5 3/3
Casp1/ 0.41  0.03 nmol 0.42  0.02 nmol ND 0.48  0.04 nmol
95% 96% 96%
6/6 4/2 3/3
VPP 0.07  0.01 nmol 0.07  0.02 nmol 0.06  0.04 nmol 0.08  0.04 nmol
17% 16% 12% 16%
3/3 3/3 17/10 7/5
VPP/Casp1/ 0.14  0.01 nmol 0.14  0.04 nmol 0.14  0.02 nmol 0.11  0.04 nmol
32% 33% 31% 23%
3/3 8/4 16/8 9/6
VPP/IL-1R/ 0.08  0.02 nmol ND 0.05  0.03 nmol ND
19% 10%
4/4 12/8
Data for each retina are given as the mean  SD. Data for wild-type mice were set to 100%, and
rhodopsin levels of the different genotypes were calculated as percentages of wild-type levels at a
particular age. Numbers divided by virgules represent the number of retinas analyzed and the number of
different animals used, respectively. Differences in rhodopsin content were significant between VPP and
VPP/Casp1/ mice at PND21, -28, and -42 (unpaired t-test with Welch correction, P  0.05). ND, not
determined.
FIGURE 6. Gene expression in wild-
type and single- and double-mutant
mice. Relative levels of indicated RNAs
in retinas of wild-type, Casp1–/–, VPP,
and VPP/Casp1–/– at PNDs 11, 15, 21,
28, 42, and 56, as determined by real-
time RT-PCR. mRNA levels are ex-
pressed relative to those of the 11-day-
old wild-type samples, which was set
to 1. RNAs isolated from three inde-
pendent retinas per time point and ge-
notype were pooled, and amplifica-
tions were performed in triplicate
(means  SD).
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VPP/Casp1–/– showed a tendency of increased CNTF expres-
sion. Because expression increased similarly in both strains,
especially at the earlier time points, CNTF may not be a factor
responsible for the observed protection by ablation of Casp-1.
In contrast to CNTF, expression of FGF-2 responded strongly to
the presence of the VPP transgene: Expression was induced 30-
to 50-fold beginning at PND21, concomitantly with the onset
of the degeneration (Fig. 6). At PND21 and PND28, expression
in double-mutant mice was slightly reduced compared with
that in VPP mice. This finding may reflect the reduced severity
of retinal injury at this time point in these mice.
Monocyte chemoattractant protein (MCP)-1 has been impli-
cated in the recruitment of macrophages to the site of injury.51
Because the lack of MCP-1 has been reported to cause an
AMD-like phenotype in aged mice,52 MCP-1 may be needed to
maintain normal retinal morphology. Whereas expression of
MCP-1 was at basal levels in wild-type and Casp1–/– animals at
all time points tested, its expression strongly increased in VPP
(from PND21) and especially in VPP/Casp1–/– mice (from
PND15; Fig. 6). At all time-points tested (except PND11),
expression of MCP-1 was stronger in the VPP/Casp1–/– animals.
Such an increased expression was not detected in Casp1–/–
animals but occurred only in combination with the disease-
causing transgene. Therefore, lack of Casp-1 did not result in an
increased MCP-1 expression per se, suggesting that MCP-1
could be one factor, which may play a role in the protective
effect of Casp-1 ablation in VPP mice.
DISCUSSION
We show that Casp-1 RNA and protein are upregulated in three
different models of retinal degeneration (light-induced, rd1,
VPP). Our data suggest that an injured retina increases expres-
sion of the proform of Casp-1 and that this proform may exhibit
a nonclassic activity different from IL-1 cleavage. Ablation of
Casp-1 slowed the disease progression only in the model with
the mildest form of retinal degeneration (VPP). However, the
protection observed in VPP/Casp–/– animals was only transient
suggesting that additional pathways, independent of Casp-1,
are involved in the regulation of retinal degeneration.
Lack of Casp-1 did not protect photoreceptors after acute
light damage, in which cell death is synchronous and proceeds
quickly and after which most photoreceptors are cleared from
the subretinal space within 10 days. Also in the rd1 model, loss
and clearance of photoreceptors occurs roughly in the same
time frame, and photoreceptors are not protected by the abla-
tion of Casp-1. In contrast, apoptosis of visual cells in the VPP
mouse proceeds slowly over an extended period. In addition
and contrary to light damage, cell death in the VPP mouse
depends on phototransduction but not on c-Fos.33,53 Thus,
significant differences in the signaling of apoptosis exist be-
tween these two models, and it appears that Casp-1 rather
affects death pathways causing retinal degeneration of a milder
phenotype with a slow progression. This is in line with results
showing that lack of Casp-1 renders neonatal mice resistant to
moderate but not to severe cerebral hypoxia–ischemia in-
sults.54
Even though degeneration of the ONL may proceed at
different speeds in the various models, the death process may
nevertheless be similar on the single cell level once apoptosis
is induced. Therefore, the amount of dying cells at any given
time may be critical for the protective effect observed by the
ablation of Casp-1. Recent theoretical and mathematical evalu-
ations of neuronal cell death in several models of inherited
retinal degeneration and other neurologic disorders suggested
that a mutation imposes a mutant steady state and that a single
event randomly induces cell death.55 This model has been
refined by the inclusion of diffusible death factors to explain
patchy cell death as it often is observed in patients with RP and
in animal models.56 Such diffusible factors or at least cell–cell
interactions between dying and neighboring cells have been
postulated earlier57 and bystander effects were suggested to
play an important role in neuronal cell death in the retina as
well.58 Similarly, the magnitude of the cell death stimulus is a
determining factor deciding over an acute or a chronic fate.59
Based on these reflections, we propose that lack of Casp-1 may
influence a bystander effect and/or may play a role in the
production, release or activity of potential death factors. The
nature of the cells that may be involved in such an effect
remains to be determined, but the high expression of Casp-1 in
rd1 retinas at PND37 (Fig. 3A) when most photoreceptors have
been cleared from the retina (Fig. 5A) suggests strong Casp-1
expression in cells different from photoreceptors. In contrast,
recent reports rather convincingly demonstrate high expres-
sion of Casp-1 in the ONL in several models of retinal inju-
ry.27,28 Clearly, a careful and more elaborate study of retinal
Casp-1 expression is needed to unravel the complete role of
Casp-1 in disease induction and progression.
In models with almost synchronous cell death as in the
light-damage model and the rd1 mouse, such effects and/or
factors may be of such concentrations that lack of Casp-1 may
not be able to influence their activity sufficiently. In models of
slow photoreceptor degeneration, however, the reduced
amount of dying cells per time may allow protection by the
lack of Casp-1.
The initial analysis of factors that could be involved in the
protection observed in the VPP/Casp1–/– double mutant mice
revealed a striking difference in the expression of MCP-1.
Expression of this chemokine is induced in the degenerating
VPP retina, and lack of Casp-1 seems to stimulate its mRNA
production even further (Fig. 6). Whether MCP-1 may be in-
volved in the protection of photoreceptors in VPP/Casp1–/–
double-mutant mice remains to be shown, but it is interesting
to note that lack of MCP-1 has been reported to lead to an
AMD-like phenotype, including photoreceptor atrophy.52 Even
though such a phenotype manifests itself only in aged animals,
MCP-1 may nevertheless play a role in the survival of retinal
cells, as has been suggested for central nervous system neu-
rons,60 and/or MCP-1 may be involved in maintaining the
integrity of the retinal structure.
VPP mice express a human transgene encoding a mutant
rhodopsin with three amino acid substitutions (V20G, P23H,
P27L), one of which (P23H) is the most prevalent mutation in
patients with RP. The proposed mechanism of P23H-mediated
degeneration involves formation of protein aggregations and
proteasome-processing defects.61 This mechanism links this
form of RP to a broad class of neurodegenerative diseases
characterized by accumulation of misfolded protein aggregates
such as Alzheimer disease, Parkinson disease, Huntington dis-
ease, prion encephalopathies, and amyotrophic lateral sclerosis
(ALS).24,62–64 Casp-1–mediated pathways and –increased ex-
pression of MCP-1 have been suggested to play a role in a
variety of these acute and chronic neurologic disorders,65,66
similar to the results presented herein.
It has been generally accepted that the common event for
caspase activation is proteolysis of the proenzyme at internal
aspartate residues producing, in the case of Casp-1, mature p20
and p10 forms. However, four lines of evidence suggests that
in the retina, Casp-1 may not exhibit classic activity: First, p10
and p20 cleavage products were not detected with two differ-
ent antibodies, as reported earlier by others42; second, we did
not detect any cleavage activity in retinal extracts; third, we did
not observe any mature IL-1, although all models showed
increased Il-1 mRNA levels; and fourth, lack of IL-1R1 did not
influence retinal degeneration, suggesting that mature IL-1,
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the product of classic Casp-1 activity, is not involved in initia-
tion and/or progression of the degeneration. Instead of mature
Casp-1, we detected overaccumulation of the Casp-1 proform.
Based on these data and the neuroprotective effect of Casp-1
ablation in the VPP mouse, we speculate that Casp-1 may
orchestrate mechanisms of cell death independent of IL-1
maturation. It has been reported for example that the CARD
domain of the proenzyme interacts with RIP2 and activates
NFB independently of enzymatic activity.67,68 Other mecha-
nisms are possible as well.
Recent work has revealed that initiator caspases may be
activated through oligomerization and a conformational
change independent of a cleavage activity.69,70 Similarly, pro-
Casp-1 can be activated through oligomerization in vitro71 a
process facilitated in vivo by asc.72 Overexpression of asc can
lead to apoptotic cell death, and asc is silenced in human breast
carcinoma and glioblastoma cells.73–75 In the retina of VPP
mice, asc is expressed at higher levels compared with controls,
whereas asc expression is almost completely silenced in mice
lacking functional Casp-1 (Fig. 6).
In summary, we showed that increased expression of
Casp-1 may be a common marker for retinal degeneration, and
that ablation of Casp-1 is neuroprotective, at least in a model of
a comparably mild form of photoreceptor degeneration. It is
important to establish the generality of these observations and
to test whether interference with classic or nonclassic Casp-1
function may be an option to protect retinal cells in slowly
progressing retinal degenerations.
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6.3.2 Summary 
Within this book chapter we briefly described the retinal response to hypoxic 
preconditioning of mice. We used micro-arrays and analyzed them with the Mas5.0 
algorithm to identify differentially regulated genes 0, 2, 4 and 16 hours after hypoxic 
preconditioning (Note: in Thiersch et al., 2008, BMC Genomics we employed the 
advanced GCRMA algorithm, which is a specific modification of the robust multi-array 
average (RMA) algorithm). Depending on the applied statistical filters we observed a 
differential regulation of 83 genes (stringent filtering) or 772 genes (less stringent 
filtering). For biological classification of differentially regulated genes we used ONTO-
Express (http://vortex.cs.wayne.edu/ontoexpress/). Hypoxic preconditioning seemed to 
affect genes involved in transport and apoptosis. With focus on neuroprotection, which 
involves a suppression of apoptosis, we particularly analyzed the expression of 
apoptosis regulating genes and observed the induction cyclin-dependent kinase 
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inhibitor 1a (p21), Bcl2-like 10 and vascular endothelial growth factor (Vegf) among the 
induced anti-apoptotic genes. The functional group of pro-apoptotic genes contained 
BCL2/adenovirus E1B interacting protein 3 (Bnip3) and Bcl2-like 11 etc. In order to 
verify our micro-array data, we selected three apoptosis-related genes (Vegf, p21 and 
Bcl2-like 10) and confirmed their induction by real-time PCR. We hypothesized, that 
p21 could be an important gene for retinal neuroprotection after hypoxic 
preconditioning. We described preliminary results of p21-/- mice, which were hypoxic 
preconditioned and illuminated 4 hours after hypoxia. Our data, suggested that p21 
might not be essential for retinal neuroprotection. 
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THE HYPOXIC TRANSCRIPTOME OF THE RETINA: 
IDENTIFICATION OF FACTORS WITH POTENTIAL 
NEUROPROTECTIVE ACTIVITY 
Markus Thiersch1*, Wolfgang Raffelsberger2, Enrico Frigg1, Marijana 
Samardzija1, Patricia Blank1, Olivier Poch2, and Christian Grimm1 
1. INTRODUCTION 
 
Most blinding diseases of the retina share a common feature – the loss of 
photoreceptor cells by apoptosis. Although degenerative diseases like age-related macular 
degeneration (AMD) and Retinitis Pigmentosa (RP) are among the main causes for 
severe visual impairment and blindness, no effective therapeutical treatments are 
available to prevent loss of vision in human patients. Protection of retinal cells against 
cell death is a promising strategy to develop therapies aiming at the rescue of retinal 
function. For the successful design of neuroprotective strategies, it is essential to 
understand the molecular events leading to the degeneration of retinal cells. To study 
signaling pathways and molecular mechanisms during the degenerative processes, several 
mouse models of inherited retinal degeneration are used (Fauser et al. 2002). These 
models are complemented by models of induced photoreceptor apoptosis like the model 
of light-induced degeneration (Wenzel et al. 2005). The advantage of the induced models 
is the synchronized apoptotic response of many photoreceptor cells to the death stimulus. 
This might raise the activation of regulatory factors above detection threshold allowing 
their detailed investigation. 
Recently, we showed that hypoxic preconditioning protects photoreceptor cells 
against light-induced cell death by preserving retinal function and morphology (Grimm et 
al. 2002). Similarly, hypoxic pretreatment can also protect other tissues like heart or brain 
against various toxic insults (Gidday et al. 1994; Emerson et al. 1999; Cai et al. 2003; 
Dong et al. 2003) suggesting that hypoxic preconditioning might induce a general 
protective response. Such a response might involve hypoxia-inducible-factor 1a (HIF-1a) 
which is stabilized in the retina after hypoxic exposure (Grimm et al. 2002). As a 
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transcription factor, HIF-1a (together with HIF-2a) is a key element of the hypoxic 
response regulating expression of many target genes. Such genes are involved in different 
physiological functions like angiogenesis, general metabolism and apoptosis. One target 
gene of HIF-1a and/or HIF-2a has been identified in erythropoietin (Epo). Epo was 
shown to prevent death of precursor cells of erythrocytes in bone marrow and was thus 
recognized as a potent anti-apoptotic factor (Koury et al. 2002). Since expression of Epo 
is strongly induced after hypoxic preconditioning in the retina and Epo receptor 
expression was localized mainly to photoreceptor and ganglion cells (Bocker-Meffert et 
al. 2002; Grimm et al. 2002; Grimm et al. 2004), Epo was considered to be a factor 
protecting the retina against degeneration. Supporting this conclusion, application of 
recombinant Epo protected photoreceptor cells against light-induced degeneration. 
However, protection was not as complete as after hypoxic preconditioning suggesting 
that exposure to reduced oxygen levels may differentially regulate expression of 
additional genes involved in the protection of photoreceptor cells (Grimm et al. 2002; 
Grimm et al. 2004). 
The goal of the present study was to analyze the retinal response to hypoxia and to 
identify differentially regulated genes that might be involved in retinal neuroprotection. 
 
 
2. MATERIAL AND METHODS 
2.1. Hypoxic preconditioning and Affymetrix microarrays 
Animals were treated in accordance with the regulations of the Veterinary Authority 
of Zurich and with the statement of ‘The Association for Research in Vision and 
Ophthalmology’ for the use of animals in research. BALB/c mice (Harlan, The 
Netherlands) were exposed to 6% oxygen for 6 h. Retinas were isolated at 0 h, 2 h, 4 h or 
16 h after the period of hypoxic preconditioning. Normoxic controls were treated in 
parallel and collected at the same time points. For each condition three retinas of three 
different mice were pooled. Total RNA was prepared, processed according to standard 
procedures and hybridized to Affymetrix GeneChip® Mouse Genome 430 2.0 
microarrays. The experiment was conducted three times independently resulting in three 
microarray replicates per condition and a total number of 9 retinas per condition. 
2.2. Quality control and Affymetrix chip analyzes 
To analyze the quality of the results after gene chip hybridization the online tool 
RACE (Remote Analysis Computation for gene Expression data) of the University of 
Lausanne was used. 
To analyze gene expression profiles and to identify differentially regulated genes, we 
used Genespring 7.0 (Agilent Technologies) software based on the Mas5.0 algorithm. In 
brief, hypoxic samples (H, hypoxic) were compared to their corresponding normoxic 
controls (N, normoxic) resulting in 4 different analyzes: N0 vs. H0, N2 vs. H2, N4 vs. H4 
and N16 vs. H16. In the first step, genes were tested for their presence or absence in the 
samples. Genes were considered to be expressed and allowed to pass the filter only when 
all 3 replicates of a particular condition (normoxic, hypoxic) got a present call. Genes that 
passed the first filter were then analyzed and filtered according to their fold change (at 
least factor 2) and to their p-value (≤ 0.05). Additionally, a statistical correction 
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according to Benjamini/Hochberg (Benjamini and Hochberg 1995) was applied. To sort 
differentially regulated genes according to their biological function the online tool Onto-
Express from Intelligent Systems and Bioinformatics Laboratory (Draghici et al. 2003a; 
Draghici et al. 2003b; Draghici et al. 2003c) was used (http://vortex.cs.wayne.edu/projects.htm). 
2.3. Real-time PCR 
Gene regulation was confirmed by real-time PCR on cDNA prepared from total 
retinal RNA, using a LightCycler 480 instrument (Roche Diagnostics AG, Rotkreuz, 
Switzerland) and LightCycler 480 SYBR Green I Master Mix (Roche Diagnostics AG). 
Primers were designed using the Universal ProbeLibrary Assay Design Centre (Roche 
Diagnostics AG) https://www.roche-applied-science.com. Relative expression was 
calculated according to the expression of b-actin using the LightCycler software package. 
2.4. Light exposure and quantification of cell death 
p21–/– mice on a mixed Bl/6;129S2 background were purchased from Jackson 
Laboratory (Bar Harbor, USA). Mice homozygous for the light sensitive Rpe65450Leu 
variant (Wenzel et al. 2001; Samardzija et al. 2006) were used to establish the breeding 
colony. After hypoxic preconditioning (see 2.1.) mice were reoxygenated in darkness 
(dark adaptation) for 4 hours prior to illumination. 45 minutes prior to illumination, 
pupils were dilated in dim red light using 1% Cyclogyl (Alcon, Cham, Switzerland) and 
5% Phenylephrine (Ciba Vision, Niederwangen, Switzerland). Mice were exposed to 
13’000 lux of white fluorescent light for 2 hours.  
36 hours after light exposure apoptotic cell death was quantified in isolated retinas 
using a sandwich ELISA system (Cell Death Detection ElisaPlus, Roche Diagnostics, 
Basel, Switzerland, used according to the manufacturer's recommendation) to determine 
the relative amount of free nucleosomes in the cytosolic fraction of isolated retinas.  
2.5. Morphology 
Eyes were removed and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 
7.3 at 4°C overnight. For each eye, the superior central and the inferior central retina 
adjacent to the optic nerve were trimmed and embedded in Epon 812. Sections (0.5 µm) 
were prepared from the inferior central retina, stained with toluidine blue and analyzed 
using an Axioplan microscope (Zeiss, Oberkochen, Germany). 
 
 
3. RESULTS 
3.1. Statistical Analyzes 
Hypoxic preconditioning was shown to completely protect photoreceptor cells 
against light–induced cell death when the light stimulus was given after a reoxygenation 
period of 4 h (Grimm et al. 2002). In contrast, mice exposed to light at 16 h after hypoxic 
preconditioning were not protected suggesting that the protective effect of hypoxia is 
transient and short-lived. Based on these findings we decided to analyze the retinal 
transcriptome at 4 different time points after hypoxic preconditioning. The first three time 
points were within the frame of full neuroprotection (0 h, +2 h, +4 h) whereas the last
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Table 1. Total number of genes differentially regulated at 0 h, 2 h, 4 h and 16 h after 
hypoxia. 
 
Condition Altered Genes with Benjamini/Hochberg False positive 
Altered Genes without 
Benjamini/Hochberg False positive 
H0 vs. N0 83 4 772 96 
H2 vs. N2 7 - 189 24 
H4 vs. N4 0 - 74 9 
H16 vs. N16 0 - 24 3 
Shown are the numbers of genes passing the stringent Benjamini/Hochberg correction in comparison to a 
normal t-test. The columns ‘false positive’ show the expected number of genes which have passed the 
respective test but which are nevertheless not differentially regulated. H0, H2, H4, H16: retinas at 0h, 2h, 4h 
and 16h, respectively, after hypoxic preconditioning. N0, N2, N4, N16: control normoxic retinas. 
 
time point was taken after neuroprotection has ceased (+16 h). Quality controls were used 
to confirm the successful performance of the experiment. Analyzes, which compare the 
global similarity of all gene chips indicated that hypoxic replicates were very similar 
within their groups and highly different to their normoxic controls (data not shown). 
Genespring 7.0 software was used to detect genes that were differentially regulated 
by hypoxic exposure. In this first statistical analysis without mathematical correction 772 
genes appeared to be differentially regulated immediately after hypoxia. This number 
decreased during reoxygenation to 189 genes after 2 h, 74 genes after 4 h and 24 genes 16 
h after hypoxia (Table 1). After application of the highly stringent statistical method of 
Benjamini/Hochberg (Benjamini and Hochberg 1995), we identified a total of 83 genes 
as significantly regulated immediately after hypoxic preconditioning. Already at 2 h after 
hypoxia, only 7 genes remained to have significantly different expression levels and at 4 
h and 16 h after hypoxia the retinal transcriptome of preconditioned mice was 
indistinguishable from normoxic controls (Table 1). Both statistical methods indicated 
that differential regulation of gene expression is strongest immediately after hypoxia. 
During reoxygenation, the retinal transcriptome quickly returned to the normoxic gene 
expression pattern suggesting a short-lived molecular effect of hypoxic preconditioning.  
3.2. Biological classification 
It is eminent to sort differentially regulated genes according to their biological 
relevance. Using the statistical online tool “Onto express” we classified the identified 
genes with respect to their various biological functions like apoptosis, transport, cell 
cycle and others (Fig. 1). The highest number of regulated genes was sorted into the 
group of transport-related genes followed by apoptosis-related processes. This may be of 
high relevance since hypoxic preconditioning induces a neuroprotective response in the 
retina, which most likely involves a number of genes related to the control of apoptotic 
events. Having in mind, that genes can be present in more than one biological group, the 
number of sorted genes does not reflect the real number of genes identified as 
differentially regulated. Individual genes of the group of ‘anti-apoptotic’ or the group of 
‘induction of apoptosis’ were also found in the group ‘apoptosis’. Table 2 summarizes 
differentially regulated genes that are considered anti-apoptotic. Note that some of these 
genes are repressed by the hypoxic pretreatment. Table 3 shows the most prominently 
regulated pro-apoptotic genes. In total, 13 genes with a known anti-apoptotic function 
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Figure 1. Classification of differentially expressed genes according to their biological function. Genes regulated 
immediately after hypoxia (0 h) without statistical correction were classified using Onto-Express. Only most 
prominent and statistically significant (p ≤ 0.05) groups are shown. Numbers of genes in each group are given 
in brackets. 
 
 
Table 2. Differentially regulated genes with anti-apoptotic functions. 
 
Gene FC 0 h FC 2 h FC 4 h FC 16 h 
p21 34.4 - - - 
Bcl2-like 10 6.3 - - - 
Snai2 - 3.1 - - 
Vegfa 2.6 - - - 
Bhlhb4 2.3 - - - 
Bfar 2.2 - - - 
Camk1d - 2.2 2.0 - 
Birc6 - 2.1 - - 
C/EBP 2.0 2.3 - - 
     
p21-activated kinase 7 0.46 - - - 
Apoptosis inhibitor 5 0.34 - - - 
Glutaminyl-tRNA-Synthetase 0.32 - - - 
Birc4 0.22 - - - 
Shown are the gene-chip deduced fold-changes (FC) at 0h, 2h, 4h and 16h after hypoxic preconditioning. p21 
is the most prominently up-regulated gene within this group. -; not detected 
 
 
Table 3. Differentially regulated genes with pro-apoptotic functions. 
 
Gene FC 0 h FC 2 h FC 4 h FC 16 h 
Pmaip1 12.9 - - - 
Sh3glb1 (endophilin) 5 4.7 - - 
Bnip3 2.3 - - - 
BCL2-like 11 2.2 - - - 
Foxo3a 2.1 - - - 
Shown are the gene-chip deduced fold-changes (FC) at 0h, 2h, 4h and 16h after hypoxic 
preconditioning. . -; not detected 
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were differentially regulated by hypoxia. Nine genes were induced whereas 4 genes were 
repressed (Table 2). Test of VEGF, p21 and Bcl2l10 gene expression by real-time PCR 
confirmed the chip data and their up-regulation in response to the hypoxic pretreatment 
(Fig. 2). In addition to the anti-apoptotic genes, expression of 5 genes expected to be pro-
apoptotic was induced during hypoxia (Table 3).  
Having both, pro- and anti-apoptotic genes regulated by hypoxia suggests that the 
preconditioning protocol induces a complex response priming the tissue to resist a toxic 
insult but also preparing the cells to induce apoptotic cell death if needed. We 
hypothesize that reducing the number of cells may be required in case of prolonged 
hypoxic exposure to ensure that at least some cells can be supplied with sufficient oxygen 
to function. 
 
Vegf p21 Bcl2l10
0
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3
Normoxia
Hypoxia
10
20
30
40
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Figure 2. Expression of apoptosis-related genes immediately after hypoxic preconditioning relative to normoxic 
controls as determined by real-time PCR. Expression of Vegf, p21 and Bcl2l10 (as indicated) was determined in 
three normoxic and three hypoxic retinas. Amplifications were done in duplicates. Normoxic samples were set 
to 1 and hypoxic samples represent the relative fold change due to hypoxia. 
 
3.3. The neuroprotective impact of p21 
One of the most prominently induced genes with reported anti-apoptotic properties 
was p21, a cyclin-dependent kinase inhibitor. To analyze its role in neuroprotection by 
hypoxic preconditioning, p21 knockout mice were exposed to hypoxia, reoxygenated for 
4 hours and exposed to 2 hours of 13,000 lux of white light. As controls, p21–/– mice were 
kept in normoxic conditions before light exposure. Light-induced photoreceptor apoptosis 
was analyzed 36 hours after exposure by light microscopy (Fig. 3A) and by the semi-
quantitative determination of free nucleosomes (Fig. 3B). In contrast to normoxic control 
mice, hypoxic preconditioned p21 knockout animals did not produce a significant amount 
of free nucleosomes after light-exposure suggesting that lack of p21 did not interfere with 
the neuroprotection by hypoxic preconditioning. These findings were confirmed by the 
morphological analysis of retinal tissue after light exposure (Fig. 3A). In contrast to 
normoxic controls where light exposure induced the formation of pyknotic nuclei and a 
severe disruption of rod inner and outer segments, retinal morphology of preconditioned 
knockout mice was completely protected. 
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Figure 3. Analysis of the role of p21 in retinal neuroprotection by hypoxic preconditioning. p21–/– mice were 
either kept in normoxia or were preconditioned with 6% O2 for 6 hours before light exposure. A) Retinal 
morphology was analyzed 36 hours after exposure. Normoxic mice (left panel) showed strong signs of 
degeneration with many pyknotic photoreceptor nuclei and severe destruction of inner and outer segments. 
Retinas of hypoxic preconditioned mice (right panel) were completely protected against light-induced 
degeneration. B) Cell death detection (CDD) assay to analyze the amount of free nucleosomes in the 
cytoplasmic fraction 36 h after light exposure. Normoxic mice showed a high content of free nucleosomes 
whereas hypoxic preconditioned mice showed no detectable release of nucleosomes. Shown are data points of 
two individual mice (dots) with the respective average (line). ROS: rod outer segments; RIS: rod inner 
segments; ONL: outer nuclear layer. 
 
 
4. DISCUSSION 
 
Photoreceptor cells are among the cells with the highest need for oxygen. Highest 
oxygen concentrations are measured at the level of the outer segments which are closest 
to the choroidal blood vessels. With increasing distance from the RPE and the choroidea, 
oxygen concentrations drop rapidly and photoreceptor cells can experience borderline 
hypoxic conditions at night, the time of highest energy consumption (Yu and Cringle 
2005). To react and/or adapt to such conditions, the retina needs a system that can sense 
oxygen levels and induce appropriate endogenous mechanisms in response to varying 
conditions. In a normal physiological situation, such a response may include an 
adaptation of the metabolism reducing or increasing the consumption of energy. In 
harsher conditions, the retina may prepare the cells to survive by the induction of an 
endogenous neuroprotective response. If unfavorable conditions persist, the sacrifice of 
some individual cells may be required in order to safe the function of the retinal tissue as 
a whole. Understanding the retinal response to hypoxia may lead to the identification of 
potent endogenous neuroprotective mechanisms. Artificial and controlled stimulation of 
such mechanisms may be beneficial for human patients suffering from loss of vision due 
to retinal degeneration. Furthermore, hypoxia is one of the driving forces for 
neovascularization, a major complication of many retinal diseases including diabetic 
retinopathy and AMD (Zhang and Ma 2007). Identification of the molecular mechanisms 
controlling the hypoxia-related production of angiogenic factors like VEGF may lead to 
the development of new and efficient treatments for these diseases. 
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Recently we showed that a transient period of strong hypoxia induces a molecular 
response in the retina which protects photoreceptors from the otherwise deleterious effect 
of light exposure (Grimm et al. 2002). A central regulator of this response might be the 
transcription factor HIF-1a which is stabilized and therefore activated in hypoxic 
conditions in several tissues including the retina (Grimm et al. 2002; Maxwell 2003; 
Sharp and Bernaudin 2004). However, since HIF-1a and other transcription factors 
modulate the expression of a large amount of genes (Ke and Costa 2006), the molecular 
mechanisms involved in the tissue response to hypoxia are still poorly understood and the 
molecular basis for hypoxia-induced neuroprotection remains unclear. Our study was 
therefore designed to increase our knowledge of hypoxia-dependent gene regulation and 
neuroprotection by analyzing the retinal transcriptome after hypoxic preconditioning. 
The highest number of differentially regulated genes was found immediately after 
hypoxia. At this time, HIF-1a is present at high levels suggesting that HIF-1a may indeed 
be one of the major factors controlling the hypoxic response in the retina. This is further 
supported by the rapid decline of HIF-1a levels (Grimm et al. 2002) and of differentially 
expressed genes during reoxygenation. 
The most prominent functional group affected by hypoxia was “transport” which 
includes genes of general metabolic activity like Slc37a4 (glucose-6phosphate 
transporter) or FABP4 (fatty acid binding protein 4). This may reflect an adaptational 
response of the retina, which may normally occur to a rather mild change in oxygen 
levels. Despite the strong neuroprotective capacity of hypoxic preconditioning, we also 
detected a number of differentially regulated genes that are pro-apoptotic and may 
therefore promote cell death. As discussed above, these factors may be produced to 
reduce the number of oxygen-consuming cells if low levels of oxygen persist. This might 
secure sufficient oxygen supply and therefore energy for a smaller cell population which 
may thus survive and function even in unfavorable conditions. Although this may reduce 
the general sensitivity of the retina, it may nevertheless rescue some (reduced) function. 
It might be interesting to analyze whether less severe hypoxic conditions would increase 
the differential regulation of genes involved in general metabolism and decrease the 
number of pro-apoptotic genes. 
Our focus, however, is the elucidation of the neuroprotective mechanisms in 
response to a harsh but transient hypoxic period. Therefore, we concentrated during our 
initial analysis on genes which might be involved in an anti-apoptotic response of the 
retina. Because p21 was one of the most prominently induced genes with known anti-
apoptotic functions (Zaman et al. 1999; Mahyar-Roemer and Roemer 2001), we focused 
on its potential role in neuroprotection after hypoxic preconditioning. We hypothesized 
that lack of p21 would reduce the neuroprotective effect if the gene was indeed involved 
in the protective response. However, mice with a functional knockout of p21 were highly 
protected against a toxic light insult when preconditioned with hypoxia. This suggests 
that this Cyclin dependent kinase inhibitor is at least not a major contributor to the 
neuroprotective response induced by hypoxic preconditioning. 
We will continue the analysis of individual genes identified in our screen. Future 
studies will focus on genes like Bcl2l10 or C/EBP which were up-regulated during 
hypoxia and which are known to be anti-apoptotic (Song et al. 1999; Naumann et al. 
2001; Buck and Chojkier 2003). Additionally, strongly up-regulated genes (not shown) 
like Paraoxonase 1, which is involved in oxidative stress response and lipid oxidation 
(Aviram et al. 1998) or Adrenomedullin, which was reported to be neuroprotective in 
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ischemia models (Miyashita et al. 2006) will be studied for their relevance to retinal 
neuroprotection after hypoxic preconditioning. 
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6.4.2 Summary 
RPE65 is a protein expressed in retinal pigment epithelium cells and is essential 
for the restoration of the photoreceptor-chromophore 11-cis-retinal after rhodopsin 
bleaching. Mutations in RPE65 cause retinal dystrophies and we generated a knock in 
mouse with the most frequent RPE65 mutation in human patients – an amino acid 
substitution at position 91 (R91W). Affected patients have cone vision during 
childhood, but progressively lose sight during adolescence. We characterized the new 
mouse model and compared it to wild type mice and RPE65 null mice (Rpe65-/-). 
RPE65 mRNA was slightly reduced in R91W mice, when compared to wild type mice 
and no mRNA was found in Rpe65-/- mice. Western blot analyzes and 
immunohistochemistry showed that RPE65 protein expression was largely reduced in 
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R91W mice but that the protein was correctly localized in the retinal pigment 
epithelium. In contrast to Rpe65-/- mice, were no 11-cis-retinal was detected, retinas of 
4, 8, 12, 24 and 40-week old R91W mice contained very low amounts of 11-cis-retinal, 
proving that the mutant RPE65 protein possessed biological activity in vivo. However, 
retinyl esters, which are the substrate for RPE65, accumulated comparably in R91W 
and in Rpe65-/- mice leading to a similar formation of lipid-like inclusions in the RPE. 
That suggested that RPE65 activity in R91W mice processed retinyl esters to slow – 
either because of the reduced protein levels and/or an impaired enzyme activity. 
Further, in dark-adapted R91W mice only 6% - 10% of wild type rhodopsin levels could 
be measured. Because the RPE65 protein determines the kinetics of rhodopsin 
regeneration, we assumed a reduced regeneration rate. After bleaching wild type mice 
regenerated approximately 90% of rhodopsin within one hour. However, R91W mice 
reached even after 5 days only 44% of the pre-bleach value. Photoreceptor function 
was assessed by electroretinography (ERG), which employs light flashes to induce an 
electrical response in the retina. Scotopic ERG measures rod and mixed rod/cone 
responses and showed a reduced electrical response in R91W mice compared to wild 
type mice. During aging (8 to 40 weeks) light sensitivity remained unaltered in R91W 
mice but the amplitude of the b-wave (response of secondary neurons) declined 
progressively. Photopic ERG measures the function of cones and shows a comparable 
light sensitivity between wild type and R91W mice. However, the shape of the waves 
was altered in R91W mice and we hypothesized that rods remained active in these 
mice, suggesting an overlapping response of the rod and the cone system even under 
photopic conditions. Similar to the scotopic ERG, the b-wave declined during aging. 
Photoreceptor cells in Rpe65-/- mice slowly undergo apoptosis. The morphology of 
R91W mice indicated, that the retina degenerates as well. However, up to 12 weeks of 
age R91W mice showed a better preservation of OS and contained more cone nuclei 
than respective Rpe65-/- mice. R91W mice were clearly distinct from Rpe65-/- mice and 
showed the formation of 11-cis-retinal, the presence of rhodopsin and a better residual 
function of the retina. Our results indicated that we generated a mouse model for a 
specific RPR65 mutation, which genetically reflects the human disease and which 
provides a tool to test therapeutic approaches for human patients with RPE65 
missense mutations. 
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RPE65 is a retinal pigment epithelial protein essential for the regeneration of 11-cis-retinal, the chromophore
of cone and rod visual pigments. Mutations in RPE65 lead to a spectrum of retinal dystrophies ranging from
Leber’s congenital amaurosis to autosomal recessive retinitis pigmentosa. One of the most frequent mis-
sense mutations is an amino acid substitution at position 91 (R91W). Affected patients have useful cone
vision in the first decade of life, but progressively lose sight during adolescence. We generated R91W
knock-in mice to understand the mechanism of retinal degeneration caused by this aberrant Rpe65 variant.
We found that in contrast to Rpe65 null mice, low but substantial levels of both RPE65 and 11-cis-retinal were
present. Whereas rod function was impaired already in young animals, cone function was less affected.
Rhodopsin metabolism and photoreceptor morphology were disturbed, leading to a progressive loss of
photoreceptor cells and retinal function. Thus, the consequences of the R91W mutation are clearly dis-
tinguishable from an Rpe65 null mutation as evidenced by the production of 11-cis-retinal and rhodopsin
as well as by less severe morphological and functional disturbances at early age. Taken together, the patho-
logy in R91W knock-in mice mimics many aspects of the corresponding human blinding disease. Therefore,
this mouse mutant provides a valuable animal model to test therapeutic concepts for patients affected by
RPE65 missense mutations.
INTRODUCTION
The vitamin A derivative 11-cis-retinal is the chromophore of
rod and cone visual pigments. Absorption of light leads to an
11-cis to all-trans isomerization followed by dissociation of
all-trans-retinal from the protein moiety (opsin) of the visual
pigment holo-complex. The regeneration of the visual chro-
mophore is a complex protein-mediated process termed the
visual cycle (1). The crucial all-trans to 11-cis-retinoid iso-
merization reaction step takes place in the retinal pigment epi-
thelium (RPE) and is catalyzed by RPE65 (2–4).
Rpe65-deficient mice lack 11-cis-retinal and consequently no
rhodopsin is detectable in their eyes (5,6). Instead, these
animals show in the RPE an over-accumulation of retinyl
esters, retinoid intermediates of the visual cycle (5).
More than 60 disease-associated mutations have been identi-
fied in the human RPE65 gene [summarized in http://www.
retina-international.com/sci-news/rpe65mut.htm; see also
Zernant et al. (7)]. The broad spectrum of mutations includes
point mutations, splice-site defects, deletions and insertions.
Mutations in RPE65 are estimated to account for 11% of
all autosomal recessive childhood-onset retinal dystrophy
cases (8). Patients suffering from mutations in the RPE65
gene are alternatively diagnosed as autosomal recessive retini-
tis pigmentosa, autosomal recessive retinal dystrophy,
early-onset severe retinal dystrophy (EOSRD) or Leber’s
To whom correspondence should be addressed at Tel: þ41 442553872; Fax: þ41 442554385; E-mail: samam@opht.uzh.ch
†Present address: Novartis Pharma Schweiz AG—BU Ophthalmics, Monbijoustrasse 118, CH-3007 Bern, Switzerland.
# The Author 2007. Published by Oxford University Press. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournals.org
Human Molecular Genetics, 2008, Vol. 17, No. 2 281–292
doi:10.1093/hmg/ddm304
Advance Access published on October 12, 2007
congenital amaurosis type II (LCAII) (8–10). These rather
diverse diagnoses reflect the phenotypic heterogeneity of the
underlying disease. Most patients suffering from mutations
in the RPE65 gene are diagnosed early in childhood as
severely visually impaired, with night blindness, distinctly
restricted visual fields and nystagmus, but no photophobia
(summarized in 11). Retinal function (ERG) is undetectable
after dark adaptation and is severely impaired following
light adaptation. However, many of these patients have suffi-
cient vision to attend elementary school. Vision is then gradu-
ally lost, resulting in blindness almost invariably in the third
decade of life (11).
Two naturally occurring models (rd12 mouse and Briard
dog) and the genetically engineered Rpe65 knock-out mouse
(Rpe652/2) have been useful for the delineation of RPE65
protein function in the visual cycle (5,12,13). These models
have meanwhile been used in pre-clinical gene replacement
therapy experiments to restore rod and cone photoreceptor
function [rd12 (14), Rpe652/2 (15–18), dog (19–22)]. All
of the above models represent a ‘null situation’ for RPE65,
in which the visual cycle has never been functional.
However, current literature indicates that more than 50% of
RPE65 mutations in patients are missense mutations. Some
of these missense mutations presumably produce mutant ver-
sions of RPE65 with some residual enzymatic activity.
Recently, we characterized three consanguineous families car-
rying the R91W mutation in RPE65 (23). All affected family
members had useful cone-mediated vision in the first decade
of life, suggesting that the mutant RPE65 protein is expressed
and possesses residual function. The consequences of a partial
loss of RPE65 activity caused by a missense mutation have not
yet been studied in an in vivo animal model and little is known
about the pathology of LCA/EOSRD under such conditions.
To assess this specific pathology, we generated the
Rpe65-R91W knock-in mouse as a model for the human
disease and analyzed the effect of the mutation on retinal func-
tion, visual cycle and morphology.
RESULTS
Generation of R91W knock-in mice
Gene targeting in mouse ES cells was used to modify exon 4
of the Rpe65 gene such that codon 91 changed from arginine
to tryptophan (R91W) (Fig. 1A). In humans, the R91W
mutation is caused by a single point mutation (TGA.TGG).
However, in mice, arginine 91 is encoded by a CGA codon;
therefore, two point mutations were introduced into codon
91 (CGA.TGG). The introduction of these two mutations
resulted in the loss of a TaqI restriction site, facilitating the
genotype analysis (Fig. 1A–C).
The gene targeting strategy is shown in Figure 1B. In
addition to mouse Rpe65 genomic DNA carrying the R91W
mutation, the targeting vector contained a floxed neo resist-
ance and a diphtheria toxin (DT) cassette as selection
markers. Sequencing of the full genomic DNA insert of the
targeting vector confirmed the presence of the R91W mutation
and the selection markers in an otherwise wild-type sequence
(Fig. 1A). The linearized construct was electroporated into
coisogenic TC1 ES cells, and correctly targeted ES cell
clones were identified and characterized in detail by Southern
blotting, PCR and PCR restriction digestion analysis (Fig. 1C;
data not shown).
These clones were used to generate germ-line competent
chimeric mice. A chimeric male was mated with coisogenic
129S6 females to propagate the line. The resulting heterozy-
gous (Rpe65R91Wneo) F1 mice were bred with a germ-line Cre-
deleter mouse line [129S6-Tg(Prnp-GFP/Cre)1Blw/J)] (24) to
excise the neo cassette (Fig. 1B). The resulting offspring was
heterozygous for the R91W mutation (R91W/wt). The only
foreign sequence in addition to the R91W substitution was a
single intronic loxP site. Finally, we interbred the heterozy-
gous R91W/wt mice to obtain pure homozygous 129S6/
SvEvTac-Rpe65tm1Lrcb (R91W) knock-in mice. Of note,
these mice were coisogenic to 129S6 control mice, except
for codon 91 and the above-mentioned loxP site.
Rpe65 expression in mutant mice
Quantitative RT–PCR, immunoblotting and immunohisto-
chemistry showed that the mutant protein is expressed in
R91W knock-in but not in Rpe652/2mice (Fig. 2A–C).
Whereas the expression of Rpe65 mRNA was only slightly
reduced in R91W mice (Fig. 2A), immunoblotting revealed
that the steady-state protein levels of the RPE65R91W mutant
variant were reduced by 95% when compared with wild-type
mice (Fig. 2B; data not shown). The mutant protein was
detected in the RPE and thus was correctly localized (Fig. 2C).
Lecithin retinol acyltransferase (LRAT) and cellular retinal-
dehyde binding protein (CRALBP) are functionally connected
to RPE65 and the visual cycle (25–28). Expression of both
proteins was comparable in eyecups of 8-week-old wild-type,
R91W knock-in and Rpe652/2 animals with a tendency of
increased LRAT levels in knock-out mice (Fig. 2B). Levels
of rod opsin were slightly reduced in retinas of R91W mice
and—as previously reported (5)—in retinas of Rpe652/2
animals.
Retinoid analysis
The absence of RPE65 results in the arrest of the visual cycle,
causing an accumulation of retinyl esters in the RPE and
visual chromophore deficiency (5). On the basis of this obser-
vation, we expected that the dramatically reduced protein
levels of the RPE65R91W variant (Fig. 2B) would also result
in a disturbance of the visual cycle. Therefore, we analyzed
the retinoid composition in dark-adapted wild-type, R91W/
wt heterozygous, R91W homozygous and Rpe652/2 mice at
different ages. HPLC analysis of whole eye preparations of
4, 8, 12, 24 and 40-week-old animals demonstrated the pre-
sence of 11-cis-retinal in R91W homozygous mice, though
at low levels between 2.5 and 6.3% when compared with age-
matched wild-type animals (Table 1). As expected, no
11-cis-retinal was detectable in Rpe652/2 mice at any age
(Table 1) (5,29). All-trans-retinal, all-trans-retinol and
9-cis-retinal levels were comparable between R91W and
Rpe652/2 mice. The retinoid content and composition in
R91W/wt heterozygous animals did not differ from wild-type
mice at all tested ages (Table 1).
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Figure 1. Generation of R91W knock-in mice. (A) Partial sequence of exon 4 wild-type and mutated R91W DNA. Note that two point mutations were introduced
in the codon for arginine (R) at position 91 to obtain tryptophan (W). This resulted in the loss of a TaqI restriction site in the mutated DNA (right panel).
Sequence data of the targeting vector showing the mutant TGG triplet at position 91 (left panel). (B) Schematic representation of the R91W targeting strategy
I: partial wild-type Rpe65 allele, with restriction enzyme sites and location of first six exons (boxes). II: targeting construct containing R91W mutation (indicated
as lost TaqI restriction site in mutated exon 4), neomycin (neo)-resistant gene flanked by loxP sites (indicated as triangles) suitable for cre-medated excision, and
diphtheria resistance cassette (DT). Note the unique XhoI restriction site used for linearization of the targeting vector. III: genomic Rpe65 DNA after integration
of targeting vector carrying the neomycin cassette (Rpe65R91Wneo). Positions of PCR primer pairs and Southern blot probe (gray box) for PCR are indicated.
Neo1 and neo2 are nested primer pairs designed to read from the selection cassette into the 30 short arm outside of targeting area. These primers were used
to confirm the HR. The Taq primer pair was used to confirm the presence of R91W mutation (see Materials and Methods). IV: the partial R91W mutant
allele after the removal of the neo cassette by crossing Rpe65R91Wneo mice with the Cre-deleter mice. (C) Genotyping of R91W mutants. Upper panel: DNA
was isolated from neomycin-resistant ES cell colonies and analyzed by Southern blotting, after digestion with EcoRI, and using 30external probe as indicated
in (B). Signal from the genomic DNA from wild-type (wt) allele is 5.6 kb. A heterozygous Rpe65R91Wneo knock-in (KI) allele gives rise to additional 7.7 kb due
to the presence of the neomycin cassette. Middle panel: PCR analysis of the same DNA using neo1 and neo2 nested primer pair. A PCR fragment of 1445 bp
detected in heterozygous Rpe65R91Wneo knock-in due to the presence of the neomycin cassette. Lower panel: RFLP-PCR analysis of the same DNA using the Taq
primer pair [see (B)]. A PCR fragment of 998 bp was digested with the TaqI restriction enzyme. In wild-type animals, this results in a 379 and a 619 bp fragment.
Heterozygous Rpe65R91Wneo knock-in DNA contains an additional 998 bp fragment due to the loss of the TaqI restriction site. This protocol was used for geno-
typing of the final R91W knock-in mice. Asterisk indicates mutated exon 4.
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The presence of 11-cis-retinal indicated that the visual cycle is
functional in R91W animals. Nevertheless, we detected a strong
and almost linear (13 pmol/day; R2 ¼ 0.93) accumulation of
retinyl esters during the first 24 weeks of life. Between 24 and
40 weeks, no further increase was detected (2186 and
2108 pmol/eye, respectively; Table 1) suggesting that a
plateau was reached in R91W mice. In Rpe652/2 animals
retinyl ester levels increased linearly (9 pmol/day; R2 ¼ 0.96)
throughout 40 weeks (Table 1). Electron microscopy revealed
that this accumulation of retinyl esters was accompanied by
the formation of lipid droplets in the RPE of R91W and, as pre-
viously reported, in Rpe652/2 mice (5) (Fig. 3).
Rhodopsin content and regeneration
We next determined dark-adapted rhodopsin levels, which
reached 30 pmol/retina (Fig. 4A) in R91W mice representing
6% of wild-type rhodopsin. This percentage was comparable
to the amount of 11-cis-retinal observed in 4-week-old
R91W mice, which corresponded likewise to 6% of wild-type
levels (Table 1).
The expression levels of RPE65 protein govern the kinetics
of rhodopsin regeneration (30,31). Given the reduced amount of
RPE65 in R91W mice (Fig. 2), we expected that rhodopsin
would regenerate with a much slower rate. To allow a
maximal rhodopsin production, we kept R91W mice in darkness
for 4, 10 and 22 days. By the time of analysis, the mice were 6–
7-weeks old. Maximal rhodopsin levels detected after 22 days in
darkness were 42 pmol, which was still ,10% of wild-type
animals (Fig. 4A; see Fig. 4C for the wild-type levels).
In order to test rhodopsin regeneration kinetics, 6–7-
week-old animals were dark-adapted for 24 h and exposed
for 10 min to 5000 lux, which bleaches 90% of rhodopsin in
Figure 2. R91W mutation causes reduced levels of RPE65. (A) Relative mRNA levels of Rpe65 expressed in eyecups of wild-type, R91W (homozygous),
Rpe652/2 and R91W/wt (heterozygous) mice at 8 weeks of age as determined by real-time RT–PCR. mRNA levels, normalized to b-actin, are expressed rela-
tive to wild-type control, which was set to 1. RNA isolated from three independent retinas per age and genotype was amplified in triplicates (means+SD).
(B) Western blotting of eyecup or retinal proteins from 8-week-old wild-type, R91W or Rpe652/2 mice. The presence of the R91W mutation resulted in
reduced amounts of RPE65 immunoreactivity. Note similar levels of LRAT and CRALBP in the eyecups of all strains with a tendency of increased LRAT
levels in Rpe652/2 mice. Slightly reduced amounts of rod opsin (Rho) were detected in retinas of mutant mice (asterisk indicates Rho monomer, dimer or
trimer, respectively). Shown are the representative blots from at least three different animals per genotype. (C) Immunolabeling with a polyclonal antibody
to RPE65, demonstrating that the RPE65R91W mutant protein is expressed only in RPE cells. Note the reduced immunoreactivity when compared with
animals expressing wild-type RPE65 protein. The Rpe652/2 animals served as negative controls.
Table 1. Retinoid analysis
Age 11-cis-retinal All-trans-retinal All-trans-retinol Retinyl ester 9-cis-retinal
Wild-type 4 380.2+60.1 39.0+11.3 4.2+3.6 30.6+5.6 n.d.
8 336.1+21.8 34.7+1.6 5.4+9.4 39.2+5.0 n.d.
12 336.7+32.4 62.6+12.9 n.d. 34.9+4.6 n.d.
24 373.6+75.5 47.9+3.7 2.2+3.8 106.2+27.2 n.d.
R91W/wt 4 394.7+22.6 53.4+7.1 6.0+0.8 44.3+5.4 n.d.
8 371.8+22.1 87.1+4.7 n.d. 55.7+8.4 3.7+0.3
12 454.8+42.0 52.4+5.5 3.0+3.7 89.6+17.9 n.d.
24 337.4+49.0 86.4+15.3 n.d. 108.9+23.3 n.d.
R91W 4 24.0+3.0 3.6+0.6 10.4+1.9 420.7+34.5 7.6+0.8
8 15.4+0.2 4.8+1.5 9.2+5.2 651.9+127.4 9.9+0.9
12 13.5+0.2 2.7+0.4 13.9+2.7 1542.7+271.8 9.2+1.2
24 9.4+8.2 1.9+1.7 20.2+17.7 2186.1+160.1 4.3+3.7
40 18.2+4.8 2.2+1.0 12.4+3.4 2107.9+138.9 10.6+3.2
Rpe652/2 4 n.d. n.d. 8.6+2.5 271.4+22.8 4.8+1.5
8 n.d. 1.3+1.2 5.4+1.0 474.9+49.1 8.5+0.7
12 n.d. 1.9+0.4 14.9+4.1 805.9+57.5 6.7+0.9
24 n.d. 2.1+0.3 8.5+4.8 1160.6+529.0 10.3+3.8
40 n.d. 2.8+1.0 15.6+5.1 2622.9+531.3 13.1+11.2
All values are given in pmol/eye+SD (n ¼ 3). Age in weeks, as indicated. n.d., not detectable.
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wild-type mice (27). Animals were returned to darkness to
allow regeneration of the visual pigment. Non-exposed
R91W mice contained 27 pmol of rhodopsin (Fig. 4B),
which was bleached by light exposure, reducing it to
1 pmol. Even after prolonged dark-adaptation (5 days) only
44% (12 pmol) of the pre-bleach value (27 pmol) was detect-
able. Thus, following a strong bleach, regeneration of rhodop-
sin was inefficient and reached a plateau at about half the
maximal level of non-bleached, dark-adapted animals.
Maximal dark-adapted rhodopsin levels were similar in
R91W/wt heterozygous (538 pmol/retina) and wild-type
(560 pmol/retina) (Fig. 4C). The calculated regeneration
rates following a strong bleach were 6.3 pmol/min in wild-
type and 4.9 pmol/min in R91W/wt mice, indicating slightly
slower rhodopsin regeneration kinetics in the heterozygous
situation.
Photoreceptor function in R91W mutant mice
Next, we studied the consequences of the reduced
11-cis-retinal levels on retinal function. Scotopic ERG
recordings revealed that higher flash intensities were
needed to induce an electrical response in R91W when com-
pared with wild-type mice (Fig. 5A, top panel). By assessing
the luminance required to generate a half maximal b-wave
amplitude (32), the reduction in light sensitivity in
8-week-old R91W mice was determined to be 2.5 log
units when compared with wild-type. Therefore, R91W
mice are about one log unit more sensitive to light than
Rpe652/2 animals (6). In age series testing of 8, 12, 24
and 40-week-old animals, the sensitivity threshold remained
unaltered, whereas the b-wave amplitude was reduced with
increasing age in R91W, this being especially prominent
between 12 and 24 weeks (Fig. 5A, top and bottom
panels). From 24 to 40 weeks of age, no further reduction
in b-wave amplitude was detected. Thus, the sensitivity of
the retina was not prone to age-related reduction, whereas
the maximal response size was.
In order to test cone function, ERG responses were recorded
under photopic conditions (Fig. 5B). Notably, there was no
difference in threshold sensitivity or in amplitude of the
b-wave between 8-week-old R91W and wild-type control
animals (Fig. 5B, top and bottom panels). Given the low
amount of chromophore available (Table 1), cone responses
should be somehow affected. In addition, the waveforms
were altered in a way similar to that observed in Rpe65 null
mice (6), indicating that rods are active under those con-
ditions. Therefore, it appears that the photopic signals are
mixed responses containing both rod and cone system
components.
A comparison of wild-type and R91W/wt heterozygous
animals resulted, as expected, in no difference between the
genotypes under scotopic or photopic conditions (data not
shown).
Figure 3. Lipid-like inclusions in R91W mice. Electron microscopy of the RPE-photoreceptor interface in 8-week-old wt, R91W/wt, R91W and Rpe652/2 mice.
Note that lipid-like inclusions (arrowheads) are present in R91W and Rpe652/2 mice only, and the better preservation of OS morphology in R91W mice when
compared with Rpe652/2.
Figure 4. Rhodopsin content and regeneration kinetics. (A) Rhodopsin levels
in 6–7-week-old R91W animals kept in darkness for 1 day or up to 22 days (as
indicated). (B) Rhodopsin regeneration of R91W and wild-type mice. Follow-
ing 24 h dark-adaptation, R91W mice were exposed to 5000 lux for 10 min
and the rhodopsin content was analyzed either immediately (i) or after differ-
ent periods of recovery in darkness (as indicated). Unexposed, dark-adapted
mice (d) served as controls. (C) Rhodopsin regeneration of wild-type and
R91W/wt heterozygous mice. Experimental protocol and abbreviations are
as in (B). Note the slightly slower regeneration kinetics in R91W/wt mice.
Filled squares, R91W/wt; open squares, wild-type. All values are given in
pmol/eye+SD. At least three animals per condition and genotype were ana-
lyzed.
Human Molecular Genetics, 2008, Vol. 17, No. 2 285
Assessment of retinal morphology
The results of the tests for retinal function, both scotopic and
photopic ERG responses, in R91W mice suggested an
age-related retinal degenerative process (Fig. 5). To analyze
the consequences of the R91W mutation on retinal mor-
phology, we compared the three different genotypes (wild-
type, R91W and Rpe652/2) at various ages (from 4 weeks
to 1 year; Fig. 6). Already at 4 weeks of age, the outer seg-
ments (OS) of R91W and Rpe652/2 mice showed signs of
disorganization (Fig. 6, top row). The reduced compactness
and shortening of OS became more obvious as mice grew
older. Although the thickness of the outer nuclear layer
(ONL) at earlier time-points was comparable with wild-type,
Figure 5. ERG responses to single-flash stimuli with increasing intensities in 8, 12, 24 and 40-week-old R91W and wild-type animals. (A) Scotopic single-flash
ERG intensity series indicating loss of sensitivity in mutant mice. (B) Photopic single-flash ERG intensity series reflecting a similar sensitivity of wild-type and
R91W animals at 8 weeks of age. Note the decline of the b-wave amplitude with increasing age. Upper panels in (A) and (B) are recordings from representative
animals for a given genotype and age and in lower panels group statistics are presented (n ¼ 3). Boxes in group statistic graphs indicate the 25 and 75% quantile
range, whiskers indicate the 5 and 95% quantile, and the black line connects the medians of the data.
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only five rows of nuclei remained in the central area of
1-year-old mutant animals, when compared with nine to 10
rows in 1-year-old wild-types. In comparison to Rpe652/2
animals, R91W mice showed a better preservation of OS, at
least up to 12 weeks of age (Fig. 6). Notably, R91W mice con-
tained more cone nuclei than respective age-matched
Rpe652/2 mice, particularly at early age.
At all ages, we found no differences between the retinal
morphology of wild-type and R91W/wt heterozygous mice
(data not shown), which is in line with a recessive inheritance
of the phenotype caused by the R91W mutation. Furthermore,
no morphological differences between genotypes were detect-
able in inner retinal structures upon examination by light
microscopy.
DISCUSSION
R91W knock-in mice phenocopy human disease
In humans, about half of the identified mutations in RPE65 are
missense mutations [http://www.retina-international.com/
sci-news/rpe65mut.htm; see also Zernant et al. (7)]. The
newly generated Rpe65 R91W knock-in mice represent the
analogous animal model to human patients carrying a mis-
sense mutation in RPE65. In patients, the different mutations
in RPE65 are associated with variable degrees of severity of
retinal dysfunction (10,33). This is likely explained by the
different functional consequences of these mutations. All pre-
sently available animal models, however, carry either null
mutations having no residual function or a variant (L450M)
which causes only a mild disturbance of the visual cycle
without retinal degeneration (34).
We found that the rod system in R91W knock-in mice is
severely desensitized, although not as much as in mice
lacking RPE65 (6). Cones, however, are better preserved
and appear to be functional at least in young animals. Simi-
larly, R91W patients diagnosed with EOSRD are typically
night-blind (desensitized rod system) but retain cone-mediated
vision in the first decade (23). Reports on patients carrying
other missense mutations in RPE65 demonstrate functional
cone vision early in life (summarized in 35). Another distinct
group of patients affected by RPE65 mutations is character-
ized as legally blind from birth or severely visually impaired
in infancy. These patients are diagnosed as LCAII. The corre-
sponding mouse model, Rpe652/2 mice, clearly has no cone
function, and the minimal residual visual function is due to
desensitized rods using isorhodopsin with 9-cis-retinal as a
chromophore (6,36). The R91W knock-in mice, like patients
suffering from EORSD, possess a phenotype clearly dis-
tinguishable from the null situation in both mice and
humans. Thus, our analysis suggests that for an understanding
of a particular disease, reproducing the real mutation is
superior to a ‘simple’ knock-out mouse model.
Metabolic changes induced by R91W mutation
Very recently, the role of RPE65 as the isomerohydrolase in
the visual cycle was demonstrated by studies in cell culture
systems (2–4,37). In these experiments, a minimal visual
cycle has been restored in cell lines different from RPE and
only cells transfected with RPE65 vectors produced 11-cis-
retinal from precursor molecules. Further studies using the
same experimental paradigm aimed at the understanding of
Figure 6. Light microscopic changes in R91W retinas in comparison to wild-
type and Rpe652/2 mice at various ages. Disorganization of OS was evident
in R91W mice already at 4 weeks and became more pronounced with aging.
By 8 weeks, more voids were visible in the ONL accompanied by the appear-
ance of pycnotic nuclei. By 1 year, only five to six rows of nuclei remained in
the ONL. When compared with Rpe652/2 mice, R91W mice showed better
retinal preservation (longer OS and higher density) and more cone nuclei
were visible in younger animals. RPE, retinal pigment epithelium; OS, outer
segments; IS, inner segments; ONL, outer nuclear layer; INL, inner nuclear
layer.
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the consequences caused by missense mutations in RPE65
related to human disease (4,38,39). In particular, a study on
RPE65R91W showed that this mutation causes decreased
protein levels due to a decreased protein stability and/or
protein mislocalization (39). Additionally, in this report no
isomerohydrolase activity of the RPE65R91W protein variant
was detected. To circumvent the limitations of the in vitro
cell culture system and to analyze the consequences of
RPE65 missense mutations in a more ‘natural’ environment,
Chen et al. (17) employed a different strategy: they delivered
mutant Rpe65 genes to the RPE of RPE65-deficient mice by
means of an adenoviral vector. This strategy reproduced the
results of the in vitro cell culture system. In particular, the
expression of Rpe65R91W did not result in detectable RPE65
immunostaining in the RPE and accordingly was not
accompanied by 11-cis-retinal production or a gain of retinal
function.
In contrast, R91W knock-in mice showed: (i) detectable
protein expression with a correct localization to the RPE and
(ii) metabolic activity as evidenced by the generation of
11-cis-retinal. Thus, not surprisingly, the in vivo situation rep-
resents the most accurate model to assess the consequences of
a mutation. This study also validates our hypothesis that the
RPE65 protein with an R91W amino acid substitution pos-
sesses residual activity in human patients.
R91W knock-in mice have an altered visual cycle
Like the wild-type protein, the mutant RPE65R91W was
detected exclusively in the RPE, but at highly reduced levels
(5% of wild-type levels). Since RNA levels were less affected
(240%), translational or post-translational mechanisms may
contribute to the reduction in the protein levels of the
RPE65R91W variant. Comparison of Rpe65 knock-out with
Rpe65 R91W knock-in mice revealed important differences
with regard to biochemical function, the most important one
being the limited, but measurable ability of R91W knock-in
mice to generate 11-cis-retinal. In order to form functional
rhodopsin, 11-cis-retinal has to be incorporated into rod
opsin. In wild-type mice, the levels of 11-cis-retinal and rod
opsin are linearly correlated (27). In R91W mice, rod opsin
was only slightly reduced in comparison to wild-type
animals (Fig. 2B). Thus, low amounts of rod opsin are not
the reason for reduced 11-cis-retinal and rhodopsin levels
(,10% of wild-type). Another limitation of the visual cycle
in R91W knock-in mice was revealed in bleaching exper-
iments. Wild-type mice recovered their rhodopsin within
1–3 h after a bleach (27,34). R91W mice did not recover rho-
dopsin to dark-adapted levels within days. Thus, in addition to
the limitation in rhodopsin production as outlined above, a
strong bleach impaired rhodopsin regeneration.
Our data suggest that large amounts of unliganded rod opsin
must be present in photoreceptors of R91W knock in mice,
despite the fact that R91W mice can produce 11-cis-retinal.
As 11-cis-retinal acts as an inverse agonist, its low availability
could cause increased spontaneous activity of the
chromophore-free opsin molecule, leading to a constitutive
activation of the phototransduction cascade (40,41). It has
been hypothesized that in the presence of unliganded opsin
the retina sends a signal that results in vitamin A uptake
from the circulation (26). Thus, an insufficient supply of
opsin with 11-cis-retinal in R91W mice may be the cause of
the observed accumulation of retinyl esters.
One might speculate that 11-cis-retinal in R91W mice does
not originate from RPE, but from the recently proposed cone
visual cycle (42). In this alternate pathway, the cone pigment
is regenerated in Mu¨ller glia cells, independently of the RPE.
Hypothetically, such a cone visual cycle could be less
affected, or even may be fully operational despite the
R91W mutation. But how would the rods acquire
11-cis-retinal under this condition? 11-cis-retinal is cova-
lently bound to rod opsin via a protonated Schiff base and
this binding is tight. The cone opsin/11-cis-retinal holo-
complex is less stable, and it has been recently shown to dis-
sociate spontaneously (43). Thus, 11-cis-retinal might be
‘stolen’ by rods from cones due to this spontaneous dis-
sociation of the visual chromophore. This scenario might
also explain why rhodopsin regeneration kinetics is ineffi-
cient. Even though RPE65 has been reported to be detected
in cones (44,45) and this disputed (6,46), there is no experi-
mental evidence that RPE65 is directly involved in the pro-
posed cone visual cycle. However, contradictory to this
hypothesis, almost equal amounts of 11-cis-retinal were
retained up to 40 weeks of age, the time when the cones in
R91W animals are almost completely lost (unpublished
data).
Retinal degeneration
Constant activation of the phototransduction cascade due to
chromophore starvation has been implicated in rod degene-
ration in Rpe652/2 mice and consequently rod degeneration
can be prevented by blocking rod specific G-protein transducin
(Gnat1) signaling (47). Nevertheless, Rpe652/2; Gnat12/2
double mutant animals accumulate similar amounts of
retinyl esters as Rpe652/2 mice, indicating that unliganded
opsin, and not the accumulation of retinyl esters, is the
primary cause of degeneration (47). This concept is reinforced
by the observation that systemic supplementation with
9-cis-retinal preserves photoreceptor structure, despite conti-
nuing accumulation of retinyl esters (26). Accordingly, a
better preservation and slower degeneration of retinal mor-
phology in R91W in comparison to Rpe652/2 animals
might be attributable to the presence of small amounts of
11-cis-retinal. Nevertheless, also in R91W mice, the photo-
transduction cascade may be permanently activated, finally
causing retinal degeneration. This possibility will be further
investigated in R91W; Gnat12/2 double mutant mice.
Conclusion
We generated a novel mouse model for retinal dystrophy
caused by a missense mutation in RPE65. There are striking
functional differences to the knock-out situation, which are
not only important for basic research but also for understand-
ing the pathology and for clinical diagnosis in patients. Fur-
thermore, our results indicate that the therapeutic window
for gene therapy—the first tests of which are being carried
out these very days—is likely to differ between patients with
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null and missense mutations. Thus, preclinical trials for gene
replacement are underway for the R91W knock-in mouse.
MATERIALS AND METHODS
Generation of R91W knock-in mice
A classical strategy using homologous recombination (HR) in
embryonic stem (ES) cells has been employed to replace the
wild-type with a modified Rpe65 allele; 13.3 kb of Rpe65
genomic DNA (derived from the 129/Sv mouse strain)
divided into two contiguous subclones: E1-12 containing
exons 1–3 and clone E2-8 containing exons 4–6 cloned into
EcoRI restriction site of pBluescriptII SK(2) vector were
kindly provided by M.T. Redmond (National Eye Institute,
Bethesda, USA) (48).
Clone E2-8 containing exon 4 served as template for the
PCR targeted site-directed mutagenesis. Two point mutations
were introduced into the mouse R91 codon (CGA . TGG)
using a respective reverse primer (C AGT CAT TGC CCA
AAC ATA AGC ATC AGT GCG GAT GAA TCT GAA
GAC TAT TGA GAA ATG GA; underlined codon denotes
position 91) to obtain the R91W mutation. The forward
primer (GCG CGT AAT ACG ACT CAC TA) was designed
to hybridize in the plasmid backbone. The presence of the
R91W mutation was confirmed by sequencing. The neomycin
(neo) resistance cassette flanked by loxP sites (floxed-neo) in
the direct repeat orientation was integrated into the NheI site
downstream exon 5. The 30 site of the vector was truncated
by BamHI digestion resulting in the creation of the short
arm of the targeting construct. In the final step, the DT cassette
was introduced at the 50 site of the vector (upstream of exon 1)
to serve as a negative selection marker. The final targeting
construct carrying the R91W mutation was sequenced.
The XhoI-linearized targeting vector was electroporated into
coisogenic TC1 ES cells derived from 129S6/SvEvTac
(129S6) mouse strain (49). Genomic DNA from G418-
resistant ES clones was analyzed for correct vector integration
by PCR and Southern blotting as described below.
The positive ES clones were injected into blastocysts origin-
ating from C57BL/6 mice to obtain chimeric mice. Two chi-
meric males were born. Germ-line transmission was
confirmed in one male. This was done by breeding the chi-
meric males with C57BL/6 females where positive selection
was performed by coat colour assessment and PCR genotyping
form tail genomic DNA using neo1, neo2 and Taq primer pairs
(Table 2).
Following the confirmation of germ-line transmission, the
chimeric male was bred to 129S6 females to propagate the
line on a coisogenic background. This breeding resulted in
the generation of a heterozygous Rpe65R91Wneo line. The geno-
type was confirmed by PCR using neo1, neo2 and Taq primer
pairs (Table 2).
For in vivo removal of the neo resistance cassette,
Rpe65R91Wneo mice were bred with deleter mice expressing
cre recombinase in their germ-line [129S6-Tg(Prnp-GFP/
Cre)1Blw/J (24)]. The Rpe65R91Wneo mice were kept on a cre-
deleter background for two generations to ensure complete
excision of the floxed-neo cassette. The deletion of the neo
cassette was confirmed by PCR genotyping using neo1, neo2
and cre primer pairs (Table 2). Finally, the resulting hetero-
zygous (R91W/wt) offspring was intercrossed to obtain
R91W homozygous mice. The R91W knock-in mice analyzed
herein were therefore on a coisogenic 129S6 background. The
genotyping of the final R91W knock-in mice was performed
by PCR on tail genomic DNA using the Taq primer pair as
described in Table 2.
Genotype assessment
DNA from G418-resistant ES cells was analyzed by Southern
blotting. An external 30 BamHI probe (759 bp) was random-
labeled using the DIG labeling kit (#1585614, Roche Diagnos-
tics, Mannheim, Germany). Genomic ES cell DNA was
digested overnight with EcoRI and electrophoresed on a
0.8% agarose gel. DNA samples were transferred onto a
nylon membrane by a capillary method. The membrane was
incubated with the DIG-labeled probe. Fragments correspond-
ing to wild-type and, knock-in alleles (5.6 and 7.7 kb, respect-
ively) were detected by enhanced chemiluminescence.
For the detection of the correctly integrated neo cassette,
two primer pairs have been selected to allow a nested PCR
approach (Table 2). For the neo1 primer pair, the forward
primer was designed within the neo cassette and the reverse
primer was positioned outside of the targeted DNA sequence.
To further minimize any false-positive result, a nested neo2
primer pair was created within the same area, thus only cor-
rectly integrated DNA should be detectable by PCR (Table 2).
A Taq primer pair (Table 2) was used to detect the presence
of the R91W mutation. This pair produced a 998 bp fragment
from both wild-type and mutant DNA. Only the wild-type
DNA amplicon included a TaqI restriction site, resulting in
619 and 379 bp fragments after incubation with TaqI restric-
tion enzyme.
Animals
All procedures concerning animals were in accordance with
the regulations of the Veterinary Authority of Zurich and
with the statement of ‘The Association for Research in
Vision and Ophthalmology’ for the use of animals in research.
All animals were raised in cyclic light (12:12 h; 60 lux at cage
level). The cre expressing mice 129S6-Tg(Prnp-GFP/
Cre)1Blw/J (24) and corresponding wild-type mice (129S6)
were purchased from the Jackson Laboratory (Bar Harbor,
USA). Rpe65 deficient mice (Rpe652/2) were maintained at
the University Hospital Zurich (5). Genotyping was performed
by PCR on tail genomic DNA, using the primers shown in
Table 2.
RNA isolation, reverse transcription and real-time PCR
RNA isolation and reverse transcription from eyecup tissue
were performed as previously described (50). cDNA quantifi-
cation was carried out by real-time PCR using the LightCycler
480 Sybr Green I Master kit and a LightCycler 480 instrument
(Roche). cDNAs were amplified with primers for Rpe65 and
b-actin described elsewhere (5,51), and normalization was
done using the DDCT (comparative threshold cycle) method.
Relative values were calculated using a suitable calibrator
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sample as indicated in the results. Three animals were ana-
lyzed per genotype and each reaction was run in triplicate.
Western blotting
The retina or the remaining eyecup tissue was separately iso-
lated and processed for immunoblotting as previously
described (27). The primary antibodies used were: rabbit
anti-RPE65 (pin5; 1:2000); mouse anti-LRAT (1:1000, gift
from K. Palczewski, University of Washington, Seattle,
USA); rabbit anti-CRALBP (UW55; 1:10 000, gift from
J.C. Saari, University of Washington, Seattle, USA); mouse
anti-Rho (4D2) (1:8000, gift from D. Hicks, Universite´
Louis Pasteur, Strasbourg, France) and b-actin as standard
(1: 1000, Santa Cruz, USA). At least three animals were ana-
lyzed per genotype.
Rhodopsin steady-state levels and rhodopsin
regeneration kinetics
Mice were dark adapted for 24 h, sacrificed under dim red
light, and retinas were isolated through a slit in the cornea.
Rhodopsin content was analyzed as described earlier (27).
The kinetics of rhodopsin regeneration after bleaching was
analyzed as previously described in detail (27). Briefly, mice
were dark adapted for 24 h and pupils were dilated 30–
60 min prior to light exposure. Animals were exposed for
10 min to 5000 lux of fluorescent white light. Following illu-
mination, mice were placed in darkness for the times indicated
in the results and rhodopsin content was analyzed as described
above. Non-exposed mice served as dark controls. At least
three animals were analyzed per condition and genotype.
Histology
Animals were sacrificed and the superior part of the eye was
marked for orientation. The enucleated eyes were fixed over-
night in 2.5% glutaraldehyde prepared in 0.1 M cacodylate
buffer and processed as described previously (50). Semi-thin
sections (0.5 mm) of Epon-embedded tissue were prepared
from the inferior central retina, counterstained with Methylene
blue and analyzed using a microscope (Axiovision, Zeiss,
Jena, Germany). For electron microscopy, thin sections were
analyzed using a Hitachi 7000 electron microscope (Hitachi,
Tokyo, Japan).
Immunofluorescence
Enucleated eyes were immersed in cryoprotective medium
(Jung, Nussloch, Germany) and processed for immunofluor-
escence as described recently (29). For detection, rabbit
anti-RPE65 primary antibody (1:500) and Cy3 conjugated
anti-rabbit secondary antibody (Jackson ImmunoResesarch,
Soham, UK) were applied. Immunofluorescence was analyzed
on a microscope (Axiovision, Zeiss) and documented using a
digital imaging system.
HPLC determination of retinoids
Mice were dark-adapted for 24 h. All steps were carried out
under dim red light. Animals were sacrificed, and lens and
vitreous were removed from the eye through a slit in the
cornea. The rest of the tissue including the retina and
eyecup was snap frozen in liquid nitrogen until further analy-
sis. Retinoid extraction and HPLC analysis was performed as
previously described (27).
ERG functional tests
ERGs were recorded binocularly according to previously
described procedures (6) in anesthetized mice with dilated
pupils using a Ganzfeld bowl, a DC amplifier and a
PC-based control and recording unit (Toennies Multiliner
Vision; Viasys Healthcare, Ho¨chberg, Germany). Recordings
were obtained in both scotopic (dark-adapted overnight) and
photopic (light-adapted 10 min at 30 cd s/m2) conditions.
Single white-flash stimulus intensity ranged from 24 to
1.5 log cd s/m2 under scotopic and from 22 to 4 log cd s/m2
under photopic conditions, divided into 10 and 13 steps,
respectively. Ten responses per intensity were averaged with
an inter-stimulus interval of either 5 or 17 s (.1 cd s/m2).
At least three animals per genotype and age were analyzed.
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6.5.2 Summary 
In this paper we show that photoreceptor injury induces the expression of the IL-6 
family member LIF in the retina initiating protective response mechanisms. We showed 
that degenerating retinas of VPP mice have increased levels of LIF mRNA beginning 
with PND21 and peaking at PND42. In correlation, the lack of LIF in double mutant 
VPP/LIF-/- mice caused an acceleration of retinal degeneration between PND28 and 
PND42 but not at early time points, which suggested a pro-survival role of LIF. Of note, 
LIF-/- mice developed normal retina and protein expression as well as localization of 
typical markers for horizontal cells (calbindin), bipolar cells (CHX10), Müller cells 
(glutamine synthetase (GS)) and ganglion cell (Brn3a) was not affected when 
compared to wild type animals. To identify the cells, which expressed LIF in 
degenerating retinas, we combined in situ hybridization and immunofluorescene. In 
contrast to wild type controls, VPP mice and light exposed mice showed a specific LIF 
mRNA staining in a few scattered cells within the INL. That signal correlated with the 
staining of the Müller cell marker GS. However, only a subset of Müller cells seemed to 
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express LIF whereby the GS intensity correlated inversely with the LIF staining 
intensity. Further, we showed that the lack of LIF in VPP/LIF-/- mice prevented the 
activation of STAT3 and Akt. GFAP as a marker for Müller cell activation was induced 
during retinal degeneration. However, VPP/LIF-/- mice had no elevated GFAP levels, 
suggesting that injury stimuli might require LIF to activate Müller cells. LIF ablation 
caused a disturbance of proper retinal signaling in response to stress or injury. As a 
response to retinal degeneration in VPP mice and light-exposed mice photoreceptor 
cells expressed increased levels of endothelin 2 (Edn2) mRNA. Additionally, Casp-1, 
GFAP, FGF2, Jak3 and SOCS3 mRNA levels were induced in those retinas. However, 
these genes were not induced or even repressed in VPP/LIF-/- mice. The intravitreal 
application of recombinant LIF to LIF-/- mice completely restored the signaling in the 
retina and caused a STAT3 reactivation as well as an induction of Edn2, GFAP and 
FGF-2 mRNA expression. To test our hypothesis that Edn2 signaling in response to 
retinal injury requires LIF to initiates the signaling cascade; we injected an End2 
receptor (Ednrb) agonist (BQ-3020) intravitreally. In wild type mice BQ-3020 indeed 
induced the mRNA expression of LIF, FGF2 and Edn2. However, in LIF-/- mice BQ-
3020 failed to induce FGF-2 expression and hardly induced End2 expression, showing 
that LIF is indeed required to mediate Edn2 signaling. Further, we showed that the 
application of BQ-3020 diminished retinal apoptosis after light exposure. In contrast, 
application of the Ednrb antagonist BQ-788 enhanced apoptosis in the VPP mouse 
supporting an important role of the Ednrb signaling system in retinal degeneration. To 
analyze, whether LIF signaling requires photoreceptor cells, we employed 
photoreceptor cell devoid rd1 mice and cone only NRL-/- mice. Application of 
recombinant LIF did not significantly induce the LIF signaling cascade when compared 
to PBS-injected controls. This suggests that the LIF mediated signaling cascade 
requires not only LIF expression in Müller cells but also the presence of rod 
photoreceptors. Finally, we proposed a model pathway in which LIF is induced in a 
subset of Müller cells after photoreceptor cell injury. LIF induces via an unknown 
pathway the expression of Edn2 in photoreceptor cells, which signals back to the INL in 
order to activate Müller cells and to stimulate the expression of the pro-survival factor 
FGF-2. 
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Survival and death of photoreceptors in degenerative diseases of the retina is controlled by amultitude of genes and endogenous factors.
Some genesmay be involved in the degenerative process itself whereas othersmay be part of an endogenous defense system.We show in
twomodels of retinal degeneration that photoreceptor death strongly induces expression of leukemia inhibitory factor (LIF) in a subset
ofMuller glia cells in the inner nuclear layer of the retina. LIF expression is essential to induce an extensive intraretinal signaling system
which includesMuller cells and photoreceptors and is characterized by an upregulation of Edn2, STAT3, FGF2 and GFAP. In the absence
of LIF, Muller cells remain quiescent, the signaling system is not activated and retinal degeneration is strongly accelerated. Intravitreal
application of recombinant LIF induces the full molecular pathway including the activation of Muller cells in wild-type and Lif–/– mice.
Interruption of the signaling cascade by an Edn2 receptor antagonist increases whereas activation of the receptor decreases photorecep-
tor cell death. Thus, LIF is essential and sufficient to activate an extensive molecular defense response to photoreceptor injury. Our data
establish LIF as a Muller cell derived neuronal survival factor which controls an intrinsic protective mechanism that includes Edn2
signaling to support photoreceptor cell survival and to preserve vision in the injured retina.
Key words: leukemia inhibitory factor; Edn2; retina; photoreceptor degeneration; neuroprotection; endogenous rescue pathway
Introduction
Human vision depends on the absorption of photons by rod and
cone photoreceptors which convert the light information into a
signal which is transported by connecting neurons to the brain.
This highly specialized process requires sophisticated molecular
interactions between a variety of intra- and intercellular retinal
components. Thus, the retina has to maintain a high integrity of
its cellular architecture and of the molecular machinery of visual
cells. Mutations and/or exogenous stimuli disturb the retinal in-
tegrity and may lead to photoreceptor apoptosis and retinal de-
generation (Reme´ et al., 1998). Cells of the retina can react to
unfavorable (stress) conditions or to injury with the production
of various cytokines and growth factors in an attempt to protect
neurons and to preserve retinal function. This might best be seen
in experimental paradigms of preconditioning in which a sub-
toxic stimulus induces the differential expression of specific
genes. This increases the resistance of the tissue to a subsequent
stronger stress and thus promotes cell survival (Kamphuis et al.,
2007; Zhu et al., 2007; Thiersch et al., 2008). Ischemic or hypoxic
exposure are classical preconditioning schemes but light expo-
sure below damaging threshold has also been successfully applied
(O’Driscoll et al., 2008) demonstrating the existence of several
activatable survival pathways in the retina.
Exposure to high levels of white light induces photoreceptor
degeneration (Reme´ et al., 1998) and activates a signaling cascade
which includes leukemia inhibitory factor (LIF), Janus kinase 2
(Jak2), signal transducer and activator of transcription 1
(STAT1) and STAT3 (Samardzija et al., 2006a). A similar retinal
response has been observed in models of inherited retinal degen-
eration (Samardzija et al., 2006a). Since recombinant LIF can
protect photoreceptor cells against light-induced degeneration
(Ueki et al., 2008), the increased expression of endogenous LIF in
response to damaging light suggests that LIF might be part of a
retinal defense mechanism to increase survival of visual cells.
Such an endogenous protective response has recently been pos-
tulated by Rattner and Nathans. In their study, they propose that
injured photoreceptors produce endothelin 2 (Edn2) which sig-
nals onto Muller cells. Activated Muller cells and/or other cells
may then produce and release fibroblast growth factor 2 (FGF2)
to support survival of viable photoreceptors (Rattner and
Nathans, 2005).
Here we focused on the role of LIF in the degenerating retina
of the VPP mouse, a model for autosomal dominant retinitis
pigmentosa (Naash et al., 1993; Grimm et al., 2004). We show
that lack of LIF prevents Edn2 expression, STAT3 phosphoryla-
tion, FGF2 production and activation of Muller glia cells and
strongly accelerates retinal degeneration. This suggests that LIF is
the key factor regulating an endogenous defense mechanism to
ensure survival and function of retinal cells. Since LIF expression
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is specifically induced in a subset of Muller glia cells, Muller cells
may coordinate the molecular response to injury and initiate an
elaborate and LIF-dependent crosstalk between various retinal
cells of the INL and ONL.
Materials andMethods
Mice, light exposure, intravitreal injections, and detection of cell death.
Animals were treated in accordance with the regulations of the Veteri-
nary Authority of Zurich and with the statement of “The Association for
Research in Vision and Ophthalmology” for the use of animals in re-
search. VPP mice [generous gift fromMuna Naash (Naash et al., 1993)]
were on amixed SV129BL/6 background. Lif –/–mice (Escary et al., 1993)
were kindly provided by Bettina Holtmann and Michael Sendtner (Uni-
versity ofWuerzburg, Germany).Ccl-2 –/– (Jackson Laboratory), BALB/c
mice (Harlan) and 129S6/SvEvTac (Taconic) were purchased from com-
mercial suppliers. All mice except BALB/c and 129S6/SvEvTac (both
Rpe65450Leu) expressed theRpe65450Met variant (Samardzija et al., 2006b).
Double mutant mice were generated by classical breeding schemes.
Primer pairs for genotyping are listed in Table 1. For rd1 genotyping,
PCR products were digested with DdeI to detect presence or absence of
the mutation as described earlier (Hafezi et al., 1998).
For light exposure, 8-week-old wild-type mice were dark-adapted over-
night and their pupils were dilatedwith 1%Cyclogyl (Alcon) and 5%phen-
ylephrine (Ciba Vision) 45 min before exposure to 5000 lux of white fluo-
rescent light for 2 h.After exposure,micewere returned todarkness for 12h.
Intravitreal injections were performed on anesthetized animals with a
34G needle mounted on a 10l Hamilton syringe. Injection site was just
behind the limbus on the superior part of the eye. Intravitreal placement
of the needle was observed through the pupil. One microliter of rLIF in
PBS (10 ng/l; Millipore), BQ-3020 in H2O (1 g/l; American Pep-
tide), BQ-788 in 10%DMSO in PBS (2 g/l; American Peptide) or of
vehicle alone was injected within 5–10 s and the empty needle was kept in
place for additional 30 s before it was slowly withdrawn. BQ-3020 injec-
tions were done in 129S6/SvEvTacmice (n 21) 24 h before exposure to
2 h of 13,000 lux of white light. Analysis of cell death was 24 h after
exposure. BQ-788 injections were done in VPP mice (n 9) at PND 35
and analysis of cell death was 48 h thereafter. Cell death was analyzed by
measuring free nucleosomes in each (total) retina individually using the
cell death detection kit (Roche) according to the manufacturer’s recom-
mendations. Retinal cell death in compound injected eyes was expressed
as fold-difference to cell death in the sham injected contralateral eyes of
the same animal.
Microscopyand immunofluorescence.For lightmicroscopy, eyeswere fixed
in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.3, at 4°C overnight.
For each eye, the superior and the inferior retina were prepared, washed in
cacodylate buffer, incubated in osmium tetroxide for 1 h, dehydrated, and
embedded in Epon 812. Sections (0.5 m) were prepared from the lower
central retina and counterstained withmethylene blue.
For immunofluorescence, mice were perfused with 4% paraformalde-
hyde in PBS. Eyes were removed and post fixed for 10 min in 4% para-
formaldehyde. Cornea and lens were removed and eyecups were post-
fixed in 4% paraformaldehyde for additional 15 min at room
temperature. The tissue was then incubated in 10% sucrose (in PBS) for
10 min, 20% sucrose for 30 min and 30% sucrose overnight at 4°C.
Eyecups were embedded in Tissue Tec OCT (Mioles), frozen in liquid
nitrogen and stored at70°C until further use. Twelve micrometer sec-
tions were cut, dried and washed in PBST (PBS 1% Triton X-100) for
3 5min at room temperature (RT). After blocking in PBS 10%horse
serum (HS) for 1 h at RT, sections were incubated with the respective
primary antibodies anti-Calbindin (AB1778), anti Brn-3a (MAB1585),
anti-CHX10 (AB9014), anti-glutamine synthetase (MAB302; all Milli-
pore), anti-Iba-1 (#019-19741, Wako), anti-PKC (sc-209, Santa Cruz;
kindly provided by S. Neuhauss, University of Zurich, Zurich, Switzer-
land), anti-Calretinin or anti-Disabled-3 (both kindly provided by E.
Strettoi, Neuroscience Institute, Italian National Research Council, Pisa,
Italy). Sections were washed 3  10 min in PBS and Cy3- or Cy2-
conjugated secondary antibodies (Jackson ImmunoResearch) were ap-
plied in PBS  10% HS (dilution 1:500) for 1–2 h at RT. Sections were
washed 3 10 min in PBS, mounted and analyzed using a Zeiss fluores-
cent microscope.
In situ hybridization. For in situ hybridization, nonfixed tissue was
frozen in Tissue TecOCT (Mioles). Twelvemicrometer sections were cut
and air dried for 20 min at room temperature and 10 min at 50°C.
Sections were post-fixed for 10 min at room temperature in 4% parafor-
maldehyde (in PBS) followed by 3 washing steps with PBS (5 min each).
Samples were acetylated for 20 min at room temperature in 100 mM
triethanolamine, 2.5 l/ml acetic anhydride followed by 3 washing steps
with PBS (5 min each). Prehybridization was done at room temperature
for 2 h in 50% formamide, 5xSSC, 1xDenhardt’s, 1 mg/ml yeast tRNA,
0.1% Tween 20, 0.1% CHAPS, 5 mM EDTA. Hybridization was done for
16 h at 65°C in 15 ml of the same solution including 7–15 g of DIG-
labeled sense or antisense RNA probe. Slides were washed 5 times in SSC
with increasing stringency and blocked in 100 mM Tris, pH 7.5, 150 mM
NaCl and 1% blocking reagent (Roche # 1096176) for 1 h at room tem-
perature. Incubation with anti-DIG antibody (Roche) in blocking buffer
was for 16 h at 4°C. Slides were washed twice in 100 mM Tris, 150 mM
NaCl at room temperature for 20min each, equilibrated for 5min in 100
mM Tris, pH 9.5, 150 mM NaCl, 50 mM MgCl2, 0.25 mg/ml levamisole
(Sigma, L9756) and incubated in the same solution including 1 l/ml
NBT and 3.5l/ml BCIP for up to 16 h at room temperature. After color
had developed, reaction was stopped in 10 mM Tris (pH 8.0)/1 mM
EDTA, slides were mounted and analyzed.
Combined in situ hybridization/immunofluorescence. In situ hybridiza-
tion was performed as described above on perfused (4% PFA) and cryo-
preserved tissue (seeMicroscopy and immunofluorescence) usingRNase
free reagents. After color development slides were washed 2 in PBS for
5 min each. Slides were then postfixed in 4% PFA for 10 min at RT,
washed 2 in PBS (5min each) and the primary antibodies were applied
in 5% HINGS (heat inactivated goat serum) for 3 h at RT. Slides were
Table 1. Primers used for genotyping and real-time PCR
Gene/allele Forward Reverse
Genotyping
VPP AGACTGACATGGGGAGGAATTCCCAGA CAGCTGCTCGAAGTGACTCCGACC
Lif/wt AAATGCCACCTGTGCCATACGC CAACTTGGTCTTCTCTGTCCCG
Lif/KO CTCTAAGCCTGAACTCTCTCATCC GATTCGCAGCGCAGCGCATCGCCTT
Ccl-2/wt GGAGCATCCACGTGTTGGC ACAGCTTCTTTGGGACACC
Ccl-2/KO CTTGGGTGGAGAGGCTATTC AGGTGAGATGACAGGAGATC
Rd1 CATCCCACCTGAGCTCACAGAAAG GCCTACAACAGAGGAGCTTCTAGC
Nrl/wt GTGTTCCTTGGCTGGAAAGA CTGTTCACTGTGGGCTTTCA
Nrl/KO TGAATACAGGGACGACACCA GTTCTAATTCCATCAGAAGCTGAC
Real-time PCR
Edn1 TCCCGTGATCTTCTCTCTGC AGTTCGGCTCCCAAGACAG
Edn2 AGACCTCCTCCGAAAGCTG CTGGCTGTAGCTGGCAAAG
Ednrb ACCTACAAGTTGCTCGCAGAGG AAAACCTATGGCTTCGGGGAC
Smad1 TGGTTCCAAGCAGAAGGAGGTC GCTCATTTTGTCCCAGGTTGC
Gfap CCACCAAACTGGCTGATGTCTAC TTCTCTCCAAATCCACACGAGC
Mcl1 GTGACTCTTATTTCTTTCGGTGCC CATCCCAGCCTCTTTGTTTGAC
Casp-1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC
Fgf2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG
Cntf CTCTGTAGCCGCTCTATCTG GGTACACCATCCACTGAGTC
Bdnf CAAAGCCACAATGTTCCACCAG GATGTCGTCGTCAGACCTCTCG
Gdnf AGATGAAGTTATGGGATGTCGTGG GGCATATTGGAGTCACTGGTCAG
Bcl-2 TTGTGGCCTTCTTTGAGTTCG ATTTCTACTGCTTTAGTGAACC
Survivin AACTACCGCATCGCCACCTTCAAG AGCCAGGGGAGTGCTTTCTATG
Jak1 TGAGCTTTGATCGGATCCTT GCAGGGTCCCAGAATAGATATG
Jak2 GAACCTACAGATACGGAGTGTCC CAAAATCATGCCGCCACT
Jak3 CACAGTGCATGGCCTATGAT AGGTGTGGGGTCTGAGAGG
Tyk2 CCTGTGTCACCTTGCTCTCA GGAATGAGGGATGCAGTTCT
Socs3 GGAGACAGATGAGGCTGGTGA GGACCTACTGACCGAGAGAT
Stat3 CAAAACCCTCAAGAGCCAAGG TCACTCACAATGCTTCTCCGC
Lif-R ACTGAAGTGGAACGACAGAGG CTTTACCACTCAGCATTGTGTTG
Gnat1 GAGGATGCTGAGAAGGATGC TGAATGTTGAGCGTGGTCAT
Lif AATGCCACCTGTGCCATACG CAACTTGGTCTTCTCTGTCCCG
Mcp-1 GGCTCAGCCAGATGCAGTTA CTGCTGCTGGTGATCCTCTT
Primers for Gnat1were from Znoiko et al. (2005).
13766 • J. Neurosci., December 17, 2008 • 28(51):13765–13774 Joly et al. • LIF Increases Photoreceptor Survival In Vivo
rinsed 1x in PBS, washed 3x in PBS (5min each)
and blocked in 20% HINGS at RT for 1 h. The
respective secondary antibodies were applied in
5% HINGS at RT for 1 h. Slides were rinsed in
PBS, washed 3  in PBS (5 min each) and
mounted.
Western blotting. Retinas were homogenized
by sonication in 100 mM Tris/HCl, pH 8.0, and
analyzed for protein content using Bradford re-
agent. Standard SDS-PAGE (12%) and West-
ern blotting of 40 g of total retinal extracts
were performed. For immunodetection, the
following antibodies were used: anti-STAT3
(#9132 Cell Signaling Technology), anti-Akt
(#9272, Cell Signaling Technology), anti-gp130
(sc-656, Santa Cruz), anti-GFAP (G-3893,
Sigma), anti-CRALBP (gift from John Saari,
University of Washington, Seattle, WA), anti-
-actin (sc-1616, Santa Cruz Biotechnology),
anti-phospho-STAT3Tyr705 (#9131, Cell Signal-
ing Technology), anti-phospho-AktTyr473
(#9271, Cell Signaling Technology). Blots were
incubated overnight at 4°C with primary anti-
bodies followed by a one hour incubation at RT
with HRP-conjugated secondary antibodies.
Immunoreactivity was visualized using the
Western Lightning Chemiluminescence re-
agent (Perkin-Elmer).
RNA isolation, cDNA synthesis, and real-time
PCR.Retinas were removed through a slit in the
cornea and snap frozen in liquid nitrogen. Total
retinal RNA was prepared using the RNeasy
RNA isolation kit (Qiagen) including a DNase
treatment to digest residual genomicDNA.One
microgram of total RNA were used for reverse
transcription using oligo(dT) and M-MLV re-
verse transcriptase (Promega). cDNAs from in-
dividual animals were amplified in duplicates
with respective primer pairs (Table 1) in a
Light-Cycler instrument 480 (Roche Diagnos-
tics AG) using SYBR Green I Master Mix
(Roche Diagnostics AG). mRNA levels were
normalized to -actin and relative gene expres-
sion was calculated using the value of one (out
of three) wild-type probe as calibrator. For sta-
tistical analysis we used ANOVA with Tukey’s
multiple comparison test (wheremore than two
conditions were compared), ANOVA with
Dunnett’smultiple comparison test (where sev-
eral conditions were compared with a control)
or a one-tailed t test for the comparison of the
treatment in Lif –/– animals, respectively. p val-
ues of 0.05 were considered statistically
significant.
Results
Lack of LIF accelerates photoreceptor
degeneration in a model of
retinitis pigmentosa
The degenerating retina of VPP mice in-
duces the expression of several factors con-
nected to an inflammatory or immune re-
sponse like LIF (Fig. 1A) (Samardzija et al.,
2006a), monocyte chemoattractant
protein-1 (MCP-1) (Fig. 1B), Casp-1,
interleukin-1 (IL-1) (Samardzija et al.,
2006c), complement component 1q
(C1q) (Rohrer et al., 2007) and comple-
Figure 1. Lack of LIF accelerates photoreceptor degeneration in the VPP retina. A, B, Retinas from wt (squares) or VPP
(triangles)micewere isolated at different postnatal days (PND) as indicated. Gene expression of LIF (A) andMCP-1 (Ccl-2) (B) was
analyzed by real-time PCR and normalized to -actin expression. Expression of both factors was strongly induced in VPP mice
starting around PND 15, concomitantly with the onset of photoreceptor degeneration. Shown are the meanmRNA levels (SD)
of three independent retinas per time point and strain (n 3) relative to the levels of wild-type (wt) at PND 10which was set to
1. C, Retinalmorphology of VPP (left) and VPP;Ccl-2 –/–mice (right) at PND 42. Lack of Ccl-2 did not influence the degeneration as
reflected by the indistinguishable retinal morphologies. Both genotypes retained 5–6 rows of photoreceptor nuclei in the ONL
comparedwith the10–12 rows inwild-type retinas (D).D, Retinalmorphologyofwild-type (wt), Lif –/–, VPPandVPP;Lif –/–mice
was analyzed at PND 15, PND 28 and PND 42 as indicated. Retinal morphology was similar in wt and Lif –/– at all ages tested.
Retinas of VPP mice developed normally until the age of 15 d. As expected (Samardzija et al., 2006b), many VPP photoreceptors
degenerated until PND 28 before the degeneration slowed down. Photoreceptors of VPP;Lif –/– mice displayed a similar degen-
eration until PND 28 but had amuchmore severe progression thereafter as seen by the single row of photoreceptors remaining at
PND 42. Shown are representative panels of at least three independent retinas. RPE, Retinal pigment epithelium; ROS, rod outer
segments; RIS, rod inner segments; ONL, outer nuclear layer; INL, inner nuclear layer. Scale bars, 25m.
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ment factor H (CFH, data not shown). To analyze their potential
role in the physiology or pathophysiology of the retina, we genet-
ically inhibited MCP-1 and LIF signaling. For this purpose, we
generated doublemutantmice expressing theVPP transgene on a
null background for either the MCP-1 chemokine (Ccl-2–/–) or
the LIF cytokine (Lif–/–), respectively. Even though MCP-1 was
upregulated 100-fold in the VPP retina, lack of functional
MCP-1 did not noticeably influence the course of the disease
process (Fig. 1C). In contrast, genetic ablation of LIF strongly
accelerated retinal degeneration and the death of photoreceptors
in VPP mice (Fig. 1D). Whereas retinas of VPP mice showed the
expected slow degeneration with6 rows of photoreceptor cells
left at PND 42, retinas of VPP mice lacking LIF showed a severely
accelerated degenerationwith only one rowof visual cells remaining
42 d after birth (Fig. 1D). Onset and first phase of the degeneration
was similar to VPPmice as suggested by the normal retinal appear-
ance at PND 15 and by the only slightly reduced number of photo-
receptor nuclei at PND 28.
Although LIF has been implicated in retinal development (El-
liott et al., 2006) and lack of LIF was recently reported to increase
microvessel density in the retina (Kubota et al., 2008), retinal
morphology of Lif–/– mice was similar to wild-type mice at all
ages tested. Retinal cell layers were well established and distribu-
tion of rods and cones was inconspicuous (Fig. 1D). In addition,
immunofluorescence stainings with antibodies specific for hori-
zontal cells (anti-calbindin), bipolar cells (anti-CHX10), Muller
cells (anti-glutamine synthetase) and ganglion cells (anti-Brn3a)
resulted in similar staining patterns in wild-type and knock-out
mice (Fig. 2). Normal retinal architecture of Lif–/– mice is further
supported by the equal numbers of retinal ganglion cells in wt
and LIF knock-out animals (additional file 1). In addition, retinal
function of Lif–/– mice was comparable to wild-type animals
(data not shown).
Photoreceptor injury induces LIF expression in a subset of
Muller glia cells
We used in situ hybridization to localize the cells expressing LIF
cytokine in response to photoreceptor injury.Whereasmost cells
did not show enhanced signal intensity compared with controls,
few scattered cells were strongly positive for LIF expression in the
INL of VPP mice at PND 28 (Fig. 3A–C). A very similar expres-
sion pattern was also found in retinas of wild-type mice at 12 h
after exposure to damaging light (Fig. 3D–F,G,J). This suggests
that the same subset of cells might be responsible for LIF upregu-
lation in both models of retinal degeneration. Hybridization of
wild-type control retinas with antisense probe did not result in
such a staining pattern (Fig. 3F) demonstrating that the signal
was specific for degenerating retinas. To identify the retinal cell
type expressing LIF, we combined in situ hybridization with im-
munofluorescence using antibodies specific for individual retinal
cell types. Whereas the in situ LIF signal did not colocalize with
calbindin (horizontal cells), calretinin (amacrine cells),
disabled-3 (type 2 amacrine cells), PKC- (cone bipolar cells) or
Iba-1 (microglia cells) (additional file 2), it labeled a subset of
Figure 2. A–D, Lif –/– retinas are similar to wild-type. Retinas of 28-day-oldwild-type (wt) and Lif –/–mice, respectively, were stainedwith antibodies specific for horizontal cells (calbindin,A),
bipolar cells (CHX10,B),Muller glia cells (glutamine synthetase,C) andganglion cells (Brn3a,D). Stainingpatternsdidnotdiffer betweenwild-typeandmutant retinas.GCL,Ganglion cell layer.Other
abbreviations as in Figure 1. Scale bar, 50m.
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cells which stained positive for glutamine synthetase (GS) (Fig.
3G–L). This clearly demonstrates that a subset ofMuller glia cells
upregulated LIF in response to retinal stress. It is interesting to
note that the intensity of the GS staining correlated inversely with
the intensity of the LIF signal (Fig. 3 J,K).
Lack of LIF prevents activation of Muller glia cells and blocks
phosphorylation of STAT3
Muller cell activation is one of the most common hallmarks in a
degenerating retina. In virtually all cases studied, retinal Muller
cells increase expression of glial fibrillary acid protein (GFAP) in
response to a degenerative process (Lewis and Fisher, 2003;
Bringmann et al., 2006). This has also been observed in the VPP
mouse retina (Fig. 4) (Samardzija et al., 2006a). In contrast to
VPP mice on a LIF wild-type background, increased expression
of GFAP was completely abolished in retinas of VPP;Lif–/– (Fig.
4). The similar expression levels of cellular retinaldehyde-binding
protein (CRALBP) (Fig. 4) and the immunofluorescence staining
for glutamine synthetase (GS) (Fig. 2), both Muller cell markers,
show that the missing glial response was not due to a generally
reduced presence of Muller cells in LIF knock-out animals.
Similarly toGFAP inMuller cells, phosphorylation of the anti-
apoptotic STAT3 protein has been commonly observed during
degenerative processes in the retina (Mechoulam and Pierce,
2005; Samardzija et al., 2006a; Yang et al., 2007; Ueki et al., 2008).
As for the increased GFAP expression, phosphorylation of
STAT3was completely blocked in retinas ofVPP;Lif–/–mice (Fig.
4). Since STAT3 protein was expressed at normal levels (Fig. 4)
and the enzymaticmachinery to phosphorylate STAT3was intact
in the Lif–/– retina (see below), a block of upstream signaling
events in the absence of LIF cytokinemust account for the lack of
STAT3 phosphorylation and themissingMuller cell activation in
the double transgenic animals.
Akt, another kinase implicated in retinal degeneration and cell
survival (Johnson et al., 2005; Jomary et al., 2006) was slightly acti-
vated in degeneratingVPP retinas as evidenced by the small increase
in phosphorylation observed byWestern blotting (Fig. 4). Similar to
STAT3, the absence of LIF prevented increased phosphorylation of
Akt in response to the degeneration in theVPP;Lif–/– retina.
LIF is required for proper signaling in the stressed retina
Recently, Rattner and Nathans (2005) identified photoreceptor-
derived Edn2 as a potential signaling molecule regulating a Mul-
ler glia cell response to light-mediated injury. Similar to the light-
Figure 3. The degenerating retina induces LIF expression in a subset ofMuller glia cells.A–F, In situ hybridization localizes LIF-expressing cells in the INL. Retinal sections of 28-day-old VPPmice
(A–C), of wild-type BALB/c mice 12 h after light exposure (D, E), or of untreated wild-type mice (F ) were hybridized with LIF sense (A, D) or LIF antisense (B, C, E, F ) riboprobes. C, Higher
magnification of boxed area in B. LIF antisense probes specifically stained scattered cells in the INL in retinas undergoing photoreceptor degeneration (B, E) but not in a healthy retina (F ). G–L,
Combined in situ and immunofluorescence stainings identified LIF-expressing cells as a subset of Muller glias. Retinal sections of wild-type 129S6/SvEvTac mice 12 h after light exposure were
hybridizedwith LIF antisense riboprobes (G, J) and anti-glutamine synthetase antibodies (H, K). Themerged pictures (I, L) identified LIF-expressing cells as a subset of Muller glia cells. J–L, Higher
magnifications of boxed area in G. Arrows, cells positive for LIF and GS. Abbreviations as in Figure 1. Scale bars, 50m.
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damaged retina (data not shown), the VPP retina strongly
upregulated expression of Edn2 (Fig. 5A). Basal expression of
Edn2 seemed to depend largely on LIF since Edn2 expression was
reduced to 2% of wild-type levels in Lif–/– mouse retinas. In VPP
mice lacking LIF (VPP;Lif–/– double mutants), Edn2 expression
was not upregulated and remained at the low basal levels ob-
served in the Lif–/– retina, despite the accelerated retinal degen-
eration in the double mutant mice. Edn1 and Ednrb were ex-
pressed at similar levels in all mouse strains tested.
In the injured retina of the VPPmouse, GFAPwas induced on
the mRNA (Fig. 5B) and protein (Fig. 4) levels. Similar to Edn2,
however, GFAP expression was strongly reduced in retinas of
mice lacking LIF (11% of wt) (Fig. 5B) and in contrast to VPP
mice (2.7-fold elevated mRNA levels) no increased expression of
GFAPwas detectable in retinas of doublemutantmice which is in
line with our protein expression data (Fig. 4). LIF influenced also
expression of Casp-1 since basal mRNA levels of this protease
were reduced by a factor of 2 in retinas of Lif–/– mice (Fig. 5B).
Similar to Edn2 and GFAP, Casp-1 expression was activated in
VPP retinas but not in VPP;Lif–/– double mutant mice. Expres-
sion of other stress related genes like Smad1 (data not shown) and
Mcl1 (Fig. 5B) were not affected by the lack of LIF and/or the
presence of the VPP transgene (Fig. 5B).
FGF2 is often implicated in a paracrine pathway of photore-
ceptor neuroprotection in various models of degeneration (Wen
et al., 1995; Gao and Hollyfield, 1996; Joly
et al., 2007) and is thought to be produced
in an attempt to protect cells in unfavor-
able conditions. As such, FGF2, was also
strongly upregulated in the VPP retina
(10.2-fold, Fig. 5C). Strikingly, however,
VPP retinas lacking LIF completely failed
to induce FGF2 expression which re-
mained at the same low basal level (38% of
wt) as observed in Lif–/– single mutant
mice (43% of wt). Expression of other
neurotrophic factors like BDNF, GDNF
and CNTF remained at basal levels in the
different strainswith a slight upregulation of
CNTF in the double transgenic retina (1.7-
fold induction, Fig. 5C). Similarly, expres-
sion of the anti-apoptotic genes survivin and
Bcl-2, bothmay be regulated in a STAT3 de-
pendent manner (Kim et al., 2006; Weeras-
inghe et al., 2007) remained at basal levels in
the retinas of all strains tested. Thus, the lack
ofFGF2 inductionmighthavebeen themain
reason for the accelerated photoreceptor de-
generation in the VPPmouse lacking LIF.
Retinal degeneration in the VPPmouse
not only induced phosphorylation of
STAT3 (Fig. 4) but also STAT3 gene ex-
pression (1.9-fold) and the expression of at
least two additional members of the Jak/
STAT signaling pathway (Jak3, 2.6-fold
and SOCS3, 3.4-fold). Again, lack of LIF in
VPP;Lif–/– mice completely blocked acti-
vation of this signaling cascade (Fig. 5D).
In summary, all genes (Edn2,GFAP,Casp-1, FGF2, STAT3, Jak3,
SOCS3) or proteins (pSTAT3, p-Akt, GFAP), which were activated
in response to VPP-mediated retinal degeneration showed basal ex-
pression in the absenceofLIF.This strongly suggests anessential and
early role of LIF in the retinal response to photoreceptor injury.
Signaling can be restored by the application of rLIF
Themissing activation of gene expression and protein phosphor-
ylation in Lif–/– mice could be specifically caused by the absence
of LIF cytokine or by a general defect in the knock-out animals.
To discriminate between these possibilities, we analyzed gene
Figure 4. Lack of LIF prevents activation of STAT3, Akt and GFAP. Total retinal extracts ofwt,
VPP, Lif –/– and VPP;Lif –/– retinas of 28-day-old mice were tested by Western blotting using
specific antibodies as indicated. TheVPP transgeneonaLIFwild-typebackground (left) induced
a strong phosphorylation of STAT3, aweak activation of Akt and a robust upregulation of GFAP.
Retinas of VPP mice on a LIF knock-out background (right) did not show any signs of STAT3
phosphorylation and did not increase expression of phospho-Akt and GFP. *Nonspecific signal.
Figure 5. Lack of LIF prevents induction of a genomic response to retinal injury. Total retinal RNA was prepared from 28-day-
old wt, VPP, Lif –/– and VPP;Lif –/–mice. cDNA from 3 independent retinas per genotypewas amplified in duplicates by real-time
PCR. Onewild-type sample served as calibrator and themeanof allwild-type sampleswas set to 1 for each gene amplified. Shown
aremeans SD of endothelin-related genes (A), stress-related genes (B), growth and survival factors (C), and of genes relevant
for the Jak/STAT signaling pathway (D) relative to wild-type levels. Lack of LIF caused very low basal expression levels of Edn2,
GFAP and FGF2. In the presence of LIF, VPP-mediated retinal degeneration induced expression of Edn2, GFAP, Casp-1, FGF2, Jak3,
SOCS3 and STAT3. The absence of LIF prevented induction of all of these genes in the VPP retina and expression levels remained at
similar low levels as in Lif –/– single mutant mice.
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expression after intravitreal injection of rLIF into wild-type and
Lif–/– mice. rLIF induced phosphorylation of STAT3 similarly in
all mice tested (Fig. 6A) and strongly activated gene expression of
Edn2, GFAP and FGF2 in both wild-type and Lif–/– retinas (Fig.
6B). Although FGF2 mRNA levels in Lif–/– retinas treated with
rLIF injections did not reach levels of treated wild-type retinas,
induction over nontreated retinas was nevertheless similar (5-
fold in wild-type and threefold in Lif–/– retinas) in the twomouse
strains. It is interesting to note that rLIF induced expression of
Edn2 14-fold in wild-type retinas and 3200-fold in Lif–/– ani-
mals resulting in similar expression levels in the two animals after
rLIF application. Control injections of carrier (PBS) resulted only
in a subtle response with low levels of STAT3 phosphorylation
(Fig. 6A) but not in a significant alteration of gene expression
(Fig. 6B). These data show that the molecular equipment re-
quired to transduce LIF-mediated signaling was present and
functional in Lif–/– retinas. This suggests that lack of gene activa-
tion was a specific consequence of the absence of LIF.
Activation of Ednrb induces the molecular response and
protects photoreceptors
The receptor for Edn2 has been found to be expressed on Muller
cells and potentially astrocytes in the mouse retina (Rattner and
Nathans, 2005). To test whether direct stimulation of Ednrb
might be able to activate the molecular response to injury we
injected the Ednrb agonist BQ-3020 into the vitreous ofwild-type
and Lif–/– mice (Fig. 7). BQ-3020 efficiently induced expression
of FGF2, Edn2 and LIF in wild-type retinas. In contrast, the
Ednrb agonist failed to significantly induce FGF2 in Lif–/– mice
and caused only a 70-fold increase of Edn2 expression in the
knock-outs compared with the 3200-fold increase after rLIF ap-
plication (Fig. 6B). This supports our con-
clusion that the signaling system can effi-
ciently be activated only in the presence of
LIF. Note that the strong upregulation of
LIF inwtmicemay have further supported
the production of Edn2 by a positive feed
forward loop resulting in a signal amplifi-
cation which was only possible in wild-
type but not Lif–/– animals.
Modulation of Ednrb activationwas di-
rectly relevant for photoreceptor survival.
Application of the Ednrb agonist resulted
in a strong tendency toward protection of
photoreceptors against light damage (Fig.
7D), whereas injection of an Ednrb antag-
onist (BQ-788) into eyes of VPP mice sig-
nificantly increased retinal cell death (Fig.
7E).
LIF-induced signaling andMuller cell
activationmay act through rod
photoreceptor cells
To investigate a potential role of photore-
ceptors for the signaling mechanisms in-
duced by LIF expression, we injected rLIF
into the vitreous of mice which are almost
devoid of photoreceptors [3-month-old
rd1 (Bowes et al., 1990)] or which have a
cone-only retina [Nrl–/– (Mears et al.,
2001)]. Most importantly, although ex-
pression of genes was induced upon injec-
tions, the response did not differ between
rLIF and PBS-injected retinas in these two mouse strains which
both lack rod photoreceptors (Fig. 8A–F), in contrast to injec-
tions into wild-type mice (Fig. 6B). This strongly suggests that a
specific LIF-mediated retinal response requires rod
photoreceptors.
However, it is interesting to note that basal gene expression
and the response to injections differed between rd1 and Nrl–/–
retinas in several points. (1) Basal expression of Edn2 in the aged
rd1mouse was1300-fold reduced (7 104 relative to wt, Fig.
8A) which is comparable to the low levels of rod specific Gnat1
(rod transducin) mRNA (1 104 relative to wt) (Fig. 8F). This
suggests that Edn2 is mainly expressed in photoreceptor cells.
Since these cells are no longer present in rd1 mice, Edn2 expres-
sion levels are strongly reduced. Since the cone retinas of Nrl–/–
mice showed only fivefold reduced levels of Edn2 mRNA (Fig.
8A) Edn2may be expressed by both rods and cones in awild-type
retina. (2) Injections (rLIF and PBS) induced expression ofGFAP
much stronger in the rd1 mouse retina than in the Nrl–/– retina
(Fig. 8B). (3) Basal levels of FGF2 mRNA were higher in the
Nrl–/– retina (Fig. 8C). (4) ThemRNA for Ednrb was increased in
rd1 (andNrl–/–) retinas (Fig. 8D) compared with wild-type. This
suggests that the receptor for Edn2 is expressed mainly in cells
different from photoreceptors which is in line with the findings
from Rattner and Nathans (2005). (5) LIF-RmRNAwas reduced
only sixfold in the rd1 mouse and 2.5-fold in the Nrl–/– mouse
(Fig. 8E) suggesting that also cells apart from photoreceptors
may express the receptor for LIF.
Discussion
Cells and tissues are equipped with endogenous protective mecha-
nisms to copewith photoreceptor injury. Knowledge of thesemech-
Figure 6. A,B, Injection of rLIF restores signaling in Lif –/–mice. A total of 1l (10 ng) of rLIF (l) or of vehicle control (PBS) (c)
was injected intravitreally and levels of proteins or mRNAs were analyzed after 24 h by Western blotting (A) or by real-time PCR
(B).A, Injectionof rLIF inducedphosphorylationof STAT3 inwild-type, Lif/– andLif –/–mice. Control PBS injections showedonly
a minor response. B, Gene expression of noninjected mice (n) or of mice at 24 h after injection of rLIF (l) or vehicle (PBS) (c) in
wild-type (black bars) or Lif –/– mice (gray bars). Shown are means SD of n 3–4 per genotype and treatment. Levels in
noninjected wild-type animals were set to 1. *p 0.05; Ap 0.05. n, Noninjected; l, rLIF-injected; c, vehicle-injected.
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anisms may allow a targeted and sustained
activation of intrinsic molecular pathways
which could protect cells against death in a
variety of degenerative diseases. Protection
against cell death may ensure functionality
of the tissue which is especially important in
tissues depending on quiescent post-mitotic
cells like brain and retina.Herewe show that
the retina contains a LIF-controlled signal-
ing system which apparently aims at the
maintenance of the viability of injured pho-
toreceptors. Activation of the system in-
volves at least photoreceptors and Muller
glia cells. The absence of LIF completely
blocks this endogenous defense pathway,
prevents activation of Muller glia cells in re-
sponse to a stress situation and keeps several
signaling and survival factors at basal expres-
sion levels. This results in a drastically accel-
erated degeneration of visual cells.
Retinal response to injury
Rattner and Nathans (2005) recently pro-
posed a specific retinal response to injury
which involves the production and secre-
tion of Edn2 by injured photoreceptors
leading to the activation ofMuller glia cells
via Ednrb and to an increased expression
of FGF2. FGF2 is a potent neurotrophic
factor that is upregulated in various situa-
tions of retinal stress (Gao and Hollyfield,
1996; Hackett et al., 1997; Grimm et al.,
2002) and that can protect retinal cells
against various insults (Unoki and LaVail,
1994; Liu et al., 1998; Yamada et al., 2001;
Schuettauf et al., 2004; O’Driscoll et al.,
2007, 2008).
Intriguingly, this response seems not to be initiated by the
damaged photoreceptors themselves but rather by a specific sub-
set of Muller glia cells which react with the expression of LIF to
photoreceptor injury (Fig. 3). What sets the LIF-expressingMul-
ler cells apart from other Muller cells needs to be investigated.
Our combined in situ and immunofluorescence stainings suggest
that cells expressing high levels of LIF have reduced GS levels.
Whether this is an artificial observation due to the staining pro-
cedure needs to be analyzed but it is interesting that GS might be
down regulated in pathological situations possibly through the
action of FGF2 (Kruchkova et al., 2001).
The presence of LIF is required to express Edn2 to normal
levels and to induce it in the stressed retina. Since Ednrb is ex-
pressed by Muller cells (which also express LIF), Edn2 signaling
may induce a positive feed forward loop resulting in an increased
stimulation LIF production. This is supported by the strong stimu-
lationofLIFexpressionafter injectionof theEdnrbagonistBQ-3020
inwild-type retinas (Fig. 7). In addition toLIF, BQ-3020 application
also induced Edn2 and FGF2 expression suggesting that the full re-
sponse is inducible through activation of Ednrb. Indeed, activation
of Ednrb protected cells against light damage and antagonizing the
receptor increased cell death in the VPP mouse (Fig. 7). This dem-
onstrates a direct relevance of the LIF-dependent Edn2 signaling for
photoreceptor survival and tissue integrity. The existence of a LIF-
dependent positive feed forward loop is further supported by the
reduced molecular response in retinas of Lif–/– mice after BQ-3020
application (Fig. 7).
Since LIF-R and gp130, the two receptor subunits required for
LIF binding are ubiquitously expressed in the retina including
photoreceptors (Ueki et al., 2008) LIF may directly target visual
cells to increase Edn2 production. This notion is supported by
our observation that injection of rLIF into eyes of mice without
photoreceptors (aged rd1 mice) did not provoke a similar strong
response (Fig. 8).
In the presence of increased LIF, the transcription factor
STAT3 is strongly phosphorylated and expression of the receptor
kinase Jak3 is induced. STAT3 is a downstream mediator of
gp130 signaling (Ernst and Jenkins, 2004) and is able to upregu-
late Jak3 expression (Mangan et al., 2004). In the absence of LIF,
STAT3 protein is not activated and expression of Jak3 is not
elevated suggesting that LIF may indeed signal through STAT3/
Jak3. Since lack of LIF also prevents upregulation of Edn2 expres-
sion, the regulation of these molecules may be correlated and
directly or indirectly be coordinated by LIF-mediated stimula-
tion of LIF-R.
Similarly to Edn2, STAT3, Jak3 and GFAP, induction of the
survival factor FGF2 depends on LIF. It has been shown that
injection of rLIF protects the retina against a toxic insult (Ueki et
al., 2008), that injection of rLIF upregulates endogenous FGF2 in
the retina (Fig. 6), that increased expression of endogenous FGF2
protects against retinal degeneration (O’Driscoll et al., 2008) and
that lack of FGF2 activation correlates with accelerated photore-
Figure 7. Modulation of Ednrb signaling influences cell survival. A–C, A total of 1l (1g/l) of BQ-3020 (BQ) or of vehicle
control (H2O) (c)was injected intravitreally intowild-type (wt) or Lif
–/–mice as indicated.Noninjectedmice (n) servedas controls.
Gene expressionwas analyzed 24 h after injection by real-time PCR on cDNA derived from total retinal RNA. n 3 per treatment.
D, Cell death after light exposure in retinas pretreated with BQ-3020. The left eye of each wild-type mouse was injected with
BQ-3020 and the right eyewith vehicle (sham). Each bar represents the fold difference in cell death between compound and sham
treated eyes of a single mouse. The last bar shows the result in a wild-type mouse not exposed to light. Of the 21 mice analyzed,
BQ-3020 treated retinas of 15 animals were less severely affected by the light exposure than the contralateral sham treated
retinas. This resulted in a strong tendency toward protection by the activation of Ednrb ( p 0.0536; paired Student’s t test). E,
Cell death in retinas of VPPmice treated with BQ-788, an Ednrb antagonist. The left eye of eachmouse was injected with BQ-788
and the right eyes with vehicle (sham). Analysis was 2 d after injection. Each bar represents the fold difference in cell death
between compound and sham treated eyes of individual VPP mice. The last bar shows the result in a wild-type mouse to test
potential toxicity of the compound.Of the9mice analyzed, BQ-788 treated retinas of 8 animalsweremore severely affectedby the
VPP mediated degeneration than the contralateral sham treated retinas. This resulted in a significantly lower survival of photo-
receptors after the inhibition of Ednrb signaling ( p0.0351; paired Student’s t test). *p0.05; Ap0.05. n, Noninjected; BQ,
BQ-3020-injected; c, vehicle-injected.
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ceptor death (Figs. 1, 5). Thus, is seems highly likely that FGF2 is
amajor factor in the LIF-controlled protectivemechanism. Since
independent studies have reported expression of FGF2 byMuller
cells (Walsh et al., 2001) and by photoreceptors (Rattner and
Nathans, 2005), respectively, regulation of FGF2 expression by
LIF needs further detailed investigation.
Together, our results show that LIF is not only essential but
also sufficient to serve as the molecular switch to activate an
endogenous protective response which may depend on the pro-
duction of the survival factor FGF2.
Rod photoreceptors are required for a specific
LIF-mediated response
Injection of rLIF specifically induced expression of Edn2,GFAP and
FGF2 (Fig. 6). Since similar injections in the absence of rod photo-
receptors did not cause a significantly different response from con-
trol injections (Fig. 8), our results suggest that rod photoreceptors
play an essential and specific role in the LIF response pathway. The
strongbutnotexclusiveproductionofEdn2 inrodphotoreceptors is
demonstrated by the 1300-fold reduced basal Edn2 levels in rd1
comparedwithwild-typemice. Since rd1miceat this age (3months)
retain some photoreceptors, mostly cones, in the far peripheral ret-
ina (data not shown) and since the all-cone retinas of Nrl–/– mice
show only fivefold reduced levels of Edn2 mRNA (Fig. 8), cones
might also express Edn2 which can be stimulated by retinal injury,
although not in a LIF specific way. This conclusion is supported by
the lackof significantEdn2 induction in the661Wconecell line after
rLIF application in vitro (data not shown).
One of the most common response to retinal injury is the up-
regulation of the intermediate filament protein GFAP inMuller glia
cells (Sarthy and Fu, 1989; Lewis and Fisher,
2003; Nakazawa et al., 2007). This is also ev-
ident during the degenerative process in the
retinaof theVPPmouse (Fig. 4).As forEdn2
and FGF2, expression and upregulation of
GFAP depends on the presence of LIF (Figs.
4, 5). The missing induction of GFAP ex-
pression in VPP;Lif–/– mice suggests that
photoreceptor degeneration cannot activate
Muller cells and/or astrocytes in the absence
of LIF. Injection of rLIF was sufficient to in-
crease expression of GFAP (Fig. 6) but the
upregulation was only specific in the pres-
ence of rod photoreceptors (Fig. 8). Thus,
LIFmaynot directly target glial cells butmay
stimulateMuller cells throughproductionof
Edn2 in rod photoreceptors.
An endogenous, LIF-mediated
neuroprotective response in the retina
Based on our data and on published results
(Rattner and Nathans, 2005), we suggest a
model pathway which may be used by ret-
inal cells to protect tissue integrity and to
preserve photoreceptor function in the
presence of damaging stress like excessive
light exposure or genemutations.We pro-
pose that a subset ofMuller glia cells senses
photoreceptor damage and reacts with the
upregulation of LIF. Only in the presence
of increased LIF, photoreceptors induce
expression of Edn2 which may then signal
back to Muller glia cells. This may cause a
gliosis-like reaction and the stimulation of GFAP expression.
Concomitantly, the survival factor FGF2 is produced in Muller
cells and/or photoreceptors aiming at the protection of visual
cells from further damage (additional file 3). Whether Edn2 ex-
pression occurs in healthy or already damaged photoreceptors is
currently unknown. Although it was shown that Edn2 is mainly
produced in the region affected by a toxic insult (Rattner and
Nathans, 2005), the specific response observed after intravitreal
injection of rLIF in wild-type animals suggests that also healthy
photoreceptors can activate this response pathway. It is thus
probable that Edn2 production is a general response of photore-
ceptors to increased local concentrations of LIF.
Our work establishes LIF as the key molecule in the induction
of an endogenous molecular pathway aiming at the protection of
photoreceptor cells in vivo. This pathway may be part of a tissue
defense system which increases the survival of visual cells in sit-
uations of environmental or mutational stress. Even though the
endogenous potency of the systemmay not be sufficient to secure
the viability of the cells over an extended period of time (photo-
receptors in the VPP mouse die eventually), an artificial increase
of its efficacy may nevertheless offer the opportunity to signifi-
cantly prolong the lifespan of visual cells in human patients.
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6.6.2 Summary 
The integrins αvβ5 and αvβ3 are involved in phagocytotic processes of a 
physiological normal retina. In this paper we addressed their role in the removal of 
cellular debris after light-induced photoreceptor apoptosis. We employed β3-/-, β5-/- and 
β3-/-/β5-/- mice, which exhibited a normal retinal morphology. After exposure to cytotoxic 
levels of white light, mutant and double mutant mice showed a pattern of progressive 
retinal degeneration similar to wild type controls. Further, we observed no differences 
in macrophage recruitment between β3-/-, β5-/- and β3-/-/β5-/- mice and wild type mice 
and electron microscopy revealed no disturbed clearance of photoreceptor debris. A 
molecular marker for lysosomal activity in RPE cells is cathepsin D (catD), which is an 
enzyme involved in the digestion of photoreceptor outer segments. We analyzed 
protein levels of the pro-form pro-cathepsin (pro-catD) and mature catD in light 
exposed wild type and in β5-/- mice. Both mouse strains expressed pro-catD and cat-D 
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with a slight tendency of elevated mature cat-D levels in wild type mice. The tyrosine 
kinase receptor MerTK is localized on the apical surface as well as on microvilli of RPE 
cells and requires the β5 integrin for activation. MerTK mRNA levels were induced after 
light exposure in β5-/- mice but not in illuminated wild type animals, suggesting a 
potential compensatory mechanism in β5 integrin ablated mice. Focal Adhesion Kinase 
(FAK) is phosphorylated (pFAK) and thereby activated after light exposure in retinas of 
wild type mice. However, illumination of β5-/- mice caused no accumulation of pFAK 
suggesting a direct role of FAK in β5 integrin mediated phagocytosis. To test whether 
phagocytic cells might compensate for the lack of β3 and/or β5, we analyzed retinal 
gene expression of the monocyte chemoattractant protein-1 (MCP-1), which is involved 
in macrophage recruitment. Retinal MCP-1 gene expression was strongly induced 6 h 
after light exposure in all employed models (wild type, β3-/-, β5-/- and β3-/-/β5-/- double 
mutant mice) with a rapid return to normal or even below normal expression levels in 
β5-/- mice. The strong activation of MCP-1 in all models and the recruitment of 
macrophages supported our hypothesis that invading phagocytic cells can compensate 
for the lack of integrins. In an attempt to confirm this theory, we employed double 
mutant mice lacking MCP-1 and β5 integrin (Ccl2-/-/β5-/-) and we exposed them to light. 
However, illuminated double mutant mice showed neither a difference in the progress 
of retinal degeneration nor a disturbed macrophage invasion when compared to wild 
type or Ccl2-/- mice. This indicated that MCP-1 was not involved in macrophage 
recruitment after photoreceptor injury. Finally, we analyzed the mRNA expression 
pattern of the chemokine fractalkine (CX3CL1) and four other chemokines (CCL4, 
CCL5, CCL12 and CCL9), which belong to the same family as MCP-1. CCL4, CCL5 
and CCL12 were induced 6 h after light exposure in all analyzed models (wild type, β3-/-
, β5-/-, Ccl2-/-/β5-/- and β3-/-/β5-/- mice). Especially CCL4 was 3.5 to 4 times stronger 
induced in β3-/-, β5-/-, and β3-/-/β5-/- mice compared to wild type or Ccl2-/-/β5-/-. However, 
whether these molecules are able to substitute β3 integrin and/or β5 integrin remains to 
be analyzed. Our results clearly show that β3 and β5 integrins are not essential for the 
clearance of photoreceptor debris after light exposure. 
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Nonessential Role of 3 and 5 Integrin Subunits
for Efficient Clearance of Cellular Debris after
Light-Induced Photoreceptor Degeneration
Sandrine Joly,1 Marijana Samardzija,1 Andreas Wenzel,1,2 Markus Thiersch,1
and Christian Grimm1
PURPOSE. During light-induced photoreceptor degeneration,
large amounts of cellular debris are formed that must be
cleared from the subretinal space. The integrins v5 and
v3 are involved in the normal physiological process of
phagocytosis in the retina. This study was conducted to inves-
tigate the question of whether the lack of 5 and/or 3 integrin
subunits might influence the course of retinal degeneration
and/or clearance of photoreceptor debris induced by acute
exposure to light.
METHODS. Wild-type, 5/ and 3/ single-knockout, and
3//5/ Ccl2//5/ double-knockout mice were ex-
posed to 13,000 lux of white light for 2 hours to induce severe
photoreceptor degeneration. Real-time PCR and Western blot
analysis were used to analyze gene and protein expression,
light- and electron microscopy to judge retinal morphology,
and immunofluorescence to study retinal distribution of pro-
teins.
RESULTS. Individual or combined deletion of 3 and 5 integrin
subunits did not affect the pattern of photoreceptor cell loss or
the clearance of photoreceptor debris in mice compared with
that in wild-type mice. Invading macrophages may contribute
to efficient phagocytosis. However, ablation of the MCP-1 gene
did not prevent macrophage recruitment. Several chemokines
in addition to MCP-1 were induced after light-induced damage
that may have compensated for the deletion of MCP-1.
CONCLUSIONS. Acute clearance of a large amount of cellular
debris from the subretinal space involves invading macro-
phages and does not depend on 3 and 5 integrins. (Invest
Ophthalmol Vis Sci. 2009;50:1423–1432) DOI:10.1167/iovs.08-
2432
Age-related macular degeneration (AMD) is one of the mostcommon retinal diseases that affect people older than 60
years.1 Lipofuscin, a major correlate for the development of
AMD, is generated during ageing by the incomplete decompo-
sition of phagocytosed material from photoreceptor outer seg-
ments (POS) in the retinal pigment epithelium (RPE).2 Efficient
and complete phagocytosis is therefore necessary to ensure the
integrity of a healthy retina. Various receptors on the mem-
brane surface of the phagocyte and the phagocytic substrates
mediate phagocytosis.3 In the retina, these molecules include
CD36, MerTK, and integrin receptors. On the apical membrane
of the RPE layer, the CD36 scavenger receptor participates in
particle recognition and regulates the internalization process of
shed POS.4–6 After POS binding to the RPE, the tyrosine kinase
receptor Mer (MerTK), also present on the apical surface of
RPE cells,7 is indirectly activated via phosphorylation by focal
adhesion kinase (FAK).8 MerTK phosphorylation in turn acti-
vates the second messenger inositol 1,4,5-trisphosphate
(InsP3), which initializes POS internalization and degrada-
tion.8,9 The v5 integrin receptor localizes similarly to the
apical membrane of the RPE and is thought to participate in
POS binding.4,10–12 Moreover, the 5 integrin subunit and
MerTK cooperate via FAK activation in the initialization step of
phagocytosis.8,11 On the other hand, v3 vitronectin recep-
tor has a crucial role in the recognition of apoptotic neutro-
phils and lymphocytes by blood-derived macrophages.13 Since
macrophages invade the lesioned retina and the 3 integrin
complex is also found in the RPE,14 3 integrin may also be
involved in the clearance of retinal debris.
AMD can be divided into two developmental stages: (1) the
early stage is characterized by the presence of deposits called
drusen15 and the loss of photoreceptor and RPE cells leading to
the development of geographic atrophy16; and (2) the hallmark
of late AMD is choroidal neovascularization with retinal hem-
orrhages and increased degeneration of visual cells and the
RPE.17 Several mouse models show AMD-like features during
ageing: ELOVL4 (elongation of very long-chain fatty acid) mu-
tant transgenic mice accumulate lipofuscin and show progres-
sive photoreceptor degeneration18; Sod1/ (Cu, Zn-superox-
ide dismutase) mutant mice develop drusen, choroidal
neovascularization, and RPE dysfunction19; the ABCR/
mouse shows an enhanced accumulation of A2E, one of the
most important and potentially devastating components of
lipofuscin20; and the mcd/mcd mice with a mutated form of
cathepsin D (catD), a lysosomal enzyme responsible for opsin
degradation, accumulate phagocytosed photoreceptor material
in the RPE, leading to the formation of deposits.21 Based on
defects of the phagocytic mechanism, three additional mouse
models have been described: (1) ageing retinas of 5 integrin
knockout mice (5/) display functional and histologic alter-
ations linked to lipofuscin deposits and impairment of phago-
cytosis22; (2) apoptotic debris accumulate in the subretinal
space of mice with a blocked 3 integrin receptor23; (3) accumu-
lation of lipofuscin, formation of drusen, photoreceptor atro-
phy, and neovascularization have been reported in mice lack-
ing monocyte chemoattractant protein (MCP)-1 (or CCL2).24
Since disturbed phagocytosis seems to be a major feature in
retinal disease, we studied the role of 3 and 5 integrin
subunits in the clearance of photoreceptor debris generated by
exposure to high levels of visible light. Our data demonstrate
that the individual or combined deletion of 3 and 5 integrin
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subunits does not lead to an accumulation of photoreceptor
outer segments or to a delayed clearance of cell debris in the
model of acute light-induced damage. Both macrophages and
RPE cells efficiently cleared the subretinal space in mice inde-
pendent of the presence or absence of 3 and/or 5 integrin
subunits. Alternative receptors such as MerTK may compen-
sate for the lack of integrin receptors. Additional deletion of
MCP-1 did not influence phagocytosis or the recruitment of
macrophages to the site of retinal injury. Gene expression
studies show that additional chemokines are strongly induced
after retinal injury and may thus account for macrophage at-
traction in the absence of MCP-1.
MATERIALS AND METHODS
Animals and Exposure to Light
All procedures were conducted in accordance with the ARVO State-
ment for the use of Animals in Ophthalmic and Vision Research and
with the regulations of the Veterinary Authority of Zurich. All animals
were raised in cyclic light (12 hours light and 12 hours dark; 60 lux at
cage level) and were homozygous for the Rpe65450Leu variant.
25 3
(3/) and 5 (5/) knockout mice (generously provided by Rich-
ard O. Hynes, MIT, Cambridge, MA), Ccl2/ mutant mice (Jackson
Laboratory, Bar Harbor, ME), and corresponding wild-type mice (all on
a mixed 129/B6 background) were maintained at the University Hos-
pital Zurich. Double-mutant mice (3//5/ and Ccl2//5/)
were generated by classic breeding schemes.
Adult (8–10 weeks of age) wild-type and mutant mice were dark
adapted for 12 hours, and their pupils were dilated with 1% Cyclopen-
tolate (Cyclogyl; Alcon, Cham, Switzerland) and 5% phenylephrine
(Ciba Vision, Niederwangen, Switzerland) 30 minutes before exposure
to 13,000 lux of white light for 2 hours. Mice were killed at different
time points (n  3 for each group) after light offset and the retinas or
eyes prepared.
RNA Preparation and Semiquantitative
RT-PCR Analysis
Retinas were removed through a slit in the cornea and immediately
frozen in liquid nitrogen. The rest of the eye (eye cup) was isolated and
also frozen in liquid nitrogen. Total RNA was prepared with an RNA
isolation kit (RNeasy; Qiagen, Hilden, Germany), including a digestion
of the residual genomic DNA by DNase treatment. Identical amounts of
RNA were used for reverse transcription using oligo(dT) and M-MLV
reverse transcriptase (Promega, Madison, WI). cDNA amplifications
were performed with primer pairs designed to span large intronic
sequences or cover exon–intron boundaries (Table 1). Gene expres-
sion was analyzed by real-time PCR using a polymerase ready mix
(LightCycler 480 SYBR Green I Master Mix; Roche Diagnostics, India-
napolis, IN) in a thermocycler (LightCycler Roche Diagnostics). For
relative quantification of gene expression, mRNA levels were normal-
ized to -actin by using the comparative threshold cycle (CT)
method, and relative values were calculated with a respective control
sample used for calibration. For the chemokine amplifications, cDNAs
from three different mice were pooled and amplified in duplicate.
Light and Electron Microscopy
Eyes were fixed in 2.5% glutaraldehyde in 0.1M cacodylate buffer (pH 7.3)
at 4°C overnight. For each eye, the superior and inferior retina was
prepared, washed in cacodylate buffer, incubated in osmium tetroxide for
1 hour, dehydrated in a series of increasing ethanol concentrations, and
embedded in Epon 812. Semithin cross sections of 700 nm in thickness
were prepared from the lower central retina, which was the most affected
region in our light-induced damage model and counterstained with tolu-
idine blue for light microscopy (n  3 for each group), and 50-nm
ultrathin sections were cut for electron microscopy analysis.
Immunohistochemistry
Mice were perfused transcardially with 4% paraformaldehyde (PFA) in
0.1 M phosphate buffer (PB; pH 7.4). After isolation of the eyes and
removal of cornea and lens, the remaining ocular tissue was immersed
for 2 hours in 4% PFA followed by cryoprotection in 30% sucrose in
PBS (pH 7.4) at 4°C. The eyes were then embedded in tissue-freezing
medium and frozen in a 2-methylbutane bath cooled by liquid nitrogen.
Retinal sections (12 m thick) were blocked in 3% normal goat serum
and 0.3% Triton X-100 in 0.1 M PBS (pH 7.4) for 1 hour at room
temperature. The sections were then incubated overnight, at 4°C, in
the blocking solution containing one of the following primary antibod-
ies: rabbit polyclonal anti-Mer (generous gift from Greg Lemke, Salk
Institute for Biological Studies, La Jolla, CA), guinea pig anti-RPE65, and
rat monoclonal anti-F4/80 (BMA Biomedicals, Augst, Switzerland). Af-
ter they were washed with PBS, the slides were incubated with the
appropriate secondary antibody coupled to Cy2 or Cy3 fluorescence
for 1 hour at room temperature and mounted with anti-fade medium
(10% Mowiol 4-88; vol/vol; Calbiochem, San Diego, CA), in 100 mM
Tris (pH 8.5), 25% glycerol (wt/vol) and 0.1% 1,4-diazabicyclo [2.2.2]
octane (DABCO). Immunofluorescent stainings were analyzed with a
digital microscope (Axiovision; Carl Zeiss Meditec, Inc., Dublin, CA).
Western Blot Analysis
Retinas or eye cups (n  3 per group) were homogenized in 100 mM
Tris/HCl (pH 8.0) and protein content was analyzed by using the Bradford
reagent. Equivalent amounts of proteins were resolved by electrophoresis
on sodium dodecyl sulfate–polyacrylamide gels and transferred to nitro-
cellulose membranes. Membranes were blocked in 5% milk (Bio-Rad,
Hercules, CA) in TBST (10 mM Tris/HCl [pH 8.0], 150 mM NaCl, and
0.05% Tween-20) for 1 hour at room temperature before they were
incubated overnight at 4°C in 5% milk (in TBST) containing one of the
following primary antibodies: anti-phospho-FAKTyr397 (cat. No. 44-624G;
Biosource, Camarillo, CA), anti-FAK (cat No. 610087; BD Transduction
Laboratory, Lexington, KY), anti-phospho-Stat3Tyr705 (cat. No. 9131; Cell
Signaling, Beverly, MA), anti-Stat3 (cat. No. 9132; Cell Signaling, Beverly,
MA), anti-cathepsin D (generous gift from Tom Cotter, University College
Cork, Ireland), and anti-actin (cat. No. sc-1616; Santa Cruz Biotechnology,
Santa Cruz, CA). After they were washed, the blots were incubated at
room temperature for 1 hour with HRP-conjugated secondary antibodies.
Immunoreactivity was visualized with chemiluminescence detection
(Western Lightning Chemiluminescence Reagent Plus kit; Perkin Elmer,
Boston, MA). Densitometry analysis was performed with NIH software
and by normalizing the band intensities to -actin values.
TABLE 1. Primer Pairs for Semiquantitative RT-PCR
Genes Upstream Downstream Product Size (bp)
-Actin CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153
MCP-1 GGCTCAGCCAGATGCAGTTA CTGCTGCTGGTGATCCTCTT 108
MerTK GAGGACTGCTTGGATGAACTGTA AGGTGGGTCGATCCAAGG 73
CCL4 CAAGCCAGCTGTGGTATTC AGCTGCTCAGTTCAACTCC 109
CCL5 GCTCCAATCTTGCAGTCGT CTAGAGCAAGCGATGACAGG 165
CCL9 CAACTGCTCTTGGAATCTGG AGGCAGCAATCTGAAGAGTC 136
CCL12 CCTCAGGTATTGGCTGGAC GACACTGGCTGCTTGTGATT 124
CX3CL1 CCGCGTTCTTCCATTTGT CTGTGCTGTGTCGTCTCCA 175
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RESULTS
Effect of Lack of 3 and/or 5 Integrin Subunits
on Photoreceptor Degeneration and the
Clearance of Cellular Debris from the
Subretinal Space
To determine whether phagocytosis or clearance of photore-
ceptor debris generated by acute photoreceptor degeneration
were affected by the deletion of 3 and 5 integrin subunits,
we examined retinal histology after exposure to bright light
(Fig. 1). In wild-type mice, exposure to light induced cell death
in a large number of photoreceptor cells. As early as 6 hours
after light offset, the retinas displayed disorganized and dis-
rupted POS compared with nonexposed control retinas (Fig.
1A). As photoreceptor degeneration progressed, typical py-
knotic nuclei with condensed chromatin appeared in the outer
nuclear layer after 1 day. After 5 days, the photoreceptor layer
FIGURE 1. Acute clearance of pho-
toreceptor debris from the subretinal
space did not depend on 3 and 5
integrins. (A) Representative pho-
tomicrographs of retinas of wild-
type, 5/, 3/, and 3//
5/ mutant mice as indicated.
Control mice were reared in a nor-
mal cyclic light environment (12
hours dark; 12 hours light) and not
exposed to light. For light-induced
damage, the mice were exposed to
13,000 lux for 2 hours and were
killed after 6 hours, 1 day, 5 days, or
10 days, as indicated. Strong vesicu-
lation and degradation of POS was
detected already at 6 hours after light
offset in all strains. The subretinal
space of all strains was invaded by
macrophages after 5 days (arrow-
heads). At 10 days, the photorecep-
tor layer (POS, PIS, and ONL) almost
completely disappeared in all groups
tested. (B) Activated macrophages,
detected by the monoclonal antibody
anti-F4/80, infiltrated the subretinal
space of wild-type mice 3 days after
exposure to light (arrowheads). Nu-
clei were stained with DAPI. RPE,
retinal pigment epithelium; POS,
photoreceptor outer segments; PIS,
photoreceptor inner segments; ONL,
outer nuclear layer; OPL, outer plex-
iform layer; INL, inner nuclear layer;
IPL, inner plexiform layer; GCL, gan-
glion cell layer. Scale bar: (A) 50 m;
(B) 100 m.
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was severely degraded, whereas many macrophages colonized
the subretinal space in the injured region of the retina (Fig. 1A,
1B, arrowheads). Recruitment of macrophages and their
invasion of the outer retina have already been documented
after light-induced damage26,27 and in a model of chemical-
induced injury.28 Nonexposed (control) 3/, 5/, and
3//5/ mutant mice exhibited normal retinal mor-
phology. The same pattern of light-induced photoreceptor
degeneration and macrophage invasion was observed in
single 5/ and 3/ mutants, as well as in 3//5/
double-mutant mice (Fig. 1). Although 5 is involved in
phagocytosis and the clearance of photoreceptor tips during
the physiological process of photoreceptor shedding14 and
3 may be relevant for phagocytosis by macrophages14,29
and/or RPE,14 our data show that a lack of these integrin
subunits, individual or combined, did not influence efficient
clearance of the large amount of photoreceptor debris gen-
erated by acute exposure to light.
Moreover, evaluation of the RPE and the subretinal space in
the region of photoreceptor degeneration by electron micros-
copy did not reveal any accumulation of photoreceptor debris
(Fig. 2A). At 6 hours after exposure to light, the time of severe
POS damage (Fig. 1), distorted outer segments showed strong
vesiculation in all mice (Fig. 2A, middle row, arrows) instead of
the regular stacks of disks apposed to the RPE in control mice
(Fig. 2A, top row). In addition, POS material was observed in
RPE cells suggesting ongoing phagocytosis in all the mouse
strains (Fig. 2A, middle row, arrowheads). After 10 days, most
of the debris in the RPE was digested, and cells of the RPE
appeared normal in all the mouse strains. We did not observe
accumulation of POS debris in the RPE or in the subretinal
space (Fig. 2A, bottom row).
As a molecular measure of phagocytosis, protein levels of
pro-cathepsin D (pro-catD) and mature cathepsin D (mature
catD) were determined by Western blot analysis in eye cups of
wild-type and of 5/ mice (Fig. 2B). CatD is one of the key
enzymes involved in lysosomal digestion of POS.21,30 Levels of
the pro form were comparable in the two mouse strains and
seemed to increase slightly with time after exposure to light.
Mature catD was also present in both mice with a slight
tendency of higher levels 1 to 5 days after exposure in wild-
type mice. Levels in the knockout mice remained constant
throughout the period of analysis.
In conclusion, our results suggest that the time course for
the clearance of photoreceptor debris from the subretinal
space after acute exposure to light was not severely disturbed
by the deletion of 3 and of 5 integrins. In addition, the
presence of similar catD protein levels in the two mouse strains
suggests no major differences in the lysosomal activity of the
RPE. However, subtle differences may still exist as may be
suspected in light of the minor increase in the levels of mature
catD (Fig. 2B) in wild-type mice.
FIGURE 2. Lack of 5 and/or 3 in-
tegrins did not lead to an accumula-
tion of photoreceptor debris after
light-induced damage. (A) A normal
ultrastructure of the RPE and POS
was detected by electron micros-
copy in unexposed (control) wild-
type, 5/, 3/ and 3//
5/mice. Six hours after exposure
to light, the POS showed severe ve-
siculation (arrows), and still undi-
gested POS were present within the
RPE of all strains tested (arrow-
heads). At 10 days after exposure, no
abnormal debris accumulation was
detected in the RPE or the subretinal
space of all mice tested. Scale bar: 2
m. (B) Western blot for the pro and
mature form of cathepsin D in the
RPE at different time points after ex-
posure to light as indicated. Retinas
of nonexposed mice served as the
control (Ctrl). Equal amounts of pro-
tein extracts from the RPE of three
animals were pooled and tested for
the levels of cathepsin D. Actin
served as loading control.
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Participation of Alternative Receptors in the
Removal of Damaged Photoreceptors
A variety of membrane receptors localized on the surface of
phagocytes can contribute to the elimination of apoptotic or
damaged cells.3 Among them, the tyrosine kinase receptor Mer
is present on the apical surface of the RPE membrane (Fig. 3A)
and on the microvilli of RPE cells7 and thus is a salient candi-
date for retinal phagocytosis.8 Since activation of MerTK pro-
tein needs the 5 integrin,22 we first analyzed gene expression
of MerTK in eye cups of the wild-type and 5/ animals.
Although the lack of 5 downregulated basal expression levels
of MerTK to 43% of wild-type (not shown), exposure to light
induced the expression of MerTK in eye cups of the 5/ but
not in the wild-type animals (Fig. 3B). The increased expres-
sion of MerTK in the 5/ animals did not detectably alter the
localization of the protein (data not shown). Altogether, these
results suggest that RPE cells may compensate for the absence
of 5 integrin by the upregulation of molecules such as MerTK
to efficiently clear the subretinal space from photoreceptor
debris.
Role of Integrin 5 in the Activation of Focal
Adhesion Kinase after Light-Induced Damage
It has been demonstrated in vitro that phospho-FAKTyr397 is
activated 2 to 3 hours after challenging RPE-J cells with pho-
toreceptor outer segments.8 Thus, we examined phospho-
FAKTyr397 levels in eye cups of the wild-type mice and of the
5/ mice (Figs. 4A–D). Light-induced damage slightly acti-
vated FAK in the RPE of the wild-type mice (Figs. 4A, 4B). In
contrast, FAK was not upregulated in the RPE of the 5/
mice (Figs. 4C, 4D) supporting a direct role of FAK in 5-
mediated phagocytosis.8 Nevertheless, a comparable increase
in retinal phospho-Stat3Tyr705 6 hours after exposure to light
showed that the retinas of both wild-type and 5/ mice had
experienced similar levels of retinal stress (Fig. 4E).
Upregulation of MCP-1 after Exposure to Light in
the Retinas of All Mice
The presence of macrophages in the subretinal space of wild-
type but also of the 3/ and 5/ mice (Fig. 1) led us to
consider the possibility that these phagocytic cells compensate
for a potential phagocytic defect in mice deficient of 3 and/or
5 integrins. MCP-1 (or CCL-2) has already been identified as an
important factor for monocyte/macrophage recruitment in
pathologic conditions such as experimental autoimmune en-
cephalomyelitis (EAE)31 and atherosclerosis.32 Ablation of the
MCP-1 gene also decreases microglial activation in the thala-
mus33 whereas in the retina, MCP-1 deficiency may result in
the formation of drusen-like deposits and other retinal features
similar to AMD.24
MCP-1 gene expression was highly induced in the neuronal
retina at 6 hours after acute exposure to light in the wild-type
mice as well as in the single- and double-integrin knockout
mice (Fig. 5). Of note, gene expression returned to basal or
even dropped below basal levels faster in the mice lacking 5
integrin, but not in those with deleted 3 integrin. The strong
activation of MCP-1 combined with the presence of macro-
phages in the subretinal space of retinas exposed to light
supports the hypothesis that invading phagocytic cells com-
pensated for integrin deficiency.
To address the role of MCP-1 in macrophage attraction and
thus in the clearance of photoreceptor debris in the retina after
light-induced damage, we generated double-mutant mice lack-
ing both MCP-1 and 5 integrin (Ccl-2//5/). However,
the time course of light-induced photoreceptor degeneration
in these double-mutant mice was similar to that in the wild-
type and single Ccl2/mice (Fig. 6A). In addition, phagocytic
FIGURE 3. Expression of MerTK was
increased in the eye cup of 5 knock-
out mice after exposure to light.
(A) Localization of MerTK receptor
in unexposed wild-type retinas was
tested by immunofluorescence using
normal fluorescence microscopy.
RPE65 specifically localized to the
RPE layer (green), whereas MerTK
staining (red) was on the apical sur-
face of RPE cells and on microvilli, as
reported by others.7 Nuclei have
been stained with DAPI. Scale bar:
100 m; inset, 33.3 m. (B) Gene
expression of MerTK in eye cups of
wild-type and 5/ mice as indi-
cated. Expression was analyzed in
nonexposed eye cups (Ctrl) or at dif-
ferent time points after exposure to
light as indicated. Values were nor-
malized to -actin, and levels in con-
trol eye cups were set to 1 for each
strain analyzed. Statistical analysis
was performed with the unpaired
Student’s t-test (*P  0.05) to com-
pare MerTK retinal levels between
wild-type and 5/mice. Amplifica-
tion reactions were performed in
triplicate and the results are shown
as the mean  SD (n  3).
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cells appeared in the subretinal space after 5 days in all mice
and by 10 days, most of the debris was cleared (Fig. 6A). It has
been reported that the absence of MCP-1 is protective in a
model of retinal detachment.34 We noticed that the retinas of
the Ccl-2/mice seemed to retain more photoreceptor nuclei
at 5 and 10 days after exposure to light, suggesting that the
absence of MCP-1 may render the retinas also less susceptible
to light (Fig. 6A). However, the biochemical quantification of
apoptosis did not result in a significantly different rate of cell
death between the strains (data not shown).
The identity of these phagocytic cells as macrophages was
verified by staining for F4/80, a specific marker for activated
macrophages.35 Three days after light offset, retinas from the
Ccl2//5/ mice displayed F4-80-positive cells, showing
that activated macrophages invaded the subretinal space of the
lesioned area (Fig. 6B). These results suggest that recruitment
of macrophages to injured photoreceptors does not depend on
functional MCP-1 protein.
Role of Induced Expression of Chemokines in
Macrophage Recruitment after
Light-Induced Stress
Since MCP-1 was not crucial for macrophage recruitment, we
hypothesized that other chemokines36 might be able to com-
pensate for the lack of MCP-1 and may thus be involved in the
activation and attraction of macrophages. To test this possibil-
ity, we analyzed the expression of five different chemokines
after exposure to light in retinas of wild-type and single- and
double-knockout mice. The tested chemokines are members of
the same CC chemokine family as MCP-1 except fractalkine
(CX3CL1) that belongs to the CX3C family.37 At 6 hours after
light offset, CCL4 (also called MIP-1, Fig. 7A), CCL5 (or
RANTES, Fig. 7B), and CCL12 (or MCP-5, Fig. 7C) were highly
induced in the neuronal retina in all mouse strains tested.
Except for the Ccl2//5/ mutant mice in which levels
were close to those of the wild-type, the 3/, 5/, and
3//5/ mice presented a 3.5- to 4-fold CCL4 mRNA
FIGURE 4. Analysis of phospho-FAK
and phospho-Stat3 protein levels af-
ter exposure to light. (A–D) Levels of
phospho-FAKTyr397 and total FAK
protein in the eye cups of wild-type
(A) and 5/ mice (C). For protein
quantifications (B, D), phospho-FAK
levels were normalized to -actin.
Shown are the mean  SEM of three
independent experiments. (E) Levels
of phospho-Stat3 protein in retinas of
wild-type (left) and 5/ mice
(right). Animals were killed at the
indicated time points after light off-
set. Ctrl: nonexposed mice. Shown
are representative blots from three
independent experiments.
FIGURE 5. MCP-1 gene expression was strongly upregulated 6 hours
after light offset in all strains. MCP-1 RNA levels were determined in
retinas of wild-type, 5/, 3/, and 3/ /5/ mice which
were or were not (Ctrl) exposed to light. Analysis after exposure was
at time points as indicated. Expression is shown relative to levels of
control wild-type mice. Amplifications were performed in triplicates
(mean  SD; n  3) and were normalized to actin values.
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superinduction (over wild-type) after 6 hours (Fig. 7A).
Whereas CCL4 and CCL12 mRNA levels steadily declined after
the initial peak of expression, the levels of CCL5 mRNA re-
mained high or increased even further at 2 and 3 days after
exposure. In contrast, expression of CCL9 (or MIP-1, Fig. 7D)
was regulated with different kinetics and to different levels.
The mRNA levels increased later after exposure and stayed
slightly elevated for up to 10 days. Of interest, mice lacking 3
or MCP-1 (with or without simultaneous lack of 5) but not
those lacking only 5 exhibited increased CCL9 expression
after 5 and 10 days compared with the wild-type. Expression of
CX3CL1 mRNA (Fig. 7E) was not affected by the light treat-
ment. Our data show that some chemokines were overex-
pressed early after exposure to light (CCL4, CCL5, and CCL12),
whereas others demonstrated a delayed increase (CCL9) or
were not differentially regulated at all (CX3CL1). The increased
expression of some of the tested chemokines may significantly
influence the migration and the recruitment of macrophages to
the injured photoreceptors and may thus substitute for MCP-1
in the Ccl2/ knockout mouse.
DISCUSSION
The 3 and 5 integrins were reported to have crucial roles
in particle recognition/internalization4 and in the binding of
shed POS,11,14 respectively, under physiological conditions.
However, both types of integrins were not essential for the
clearance of the subretinal space from debris generated after
light-induced photoreceptor degeneration. The increased
expression of alternate receptors present on the RPE mem-
brane such as MerTK suggests the existence of mechanisms
that can compensate for the lack of 5 and/or 3 integrins
in acute situations such as light-induced damage. An impor-
tant part of such mechanisms may be invading macrophages
that are attracted and activated by the action of several
chemokines. Since the deletion of MCP-1 (Ccl2/) did not
dramatically reduce macrophage infiltration, our results sug-
gest a functional redundancy among chemokines in the
retina. Expression of chemokines other than MCP-1 seems to
be sufficient to attract a large number of macrophages to
support efficient clearance of photoreceptor debris after
FIGURE 6. Lack of MCP-1 did not
prevent infiltration of the subretinal
space by macrophages after light-in-
duced stress. (A) Representative pho-
tomicrographs of retinas from wild-
type, Ccl2/, and Ccl2//5/
mice not exposed to light (Control)
showed regular morphology in all an-
imals. At 5 and 10 days after expo-
sure to light, the subretinal space of
all mice was infiltrated by phagocytic
cells (arrowheads) (B) Activated
macrophages, detected by the mono-
clonal antibody anti-F4/80, infiltrated
the subretinal space of Ccl2//
5/ knockout mice 3 days after
exposure to light (arrowheads). Nu-
clei were stained with DAPI. Layer
abbreviations are as in Figure 1. Scale
bar: (A) 50 m; (B) 100 m.
IOVS, March 2009, Vol. 50, No. 3 3 and 5 Integrins in Retinal Phagocytosis 1429
light-induced damage, even in the absence of 3 and/or 5
integrin.
Similarity of Physiological Phagocytosis and
Clearance of Large Amounts of Photoreceptor
Debris Generated by Acute Exposure to Light
The 5 integrin receptor, localized on the apical surface of the
RPE, is known to be crucial for recognition and binding of POS
to the RPE membrane during physiological phagocytosis of
shed photoreceptor tips.14 It has been reported that loss of 5
integrin leads to a desynchronization of retinal phagocytosis
and that during ageing, it induced retinal features similar to
human AMD including decreased retinal function.22 These
functional defects were associated with morphologic impair-
ments such as vesicular autofluorescent storage bodies and
inclusion bodies in the RPE of 12-months-old 5/ mice. In
contrast, our results did not show any dysfunction in the
clearance of cellular debris after acute exposure to light. This
disparity may be due to the age of animals used and/or to the
level of cellular stress. Whereas 5 integrin seems to be crucial
for the daily task of phagocytosing shed photoreceptor seg-
ments, 5 may be dispensable in pathologic situations in which
a large amount of cellular debris is generated (as after light-
induced damage). The overload of material may trigger addi-
tional and 5-independent mechanisms to ensure an efficient
clearing of the subretinal space. An important and integral part
of such mechanisms may be the recruitment of macrophages—
the classic phagocytes—to the lesion site. Thus, lack of 5 may
cause more severe alterations in situations where macrophages
are not recruited (as in the daily phagocytosis of shed POS) and
may be less deleterious in acute situations where additional
clearing mechanisms are activated.
Role of the MerTK Receptor in the Removal
of Debris after Light-Induced
Photoreceptor Degeneration
In vitro blockade of 5 integrin receptor with specific antibod-
ies resulted in an 84% decrease in the uptake of photoreceptor
outer segments after 2 hours, but only a 19% decrease after 5
hours,14 suggesting that RPE cells can activate alternative
routes of phagocytosis if the normal pathway has acutely been
inactivated.
Many receptors are localized on the apical membrane of the
RPE such as MerTK7 and CD36.4–6 MerTK is a tyrosine kinase
that plays a critical role in the engulfment and clearance of
apoptotic cells.38 It has been demonstrated recently that
MerTK cooperates with 5 integrin via FAK phosphoryla-
tion.39,40 Another study reported that initial activation of
MerTK by Gas6 ligand (growth arrest-specific gene 6) leads to
phosphorylation of FAK and to a secondary activation of the 5
FIGURE 7. Specific regulation of
chemokine expression after expo-
sure to light. Relative RNA levels of
CCL4 (A), CCL5 (B), CCL12 (C),
CCL9 (D), and CX3CL1 (E) in retinas
of wild-type, Ccl2//5/, 5/,
3/, and 3//5/mice at var-
ious time points after exposure to
light as indicated. For each strain,
expression is shown relative to the
levels of nonexposed mice that were
set to 1. Pooled RNA of three differ-
ent mice was amplified in duplicates.
Results are expressed as the mean 
SD and are normalized to actin val-
ues.
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receptor, suggesting bidirectional interactions between MerTK
and 5.41
Our data show that total MerTK gene expression was sig-
nificantly induced in eye cups after exposure to light in 5/
deficient mice but not in wild-type mice (Fig. 3D), suggesting
that this receptor may contribute to the removal of photore-
ceptor debris in the absence of 5 integrin. Moreover, MerTK
receptor is also expressed at the surface of macrophages,42
which could be relevant as we observed a massive invasion of
macrophages to the subretinal lesion site (Figs. 1, 6). Whether
MerTK stimulates an intracellular signaling pathway in the
absence of 5 integrin remains to be determined.
Involvement of Chemokines Other Than MCP-1
in Attracting and Recruiting Macrophages to the
Injured Photoreceptors
Chemokines are chemotactic cytokines involved in a variety of
physiological activities. They are also considered to be impor-
tant mediators of pathologic responses such as leukocyte re-
cruitment and activation, viral infections, neurodegenerative
diseases,43 tumor progression44 and angiogenesis.45 So far, 50
chemokines and 20 chemokine receptors have been identified
indicating the existence of redundant mechanisms since each
chemokine has specificity for more than one receptor and each
receptor can be activated by a range of chemokines.37
MCP-1 has been shown to attract monocytes, activated
T-cells, and natural killer cells, but not leukocytes.46 MCP-1 is
the ligand for CCR2 receptor, but it can also act via the
alternative receptor CCR11.47 Investigators in several studies
have reported that MCP-1 knockout mice present a reduction
in the number of recruited macrophages24 after retinal detach-
ment34 and in a model of experimental autoimmune enceph-
alomyelitis (EAE).31 After acute light-induced damage, how-
ever, single Ccl2/ and double Ccl2//5/ mouse retinas
displayed many activated macrophages in the subretinal space,
suggesting that MCP-1 was dispensable for the attraction of
these cells to the site of injury (Fig. 6). The strong induction of
other chemokines suggests that other chemotactic factors can
replace MCP-1 function (Fig. 7). This is consistent with other
studies that have reported such redundant mechanisms in
vitro48 and in vivo,49 where a correlation between MCP-1,
CCL3, CCL4, and CCL5 mRNA levels and the intensity of
inflammation was found in autoimmune anterior uveitis asso-
ciated with EAE.
In summary, our data show that 5 and/or 3 integrins do
not have an essential role in the clearance of cellular debris
from the subretinal space after photoreceptor degeneration
induced by acute exposure to light. This finding suggests that
phagocytic mechanisms during normal physiological processes
such as phagocytosis of shed outer segments differ from mech-
anisms that are activated in situations of acute overload of
cellular debris.
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6.7.2 Summary 
In the previous paper, we showed that R91W mice have low protein expression 
levels of RPE65, reduced 11-cis-retinal restoration and an impaired visual function. 
Here we focused on cone function and cone pathophysiology in these mice. We 
showed that the mRNA expression pattern of specific cone markers was reduced in 
R91W mice beginning with 2 weeks of age. We observed moderately reduced 
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expression levels of the general cone marker cone-transducin (Gnat2), a mild reduction 
of the green cone opsin marker (Mwl) and a strong reduction of the blue cone opsin 
marker (Swl). Further, we quantified the number of cones and their spatial distribution 
by immunohistochemistry in 4 to 40 week old R91W mice in relation to wild type 
controls. In general, the dorsal retina was less affected than the ventral retina. The 
number MWL and SWL cones declined rapidly, reaching the minima between 32 and 
40 weeks of age. Gnat2 positive cells vanished in the ventral retina already in 16-week-
old R91W mice and in the dorsal retina in 32-week-old mutant mice. To visualize the 
morphological consequences, we employed cone-specific GFP (coGFP) expressing 
transgenic mice. We generated double mutant R91W/coGFP mice and analyzed GFP 
positive cells with scanning laser ophthalmoscopy (SLO) to follow cone degeneration in 
individual animals in vivo. Our results were compared to wild type controls as well as to 
Rpe65-/-/coGFP mice and showed that both RPE65 mutant strains start to lose the GFP 
signal at 6 weeks of age in the ventral retina. However, the loss of the GFP signal was 
more gradual in R91W/coGFP mice. In order to analyze the implication of 11-cis-retinal 
deficiency on cone opsin trafficking and on cone structural integrity we analyzed retinal 
morphology in 4-week-old R91W, Rpe65-/-, Rpe65-/-/rho-/-, R19W/Rho-/-, and Rho-/- mice 
in comparison to age-matched wild type mice. Rho-/- mice lack rhodopsin and do not 
form rod outer segments. R91W and Rpe65-/- mice showed shorter and less densely 
packed outer segments – the first evidence of retinal degeneration. All animals on Rho-
/- background had similar retinal morphology. Further, R91W and Rpe65-/- mice 
exhibited mislocalized cone opsin, which was corrected in R19W/Rho-/- double mutant 
mice but not in Rpe65-/-/Rho-/- double mutant mice. R19W/Rho-/- mice have low levels 
of 11-cis-retinal but due to the absence of rod outer segments and rhodopsin the 
chromophore is exclusively available for cones. Rpe65-/-/Rho-/- mice have no 11-cis-
retinal and the mislocalization of cone opsin persists in these animals. Therefore we 
concluded, that 11-cis-retinal was required to correctly localize cone opsin in 
R19W/Rho-/- mice and that rods and cone might compete for the uptake of 11-cis-
retinal. To test this hypothesis, we measured photopic (rod and cone function) and 
scotopic (cone function) ERG in R91W mice on either Rho-/-, Gnat1a-/- or Gnat1a-/-/Rho-
/- background. The results indicated, that residual functionality in R91W single mutant 
mice depends on rod function in photopic and even in scotopic conditions. The ERG 
response was abolished in R91W mice with an ablation of rod function (Gnat1a-/- 
background) but with normal photoreceptor outer segment formation. In contrast, we 
observed that R91W on Rho-/- background had no rod outer segments but showed an 
ERG response, which was caused by cones. Rods outnumber cones by 95% and our 
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results show that rods take up the majority of 11-cis-retinal. Under these conditions 
only rods can generate ERG responses (in scotopic and uncommonly also in photopic 
conditions). In the absence of rod outer segments 11-cis-retinal is available for cones 
leading to a near-normal cone response in the ERG. That confirmed our hypothesis 
that rods and cones compete for the binding of 11-cis-retinal and that rods entrap 11-
cis-retinal under conditions of limited chromophore supply leading to cone opsin 
mislocalization and cone degeneration. 
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RPE65 is a retinoid isomerase required for the production of 11-cis-retinal, the chromophore of both cone and
rod visual pigments. We recently established an R91W knock-in mouse strain as homologous animal model
for patients afflicted by this mutation in RPE65. These mice have impaired vision and can only synthesize
minute amounts of 11-cis-retinal. Here, we investigated the consequences of this chromophore insufficiency
on cone function and pathophysiology. We found that the R91W mutation caused cone opsin mislocalization
and progressive geographic cone atrophy. Remnant visual function was mostly mediated by rods. Ablation of
rod opsin corrected the localization of cone opsin and improved cone retinal function. Thus, our analyses
indicate that under conditions of limited chromophore supply rods and cones compete for 11-cis-retinal
that derives from regeneration pathway(s) which are reliant on RPE65. Due to their higher number and the
instability of cone opsin, rods are privileged under this condition while cones suffer chromophore deficiency
and degenerate. These findings reinforce the notion that in patients any effective gene therapy with RPE65
needs to target the cone-rich macula directly to locally restore the cones’ chromophore supply outside the
reach of rods.
INTRODUCTION
Vertebrate retinas have two types of photoreceptor cells med-
iating vision—rods and cones. Rods are exquisitely sensitive
to light but cones are more critical for daytime vision, acuity
and color discrimination. Despite this functional specializ-
ation, cone and rod visual pigments use the same chromophore
(11-cis-retinal) to capture light. The retinal pigment epi-
thelium protein of 65 kDa (RPE65) was shown to be a retinoid
isomerase essential for the synthesis of 11-cis-retinal. RPE65
is catalyzing the conversion of all-trans-retinyl esters to
11-cis-retinol (1–3) and mutations in this enzyme cause blind-
ness in humans (OMIM 180069) (4–6). Pathogenic mutations
are found in different regions of the RPE65 gene where they
may cause RPE65-deficiency or affect protein structure,
modulate docking of binding protein partners and/or influence
catalytic activity (3,7).
Studies on different animal models with RPE65 mutations
indicated that the cause and timeframe of cell death is different
for cones and rods. In animals with no RPE65, e.g. no
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11-cis-retinal production, rod cell death is proposed to result
from constant activation of the phototransduction cascade by
unliganded opsin (8). Even though this ‘death signal’ is
present from birth, substantial degeneration occurs only late.
Cones, however, appear to be more sensitive to chromophore
deficiency. Patients with mutations in RPE65 show cone photo-
receptor loss early in life (9) and in Rpe652/2animals, most of
the cones degenerate within few weeks after birth (10).
In mouse models, early interventions, such as Rpe65 gene
replacement or retinoid supplementation therapy, rescue
cone function and preserve cones against degeneration (10–
13). The beneficial effect for cones has been directly attributed
to 11-cis-retinal since it stabilizes cone opsin and promotes
proper cone opsin trafficking from the inner to the outer seg-
ments (14,15). Thus, while rods are quite resistant to chromo-
phore deficiency, cones are more vulnerable and degenerate
earlier. This observation is clinically relevant and of special
importance for choosing the treatment window to further
improve the outcome of human trials using RPE65 gene
therapy (16–19).
Studies addressing cone function and degeneration have
been mainly conducted in RPE65 null animals (20–22) that
lack the visual chromophore. Current literature, however, indi-
cates that more than 50% of RPE65 mutations in patients are
missense mutations. Recently, we generated a mouse model
carrying the R91W mutation in RPE65 (23), which is the
most common missense mutation found in patients (24). As
these patients retain useful vision at younger ages (25), it
was suggested that the mutant RPE65 protein has some capa-
bility to produce 11-cis-retinal. In R91W mutant mice, we
showed that—though strongly reduced—RPE65 protein
levels enable visual function superior to that found in
RPE65 null mutants. Indeed, small but detectable amounts
of 11-cis-retinal exist in the eyes of this mouse mutant.
Thus, R91W mutant mice represent a unique animal model
to analyze the consequences of very limited 11-cis-retinal
supply for retinal function and integrity.
Here, we focused on the consequences of this phenotype for
cone structure and function. We analyzed the time course and
characteristics of cone degeneration. Our analysis provides
evidence that in R91W mutants rods and cones compete for
11-cis-retinal and that cone degeneration is caused by
11-cis-retinal insufficiency. Our data reinforce the notion
that both photoreceptor types depend on RPE65 for chromo-
phore supply.
RESULTS
Cone loss
Previous studies in Rpe652/2 mice have shown that cone
markers are reduced very early during and after postnatal
development (10). RPE65 gene delivery (12,13) or adminis-
tration of 9- or 11-cis-retinal (10,11) prevents the downregula-
tion of cone-specific gene expression. Recently, we have
shown that 5–10% of normal 11-cis-retinal levels can be pro-
duced by a hypomorphic RPE65 protein carrying the R91W
amino acid substitution (23). Here, we sought to analyze the
influence of these limited amounts of 11-cis-retinal on the
structural and functional integrity of cones.
To approach this question, we examined the mRNA levels
of cone-specific markers in 2-, 4-, 8-, 12- and 24-week-old
R91W and corresponding wild-type animals (Fig. 1A). All
of the tested cone markers {cone opsins [middle wavelength
Figure 1. Geographical distribution and temporal cone loss caused by the R91W mutation. (A) Relative mRNA levels of cone markers as indicated. Expression
was determined in retinas of wild-type and R91W mice at 4, 8, 12 and 24 weeks of age by real-time PCR. Average mRNA levels+SD (black bars) are expressed
relatively to age-matched wild-type controls, which were set to 1 (white bars). RNA isolated from three independent retinas per time-point and genotype was
amplified in triplicates. (B) Cones were quantified by counting the number of MWL-, SWL- or GNAT2-positive outer segments in dorso-ventrally oriented
retinal sections cut trough the optic nerve. Graphs represent values relative to 4-week-old R91W (set to 1) for a given cone-marker and region of the retina
(mean+SEM). An age-dependent decrease of cone marker labeling was observed resulting in an almost complete absence of cones at 32 weeks of age.
GNAT2, cone-specific transducin a-subunit; MWL, middle wavelength cone opsin; SWL, short wavelength cone opsin.
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(Mwl), short wavelength (Swl)] and cone-specific transducin
a-subunit (Gnat2)} were transcriptionally downregulated as
early as at 2 weeks of age (Fig. 1A). At 4 weeks, a time-point
when the mouse retina can be considered mature, Mwl
expression was reduced to 84% and by 24 weeks only 52%
of wild-type levels were expressed (Fig. 1A). The Swl
marker was even more suppressed: to 43% in 4 weeks and
to only 6% in 24-week-old animals (Fig. 1A). Expression of
Gnat2 was 55–32% in the period between 4 and 24 weeks
of age (Fig. 1A).
We additionally analyzed these cone markers by immunos-
taining in 4-, 8-, 16-, 24-, 32- and 40-week-old animals and
quantified the number of cells positive for MWL, SWL and
GNAT2-cone opsin (Fig. 1B). A dorso-ventral gradient of
expression for MWL and SWL cones has been described in
the mouse retina (26). In order to analyze the spatial localiz-
ation of cones, we quantified their dorso-ventral distribution
in R91W (see Materials and Methods) at different ages. We
compared it with 4-week-old wild-type animals, levels of
them were set to 1 for dorsal, ventral or total expression,
respectively (Fig. 1B). By 4 weeks of age, the most prominent
cone loss occurred in the ventral retina of R91W mice. The
MWL and SWL opsins were reduced to 58% and 68%,
respectively, when compared with age-matched wild-type con-
trols (Fig. 1B). Degeneration continued gradually and by 16
weeks of age the ventral retina of R91W mice was virtually
cone-free. The dorsal retina was better preserved at all time-
points tested (Fig. 1B). At 4 weeks of age, the amount of
MWL- and SWL-positive cells in the dorsal retina was
comparable to the respective wild-type control (Fig. 1B).
However, at the same time-point, GNAT2 levels were
already reduced to 47%. After 32 weeks of age,
GNAT2-positive cells were no longer detectable, but some
MWL- and SWL-positive cells remained in the retina of
R91W mice (Fig. 1B).
The SWL cones seemed to be the most strongly affected
cone type. Between 4 and 8 weeks of age, more than 50%
of SWL-positive cells were lost in R91W animals. In the
same period, MWL dropped only by 40% (Fig. 1B and data
not shown). By 24 weeks, only 16% of SWL cones remained
in the upper central retina, whereas 27% of the MWL marker
was still detectable.
To explore the morphological consequences of Rpe65
mutations on cone degeneration in vivo, we crossed R91W
and Rpe652/2 strains to a transgenic mouse line that expresses
GFP under the control of a cone opsin promoter (coGFP).
Using scanning laser ophthalmoscopy (SLO) to detect
GFP-positive cells, we followed cone degeneration in individ-
ual animals in the period between 3 and 12 weeks of age
(Fig. 2). The loss in GFP signal, which is representative for
cone loss, was detectable already at 6 weeks of age in both
Rpe65 mutant mice strains (Fig. 2). The signal started disap-
pearing in the ventral region of both Rpe652/2;coGFP and
R91W;coGFP retinas. However, while in Rpe652/2;coGFP
mice this polarization was strongly established already at 6
weeks of age, degeneration in R91W;coGFP mice proceeded
more gradually (Fig. 2). These data are in line with our immu-
nostaining data showing that the ventral retina in R91W
animals was more prone to cone degeneration.
Cone opsin mislocalization
Lack of 11-cis-retinal has been implicated in improper cone
opsin trafficking, which results in cone degeneration (14,15).
Figure 2. Cone loss in different Rpe65-related genetic backgrounds monitored in vivo. Fundus autofluorescence in transgenic mouse lines expressing GFP under
the control of a cone opsin promotor (coGFP) monitored by scanning laser ophthalmoscope. Mice were on different Rpe65 genetic backgrounds (R91W,
Rpe652/2 and Rpe65þ/þ) as indicated and fluorescence was monitored every 3 weeks until 12 weeks of age in individual animals. Shown is the temporal
cone loss of one representative mouse per genotype. coGFP transgenic mice on a wild-type Rpe65 background served as controls (Rpe65þ/þ). Note the accel-
erated loss of GFP-positive cells from the ventral retina in Rpe652/2 animals.
1268 Human Molecular Genetics, 2009, Vol. 18, No. 7
Here, we analyzed the impact of limited amounts of
11-cis-retinal in R91W mice on cone structural integrity.
We compared retinal morphology of six different mouse
strains (wt, R91W, Rpe652/2, Rpe652/2;rho2/2,
R91W;rho2/2 and rho2/2) at 4 weeks of age by light
microscopy (Fig. 3A) and by immunostaining of SWL cone
opsin (Fig. 3B–D). As previously reported (23), the first
signs of degeneration were already present in 4-week-old
R91W and Rpe652/2 animals, visible as shorter and less
densely packed photoreceptor outer segments (Fig. 3A). We
did not observe major differences in retinal morphology
between animals on a rho2/2 background (Fig. 3A:
Rpe652/2;rho2/2, R91W;rho2/2 and rho2/2). Immunostain-
ing of SWL cone opsin in wild-type mice predominantly
stained cone outer segments (Fig. 3B: wt). In R91W
animals, however, a strong cone opsin specific signal was
detected in synaptic termini of photoreceptors and a weak
perinuclear staining was observed as well (Fig. 3B: R91W).
In Rpe652/2 animals, the staining pattern was qualitatively
similar, but signal intensity was generally lower and a
reduced number of cones was observed (Fig. 3B: Rpe652/2).
Using rho2/2 animals, we analyzed if structural ablation of
rod opsin in R91W would rescue cone opsin mislocalization.
This experiment was based on the assumption that
11-cis-retinal in R91W;rho2/2 mice should be exclusively
available to cones. As control we used Rpe652/2;rho2/2
animals. Ablation of rod opsin in Rpe652/2 mice had no
effect on cone opsin mislocalization (Rpe652/2;rho2/2,
Fig. 3B). In contrast, in R91W;rho2/2 mice cone opsin local-
ization was corrected. It was absent from synaptic termini and
was found predominantly in outer segments (Fig. 3B:
R91W;rho2/2). Immunostaining was almost indistinguishable
Figure 3. Cone opsin mislocalization in R91W can be corrected by ablation of rod outer segments. Retinas of age-matched 4-week-old mice of indicated geno-
types were analyzed. (A) Representative light microscopy photographs of retinal morphology. Note the slightly better structural preservation of OS in R91W
mice when compared with Rpe652/2 single mutant animals. No gross morphological differences were detected among the three rho2/2 mutant mice
(Rpe652/2;rho2/2, R91W;rho2/2 and rho2/2, respectively). (B–D) Immunolocalization of short wavelength (SWL) cone opsin at low (B and C) or higher
magnification (D). Nuclei were contrasted with DAPI (C). SWL localized to cone outer segments in all animals. However, in R91W, Rpe652/2 and
Rpe652/2;rho2/2 mutant mice, SWL mislocalized to synaptic termini in the OPL, to perinuclear regions in the ONL and to cellular protrusions. Ablation
of rod OS almost fully corrected cone opsin mislocalization in R91W;rho2/2 but not in Rpe652/2;rho2/2 mice. RPE, retinal pigment epithelium; OS, outer
segments; IS, inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; GCL, ganglion cell layer. Scale bar: 25 mm.
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to single rho2/2 mutants (Fig. 3B: rho2/2). To ensure that the
rescue effect was indeed mediated by 11-cis-retinal, we
measured the retinoid content in the eyes by HPLC. The
11-cis-retinal and 11-cis-retinol content in eyes of
4-week-old R91W;rho2/2 animals was 1.3+ 0.1 pmol and
2.0+ 0.2 per eye, respectively. No 11-cis-retinoids were
detected in Rpe652/2;rho2/2 double mutants, as reported
before (27).
These data show that the rescue of cone opsin misrouting
observed in R91W;rho2/2 can be attributed to the availability
of 11-cis-retinal for cones and suggest that cone and rod opsins
compete for the chromophore.
Photoreceptor competition for the visual chromophore
Ablation of RPE65 eliminates cone function and remnant
minimal visual responses can be attributed to rod function
due to the presence of 9-cis-retinal forming the visual
pigment isorhodopsin (28,29). R91W mice contain similar
amounts of 9-cis-retinal, but, in contrast to Rpe652/2 mice,
they also contain small amounts of 11-cis-retinal (23). Accord-
ingly, R91W mice are about 1 log unit more sensitive to light
than Rpe652/2 animals under scotopic conditions. The pre-
vious functional analysis indicated that electroretinogram
(ERG) responses under photopic conditions might originate
from both the rod and the cone system (23).
To specifically analyze the source of vision in R91W mutant
mice, we abolished rod function by intercrossing R91W
knock-in mice with rho2/2 and Gnat1a2/2 knock-out
animals. Rho2/2 mice do not develop rod outer segments
but initially have a functional cone system (30). Similar to
the rho2/2 animals, Gnat1a2/2 mice have no rod function,
but, in contrast, develop normal rod outer segments with
regular rod opsin content (31). Functionally, retinas of both
mouse strains are considered as pure-cone retinas.
We generated R91W;Gnat1a2/2, R91W;rho2/2 double
mutant and R91W;Gnat1a2/2;rho2/2 triple mutant mice and
compared their function with the previously described wild-
type, R91W, rho2/2 and Rpe652/2;rho2/2 mutant mice
(Fig. 4A and B). By the time of analysis all mice were
4-weeks-old.
Dark-adapted ERG intensity series revealed severely
depressed responses in R91W mice when compared with wild-
type animals (Fig. 4A). As expected, minimal or no responses
were detected under the same conditions in rho2/2 and all
double- or triple mutant animals due to the functional rod abla-
tion (Fig. 4A).
To analyze light-adapted responses, photopic flash intensity
series across a 6-log-unit intensity range was recorded in all
genotypes (Fig. 4B). Under this condition, R91W and
rho2/2 revealed very similar threshold sensitivities when
compared with wild-type animals (Fig. 4B). Ablation of rod
opsin in R91W (R91W;rho2/2) caused an additional reduction
in sensitivity by 1–1.5 log units (Fig. 4B). However, photo-
receptors in R91W;Gnat1a2/2 animals lacking rod function
but not rod outer segments were much more desensitized
than those in R91W;rho2/2 animals (Fig. 4B). The severely
desensitized response in R91W;Gnat1a2/2 was not due to
the absence of 11-cis-retinal. HPLC analysis of the retinoid
content showed that R91W;Gnat1a2/2 contained 23.7+
1.2 pmol, an amount similar to single mutant R91W animals
(23). The mice with the better ERG response
(R91W;rho2/2) had with 1.3+ 0.1 pmol per eye an even
lower content of 11-cis-retinal.
The strongly reduced cone function in R91W;Gnat1a2/2
mice thus suggested that in the presence of limited amounts
of 11-cis-retinal, a substantial cone response can only be gen-
erated when rod opsin is absent, as in R91W;rho2/2. To prove
this principle and to exclude a possible non-specific effect of
the Gnat1a2/2 knock-out, we generated R91W;rho2/2;
Gnat1a2/2 triple mutant animals. We found no difference in
ERG responses between R91W;rho2/2 double mutants and
R91W;Gnat1a2/2;rho2/2 triple mutants (Fig. 4B). This
suggests that 11-cis-retinal in the triple mutants (captured by
rod opsin in R91W;Gnat1a2/2 animals) was now available
for cone opsins, supporting our hypothesis of chromophore
competition between rod and cone opsins.
DISCUSSION
We investigated the cone pathophysiology resulting from
11-cis-retinal chromophore insufficiency. We show that (i)
the R91W mutation causes an early progressive geographic
cone atrophy characterized by a ventro-dorsal gradient of
degeneration; (ii) cone opsin mislocalization in R91W can
be rescued by the ablation of rod opsin; and (iii) ablation of
rod opsin increases cone function in R91W mice.
Collectively, our data suggest that rod opsin and cone
opsins compete for the available 11-cis-retinal. In a situation
where only 5–10% of normal 11-cis-retinal levels are
present (as in R91W knock-in mice), rod opsins seem to
entrap almost all available chromophore. Rods may outcom-
pete cones for the following reasons: (i) rods massively out-
number cones; (ii) cones have much higher spontaneous rate
of chromophore dissociation (32); and (iii) rods have a
larger interface with the RPE—the major chromophore source.
The genetic ablation of rod opsin increases the availability
of 11-cis-retinal and improves cone structure and function.
The functional ablation of rods (Gnat1a2/2), however, is not
sufficient, which indicates that rod opsin works as a ‘chromo-
phore trap’ preventing cone function. Our data also suggest
that mice do not have an isolated pathway of chromophore
delivery specifically reserved for cones, as supply of the chro-
mophore for both rods and cones depends on RPE65.
Cone degeneration
We have shown by RT–PCR, immunofluorescence and by
SLO in vivo analysis that cone markers were very early
reduced in R91W mice. The ventral retina was most affected
and was devoid of cones already at 16 weeks of age. It has
been shown that the mouse ventral retina is enriched with
SWL opsin (26) and SWL cones are reduced particularly
early in Rpe652/2 mice (10). Thus, the geographic cone
atrophy was qualitatively similar in Rpe65 knock-out and
R91W knock-in mice, and in both models, SWL cones were
more severely affected than MWL cones. However, in
Rpe65 knock-outs, SWL cone opsin loss is more pronounced:
Swl RNA is reduced by more than 50% by 2 weeks of age as
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opposed to a reduction of only 10% in R91W knock-in mice
(data not shown). We also qualitatively followed cone cell
loss in Rpe65 mutant animals in vivo by using coGFP reporter
animals monitored by SLO. This method clearly showed that
the cone degeneration in R91W animals proceeded more
slowly than in Rpe65 knock-out mice. It has to be noted that
in coGFP mice the interference with opsin production or the
presence of GFP is toxic for cones leading to their death by
Figure 4. Effect of the R91W mutation on retinal function. Electroretinogram (ERG) evaluation of 4-week-old wt, R91W, rho2/2, R91W;rho2/2,
R91W;Gnat1a2/2, R91W;Gnat1a2/2; rho2/2 and Rpe652/2;rho2/2 mice. Single flash ERGs were recorded under dark-adapted (A, scotopic) and light-adapted
(B, photopic) conditions. Additional deletion of rho in R91W and Rpe652/2 enabled the examination of pure cone function in the absence of the rod system. The
vertical lines indicate the timing of the light flash. Note that an initial negative deflection in the higher intensity range (above 1.5 log cds/m2) is no retinal
electrical response but a flash artifact.
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about 6 months of age, with some individual variability (data
not shown). Thus, the true cone status can probably only be
assessed during the first 3–4 months of life in coGFP line
and the respective double mutant mice.
By immunofluorescence, we noted a certain discrepancy in
the number of GNAT2-positive cells when compared with
MWL- and SWL-positive cells. At 4 weeks of age, fewer
GNAT2-positive cells were detected than MWL or SWL cone
opsin-labeled cells. This discrepancy cannot be explained by
lower transcriptional activity since mRNA expression of all
three markers was comparably reduced. This may suggest that
in degenerating cone cells, GNAT2 is less stable than cone
opsins. A similar conclusion has been made in young Lrat2/2
and Rpe652/2 mice where posttranslational degradation was
accounted as reason for decreased GNAT2 levels (14).
Cone preservation and chromophore competition
An optimal delivery of 11-cis-retinal to cones has not only a
functional relevance but it is also important for structural
maintenance. Recently, Rohrer et al. (11) detected cone
opsin mislocalization in Rpe652/2 mice, which was corrected
upon administration of 11-cis-retinal or 9-cis-retinal (10).
Based on this observation, the authors hypothesized that
cones degenerate because of opsin mislocalization as a
direct result of 11-cis-retinal starvation. Later studies
showed, accordingly, that viral Rpe65 gene delivery to
Rpe652/2 mice restores cones (12,13). Finally, 11-cis-retinal
has been shown to be necessary for proper trafficking of
membrane-associated phototransduction components from
their synthesis place within the cone inner segment trough
the connecting cilium to the outer segment (14,15). Retinas
of R91W single mutant mice receive only small [5–10% of
wild-type (23)] amounts of 11-cis-retinal. Immunostaining
data show that cone opsin in R91W animals is mislocalized.
This suggests that most of the available 11-cis-retinal in
R91W animals ends up in rods for reasons explained below.
This further suggests that chromophore starvation is the
cause for cone degeneration in R91W animals—as for
11-cis-retinal deficient animals (Rpe652/2 and Lrat2/2). As
R91W mice show delayed cone cell death compared with
retinas without measurable chromophore, our results suggest
that the progression of cone degeneration can be directly
attributed to the degree of impairment in the 11-cis-retinal
supply.
In situations of limited 11-cis-retinal delivery to retinas
where the vast majority of photoreceptors are rods, the chro-
mophore uptake is presumably based on a ‘tyranny of the
majority’ rule, which favors rods over cones. Additionally,
the thermodynamic stability of the rod opsin–11-cis-retinal
holocomplex and the proximity to the RPE as chromophore
source are also favorable for rods. A competition between
rods and cones for limited amounts of chromophore has
been previously described in vitro (33). In our experiments,
a competitive chromophore uptake is supported by the fact
that even though comparable amounts of 11-cis-retinal were
found in age-matched R91W single- and R91W;Gnat1a2/2
double mutant animals (25 pmol/retina), the later had only
minor ERG responses under photopic conditions. This
argues that most 11-cis-retinal in R91W is captured by rods
and that the retinal function recorded in R91W under photopic
conditions is almost completely mediated by the rod system.
However, once rod opsin is taken away from the retina
(R91W;rho2/2), the chromophore becomes available for
cones resulting in a corrected opsin targeting and improved
cone function.
Biochemical and genetic evidence for a cone-specific visual
cycle involving Mu¨ller cells and a novel type of all-trans to
11-cis-retinol isomerase different from RPE65 has been pro-
vided by studies in lower vertebrates (34–39). Our findings,
however, argue against separate pathways for the regeneration
of cone and rod-specific visual pigments in mice. We clearly
show that chromophore delivery to both rods and cones strictly
depends on functional RPE65. In R91W animals, no other
enzyme can compensate for the reduced activity of the
mutant RPE65 protein and only the physical ablation of the
rod opsin chromophore trap enables cones to incorporate suf-
ficient chromophore to correctly localize opsin to their outer
segments. Furthermore, a putative RPE65-independent cone
visual cycle involving Mu¨ller cells would be expected to be
only marginally affected by the presence or absence of rods.
The close physical proximity of cones and Mu¨ller cells
would strongly reduce the ability of rods to compete for the
chromophore regenerated and released by Mu¨ller cells specifi-
cally for cones. Indirect evidence from the current literature
further supports the importance of a strong RPE65 activity
for proper cone function: the RPE65 protein from the cone-
dominated chicken retina is a more efficient enzyme than
RPE65 from rod dominated species (40) and the central RPE
layer of primates, which localizes to the cone-rich area of
the retina, has a higher RPE65 protein expression and activity
than the RPE in the peripheral, rod-rich retina (9). The result-
ing wealthier local chromophore pool in the macular region of
the primate retina and the physical absence of competing rods
in this area may less strongly affect chromophore delivery to
cones in the fovea allowing initial useful central vision by
RPE65 patients. Since blue cones are reported to be comple-
tely absent from the central fovea (41,42) and instead localize
to rod-dominated regions of the human retina, blue cones may
be in strong competition with rods for the available chromo-
phore. Except for the macular region, the human retina is com-
parable to the mouse retina. Our data thus predict that blue
cones in RPE65 patients may be more affected than other
cone types and may not receive sufficient chromophore for
proper function and survival, as proposed recently (43).
Indeed, most patients with RPE65 mutations report early dif-
ficulties with blue color vision (43,44) supporting our con-
clusions based on the R91W mouse model.
To our knowledge, this study demonstrates for first time an
in vivo competition between rods and cones for limited
amounts of chromophore and its functional and pathological
consequences. Our data suggest that a successful RPE65
gene therapy requires delivery of the functional gene directly
to the macular region to supply cones and avoid chromophore
‘theft’ by rods. The importance of 11-cis-retinal supplemen-
tation for the cone structural integrity should also be con-
sidered in therapies aiming at the inhibition/slowing of the
visual cycle and thus at the reduction of available chromo-
phore in the retina. It seems important that the therapeutic
value of visual cycle inhibitor compounds should be carefully
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evaluated with respect to their specific impact on the cone
visual system.
MATERIALS AND METHODS
Mice
All procedures concerning animals were in accordance with
the regulations of the Veterinary Authority of Zurich and
with the statement of ‘The Association for Research in
Vision and Ophthalmology’ for the use of animals in research.
All animals were raised in cyclic light (12:12 h; 60 lux at cage
level).
The knock-in mice with an amino acid exchange of Arg by
Trp at position 91 in Rpe65 (R91W) on a 129S6 genetic back-
ground are described elsewhere (23). Wild-type (129S6),
Rpe652/2 (20), rho2/2 (30) and Gnat1a2/2 (31) mice were
maintained at the animal facility of the University Hospital
Zurich. Transgenic coGFP mice, in which GFP expression is
driven by 50 regulatory sequences of the human red pigment
(45), were provided by Thomas Hughes, Yale University
School of Medicine. The R91W;rho2/2, Rpe652/2;rho2/2,
R91W;Gnat1a2/2, R91W;rho2/2;Gnat1a2/2, R91W;coGFP,
Rpe652/2;coGFP double- or triple transgenic mice were gen-
erated by classical breeding schemes. Genotyping was per-
formed by PCR on tail genomic DNA using primer pairs
indicated in Table 1.
Histology
Animals were sacrificed and the nasal part of the eye was
marked for orientation. The enucleated eyes were fixed over-
night in 2.5% glutaraldehyde prepared in 0.1 M cacodylate
buffer and processed as described previously (46). Semi-thin
sections (0.5 mm) of Epon-embedded tissue were prepared
from the central retina, counterstained with methylene blue
and analyzed using a light microscope (Axiovision, Zeiss,
Jena, Germany).
Immunofluorescence and cone quantification
Animals were sacrificed, their eyes were marked nasally, enu-
cleated and perforated at the cornea to allow better penetration
of the fixative. After fixation for 1 h in 4% PFA (in PBS), the
eyes were cryoprotected in 25% sucrose solution. The eyes
were embedded in albumin from hen egg white (Fluka,
Buchs, Switzerland) and cut dorsal to ventral through the
optic nerve head. Sections (14 mm) were blocked for at least
1 h at room temperature in PBS containing 0.2% Triton
X-100 and 10% normal goat serum (Dako, Zug, Switzerland)
or 10% normal horse serum (Jackson Immunoresearch, West-
grove, PA, USA). Primary antibodies used were: rabbit anti-
GNAT2 (Santa Cruz, CA, USA), goat anti-SWL-opsin
(Santa Cruz) and rabbit anti-MWL (Chemicon, Temecula,
CA, USA). The immunostaining procedure was as described
previously (13).
The most transversal sections, cut through the optic nerve,
were chosen to quantify the number of cells positive for
GNAT2, MWL and SWL-cone opsins, respectively. The
immunoreactive outer segments were counted from periphery
to periphery using a BX60 microscope equipped for epifluor-
escence (Olympus Suisse SA, Aigle, Switzerland) and coupled
to the analySISw 3.0 software (Soft Imaging System). At least
four eyes per condition and genotype were analyzed.
RNA isolation and RT–PCR
RNA isolation from retinal tissue and reverse transcription
were performed as described previously (46). cDNA quantifi-
cation was carried out by real-time PCR using the LightCycler
480 Sybr Green I Master kit and a LightCycler 480 instrument
(Roche, Mannheim, Germany). cDNAs were amplified with
primers for Gnat2, Mwl and Swl (10) and normalized to
actin (47). The normalization was done using the comparative
threshold cycle method. Relative values were calculated using
a suitable calibrator sample. At least three retinas from three
different animals were analyzed in triplicates.
Electroretinography
Electroretinograms were recorded binocularly according to
previously described procedures (28,48) in anesthetized mice
with dilated pupils using a Ganzfeld bowl, DC amplifier,
and a PC-based control and recording unit (Multiliner
Vision; VIASYS Healthcare GmbH, Hoechberg, Germany).
Recordings were obtained in both scotopic (dark-adapted
overnight) and photopic (light-adapted 10 min at 30 cd/m2)
conditions.
Single white-flash stimulus intensity ranged from 24 to 1.5
log cds/m2 under scotopic and from 22 to 4 log cds/m2
under photopic conditions, divided into 10 and 13 steps,
respectively. For the intensities from 2 to 4 log cds/m2, a
Table 1. PCR primers used for genotyping
Genotype Forward (50 –30) Reverse (50 –30) Size (bp)
coGFP CAATTAAGAGATCAGGTAGTGT AGTTCACCTTGATGCCGTTCTT 641
R91Wa GCTGGTCTTGCCTGTATCA GTCAGAGACAGTGCTGTGTT 998
Rpe65þ/þ GATGTGGGCCAGGGCTCTTTGAAG CCCAATAGTCTAGTAATCACAGATG 546
Rpe652/2 GATGTGGGCCAGGGCTCTTTGAAG GGGAACTTCCTGACTAGGGGAGG 459
Rhoþ/þ TCTCTCATGAGCCTAAAGCT ATGCCTGGAACCAATCCGAG 470
Rho2/2 TCTCTCATGAGCCTAAAGCT TTCAAGCCCAAGCTTTCGCG 310
Gnat1aþ/þ TATCCACCAGGACGGGTATTC GCGGAGTCATTGAGCTGGTAT 387
Gnat1a2/2 TATCCACCAGGACGGGTATTC GGGAACTTCCTGACTAGGGGAGG 273
aPCR product was additionally cut with TaqI restriction enzyme. Expected fragments: 998 bp for knock-in and 619 bp þ 379 bp for wild-type.
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Mecablitz 60CT4 flash gun (Metz, Germany) added to the
Ganzfeld bowl was used. Ten responses per intensity were
averaged with an inter-stimulus interval of either 5 or 17 s
(.1 cds/m2). At least three animals per genotype were ana-
lyzed at 4 weeks of age.
In vivo monitoring by SLO
Scanning laser ophthalmoscopy was obtained in dark-adapted
GFP-positive mice according to procedures reported pre-
viously (49). Mice were anesthetized with ketamine
(66.7 mg/kg) and xylazine (11.7 mg/kg) and the pupils were
dilated with tropicamide eye drops (Mydriaticum Stulln,
Pharma Stulln, Stulln, Germany). SLO was performed with a
Heidelberg Retina Angiograph (Heidelberg Engineering), a
confocal scanning-laser ophthalmoscope. Laser wavelength
used for fundus autofluorescence visualization was 488 nm.
HPLC determination of retinoids
Mice were dark-adapted overnight. All the following steps
were carried out under dim red light. Animals were sacrificed,
and lens and vitreous were removed from the eye through a slit
in the cornea. The rest of the tissue including the retina and
eyecup was snap frozen in liquid nitrogen until further analy-
sis. Retinoid extraction and HPLC analysis was performed as
described previously (50). Three to six animals per genotype
were analyzed.
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